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Allopregnanolone infusion asymmetrically increases
MRNA expression of the delta GABAA receptor subunit in
the hippocampus of rats
F. Almeida1, R. Gomez2, A. Hansen2, H. Barros1, M. Nin3,2
1UFCSPA, Departamento de Farmacocie^ncias, Porto Alegre, Brazil
2UFRGS, Departamento de Farmacologia, Porto Alegre, Brazil
3Centro Universitario Metodista do IPA, Curso de Farmacia, Porto
Alegre, Brazil
Allopregnanolone (ALLO) is a neurosteroid that acts as a
positive allosteric modulator on GABAA receptors (GABAAR) in
the brain. Such modulations appear to be responsible for its
antidepressant effects and for modifying the expression of different
GABAAR subunits. The d subunit, for instance, was found to be
upregulated in the hippocampus after ALLO infusions in the
prefrontal cortex and nucleus accumbens. Moreover, intra-hippo-
campal ALLO infusion produces antidepressant-like effects in rats,
but its effects on the hippocampal d GABAAR subunit expression
are still unknown. This study aimed to verify the sub-acute effect of
the intra-hippocampal infusion of ALLO (1.25; 2.5; and 5 μg/rat) on
the d GABAAR subunit mRNA expression in each hippocampal
hemisphere of male rats. An ANOVA detected an interaction between
treatment and hemisphere regarding the expression of the d subunit
(p = 0.010), and post-hoc analyses showed that the infusion of 5 μg/
rat of ALLO induced a higher d GABAAR subunit mRNA
expression in the right hemisphere in comparison to the left (P<
0.001). Additionally, the mRNA expression in the right hemisphere
was higher in the 5 μg/rat dose when compared to the 1.25 μg/rat
dose (p = 0.028). Thus, intra-hippocampal ALLO infusion asym-
metrically increased the mRNA expression of the d GABAA
receptor subunit in the same brain region of rats. These results
support the importance of the d GABAAR subunit on the
antidepressant effects of ALLO, as well as the relevance of
exploring inter-hemispheric analysis.
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Gender-speciﬁc effect of 5-HT and 5-HIAA on threshold
level of behavioral symptoms associated with autism
spectrum disorder
B. Chakraborti1, D. Verma1, S. Guhathakurta2, S. Sinha1,
K. Mohanakumar3, U. Rajamma3,1
1Manovikas Kendra, Manovikas Biomedical Research and
Diagnostic Centre, Kolkata, India
2UCF College of Medicine, Division of Neuroscience, Orlando,
Florida
3Inter University Centre for Biomedical Research and Super
Speciality Hospital, CDAR, Kottayam, Kerala
ASD is a group of behaviorally deﬁned neurodevelopmental
disorders having genetic origin with a distorted sex ratio being
observed in the affected. One of the remarkable aspect of this
disorder is platelet hyperserotonemia where this imbalanced sero-
tonin level is taken to be the regulating factor for the deﬁcits in their
behavioral presentation. Platelet hyperserotonemia in ASD subsets,
efﬁcacy of SSRI in reducing behavioral deﬁcits and gender-bias in
normal serotonin synthesis suggest a disruption in stringent
regulation of serotonin metabolism in ASD. Therefore, we inves-
tigated gender-speciﬁc changes in 5-HT and 5-HIAA in ASD to
assess its effect on behavior of male and female subjects. ASD cases
(n=215) were examined using CARS. Platelet 5-HT (104 cases and
26 controls), and platelet/plasma 5-HIAA (73 cases and 17 controls)
were estimated using HPLC-ECD. In male probands, we observed
increase in platelet 5-HT content in association with increase in the
score for adaptive responses and increase in platelet 5-HIAA levels
with concomitant decline in the score for intellectual response.
Interestingly, platelet/plasma 5-HT and plasma 5-HIAA were higher
in female controls and female probands displayed more severe
autism-associated behaviors. Overall results indicate a gender-bias
in the regulation of 5-HT and 5-HIAA, which probably increases the
threshold level of ASD phenotypes in the females, thereby affecting
ASD prevalence in a sex-speciﬁc manner.
MTU01-03
MAOA and MAOB genes associated with attention deﬁcit
hyperactivity disorder in indo-caucasoid population from
eastern india
A. Karmakar1, B. Chakraborti1, D. Verma1, S. Sinha1,
K. P. Mohanakumar2, U. Rajamma2, K. Mukhopadhyay1
1Manovikas Kendra, Biomedical Research & Diagnostic Centre,
Kolkata, India
2Inter University Centre for Biomedical Research, Centre for
Development and Ageing Research, Kerala, India
Attention deﬁcit hyperactivity disorder (ADHD) is a behavioral
disorder, characterized by symptoms of inattention, excessive motor
activity, and impulsivity, detected mostly during the early child-
hood. Inﬂuence of monoamine neurotransmitters (such as dopamine,
serotonin, and norepinephrine) in ADHD associated symptoms is
well accepted. Monoamine oxidase A (MAOA) and B (MAOB),
mitochondrial outer membrane bound enzymes, catabolize those
monoamines and hence regulate neuronal activities. Genetic poly-
morphisms in MAOA andMAOB showed association with ADHD in
different populations. In this study, we have tested association of
three polymorphisms in MAO genes (30bp-uVNTR and rs6323 in
MAOA, and rs56220155 in MAOB) with ADHD in Indo-Caucasoid
population from eastern India. Nuclear families with ADHD-
probands (N=190) and ethnically matched controls (N=156) were
recruited in the study following DSM-IV. Genotyping was
performed through PCR-based methods/DNA sequencing. Data
were analyzed through population based and family based statistical
methods. rs6323 ‘G’ allele, rs56220155 ‘A’ allele, 30bp-uVNTR-
rs6323 ‘3R-G’ haplotype, and rs6323-rs56220155 ‘G-A’ haplotype
showed signiﬁcant (p≤0.04) higher frequencies in ADHD-probands
as compared to controls. These alleles/haplotypes also revealed
signiﬁcant (p≤0.05) higher frequencies in male-ADHD-probands as
compared to sex-matched controls. Along with these alleles/
haplotypes, 30bp-uVNTR-rs56220155 ‘3R-A’ haplotype showed
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signiﬁcant (p≤0.03) maternal transmission to male-ADHD-pro-
bands. rs56220155 ‘GA’ genotype showed signiﬁcant (p=0.03)
higher frequencies in female-ADHD probands as compared to sex-
matched controls. It may be inferred that both MAOA and MAOB
genes are contributing to the etiology of ADHD in Indo-Caucasoid
population from eastern India.
MTU01-04
Association of a coding TLR4 variant with biomarkers of
prodromal Alzheimer’s disease
J. Miron1,2,3, C. Picard1,2,3, M.-E. Lafaille-Magnan1,2,3, A.
Labonte1,3, M. Savard1,3,4, P. Rosa-Neto1,4,6, D. Auld5, J. Poirier1,3,6
1Douglas Mental Health University Institute, Douglas Hospital
Research Centre, Verdun, Canada
2McGill University, Neuroscience, Montreal, Canada
3McGill University, STOP-AD Centre, Verdun, Canada
4McGill University, Research Centre for Studies in Aging, Verdun,
Canada
5McGill University, Genome Quebec Innovation Centre, Montreal,
Canada
6McGill University, Psychiatry, Montreal, Canada
Introduction: A coding variant in the TLR4 receptor (the G
minor allele of the rs4986790 polymorphism) was associated with
increased longevity and protection against Alzheimer’s Disease
(AD) in two Italian cohorts. Our team further analyzed the
association of this variant with biomarkers of prodromal AD in
presymptomatic individuals with a familial history of AD (PRE-
VENT-AD).
Methods: Genotyping was performed with the Omni2.5 bead-
chip. Cognition was assessed using the RBANS. Structural MRI was
performed with a 3T Siemens Trio scanner. CSF concentrations of
IL-1b, IL-6, and TNF-a were obtained with Milliplex assays.
Results: Among the different RBANS index scores that were
surveyed (including the total score), only the visuospatial construc-
tional index score is signiﬁcantly higher in rs4986790 G carriers.
Analyses of the associations between baseline whole-brain cortical
thickness, RBANS visuospatial constructional index scores, and
rs4986790 genotypes revealed clusters in the occipital and frontal
lobes as well as in the fusiform gyrus. Finally, a signiﬁcant
interaction was observed between rs4986790 genotypes and visits
for CSF IL-1b levels.
Conclusion: The association, in at risk presymptomatic subjects,
of the TLR4 rs4986790 G variant with a stabilization over time of
CSF IL-1b levels may help maintain their visuospatial and
constructional abilities as well as their cortical thickness.
MTU01-05
Role of antioxidants on attention deﬁcit hyperactivity
disorder: question of behavior and genetics
M. Moghadas1, T. Ba-Omar1, A. Al-Shehi1, M. M. Essa2, E. Eltayeb1
1Sultan Qaboos University, College of Science, Department of
Biology, Muscat, Oman
2Sultan Qaboos University, College of Agricultural and Marine
Sciences, Department of Food Science and Nutrition, Muscat,
Oman
Attention Deﬁcit Hyperactivity Disorder (ADHD) is a common
behavioral disorder. Several studies have tended to highlight the
effects of antioxidants on regulation of ADHD. The present work
investigated the effect of Gallic Acid (GA) and Ellagic Acid (EA) in
a Trimethyltin Chloride-induced animal model of ADHD with
insights from behavioral and genetic aspects. In this study, 60
pregnant Wistar rats were used in six groups (N=10 per group),
namely Control (saline only), Sham (TMT 9 mg/kg), Ellagic Acid
(TMT 9 mg/kg+ EA 10 mg/kg), and Gallic Acid (TMT9 mg/kg+ 50,
100, 200 mg/kg) groups. To induce ADHD, TMT was injected to
animals on gestational day 15 (G15) intraperitoneally. Treated
groups received EA and GA as gavage on G12 to G18. After
delivery, 10 pups were selected out of each group to be studied.
Then, on day 60 of delivery, Elevated Plus Maze, Open Field and T-
Maze were conducted. Following, animals were terminated humanly
and prefrontal cortex of their brains was collected for molecular
studies followed by SYBER green qPCR to investigate the
expression level of DRD4 and DRD5 genes. Behavioral ﬁndings
revealed that EA and GA could signiﬁcantly decrease hyperactivity,
impulsivity and inattention in rats. The expression level of DRD4
and DRD5 were signiﬁcantly down-regulated in the sham group as
compared to the controls. In addition, EA and GA in all dosages
caused an up-regulation of DRD4 and DRD5 expression, although
these differences were not signiﬁcant as compared to the sham
group.
MTU01-06
Epigenetic control of the RHOA/rock pathway by the
histone methyl-transferase G9A promotes neuronal
development
C. Wilson1, L. Giono2, V. Rozes-Salvador1, A. Fiszbein2,
A. Kornblihtt2, A. Caceres1
1Instituto Ferreyra INIMEC-CONICET-UNC, Neurobiology,
Cordoba, Argentina
2Instituto de Fisiologıa, Biologıa Molecular y Neurociencias
IFIBYNE-UBA-CONICET, Neurobiology, Buenos Aires, Argentina
Neurons are polarized cells characterized by the presence of
dendrites and the axon, two highly specialized compartments.
Mechanisms controlling polarization have been studied, but its
genetic regulation is unknown. In this regard, epigenetics is a global
mechanism for gene regulation, based on modiﬁcations of histones
and DNA that remodel chromatin conformation. Emerging evidence
links epigenetic regulators with neuronal functions in health and
disease. Among these, the enzyme G9a, which methylates lysine 9
of histone 3 (H3K9, a repressor code for gene expression), has been
associated with broad aspects of neuronal life, ranging from
neurogenesis to chronic pain. Nevertheless, its contribution to early
neuronal development is missing. In this work, using both in vitro
and in vivo neuronal models (cultured neurons and in utero
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electroporated embryonic brains), we describe that genetic suppres-
sion of G9a inhibits polarity acquisition and axonal speciﬁcation of
central neurons. In this regard, our data suggest that the RhoA/
ROCK pathway, an inhibitor of neuronal polarity, is regulated by
G9a. This hypothesis is based on the following evidence. First, we
detected that genes encoding RhoA activators, including the guanine
exchange factor Lfc, are bi-methylated at H3K9 and repressed by
G9a. Second, G9a suppression increased both RhoA and ROCK
activities. Finally, the loss of function of ROCK recovered axonal
growth after G9a suppression. Collectively, our data suggest that
G9a represses by default the RhoA/ROCK pathway, which is
needed for neuronal polarization. In summary, our work reports a
novel epigenetic mechanism controlling neuronal polarity acquisi-
tion, with implications for growth and function of central and
peripheral neurons.
MTU01-07
Hypoxia contributes to Alzheimer’s disease by regulating
CNTNAP2 gene
Q. Zhang, Y. Zhang, F. Cai, W. Song
The University of British Columbia, Psychiatry, Vancouver, Canada
Stroke is a risk factor for Alzheimer’s disease (AD). Hypoxia is a
major consequence of stroke. Contactin-associated protein-like 2
(CNTNAP2) functions as a presynaptic cell adhesion molecule, and
plays important roles in neuronal network formation during
development. CNTNAP2 rs802571 is a locus for susceptibility to
late-onset AD, and abnormal CNTNAP2 expression has been found
in the hippocampus of AD patients. However, it remains elusive
how CNTNAP2 is regulated at the transcriptional level. In this
study, we cloned a 2949 bp 5’-ﬂanking region of the human
CNTNAP2 gene. To investigate the activity of human CNTNAP2
gene promoter, thirteen deletion fragments of its 5’-ﬂanking region
were cloned into pGL3-Basic vector. Functional analyses showed
that the transcriptional start site was located between -524 to -472
upstream of translational start site. The fragment -524 to -81 bp
upstream of translational start site had the minimum promoter
activity required for transcription. There were ﬁve 5’-RCGTG
hypoxia-responsive elements (HRE) in the human CNTNAP2 gene
promoter. Three putative functional HREs were located between -
1322 to -1268 bp upstream of translational start site. The activity of
CNTNAP2 promoter was increased to 270% when treated with
hypoxia (1% O2). Co-transfection with hypoxia-inducible factor 1
subunit a (HIF-1 a) expression plasmid signiﬁcantly increased the
CNTNAP2 promoter activity to 133%. This is the ﬁrst study
deﬁning the promoter region of human CNTNAP2 gene. Our results
demonstrated that CNTNAP2 is tightly regulated by hypoxia at the
transcriptional level. Our study suggests a novel role of hypoxia in
contributing to AD pathogenesis by regulating CNTNAP2 gene
expression.
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GSK3-mediated phosphorylation of PI4KII-alpha regulates
ADBE via control of protein interactions
E.-M. Blumrich1, Jessica. C. Nicholson-Fish1, D. Kurian2, Karen. J.
Smillie1, Michael. A. Cousin1
1The University of Edinburgh, Center for Brain Discovery Sciences,
Edinburgh, United Kingdom
2The University of Edinburgh, 2The Roslin Institute, Edinburgh,
United Kingdom
Activity dependent bulk endocytosis (ADBE) is triggered during
high neuronal activity in central neurons. It is a two-step process that
generates synaptic vesicles from large bulk endosomes, which are
directly invaginated from the presynaptic plasma membrane. The
activity of glycogen synthase kinase 3 (GSK3) is essential for
ADBE, however how this control is mediated is still incompletely
understood. One GSK3 substrate that is present at the synapse is
phosphatidylinositol 4-kinase IIa (PI4KIIa). Depletion of PI4KIIa
using shRNA in cultured cerebellar granule neurons (CGNs)
arrested ADBE. Delivery of exogenous PI4KIIa to these neurons
fully restored ADBE, highlighting an important role of PI4KIIa.
Interestingly, molecular replacement of endogenous PI4KIIa with a
GSK3- phospho-mimetic mutant failed to rescue ADBE. However,
kinase-dead and phospho-null mutants both fully restored ADBE,
suggesting that GSK3-dependent phosphorylation of PI4KIIa
negatively regulates this endocytosis mode. To determine potential
phosphorylation-speciﬁc interactions, GST-PI4KIIa pull downs
were performed. Mass spectrometry analysis revealed 5 presynaptic
molecules that displayed an increased interaction with the phospho-
mimetic PI4KIIa mutant, which were conﬁrmed by Western
blotting. Truncation and domain swop mutations revealed that
mock phosphorylation of Ser-47 on PI4KIIa is critical in controlling
these interactions. Intriguingly, individual depletion of two of these
phospho-dependent interaction partners greatly reduced ADBE in
CGNs. These results indicate a key role for PI4KIIa in ADBE and
conﬁrm the constitutively active GSK3 as a master regulator of this
process. We propose that activity-dependent dephosphorylation of
Ser-47 on PI4KIIa induces the release of key molecules which are
crucial for the initiation of ADBE.
MTU02-02
Constitutive neuronal interleukin-1b release: inﬂuence on
neuronal excitation
S. Dutta, J. Hewett
Syracuse University, Dept. of Biology, Program in Neuroscience,
Syracuse, USA
Interleukin-1b(IL-1b) is a pro-inﬂammatory cytokine of the
immune system. While it contributes to various neuroinﬂammatory
and neurodegenerative disease of the central nervous system (CNS),
it also modulates several physiological functions. Thus, IL-1b is a
neuromodulator in both dysfunctional and normal CNS. Epilepsy is
a brain disorder hallmarked by excessive neuronal ﬁring. IL-1b’s
role has been implicated in seizures, the deﬁning feature of epilepsy.
Of relevance to my research, we previously showed that the innate
seizure threshold was lowered in mice in which IL-1b receptor was
genetically disrupted. This provided compelling evidence to support
the premise that constitutive IL-1b production in the normal brain
inﬂuences neuronal excitability. However, cellular location and
regulation of IL-1b release remain unknown. I hypothesized, i)
unlike neuroinﬂammatory glial release, IL-1b is released constitu-
tively by neurons and ii) P2X7R activation (a purinergic receptor
implicated in the inﬂammatory release of IL-1b in periphery and in
brain) will be necessary for physiological IL-1b release in CNS.
This possibility was tested both in vivo and in vitro. In vivo,
treatment with a selective antagonist of P2X7R, caused buildup of
IL-1b in pyramidal neurons of CA3 region of hippocampus of mice
brain. Using the convulsant agent, pentylenetetrazole, to model
excessive neuronal excitation, I found that the seizure threshold was
lowered in these mice relative to vehicle-treated controls in
agreement with receptor knockout mice. Using P2X7R antagonism
in primary hippocampal neuronal culture, similar IL-1b accumula-
tion was found. The possible mechanism of constitutive release of
IL-1b from neurons is under active investigation. Thus, constitutive
IL-1b release from hippocampal neurons, which when restricted
from release through P2X7R antagonism, appears to serve as
modulated neuronal excitation. My research adds novel information
regarding the physiological roles of IL-1b in CNS.
MTU02-03
Evoked release of soluble amyloid-beta species
R. Hendrix1, C. Yuede2, J. Cirrito1
1Washington University in St. Louis, Department of Neurology, St.
Louis, USA
2Washington University in St. Louis, Department of Psychiatry, St.
Louis, USA
The synaptic activity-driven release of Ab and tau to the
interstitial ﬂuid (ISF) is a key step in the progression of Alzheimer’s
disease (AD). A fundamental question regarding this process
remains: does activity drive aggregation? Brain regions with the
highest neuronal activity correlate with the greatest degree of plaque
and tangle pathology. Ab and tau pathology spreads along speciﬁc
neuronal networks in both mice and humans, such as the perforant
pathway connecting the entorhinal cortex to the hippocampus.
Sustained increase in excitatory synaptic strength, i.e. long-term
potentiation (LTP), is impaired in the AD hippocampus. We
hypothesize that a threshold of neuronal activity exists in which
monomeric release of Ab and tau reaches a pro-aggregative level.
Though the threshold of activity at which this occurs may differ
between Ab and tau, both will contribute to the sequence of
neuropathogenesis of plaques and tangles. Using a novel micro-
immunoelectrode (MIE) allows for detection of Ab and tau species
every 60 seconds for approximately three hours in vivo, or in living
acute brain slices. MIEs utilize an antibody-attached electrode to
measure the oxidation of tyrosine residues, such as those in human
Ab or tau. The amount of current detected is proportional to the
concentration of target molecule present. Baseline Ab was measured
in acute slices, followed by high frequency stimulation to induce
LTP. There was a rapid increase in Ab levels concurrent with the
induction of LTP. Greater understanding of these processes may
enable interventions aimed at homeostatic control of
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hyperexcitability to be developed to prevent the formation and
spread of Ab and/or tau pathology.
MTU02-04
GM1 oligosaccharide is the active portion responsible for
GM1 neuroprotective properties
G. Lunghi1, M. Maggioni1, E. D. Biase1, M. Fazzari1, G. Tedeschi2,
E. Maffioli2, F. G. Scalvini2, S. Sonnino1, E. Chiricozzi1
1University of Milan, Department of medical biotechnology and
translational medicine, Segrate, Italy
2University of Milan, Department of Veterinary Medicine, Milano,
Italy
GM1 ganglioside has been considered as a master regulator of
the nervous system and accumulating evidence is pointing out age-
dependent GM1 deﬁciency as initiator of sporadic Parkinson’s
disease (PD) pathogenesis. Preclinical data and clinical trials have
reported that GM1 administration exerts neuroprotective and
neurorestorative properties both in PD animal model and PD
patients, although the beneﬁt resulting from GM1 replacement
therapy is extremely limited by its amphiphilicity. Recently, we
demonstrated in neuronal cell that the oligosaccharide portion of
GM1 (OligoGM1) is the actual moiety responsible of GM1
neurodifferentiative properties, by the activation of the TrkA-
MAPK pathway. To understand if the exogenous administration of
OligoGM1 and the resulting activation of TrkA pathway could
account also for GM1 neuroprotective effects we performed a
proteomic analysis on N2a cells treated with 50 μM OligoGM1 for
24 hours. The analysis led to the identiﬁcation and quantiﬁcation of
more than 3500 proteins, among these 324 proteins were exclusively
expressed in OligoGM1-treated cells. Interestingly, the OligoGM1-
only proteins are mainly involved in crucial biochemical signaling
with a neuroprotective potential, reﬂecting the GM1 neuroprotective
effect. In addition, biochemical analysis showed that OligoGM1 is
able to reduce the cellular oxidative stress and to confer a protection
against the cell death induced by different toxic molecules (MPTP,
glutamate) in N2a cells. Our results suggest that the molecular
mechanisms underlying the GM1 protective role, as described in the
past, depend on its oligosaccharide chain, making the OligoGM1 a
promising therapeutic molecule.
MTU02-05
Neuroplastin-plasma membrane Ca2+ ATPases
complexes: a new team regulating Ca2+ clearance,
signaling, and synaptic plasticity
A. Malci1,2, M. Naumann3, Eckart. D. Gundelfinger2,4, Constanze. I.
Seidenbecher2,4, R. Herrera-Molina2
1Otto-von-Guericke-University Magdeburg, Faculty of Natural
Sciences, ESF Graduate School ABINEP, Magdeburg, Germany
2Leibniz Institute for Neurobiology, Department of Neurochemistry
and Molecular Biology, Magdeburg, Germany
3Otto-von-Guericke-University Magdeburg, Institute of
Experimental Internal Medicine, Magdeburg, Germany
4Center for Behavioral Brain Sciences, CBBS, Magdeburg, Germany
Neuroplastins, type-1 transmembrane proteins with extracellular
Ig-like domains, play a crucial role in synapse architecture and
plasticity. We and others have shown that neuroplastins bind all four
isoforms of the plasma membrane Ca2+ ATPase (PMCA) to regulate
expression levels and Ca2+-extruding activity of these pumps.
Indeed, we have also shown that in neuroplastin-deﬁcient neurons
with altered long-term potentiation, the protein levels of PMCAs are
reduced. A crucial Ca2+-dependent downstream signaling pathway
implicated in synaptic plasticity is via extracellular signal-regulated
kinases (ERK). Thus, we hypothesize that neuroplastin-PMCA-
modulated Ca2+ signals may regulate ERK activation during
synaptic plasticity. Our preliminary results indicate that ERK
phosphorylation and PMCA abundance are drastically altered in
brain homogenates from neuroplastin-deﬁcient mice. Using super
resolution STED microscopy and FLIM/FRET-based biosensors, we
monitor ERK activation and Ca2+ dynamics in synapses of cultured
hippocampal neurons. We assessed the contribution of neuroplastin
to PMCA levels and activity-dependent plastic mechanisms using
lentivirus-driven overexpression and small extracellular peptides
targeting neuroplastin and PMCA. We have observed that pharma-
cological inhibition of PMCA activity alters the normal ERK
activation in electrically stimulated neurons. Also, we employ high-
frequency stimulation protocols to study the link between neuro-
plastin/PMCA with ERK activation in synaptic junction fractions
from hippocampal slices. Taken together, considering Ca2+-
dependent ERK activation as a prominent mechanism underlying
activity-dependent synaptic plasticity, we propose neuroplastin-
PMCA complexes as major regulators of synaptic Ca2+ clearance
during synaptic plasticity.
MTU02-06
A distinct neurodevelopmental disorder is caused by
mutations in synaptotagmin-1 that alter neurotransmitter
release dynamics
H. Melland1, F. Bumbak1, S. L. Leech1, D. J. Scott1, K. Baker2, S. L.
Gordon1
1The University of Melbourne, The Florey Institute of Neuroscience
and Mental Health, Melbourne, Australia
2MRC Cognition and Brain Sciences Unit, Executive Processes
Group, Cambridge, UK
Synaptotagmin-1 (syt1) is an essential synaptic vesicle protein
that acts as the Ca2+-sensor for fast, synchronous neurotransmitter
release, with additional roles in other aspects of synaptic physiology.
We have recently characterised the ﬁrst known cases of human
mutations in syt1, revealed through whole exome sequencing of 11
individuals with neurodevelopmental impairments not typical of any
recognised disorder. 5 discrete de novo missense mutations have
been identiﬁed in these individuals who exhibit a phenotypic
spectrum of common symptoms including motor delay, intellectual
disability, movement disorders and behavioural abnormalities.
Given all human mutations cluster within the C2B domain, a
Ca2+-binding region crucial for syt1 function, we investigated
whether these syt1 variants perturb the dynamics of neurotransmitter
release. The homologous mutations were induced in pHluorin-
tagged rat syt1 and expressed in cultured mouse hippocampal
neurons, establishing that expression level and synaptic vesicle
localisation of syt1 variants were equivalent to that of the WT
protein, with the exception of one mutant (p<0.01, n=3-4). pHluorin
imaging revealed that syt1 mutants slow the rate of evoked
exocytosis in a dominant-negative manner (p<0.05, n=5-7), and
notably this slowing was less pronounced for the variant presenting
with a less severe clinical proﬁle. These results suggest that
© 2019 The Authors
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impairment of Ca2+-dependent neurotransmitter release is likely an
important pathophysiological mechanism underpinning this disorder
and, together, our ﬁndings demonstrate that syt1 variants with
mutation-speciﬁc impacts on protein functionality give rise to a
distinct and recurrent neurodevelopmental disorder.
MTU02-07
Alpha 2 adrenergic receptor agonist guanabenz directly
inhibits HCN channels
S. Oh1,2, J. Won2, P. R. Lee2
1School of Dentistry, Seoul National University, Department of
Neurobiology and Physiology,, Seoul, Korea South
2College of Natural Sciences, Seoul National University,
Department of Brain and Cognitive Sciences, Seoul, Korea South
Alpha 2 (a2-) adrenergic receptor agonists, such as clonidine or
dexmedetomidine, have been found to inhibit hyperpolarization-
activated, cyclic nucleotide-modulated (HCN) channels, not only
by reducing intracellular cyclic AMP levels but also by directly
blocking HCN channels. In this study, we examined the inhibitory
effect of guanabenz, a centrally acting a2-adrenergic receptor
agonist with high speciﬁcity for a2A-subtype, on HCN channels in
mesencephalic trigeminal nucleus (MTN) neurons which robustly
express HCN channels and have been suggested to coexpress a2A-
adrenergic receptors. By performing whole-cell patch-clamp
recording on MTN neurons in brainstem slices, hyperpolariza-
tion-activated inward current (Ih) was examined during guanabenz
treatment. Guanabenz inhibited Ih in a dose-dependent manner,
which was likely to be ZD7288-sensitive HCN current as it did
not affect barium-sensitive inward rectifying potassium current.
Guanabenz not only inhibited Ih but also shifted the voltage-
dependent activation curve to hyperpolarizing potentials. Interest-
ingly, Ih inhibition by guanabenz was not reversed by a2-
adrenergic receptor antagonist atipamezole treatment or by intra-
cellular cyclic AMP perfusion, suggesting that the inhibition may
not result from a2A-adrenergic receptor signalling pathway but
from direct inhibition of HCN channels. Coherent to our
electrophysiological results, single-cell RT-PCR revealed that
most MTN neurons lack a2A-adrenergic receptor mRNA. Our
study demonstrates that guanabenz can directly inhibit HCN
channels in addition to its primary role of activating a2A-
adrenergic receptors.
MTU02-08
EM17 - a new kainate receptor selective antagonist:
pharmacology and X-ray crystallography
D. Pickering1, S. Møllerud1, K. Frydenvang1, J. Kastrup1, J.
Andreasen1, R. Hansen1, M. Diaz-delCastillo1, A. Paternain2, T.
Johansen1
1University of Copenhagen, Drug Design & Pharmacology,
Copehagenn, Denmark
2CSIC-UMH, Institute of Neuroscience, San Juan de Alicante,
Spain
Most fast excitatory neurotransmission in the mammalian CNS is
mediated by glutamate acting through ionotropic glutamate recep-
tors (iGluRs). This receptor family includes the kainate receptors
(KAR) consisting of the subunits GluK1-5, located both pre- and
postsynaptically. KAR are believed to modulate the activity of
neuronal networks by regulating neurotransmitter release. This
modulatory role of KAR provides a therapeutic target for ﬁne-tuning
the balance of excitatory and inhibitory signaling. The physiological
functions of KAR are incompletely understood, partially due to a
lack of selective KAR pharmacological compounds. Extensive effort
has thus been put into development of KAR selective antagonists
but there still exists an unmet need for subunit-selective KAR
ligands. 2,3-Quinoxalinediones were among the ﬁrst antagonists
applied in non-NMDA receptor research. Nonetheless, these initial
compounds were not optimal for elucidating the functions of KAR
as they are also antagonists of AMPA receptors. We have recently
published on 2,3-quinoxalinediones substituted at the N1-, 6- and 7-
positions which demonstrated GluK3 preference. Here, a new series
of 2,3-quinoxalinedione analogues with substitutions in the 7-
position have been characterized. One compound (EM17) showed
high afﬁnity at GluK3 (Ki = 78 nM) and was further characterized
by patch clamp electrophysiology in HEK293 cells expressing
GluK3 (KB = 39 nM) and in vivo in the mouse tail ﬂick test where it
was efﬁcacious as an analgesic. Finally, to understand the molecular
interactions of this series of 2,3-quinoxalinediones we report a
crystal structure of EM17 in complex with the GluK1 ligand-
binding domain.
MTU02-09
Actin regulation by non-prenylatable RHOA and RAC1 in
neurite outgrowth and cell clustering
N. Raut
Texas Woman University, Biology, Denton, USA
Encouraging axon regeneration after traumatic lesions to the
central nervous system (CNS) or the onset of neurodegenerative
conditions like Alzheimer’s disease (AD) may increase the
functional recovery. Unfortunately, there is no effective treatment
that promotes axon regeneration or synaptic plasticity. Both
regeneration and synapse formation involve dynamic rearrange-
ments of the growth cone actin cytoskeleton. For process extension,
actin monomers polymerize to ﬁlaments near the leading edge and
monomers are removed at the transition to the axon. Actin
polymerization and depolymerization are controlled in large part
by Rho guanosine triphosphatases (GTPases). These proteins are
active when bound to guanosine triphosphate (GTP) and inactive
when bound to guanosine diphosphate (GDP). Rho GTPases are
targeted to the plasma membrane by addition of a 20-carbon
lipophilic geranylgeranyl isoprene. It is not known how Rho and
RhoA geranylgeranylation affects the location and activity of
downstream effectors to facilitate either polymerization or depoly-
merization of actin. We used non-geranygeranylatable RhoA and
Rac1 constructs to test how inhibiting geranygeranylation affects
morphology, localization of activation of RhoA and Rac1 cell
signaling pathways. Western blot analysis and confocal microscopy
show that expressing non-geranygeranylatable constructs increases
cortical actin ﬁlament content in growth cones, but have differential
effects on process outgrowth from neuroblastoma cells and rat
primary cortical neurons. Expressing non-geranylgeranylatable
Rac1 decreased neurite initiation and elongation, while expressing
non- geranylgeranylatable RhoA increased neurite elongation.
Furthermore, expressing non-geranylgeranylatable RhoA or Rac1
signiﬁcantly altered formation of the actin nucleation complex of
WAVE with the Arp2/3 complex. Elucidating the signaling cascades
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of the aberrantly-localized active Rho GTPases and the effect on
actin may identify the downstream effectors that can be used as a
novel targets to facilitate axon regeneration in traumatic or
degenerative neurological conditions.
MTU02-10
Inhibition of MMP-9 enhances cholinergic-induced
synaptogenesis in hippocampal CA1 pyramidal neurons
A. Salamian, A. Beroun, L. Kaczmarek
Nencki Institute of Experimental Biology, Molecular and Cellular
Neurobiology, Warsaw, Poland
Matrix metalloproteinases (MMPs) are enzymes modifying
synaptic function via remodeling the milieu surrounding chemical
synapses. Matrix metalloproteinase-9 (MMP-9) is of particular
importance because of being able to change dendritic spine
morphology, suggesting its contribution to structural synaptic
plasticity. One potential way to trigger synaptic plasticity changes
is activation of cholinergic system –a model that has been recently
extensively studied. Little is known, however, regarding the
involvement of MMP-9 in cholinergic activation in the hippocam-
pus. Therefore, using organotypic hippocampal slice, we investi-
gated the role of MMP-9 in synaptic plasticity evoked by carbachol
– a cholinergic agonist. We found the elevation of MMP-9 activity
following 1 h of carbachol treatment, with a peak at 24 h after
stimulation. We tested the hypothesis that elevated MMP-9 activity
contributes to modifying synaptic function evoked by cholinergic
activation. We assessed excitatory and inhibitory synaptic trans-
mission of the CA1 pyramidal neurons after carbachol induction
using whole-cell patch-clamp electrophysiology technique. Data
revealed an enhancement of the frequency of miniature inhibitory
postsynaptic currents (mIPSCs) a few hours after carbachol, which
was impaired by blocking the MMP-9 activity. We also found an
increase in the frequency of miniature excitatory postsynaptic
currents (mEPSCs) evoked by carbachol within a longer time after
carbachol treatment. Interestingly, blocking MMP-9 further
increased the frequency of mEPSCs evoked by carbachol. Evalu-
ation of size and distribution of excitatory presynaptic (VGLUT)
and postsynaptic (PSD-95) markers revealed that the enhancement
of excitatory postsynaptic currents is mediated by the increase in the
number of synapses. Our data emphasize the contribution of MMP-9
to the balance between excitatory and inhibitory synaptic transmis-
sion affecting excitatory synaptic contacts in the hippocampus,
induced by cholinergic activation.
MTU02-11
Subcellular localization of sphingosine 1-phosphate
receptors in synapses of the mouse cortex
C. Skoug1, A. Meissner1,2, J. Duarte1,2
1Lund University, Dep. Experimental Medical Science, Lund,
Sweden
2Lund University, Wallenberg Centre for Molecular Medicine,
Lund, Sweden
Sphingosine 1-phosphate (S1P) has pleiotropic biological func-
tions in the regulation of proliferation, survival, migration, inﬂam-
mation or angiogenesis. S1P acts as intracellular second messenger,
as well as extracellular receptor ligand via ﬁve G-protein coupled
receptors (S1PR1-5). In the brain, S1P regulates neuronal prolifer-
ation or apoptosis, excitatory neurotransmission and neuroglia
activation, and S1P metabolism alterations have been associated to
neurodegenerative disorders. Interestingly, an agonist targeting
S1PR1,3,4,5 (FTY720) shows neuroprotective properties through
mechanisms that are not fully unveiled, but might include the
control of neuroinﬂammation, vascular deterioration and synaptic
dysfunction. The subcellular distribution of S1PRs in nerve
terminals is hitherto unknown. The present study aimed at
determining the synaptic localisation of S1PRs in the cortex of
adult male mice. Synaptosomes were puriﬁed from mouse cortex
homogenates using a sucrose density gradient centrifugation, and
further fractioned into pre-, post- and extrasynaptic zones using a
series of pH shifts that allow successive solubilisation of synaptic
components (Phillips et al., Neuron 32:63, 2001). Western blot
analysis of the obtained fractions, as well as total protein extracts
from cortex revealed that S1PR1 is present in similar amounts in
total extracts, synaptosomes and the extrasynaptic fraction, but
absent from the pre- and postsynaptic fractions. S1PR2 was
ubiquitously distributed, showing 3-fold higher levels in the
presynaptic zone than the post- (P<0.05) and extrasynaptic
(P<0.05) fractions. Similarly, S1PR4 was also distributed across
all synaptic fractions but 4-fold more enriched presynaptically.
S1PR3 and S1PR5 were not efﬁciently detected by immunoblotting
in synaptosomes and synaptic fractions. Altogether, these results
point towards S1PR2 and S1PR4 being particularly well poised to
directly modulate synaptic transmission and plasticity upon S1P
activation.
MTU02-12
The sonic hedgehog and WNT/beta-catenin signalling
pathways under the chronic stressful condition is
inﬂuenced by nicotine
M. Tayyab, S. Farheen, M. P. M Mubeena, N. Khanam, M. Mobarak
Hossain, M. Shahi
Aligarh Muslim University, Interdisciplinary Brain Research Centre
(IBRC), J.N. Medical College, Faculty of Medicine, Aligarh, India
Background: Sonic hedgehog (Shh) is a member of the
hedgehog family and regulates embryonic development. Recently,
various studies recommended its signiﬁcant role in adult neural
tissues through its distinctive mechanisms such as hippocampal
neurogenesis, anti-oxidation and anti-inﬂammation. On the other
hand, Shh is a critical target in various neurological diseases like
brain cancer and depressive disorders. Moreover, Brain-derived
neurotrophic factor (BDNF) and Wnt/b-catenin signalling also plays
important role in the neuropathology of depression. In our study, we
focused on the role of Shh and Wnt/b-catenin signalling pathways in
chronic stress-induced depression including loss of learning and
memory caused by depression and the inﬂuence of nicotine.
Nicotine is the most common and highly addictive drug of abuse.
Interestingly, studies suggested that nicotine abuse is the self-effort
to feel reward and ﬁght depression in depressed individuals.
Method: Twenty-four male Wistar rats were randomly divided
into four groups; Control (saline), Nicotine (NIC 0.3mg/kg), chronic
unpredictable mild stress (CUMS) and CUMS+NIC. Forced swim
test, open ﬁeld test and Morris water maze were performed and the
hippocampal mRNA expression of BDNF, Shh, GLI1/2, NKX2.2,
PAX6 and b-catenin were observed.
© 2019 The Authors
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Results: We observed that nicotine reversed CUMS induced
depressive behaviour as well as CUMS associated cognitive deﬁcits.
The mRNA expression of BDNF, Shh, GLI1/2, NKX2.2 and b-
catenin were decreased in CUMS, and these decreased mRNA levels
were recovered by nicotine. To conclude our study, we suggest that
BDNF, Wnt/b-catenin and Shh signalling pathways play important
role in the pathophysiology of depression and in providing the
nicotine-mediated antidepressant effect.
MTU02-13
TGFb1-signaling importance in insulin-sensitive GLUT4
trafﬁcking to membrane in the cortex of mice with acute
liver failure
M. Popek, M. Zielinska
Mossakowski Medical Research Centre Polish Academy of Sciences,
Neurotoxicology, Warsaw, Poland
Hepatic encephalopathy is a neuropsychiatric syndrome caused
by liver failure (ALF) with multifactorial pathomechanism in which
ammonia and neuroinﬂammation play a key role. TGF-b1, a
pleiotropic cytokine controls different cell functions, among other
glucose metabolism-dependent on insulin. TGF-b1 signaling is
impaired in ALF mouse model. In the presented study the role of
TGF-b1 signaling in insulin-sensitive glucose 4 transporter (Glut4)
trafﬁcking through PI3K/Akt/PKCz signaling pathway in cerebral
cortex of ALF mice was measured. C57Bl6 mice with ALF induced
by AOM injection (i.p.100 mg/kg), and mice with TGF-b1
neutralization (i.p.ab-TGF-b1, 1 mg/kg) were used. The redaction
in TGF-b1 level by ~200% and ~100% in serum and cortex
homogenates were observed. The expression of Insulin Receptor b
and Insulin Receptor Substrate 1 were unaltered in both models. In
addition, decreased expression of TGF-b Receptor 2 by ~15% in
mice after neutralization of the cytokine in the absence of changes in
ALF mice was observed. The subtle changes in the expression of p-
PDK1 and p-Pi3K proteins were demonstrated in ALF brain
homogenates, accompanied with reduction in p-PKCz by ~15% in
mice after neutralization and decrease in p-AKT by ~50% in ALF
mice were observed. In both groups the increase in Glut4 protein by
~100% and ~80% in the cytosolic fraction was observed, without
changes in the membrane fraction. The results indicate that ALF
alters brain glucose metabolism, however the mechanism of Glut4
translocation to the membrane in ALF mice might be not solely
associated with TGF- b1 signaling. Particular mechanism requires
additional research. Supported by the grant Prelludium10 2015/19/
N/NZ5/02249.
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MTU03-01
N-butanol fraction of OLAX subscorpioidea attenuates
lipopolysaccharide-induced depression by inhibiting NF-
KB in mice
O. Adeoluwa
Afe Babalola University Ado Ekiti Ekiti State, Pharmacology and
Therapeutics, Ado Ekiti, Nigeria
Background: The leaves of Olax subscorpioidea (0S) is a
mainstay in the management of mental illness in folkloric medicine
in Nigeria. Studies have shown its antidepressant, and anti-
inﬂammatory properties in animals. However, with emanating
evidences suggesting link between immuno-inﬂammatory pathways
and depression, there is dearth of information linking or attributing
its antidepressant effect to its anti-inﬂammatory mechanism. We
thus evaluated antidepressant effect of n-butanol fraction (BF) of OS
on LPS-induced depressive behaviours with respect to its action on
inﬂammation.
Methods: Sixty mice were randomly assigned into six groups
(n=10): group1 (vehicle), group2 (BF/5mg/kg), group3 (BF/10mg/
kg), group 4 (BF/20 mg/kg), group5 (Imipramine/10 mg/kg), group6
(vehicle). Mice were treated with vehicle or BF or imipramine for
seven days. Thirty minutes after treatment on day seven, animals
were injected with LPS (0.83mg/kg,i.p.) except group1 (vehicle
only). Twenty-four hours after LPS injection, animals were assessed
for depressive symptoms using sucrose preference test, locomotor
and exploratory activity and immobility using tail suspension test.
Brain levels of Interleukin-1b, TNF-a, malondialdehyde, reduced
glutathione and corticosterone were measured by ELISA technique.
Expressions of Indolamine-2,3-Dioxygenase(IDO), inducible-nitric-
oxide synthase (iNOS) and nuclear factor-kappa B(NF-kB) were
quantiﬁed by immunohistochemistry.
Results: LPS increased immobility of mice in TST and decreased
sucrose preference indicating of depressive-like behaviours com-
pared to controls. These behaviours were attenuated by BF
compared to control. The altered levels of MDA, GSH, corticos-
terone, TNF-a, and IL-1b were signiﬁcantly reversed by BF.
Induction of IDO, iNOS and NF-kB translocation were also reversed
by BF.
Conclusion: Attenuation of LPS-induced depression may be
attributed to its inhibitory effect on immnoinﬂammatory pathways.
MTU03-02
Ultrastructural study of mature and immature corpora
amylacea in human brain
E. Auge1,2, M. Riba1,2, J. Duran-Vilaregut1, I. Bechmann3, N. Llor1,
M. Krueger3, C. Pelegrı1,2, J. Vilaplana1,2
1Universitat de Barcelona, Facultat de Farmacia i Ciencies de
l’Alimentacio, Barcelona, Spain
2Universitat de Barcelona, Institut de Neurociencies, Barcelona,
Spain
3University of Leipzig, Institute for Anatomy, Leipzig, Germany
Corpora amylacea (CA) are spherical bodies of unknown origin
and function, which accumulate in the human brain during the aging
process and neurodegenerative disorders. CA have been associated
with PAS granules, which are degenerative granular structures that
appear progressively with age in the mouse brain. Although
immature PAS granules have been described, the formation of CA
is un unknown process. The aim of the present study is to identify
CA during their genesis and describe them at ultrastructural level.
We show that most CA, which are mature CA, consist of a core or
compacted mass of randomly oriented short linear structures
surrounded by some cytoplasmic organelles such as mitochondria
and all encircled by a plasma membrane. Moreover, we observed
some CA in early stages. These immature CA contain an inner
region that is less compact than that of mature CA, and this inner
region contain mitochondria, cellular debris and membranous blebs.
All these ﬁndings support the correspondence between human CA
and PAS granules and reinforce the hypothesis that CA, as PAS
granules, are involved in the entrapment of damaged and non-
degradable products and have a role in protective or cleaning
mechanisms.
MTU03-03
Cytokine proﬁle of patient with major depressive disorder
E. Babusikova1, I. Ondrejka2, I. Hrtanek2, D. Dobrota1
1Comenius University in Bratislava, Department of Medical
Biochemistry, Jessenius Faculty of Medicine in Martin, Martin,
Slovakia
2Comenius University in Bratislava, Clinic of Psychiatry, Jessenius
Faculty of Medicine in Martin, Martin, Slovakia
Major depressive disorder (MDD) is a common mental disorder
associated with signiﬁcant negative impact on quality of life. Two
percentages of Slovak population undergo treatment but 10 – 20%
of population is not diagnosed.MDD is a complex disorder in
which psychological, biological, genetic and environmental factors
are affected by the onset and development of disease. The
dominant hypothesis of MDD described abnormalities in interac-
tions between neurotransmitters and hormones in the brain.
Nowadays it is believed that a number of complex metabolic
pathways will be involved in etiology and pathogenesis: oxidative
damage, inﬂammation, neuro-immune pathways, serotonergic
system, and tryptophan catabolism. In the present study, we
examined the hypothesis that increased inﬂammation is associated
with MDD. All patients have endogenous MDD, 96% of patients
have severe MDD. We analysed concentration of 12 cytokines:
interleukins (IL-1a, 1b, 2, 4, 6, 8, 10) and growth factors (vascular
endothelial growth factor, tumor necrosis factor a, epidermal
growth factor, interferon gamma, and monocyte chemoattractant
protein 1). Concentration of six interleukins (IL-1a, 1b, 2, 4, 8,
10) was increased in patients with depression (5 – 60%).
Concentration of TNFa was decreased in 55% of patients and
90% of patients have decreased epidermal growth factor concen-
tration. Basic clinical biochemical parameters were in physiolog-
ical ranges in all patients. There is a lack of precisely characterised
populations of MDD patients. Deeper analysis of interleukins
together with polymorphisms of interleukins could help explain
effects of interleukins changes in MDD patients. The project was
supported by: VEGA 1/0266/18.
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MTU03-04
Vascular and neurogenic rejuvenation in aging mice by
modulation of ASM
J.-S. Bae1, M. H. Park1, K. H. Park1, I. K. Jung1, M. S. Jeong2, B. J.
Choi2, H. K. Jin2
1 School of Medicine, Kyungpook National University, Department
of Physiology, Daegu, Korea South
2 College of Veterinary Medicine, Kyungpook National University,
Department of Laboratory Animal Medicine, Daegu, Korea South
Although many reports have revealed dysfunction of endothelial
cells in aging, resulting in blood-brain barrier (BBB) breakdown, the
underlying mechanism(s) remain to be explored. Here, we ﬁnd that
acid sphingomyelinase (ASM) is a critical factor for regulating brain
endothelial barrier integrity. ASM is increased in brain endothelium
and/or plasma of aged humans and aged mice, leading to BBB
disruption by increasing caveolae-mediated transcytosis. Genetic
inhibition and endothelial speciﬁc knock-down of ASM in mice
ameliorated BBB breakdown and neurocognitive impairment during
aging. Using primary mouse brain endothelial cells, we found that
ASM regulated the caveolae-cytoskeleton interaction through pro-
tein phosphatase 1-mediated ezrin/radixin/moesin (ERM) dephos-
phorylation, as well as apoptosis. Moreover, mice with conditional
ASM overexpression in brain endothelium accelerated signiﬁcant
BBB impairment and neurodegenerative change. Overall, these
results reveal a novel role for ASM in the control of neurovascular
function in aging, suggesting that ASM may represent a new
therapeutic target for anti-aging.
MTU03-05
Characterization of neurotropic virus-induced acute
ﬂaccid paralysis and motor neuron death in an
experimental model
A. Basu, M. Bhaskar, S. Mukherjee, I. Akbar
National Brain Research Center, Molecular and Cellular
Neurosciences, Gurugram, India
Poliomyelitis like illness is a common manifestation associated
with neurotropic virus infection. Functional loss and death of motor
neurons in spinal cord often lead to reduced muscle tone and
paralysis, which subsequently result in clinical symptoms like
movement disorders, cognitive impairment and long term neuro-
logical sequelae amongst the survivors. Despite of several reports on
molecular basis of encephalopathy, the pathogenesis of ﬂaccid
paralysis upon viral infection remained largely unknown. The
present study aims to elucidate the mechanism responsible for limb
paralysis by studying clinical isolates of Japanese encephalitis virus
(JEV) and Chandipura virus (CHPV) causing clinical-AFP (Acute
ﬂaccid paralysis) in vast region of south-east Asia. Experimental
model for studying virus-induced AFP was generated by intra-
peritoneal infection of 10-day old BALB/c mice. Mice were
subjected to a series of behavioural tests to assess gait, neurode-
generation and locomotory behaviour. Progressive decline in motor
performance of infected animal was found when compared with
mock. Paralysis was correlated with death of motor neuron (MN) by
studying various cell death-assays both in vivo and in vitro.
Furthermore, this study demonstrate that upon viral infection MN
trigger type-I interferon production through RIG-I dependent
pathway via activation of transcription factor IRF-3 and IRF-7.
Once activated, this pathway in turn leads to interferon-induced
extrinsic apoptosis of MN. Both, gene silencing using speciﬁc RIG-I
siRNA and INFAR receptor blocking abrogate MN apoptosis
in vitro, thus validating the important role of RIG-I and interferon in
MN death upon viral infection. Hence, we are hypothesizing that
host innate antiviral response is critical in deterioration of motor
functioning and pathogenesis of ﬂaccid paralysis upon neurotropic
virus infection.
MTU03-06
Neuroimmune interactions mediated by TNF-a-mediated
in the induction of rapid plasticity after CNS injury
L. Chagas1, P. Trindade2,3, R. Antonioli-Santos4, A. Rodrigues1,
T. Mazala-de-Oliveira1, C. A. Serfaty1
1Federal Fluminense University, Neurobiology, Niteroi, Brazil
2Unirio, Biochemistry, Rio de Janeiro, Brazil
3IDOR: Instituto D’OR de Pesquisa e Educac~ao, Neuroscience, Rio
de Janeiro, Brazil
4Instituto de Pesquisas Biomedicas. Hospital Naval Marcılio Dias,
Biomedical science, Rio de Janeiro, Brazil
Introduction: CNS lesions are often folby structural reorganiza-
tion within incircuits of the brain. In para focal lesions also induce
neuroreaction that encourages the under-ing of the mechashared
beneuroplasticity and immune activation, within CNS injury con-
text. TNF-a is a key procyto that exerts its effects via TNF receptor
subtype-1 (TNFR1) or -2 (TNFR2). Calcineurin (CaN) is a
phosrelated to synaptic pruning and immune func that mediates
microactivation and TNF-a release.
Goal: Here we evaluthe role of TNF-a and microon the sproof
inretinotectal axons folmonocular enucleation (ME) and the tempo-
ral expreof TNFR1/2 and Arg-1 after lesion.
Results: Lister Hooded rats were submitted to ME at P10 and
evaluin different survival times. Animals also received systemic
injections of cyclosporin A (50mg/kg,sc) or minocycline (125 mg/
kg,sc) 3h folME. A third group received local delivery (ELVAX) of
a TNF-a neutralizing anti3 days before. Neurotracers mapped
structural plasticity while immunoand western blot were used to
study microglia morphology, TNF-a, TNFR1/2 and CaN content. A
proinof activated microin the contralateral supercolliculus (SC) 24h
after ME, peaking at 72h prea temporal corwith an inin TNFR1 and
TNFR2 immunoreactivity, that ceased 7d after. Inhibition of
microor TNF-a resproof intact uncrossed retinotectal axons, amoe-
boid microand TNF-a exssion. We also oba transinof Arg-1, a anti-
inmarker of microreactivity, 24h and 7days after lesion. Inibitors
decreased the Iba-1 and iNOS levels, 72h after lesion sugan anti-
ineffect.
Conclusion: Data support the hypothat TNF-a signalling is
reguduring a micro-deneuroplasticity induced by lesions during
early brain de Approby local animal care committee (CEUA/UFF:
pro0015109).
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MTU03-07
Combined administration of dopaminergic and
nondopaminergic drugs reverses neuroinﬂammation in a
rat model of parkinson’s disease
G. Costa1, M. Serra1, M. Morelli1,2,3, A. Pinna3
1University of Cagliari, Department of Biomedical Sciences,
Section of Neuroscience, Cagliari, Italy
2National Institute of Neuroscience, University of Cagliari,
Cagliari, Italy
3National Research Council of Italy, Institute of Neuroscience,
Cagliari, Italy
A previous study of our laboratory demonstrated an improved
motor performance in 6-hydroxydopamine (6-OHDA) unilaterally
lesioned rats, a model of Parkinson’s disease (PD), that were treated
with the combination of L-dopa, the serotonin 5-HT1A/1B receptor
agonist eltoprazine, and the adenosine A2A receptor antagonist
preladenant. Starting from these ﬁndings, and from evidences that
implicates neuroinﬂammation in PD progression, the present study
investigated whether counteraction of neuroinﬂammation partici-
pated in the motor effects of the L-dopa+eltoprazine+preladenant
combination.
6-OHDA-lesioned rats were chronically treated with L-dopa+el-
toprazine+preladenant. Then, we evaluated in the denervated
caudate-putamen (CPu) and substantia nigra pars compacta (SNc)
the immunoreactivity (IR) for the glial ﬁbrillary acidic protein
(GFAP), and the co-localization of the ionized calcium binding
adaptor molecule 1 (IBA1), with interleukin (IL)-1b, tumor necrosis
factor-a (TNF-a) and IL-10. Finally, the IR for tyrosine hydroxylase
(TH) and the dopamine (DA) transporter (DAT) was quantiﬁed.
Combined treatment with L-dopa+eltoprazine+preladenant
induced a reduction of basal GFAP and IBA1 IR in both CPu and
SNc. Moreover, a reduction of IL-1b in IBA1-positive cells both in
CPu and SNc and of TNF-a in IBA1-positive cells in SNc was
observed. Besides, a signiﬁcant increase in IL-10 in IBA1-positive
cells was also observed in SNc. Finally, a signiﬁcant reduction of
DAT and TH IRs was found in all the experimental groups.
The present ﬁndings indicate that the combined administration of
L-dopa+eltoprazine+preladenant reduced the inﬂammatory and
neurodegenerative responses in the nigrostriatal system of 6-
OHDA-lesioned rats.
MTU03-08
Systemic LPS induces vesicular co-expression of rage
and LC3 in dopaminergic neurons of the substantia nigra
D. Gelain, J. Gasparotto, C. Tiefensee-Ribeiro, N. Somensi, P.
Brum, D. Peixoto, J. C. Moreira
Universidade Federal do Rio Grande do Sul, Departamento de
Bioquimica, Porto Alegre, Brazil
The receptor for advanced glycation endproducts (RAGE) is a
pattern-recognition receptor that triggers pro-inﬂammatory gene
transcription mainly through NF-kB activation. Induction of RAGE
is observed in several non-infectious pathologies with a pro-
inﬂammatory characteristic, including diabetes, atherosclerosis,
cancer and Alzheimer’s disease. Disruption of autophagy ﬂux and
induction of macroautophagy are observed in a-synuclein mutants
and are suggested to be a key step in Lewy’s bodies formation. Here
we used a rat model of long-term dopaminergic neurodegeneration
induced by systemic LPS injection to evaluate the involvement of
RAGE in a-synuclein and LC3-I/II expression and progression of
dopaminergic cell death. Adult Wistar rats were subjected to
systemic LPS injection (5 mg/kg, i.p.) and the substantia nigra was
isolated at 6 and 10 months after injection for IF. RAGE, a-
synuclein and LC3-I/II staining were all increased in dopaminergic
neurons, although the number of TH-positive cells in the substantia
nigra decreased in the course of 10 months. Co-localization of
RAGE and LC3-I/II staining is observed in vesicles of TH-positive
cells. Systemic (previous to LPS) or intranigral (2 months after LPS)
injection of the RAGE inhibitor FPS-ZM1 inhibited RAGE and
LC3-I/II expression, a-synuclein staining and preserved the number
of TH-positive cells. These data indicate an important role for
RAGE in dopaminergic neurodegeneration triggered by systemic
inﬂammation, and also suggest that changes in the regulation of
autophagic ﬂux are a key step in the mechanism of neurodegener-
ation associated to RAGE. Financial support: CNPq, FAPERGS,
CAPES and Propesq-UFRGS.
MTU03-09
Smoking mice: the effects of sub-chronic cigarette smoke
exposure on microglia
F. G. Iba~nez1, M.-K. St-Pierre1, M. Carrier1, J. Savage1, M.
Morissette2, M.-E. Tremblay1
1Universite Laval CRCHU de Quebec, Axe Neurosciences, Quebec,
Canada
2CRIUCPQ, Pneomologie, Quebec, Canada
According to World Health Organization, in 2015, there were 1.1
billion smokers worldwide. Smoking is responsible for 7 million
deaths per year and constitutes an important risk factor for several
diseases, including mental diseases. Animal studies on cigarette
smoke exposure have shown increased levels of inﬂammatory
markers and oxidative stress in several organs including the brain.
Microglia are the resident immune cells of the brain. They are
required for the proper functioning of the brain and are equipped
with a myriad of receptors that allow them to monitor their
environment, recognize damage, eliminate cells and debris. They
also have a role in plasticity by promoting the growth or directly
eliminating synapses by phagocytosis, making them active modiﬁers
of the neuronal network circuitry. Microglia are able to respond to
inﬂammation as well as to external environmental changes,
suggesting possible alteration of their physiological functions by
cigarette smoke exposure. Using a model of sub-chronic cigarette
exposure, this project aims to study the effects that cigarette smoke
has on hippocampal microglia of 4-month-old male mice. The
hippocampus is essential for memory and learning, in addition to
being a niche for adult neurogenesis. With the use of immunohis-
tochemistry against the microglial marker IBA1, we have analyzed
microglial density, distribution, and morphology. Using array
tomography and scanning electron microscopy, we are currently
characterizing ultrastructural changes of microglial morphology,
phagocytic activity and interactions with synaptic elements. Overall,
this study will unravel the consequences of cigarette smoke on
microglia and shed light on a possible mechanism by which
smoking could affect brain health.
© 2019 The Authors
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MTU03-11
Attenuation of acute inﬂammatory pain following a
surgical incision by neuropeptide y in rats
S. Gupta, R. Kumar, M. Gautam, S. B. Ray
All India Institute of Medical Sciences, Anatomy, New Delhi, India
Aim: Postoperative pain continues to be an important health care
problem. Pain signals are modulated at spinal level by various
neurotransmitters and neuropeptides. Neuropeptide Y (NPY) is
abundantly distributed in the mammalian nervous system. Several
reports have shown its involvement in various pain models but its
role in postoperative pain is poorly understood. In the current study,
on the hind paw incision model temporospatial change in expression
of NPY in the spinal cord was observed.
Methods: Male Sprague-Dawley rats were subjected to hind paw
incision. Immunohistochemical localization of NPY was performed
at the spinal level (L4-L5). Another set of animals (n=12) were
administered NPY or saline through an intrathecal catheter. Finally,
NPY antibody (n=6) was administered through catheter followed by
NPY and the effect observed. Three nociceptive assays were used to
evaluate the antinociceptive effect starting from 2h post-incision
until postoperative day 7.
Results: NPY immunoreactivity was observed as punctate vari-
cosities in the superﬁcial laminae of the dorsal horn. On the
contrary, neurons positive for NPY, was observed in the deeper
laminae. NPY immunostaining decreased after incision at 3 h
followed by an increase at 12 h. At day 1, it decreased again. This
variable pattern of expression suggested the involvement of NPY in
postincisional nociception. Subsequently, on intrathecal administra-
tion, nociception was signiﬁcantly decreased between 2 h to day 2,
which was reversed by antibody to NPY.
Conclusion: Neuropeptide Y likely acts as an antinociceptive
factor in the spinal modulation of pain. This information could have
clinical relevance.
MTU03-12
Complement mediates dysfunction and
neurodegeneration in amyloidosis and tauopathy models
and is activated in Alzheimer’s disease
J. Hanson
Genentech Inc., Neuroscience, South San Francisco, USA
Complement pathway overactivation can lead to neuronal
damage in a variety of neurological diseases. While Alzheimer’s
disease (AD) is characterized by both amyloid-beta plaques
(amyloidosis) and Tau tangles, previous work examining comple-
ment has largely focused on amyloidosis models. We ﬁnd that in
mouse models of amyloidosis (PS2APP) or tauopathy (TauP301S),
glial cells show increased expression of complement classical
pathway components including C1q and the central component C3;
however, complement proteins accumulate more extensively in
TauP301S mice. Blocking complement function by knockout (KO)
of C3 not only rescued the plaque-associated synapse loss in
PS2APP mice, but also ameliorated neuron loss and brain atrophy in
TauP301S mice. Neuroprotection in TauP301SxC3KO mice was
accompanied by improvements in neurophysiological and behav-
ioral measurements. We also ﬁnd that C1q and C3 protein are
elevated in AD patient brains, including at synapses. In AD patient
CSF we ﬁnd that levels and processing of C3 are increased and
correlate with tau but not amyloid-beta. Together these results
demonstrate that complement activation can contribute to neurode-
generation caused by tau pathology and suggest that blocking C3
function might be protective in AD and other tauopathies.
MTU03-13
Nx-NITRO-l-arginine methyl model of pre-eclampsia
elicits differential IBA1 and EAAT1 expressions in brain
O. Ijomone, P. Shallie, A. Naicker
University of KwaZulu-Natal, Optics and Imaging Centre, Durban,
South Africa
Pre-eclampsia (PE) is a pregnancy syndrome associated with an
increased risk of both the mother and the baby developing
cardiovascular disorders later in life. It is widely accepted that
women with severe PE develop a neurological impairment however
studies have revealed that the mother and baby are at jeopardy for a
neurological deﬁcit later in life. The present study examined
expression of Iba1 and EAAT1 as neuroinﬂammatory markers in an
Nx-nitro-L-arginine methyl (L-NAME) model of early- and late-
onset PE-like syndrome in rat models. Forty-ﬁve adult nulliparous
pregnant Sprague-Dawley rats were used for this experiment. They
were divided into Control, EOPE and LOPE groups. Administration
of L-Name was done between gestational days 8-17 for the treated
groups. Animals were sacriﬁced at GD 19, PND 1 and 60 and the
brain excised for further analysis. Our study conﬁrmed L-NAME
induced PE-like symptoms in rat models as evidenced by signiﬁcant
increase in systolic blood pressure and urine protein compared with
Control. There was upregulation of IBA1 expression and increased
microglial activation in the brain of PE rat models assessed at
gestational day 19, post-natal day 1 and 60. Also, IBA1 expression
is up regulated in the pups at post-natal day 1 and 60. Contrastingly,
EAAT1 expression is down-regulated in the brain of PE rat models
assessed at gestational day 19, post-natal day 1 and 60, as well as
offspring at post-natal day 1 and 60. These results demonstrate
likely neuro-inﬂammation within the brain of PE mothers during
pregnancy, that persist into later life, as well as possible neuro-
inﬂammation in brains of offspring of PE mothers.
MTU03-14
Neuronal SPHK1 acetylates COX2 and contributes to
pathogenesis in a model of Alzheimer’s disease
H. K. Jin1, M. H. Park2, B. J. Choi1, M. S. Jeong1, K. H. Park2, I. K.
Jung2, J.-s. Bae2
1College of Veterinary Medicine, Kyungpook National University,
Dept. of Laboratory Animal Medicine, Daegu, Korea South
2School of Medicine, Kyungpook National University, Dept. of
Physiology, Daegu, Korea South
Although many reports have revealed the importance of defective
microglia-mediated amyloid beta phagocytosis in Alzheimer’s
disease (AD), the underlying mechanism remains to be explored.
Here we demonstrate that neurons in the brains of patients with AD
and AD mice show reduction of sphingosine kinase1 (SphK1),
leading to defective microglial phagocytosis and dysfunction of
inﬂammation resolution due to decreased secretion of specialized
proresolving mediators (SPMs). Elevation of SphK1 increased
SPMs secretion, especially 15-R-Lipoxin A4, by promoting acety-
lation of serine residue 565 (S565) of cyclooxygenase2 (COX2)
84 Journal of Neurochemistry © 2019 International Society for Neurochemistry, J. Neurochem. (2019) 150 (Suppl. 1), 73--161
© 2019 The Authors
MTU03 Neuroinflammation & neuroimmunology (Session A)
using acetyl-CoA, resulting in improvement of AD-like pathology in
APP/PS1 mice. In contrast, conditional SphK1 deﬁciency in neurons
reduced SPMs secretion and abnormal phagocytosis similar to AD.
Overall, these results reveal a novel mechanism of SphK1 patho-
genesis in AD that leads to defective microglial phagocytosis due to
impaired SPMs secretion, and suggests that SphK1 in neurons has
acetyl-CoA dependent cytoplasmic acetyltransferase activity
towards COX2.
MTU03-15
TRPV4 activation contributes more to inﬂammation and
endothelial damage rather than calcium after spinal cord
injury
H. Kumar, I. Han
CHA University, Neurosurgery, Seongnamsi, Korea South
Importunate activation of transient receptor potential vanilloid
type 4 (TRPV4) is associated with cellular toxicity and might
contribute to the degeneration of neural tissue after spinal cord
injury (SCI). We examined the TRPV4 role and its involvement in
major biological cascades in the pathology of SCI. We studied
expression at 3 hours, 8 hours, 1, 3, 5, 7, 14, 21 and 28 day (s) in a
clinically relevant model of moderate compression (35 g for 5 min
at T10 level in rats) for SCI. Also, we checked the TRPV4
expression in injury dependent manner (compression using 20 g, 35
g and 50 g for 5 min) and transaction model of SCI. We
quantitatively estimate Ca²⁺ at the same time points using two-
photon microscopy and co-related the TRPV4 expression with Ca²⁺
after SCI. Additionally, we used a speciﬁc TRPV4 antagonist (RN-
1734 5 mg/kg, i.p.) and TRPV4 KO mouse to elucidate the role of
TRPV4 in SCI pathology. TRPV4 inhibition using speciﬁc antag-
onist (RN-1734 5 mg/kg, i.p.) attenuated the inﬂammatory cytoki-
nes, chemokines, promotes vascular stabilization prevented the tight
junctions protein degradation and blood-spinal cord barrier (BSCB)
break down after SCI. Likewise, TRPV4 KO mouse showed
reduced inﬂammation and prevented the tight junctions protein
degradation, BSCB breakdown, and neuropathic pain after SCI (20
g for 1 min). Thus, our result suggests that increased TRPV4
expression was associated with the early inﬂammatory phase of SCI,
tissue damage, vascular destabilization, BSCB breakdown, and cell
injury. Inhibiting TRPV4 signiﬁcantly attenuated SCI-induced
inﬂammation, BSCB breakdown, and cell injury. Additionally,
TRPV4 inhibition serves as a promising therapeutic strategy to
attenuate neuropathic pain, secondary damage and promoting
vascular stabilization after SCI.
MTU03-16
Evaluation of role of somatostatin and somatostatin type-
2 receptor in post-incisional nociception in rats
R. Kumar, P. Prasoon, S. Gupta, S. B. Ray
All India Institute of Medical Sciences, Anatomy, New Delhi, India
Background: Somatostatin (SST) is widely expressed in mam-
malian central and peripheral nervous system. It has signiﬁcant
modulatory effect on the release of neurotransmitters. Several
studies have observed the anti-nociceptive effect of its analogue
octreotide. However, its expression at the spinal level following an
acute nociceptive stimulus is not well known. Moreover, its
involvement in mediating nociception at the periphery is also not
well established. In the present study, the spatio-temporal expression
of SST and its receptor (type-2) was observed at the spinal level.
Thereafter, antinociceptive effect of somatostatin was assessed by
behavioural assays.
Methods: Male Sprague-Dawley rats (N = 88) were subjected to
hind paw incision. The expression study of SST and its receptor
type-2 was performed by Immunohistochemistry and Western blot
at different post-incisional time points (2 h, 8 h, day 1, day 3).
Comparison of anti-nociceptive effect of intra-wound (10, 30,
100mcg) and systemic (400 μg/Kg i.p.) SST administration was
evaluated by 3 different behavioural assays. Blood glucose level was
examined. c-Fos expression in the spinal cord was also studied.
Results: Expression of SST showed an upregulation at 2 h,
which decreased at 8 h and on day1. SSTr2 was also upregulated at
2 h and 8 h but decreased by day1. Repeated systemic administra-
tion relieved mechanical allodynia from 2 h to day 3. Intra-wound
SST relieved guarding pain between 2 h to day 3 and mechanical
allodynia from day 4 onwards. Blood glucose level remained
unaltered. c-Fos positive nuclei were signiﬁcantly less after SST
administration.
Conclusion: Somatostatin is involved in nociceptive modulation
at both central as well as peripheral levels. This information could
have clinical signiﬁcance.
MTU03-17
Novel curcumin derivatives and carotenoids as inhibitors
of amyloid-B aggregation and inﬂammation in Alzheimer’s
drug discovery
J. L. Beitia1, P. Llanes1, O. Larionov2, A. Durant1, K. S. Jagannatha
Rao1
1Institute of Scientiﬁc Research and High Technology Services
INDICASAT, Centre for Biodiversity and Drug Discovery,
Panama, Panama
2University of Texas at San Antonio, Chemistry, San Antonio, USA
Alzheimer’s disease (AD) is the most common neurodegenera-
tive disorder affecting the elderly population worldwide. Brain
inﬂammation plays a key role in the progression of AD. Deposition
of senile plaques in the brain stimulates inﬂammatory response with
the overexpression of pro-inﬂammatory mediators as IL-6. Drug
discovery based on nutraceutical molecules for prevention and
treatment of AD is a growing topic. In this sense, carotenoids and
polyphenols such as curcumin have been reported beneﬁts for
human health. Crypotcapsin showed the highest bioactivity, while
cryptocapsin-5,6-epoxide and zeaxanthin exhibited similar activity
on anti-aggregation assays. Meanwhile, curcumin has revealed to be
a potential compound for treating of AD following different
neuroprotective mechanisms, such as inhibition of aggregation and
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decrease in brain inﬂammation. Its low bioavailability, and suscep-
tibility to degradation in biological systems and poor solubility in
plasma has, however, prevented the curcumin as drug. We
synthesized new curcumin derivatives with the aim of providing
good anti-aggregation capacity but also improved anti-inﬂammatory
activity. Nine curcumin derivatives were synthesized by etheriﬁca-
tion and esteriﬁcation of the aromatic region. Compound 4 exhibited
a strong anti-aggregation effect higher than curcumin. Monofunc-
tionalized curcumin derivatives showed better bioactivity than
difunctionalized compounds. Moreover, the presence of bulky
groups in the chemical structure of curcumin derivatives decreased
bioactivity. Molecular docking analysis revealed that carotenoids
and curcumin derivatives might follow two mechanisms for
inhibiting Ab aggregation: one by preventing the formation of the
ﬁbril and second through disruption of the Ab aggregates.
MTU03-18
Alterations in CD300F immunoreceptor are associated to
depression in mice and humans
F. N. Kaufmann1, N. Lago2, M. L. Negro-Demontel3,2, R. Lopez-
Vales4, A. Abin5, R. Silva6, D. Lara7, G. Ghisleni6, M. Kaster1, H.
Peluffo2,3
1Federal University of Santa Catarina, Santa Catarina,
Florianopolis, Brazil
2Institut Pasteur de Montevideo, Montevideo, Montevideo, Uruguay
3Universidad de la Republica, Montevideo, Montevideo, Uruguay
4Universitat AutoÐ€noma de Barcelona, Bellaterra, Barcelona,
Spain
5Instituto de Investigaciones Biologicas Clemente Estable,
Montevideo, Montevideo, Uruguay
6Catholic University of Pelotas, Rio Grande do Sul, Pelotas, Brazil
7 Pontiﬁcal Catholic University of Rio Grande do Sul, Rio Grande
do Sul, Porto Alegre, Brazil
Depression is a high prevalent psychiatric disorder, especially
among women. Low-grade inﬂammation has been linked to
depression in mice and humans. CD300f immunoreceptor activation
leads to further inhibition of inﬂammatory process and appears to
have a protective role against injuries. However, the role of CD300f
immunoreceptors in depression was not elucidated yet. Here, we
demonstrated that female CD300f knockout mice (CD300f-/-) with
5 months old presented depressive and anhedonic behavior that
were persistent at 18 months of age. The 5-month-old CD300f-/-
females presented altered IL-6, IL1RN and IL-10 brain gene
expression and decreased hippocampal noradrenaline levels. Acute
bupropion treatment (noradrenaline/dopamine reuptake inhibitor)
improved female mice anhedonic behavior. Moreover, acute
lipopolysaccharide treatment exacerbated female mice anhedonic
behavior. In humans, the T allele from the polymorphism
(rs2034310 C/T) on CD300f immunoreceptors was associated with
protection against MDD in women in a cross-sectional population-
based study that included 1.110 individuals. In sum, we character-
ized for the ﬁrst time the potential role of CD300f immunoreceptors
in the regulation of mood and hedonic processes in mice and
humans, suggesting it may be useful as diagnostic biomarkers and as
new target for pharmacological intervention in depressive patients.
MTU03-19
Induction of cerebral hyperexcitability by peripheral viral
challenge is mediated by CXCL10
T. Petrisko1, S. Srinivas2, J. Bloemer2, Y. Du2, S. Setti2, V.
Suppiramaniam2, M. Reed2, G. Konat1
1West Virginia University, Biochemistry, Morgantown, USA
2Auburn University, Drug Discovery and Development, Auburn,
USA
Peripheral viral infections are potent comorbid factors that
exacerbate neurodegeneration, albeit, the underlying mechanisms
have not been deﬁned. In a quest to elucidate these mechanisms, we
have developed a preclinical model, in which a viral mimetic,
polyinosinic-polycytidylic acid (PIC) is injected intraperitoneally to
simulate peripherally-restricted viral challenge. We have demon-
strated that PIC challenge elicits robust hyperexcitability of cerebral
networks as seen from the development of seizure hypersuscepti-
bility, increased basal synaptic transmission (BST), and the
enhancement of long-term potentiation (LTP). Because neuronal
hyperexcitability is a causative factor in neurodegeneration, our
ﬁnding buttresses the contention that the enhancement of neuronal
hyperexcitability is the putative mechanistic link between peripheral
viral infections and exacerbations of neurodegeneration. At the
molecular level, PIC challenge-induced hyperexcitability is concur-
rent with robust generation of cerebral CXCL10, a chemokine
known to modulate neuronal activity. The present study was
undertaken to determine the involvement of CXCL10 and its
cognate receptor, CXCR3 in the development of neuronal hyper-
excitability. Brieﬂy, 8-week old female C57BL/6 mice were ip
injected with 12 mg/kg PIC or equivolume saline, and after 24 h,
the brains were analyzed. Confocal microscopy revealed CXCL10
to be generated primarily by neurons and astrocytes in the
hippocampus and cortex. No CXCL10 generation was found in
microglia. The expression of CXCR3 was conﬁned to neurons.
Blockage of CXCR3 through intracerebroventricular injection of an
inhibitor, AMG-487 (3 mg/kg), abolished PIC-induced increase of
BST and LTP. Based on these results, we posit that the activation of
neuronal CXCL10/CXCR3 axis drives the development of hyper-
excitability instigated by PIC challenge.
MTU03-20
Development of novel therapeutics against Alzheimer’s
disease by targeting neuroinﬂammation in SH-SY5Y cells
K. Rafi1, S. S. Hussain2, S. Faizi2, S. U. Simjee1,2
1ICCBS, Dr. Panjwani Center for Molecular Medicine and Drug
Research, Karachi, Pakistan
2ICCBS, H.E.J. Research Institute of Chemistry, Karachi, Pakistan
Neuroinﬂammation plays an important role in pathogenesis and
progression of Alzheimer’s disease (AD), mainly characterized by
the presence of senile plaques and neuroﬁbrillary tangles. The
production of inﬂammatory mediators, ROS and RNS causes
synaptic dysfunction that is responsible for AD associated memory
decline. To understand the role of inﬂammation in AD pathogenesis,
we have developed an in vitro model of AD using Phytohaemag-
glutinin (PHA) to target AD at early stage by suppressing
neuroinﬂammation and delay its onset and progression. Initially
plaques formation was observed using Phytohaemagglutinin (PHA).
SH-SY5Y cells were incubated with 5-40 μg/ml PHA for 24 hours
and cellular morphology was observed by microscopy. Oxidative
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stress was analyzed at same concentrations by ﬂuorimetric method
using 2’,7’-dichlorodihydroﬂuorescein diacetate. Presence of Ab
plaques upon PHA stimulation was conﬁrmed by immunocyto-
chemistry. RT-qPCR was performed to analyze the gene expression
of inﬂammatory markers (TNF-a, IL-1b, iNOS, P38-a and P38-b)
and secretases involved in plaques formation. Morphologically no
prominent changes appeared at 5 μg/ml PHA while visible aggre-
gates were observed at 10, 20 and 40 μg/ml concentrations.
Oxidative stress analysis demonstrated signiﬁcant increase in ROS
levels at 10 μg/ml PHA. Immunocytochemistry at 10 μg/ml PHA
showed signiﬁcant increase in Ab expression than unstimulated
cells. Gene expression analysis showed altered expression of genes
in PHA stimulated cells. Further we have screened different
compounds for their neuroprotective effect and found that quinic
acid and N-(2-hydroxyphenyl) acetamide increased cell viability.
Next, we will test these compounds and determine their molecular
mechanism in reducing PHA-induced neuroinﬂammation and Ab
generation.
MTU03-21
Differential effects of age and cytokines between brain
areas: when histology meets biophysics
P. Sanchez-Molina1, N. Benseny-Cases3, B. Gonzalez1, B.
Castellano1, A. Peralvarez-Marın2, B. Almolda1
1Autonomous University of Barcelona, Cell Biology, Physiology and
Immunology, Barcelona, Spain
2Autonomous University of Barcelona, Biochemistry and Molecular
Biology, Barcelona, Spain
3ALBA Synchrotron Light Source, MIRAS, Barcelona, Spain
Microglial cells become hyper-activated during physiological
aging. This activation varies among brain areas, being higher in
white matter (WM) compared to grey matter (GM). Previous results
from our laboratory show that microglial cells expressed phagocytic
receptors involved in myelin recognition solely in WM areas during
aging, indicating aging-derived myelin damage. Moreover, trans-
genic (Tg) animals overproducing IL-6 and IL-10, two altered
cytokines during aging, show differences in the expression of these
myelin-recognition receptors. Thus, our aim is to evaluate whether
the speciﬁc microglial changes observed in WM areas of aged and
transgenic mice are related to alterations in myelin composition. We
used the synchrotron-μFTIR as a highly sensitive method to asses
lipid and protein composition in tissues. Our results indicate that
there are regional differences between GM and WM regardless of
age and genotype. Low lipid:protein ratio and high oxidation are
found on GM compared to WM. We observe decreased lipid:protein
ratio and lipid oxidation in WM areas of WT aged compared to adult
animals. We also detect lower lipid:protein ratio and higher
oxidation in Tg adults compared to WT in WM, but no signiﬁcant
difference is observed between WT and Tg aged. In GM, we
observe lower lipid oxidation in Tg aged animals compared to WT.
The present study shows that aging correlates with a loss of lipid in
WM, supporting our aging-related myelin damage/deterioration
hypothesis. Besides, changes in the cytokine microenvironment
modify lipid composition in aging and adulthood.
MTU03-22
Inﬂammation contributes to greater visual pathway
dysfunction in animal models of multiple sclerosis
M. Sekyi, K. Atkinson, C. Diaz, M. Feri, S. Noori, W. Rincon, S.
Tiwari-Woodruff
University of California - Riverside, School of Medicine -
Biomedical Sciences, Riverside, USA
Multiple sclerosis (MS) is an inﬂammatory, demyelinating and
neurodegenerative disease with impaired visual function, a prevalent
feature in the majority of patients. Considering optic neuritis is an
early marker of MS, we hypothesize that the presence of inﬂam-
mation throughout the visual pathway combined with demyelination
plays a signiﬁcant role in visual dysfunction. To understand the role
of inﬂammation and chronic demyelination on visual dysfunction in
MS, two commonly used mouse models for MS, the lymphocyte-
mediated chronic experimental autoimmune encephalomyelitis
(EAE) and the non-lymphocyte mediated chronic cuprizone diet
demyelination model were used to assess and compare visual
pathway pathology. Longitudinal in vivo electroretinograms and
visually evoked potentials (VEP) were used to assess visual function
in EAE (1, 3, 5, and 8 weeks) and cuprizone (3, 6, 9, and 12 weeks)
mice. Five mice were euthanized at denoted time points for
immunohistochemistry analysis correlating to in vivo assessments.
Myelination, inﬂammation, and neurodegeneration in visual path-
way structures was assessed by immunohistochemistry. Elec-
troretinograms and VEPs for both EAE and cuprizone animals
exhibited changes in latency and/or amplitude. Response time to
light stimulus stabilized with disease progression, however magni-
tude of the visual responses did not. IHC analysis revealed
differences in EAE and cuprizone groups. Inﬂammation, demyeli-
nation and neurodegeneration was substantial in EAE thought the
visual pathway, however, cuprizone showed signiﬁcantly less
inﬂammation and neurodegeneration, but exhibited localized struc-
tural demyelination as compared to EAE. In summary, our results
reveal a signiﬁcant role of inﬂammatory demyelination in causing
signiﬁcant visual pathway neurodegeneration in EAE as compared
to minimal axon damage with cuprizone demyelination, mimicking
diverse pathology observed in MS patients.
MTU03-23
TGF-b associated MAPK pathway: a possible approach to
halt pentylenetetrazole-induced epileptogenesis in mice
M. Shahid1, U. Nisar1, F. Shaheen1, A-u. Rahman1,2, M. I.
Choudhary1,2, M. Askani1, S. U. Simjee1,2
1 ICCBS, H.E.J. Research Institute of Chemistry, Karachi, Pakistan
2 ICCBS, Dr. Panjwani Center for Molecular Medicine and Drug
Research, Karachi, Pakistan
Epilepsy is illustrated by persistent predisposition of the brain to
generate seizures and considered as one of the most common
neurological disorder affecting 1% of the individuals worldwide. A
growing body of advanced researches now points a link between
inﬂammation and various epilepsy syndromes, reﬂecting both an
inﬂammatory state inside the epileptic brain along with increased
BBB permeability, heading towards enhanced neuronal excitability.
The probable contribution of TGF-b in epileptogenesis is reinforced
by animal studies viewing TGF-b up-regulation as measure of
inﬂammatory reaction in the brains of kindled animals that are
exposed to status epilepticus. The main focus of this study was to
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investigate the potential relationship between the TGF-b associated
MAPK pathway and epilepsy which will aid in conﬁrming that up
regulation of TGF-b genes might be one of the underlying cause of
epilepsy. A novel anticonvulsant [E/Z] isoxylitones was used to treat
epileptic seizures in pentylenetetrazole-induced kindling model of
mice. To conﬁrm aforementioned evidences, expression levels of
TGF-b, TRAF6, and JNK3 with inﬂammatory cytokine IL-1 b were
analyzed. It was observed that as compared to the PTZ-control
group, there was a signiﬁcant decrease in the response of seizures
observed in [E/Z] isoxylitones treated group. Furthermore, expres-
sions of these genes were signiﬁcantly reduced in [E/Z] isoxylitones
treated groups. It is concluded that, TGF-b signaling pathway can be
a potential subcellular target for reducing seizure duration and [E/Z]
isoxylitones is an effective way to achieve this therapeutic target.
MTU03-24
The effect of guarana (paullinia cupana mart.) in a
LPS-induced inﬂammation rat model
A. Silveira, A. Kunzler, C. T. Ribeiro, J. Gasparotto, P. Brum, D.
Gelain, J. C. Moreira
Federal University of Rio Grande do Sul, Biochemistry, Porto
Alegre, Brazil
Neuroinﬂammation is present in several neurodegenerative
disorders. Polyphenols have been proposed to be useful as adjuvant
therapy in inﬂammatory process, because of their anti-inﬂammatory
effects. Besides, epidemiological evidence suggests that caffeine
consumption reduces the risk of several neurological and neurode-
generative diseases. Guarana (Paullinia cupana Kunth var. sorbilis
(Mart.) Ducke) is a nontraditional medicinal plant, which effects are
mainly related to the high polyphenol content and large amount of
caffeine. The effects of Guarana supplementation on a neurological
and systemic inﬂammation state are still poorly understood. In this
work, we investigate the role of Guarana supplementation in a
systemic inﬂammation induced by lipopolysaccharide (LPS). Wistar
rats received oral supplementation of guarana (42 mg/Kg/day) for
28 days prior to an intraperitoneal LPS injection (5 mg/Kg).
Immunostaining of Iba-1 and GFAP demonstrated that LPS
modulates glial activation in the substantia nigra 24 h after LPS
stimulus, effect that was prevent by Guarana supplementation.
However, ELISA analyses revealed that guarana was not able to
prevent the LPS-induced increase of IL-1b in the substantia nigra. In
fact, guarana slightly increased the amount of this proinﬂammatory
cytokine. In serum, guarana supplementation did not present any
effect on IL-1b levels. Guarana pre-treatment reduced TNF-a levels
in serum in healthy conditions, but it had no protective effect against
LPS insult. Spleen ﬂow cytometry shown that guarana did not
induced an antibody immune response through CD3 + antibodies
activation. Therefore, these results indicate Guarana supplementa-
tion had an effect on glial modulation, without had an effect on
proinﬂammatory cytokines release nor on antibody immune
response.
MTU03-25
Ameliorative potential of furanocoumarin for acute and
chronic pain studies: synthesis, molecular docking
analysis and biological
G. Singh, R. Bhatti
Guru Nanak Dev University, Amritsar-143005, Punjab,India,
Department of Pharmaceutical Sciences, AMRITSAR, India
Objective: Furanocoumarin are substituted 6,7-furylcoumarins
with wide range of pharmacological activities. In this study,
synthesis and investigation biological activity of FCs an acute and
chronic inﬂammatory pain has been undertaken.
Methods: A series of FCs were synthesized (Gs1-Gs5) and
docked at the sites of iNOS, COX-2 and NFjB. Acute toxicity of
most active compound was carried as per OECD guidelines. In acute
study, analgesic and anti-inﬂammatory activity of compounds were
tested using acetic acid writhing, formalin induced nociception and
carrageenan test in mice. In chronic studies, vincristine induced
neuropathic pain was employed. Post mortem studies including
biochemical analysis for inﬂammatory mediators and immunohis-
tological examinations were performed.
Results: Docking studies on the active sites of COX-2, iNOS and
NFjB indicated good binding of compound Gs4 with appreciable
docking score. Acute toxicity studies revealed largely unremarkable
visceral organs including heart, liver and kidney. Pharmacological
studies indicated signiﬁcant analgesic effect and anti-inﬂammatory
activity of different compounds with maximum activity of com-
pound Gs4. In neuropathic pain, marked reduction in pain behavior
was observed in compound treated group. Compound Gs4 also
attenuated expression of COX-2, iNOS and NFkB, as well as
inﬂammatory cytokines and oxidative stress.
Conclusion: It based on the results of the current investigation, it
may be concluded that FCs nucleus provide interesting leads for an
molecules with promising analgesic & anti-inﬂammatory potential.
MTU03-26
Esculetin ameliorates polyi:C-induced autism spectrum
disorder in mice by impeding neuroinﬂammation and
improving BDNF signaling
K. Sulakhiya1, V. Paramanik2
1Indira Gandhi National Tribal University IGNTU, Department of
Pharmacy, Amarkantak, India
2Indira Gandhi National Tribal University IGNTU, Department of
Zoology, Amarkantak, India
Maternal immune activation (MIA) in pregnant mother causes
autism spectrum disorder (ASD) in offspring by stimulating
immuno-inﬂammatory and oxido-nitrosative pathway while inhibit-
ing serotonergic neurotransmission and brain derived neurotrophic
factor (BDNF) level. Esculetin (ESC) possesses antioxidant, anti-
inﬂammatory and neuroprotective activities. The study is designed
to investigate the effect of ESC against poly(I:C)-induced ASD in
mice and biochemical changes in placenta, fetal brain and adult
mouse brain. Female C57BL/6 mice (n = 4-5) were pre-treated with
esculetin (25 & 50 mf/kg, p.o.) from E0.5 to E12.5 and injected poly
(I:C) (20 mg/kg, i.p.) on E12.5 to induce MIA. After 4 h of poly(I:
C) injection mice were sacriﬁced to measure cytokines (IL-17a, IL-6
& IL-10), NO, and BDNF level in placenta and fetal brain. Other
pregnant mice were allowed to deliver pups, and these offspring
were subjected to behavioural testing in EPM & 3 chambered test at
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5 & 12 weeks of age to assess anxiety and social interaction, and
then sacriﬁced for cytokines, serotonin and BDNF analysis.
Findings demonstrated that poly(I:C) signiﬁcantly decreased both
open arms entries and duration in EPM (p < 0.01) and decreased
time spent with novel mouse in 3 chambered test (p < 0.001) which
was signiﬁcantly (p < 0.01) ameliorated by ESC pre-treatment.
Cytokines and NO level in mice were increased signiﬁcantly
(p < 0.001) after poly(I:C) injection which were reversed by ESC
pre-treatment. Furthermore, ESC pre-treatment attenuated poly(I:C)-
induced decrease in IL-10, 5-HT & BDNF level in mice. In
summary, results suggested that ESC provided ameliorating effect
against poly(I:C)-induced neurobehavioral and neurochemical alter-
ations by impeding neuroinﬂammation, nitrosative stress, and up-
regulating serotonergic & BDNF signaling mechanism.
MTU03-27
DA attenuates LPS-induced cytokine expression by
inhibiting the microtubule-dependent nuclear transport of
NF-KB P65 in BV-2 cells
Y. Yoshioka, Y. Sugino, F. Shibagaki, A. Yamamuro, Y. Ishimaru, S.
Maeda
Setsunan University, Pharmaceutical Sciences/
Pharmacotherapeutics, Hirakata, Japan
We recently reported that dopamine (DA) attenuated lipopolysac-
charide (LPS)-induced mRNA expression of cytokines by inhibiting
the nuclear translocation of NF-jB p65 in mouse microglial cell line
BV-2, and that the covalent modiﬁcation of proteins by dopamine
quinone might be involved in its inhibition. It has been reported that
NF-jB p65 is microtubule-dependently transported to nuclei in
neuronal cells and that b-tubulin, a component of microtubules, is
one of the proteins that are susceptible to covalent modiﬁcation by
dopamine quinone. To further investigate the mechanism by which
DA inhibited the nuclear translocation of NF-jB p65, in the present
study, we examined the involvement of the microtubule-dependent
transport system in the nuclear translocation of NF-jB p65 in BV-2
cells by using vinblastine, a microtubule-disrupting agent. Vin-
blastine (0.3 lM) inhibited the LPS (10 lg/mL)-induced increase in
the NF-jB p65 level in the nuclear fraction, but not affect the LPS
(10 lg/mL)-induced decrease in the IjBa level in the whole cell
lysate. Immunocytochemistry revealed that the treatment with
vinblastine (0.3 lM) disrupted microtubules, changed the morphol-
ogy of BV-2 cells, and blocked the LPS (10 lg/mL)-induced
nuclear translocation of NF-jB p65. On the other hand, although
DA (30 lM) inhibited the LPS (10 lg/mL)-induced nuclear
translocation of NF-jB p65, it did not affect the morphology of
BV-2 cells or the structure of the microtubules. These results
indicate that NF-jB p65 was transported to the nuclei via the
microtubule-dependent transport system in BV-2 cells and that DA
inhibited the microtubule-dependent transport system.
MTU03-28
Motor and synaptic deﬁcit in 5-lipoxygenase knockout
mice
M. C. Silva1, R. M. Campos1, J. Franca2, P. Frost2, J. Clarke2, V. T.
R. de Resende1, C. Canetti1
1Federal University of Rio de Janeiro, Institute of Biophysics, Rio
de Janeiro, Brazil
2Federal University of Rio de Janeiro, School of Pharmacy, io de
Janeiro, Brazil
The 5 (5-LOX) is an essential enzyme in the synthesis of
leukotrienes and lipoxins. It is widely expressed in cells involved in
the regulation of inﬂammation, allergies and other immune
responses. However, recent works show that central nervous system
(CNS) neurons express high levels of 5-LOX, although the
physiological role of neuronal 5-LOX remains unclear. The present
work aims to evaluate how the absence of 5-LOX enzyme can
inﬂuence synaptic plasticity, microglial activation and regeneration.
For this purpose, 129/sv male adult mice knockout for 5-LOX (5-
LO-/) or wild type (5-LO +/+) were used. The basal levels of
synaptophysin and PSD95 were evaluated by western blot analysis
in the motor cortex and hippocampus of both groups. Synaptophysin
levels were signiﬁcantly higher both in motor cortex and hippocam-
pus of 5-LO -/- animals, when compared to WT animals (n = 6;
p < 0.01). Moreover 5-LO-/- animals show a lower baseline motor
performance, assessed by the rotarod test, when compared to WT
animals (n = 10, p < 0.01). In spite of the results obtained in the
motor analysis, no differences were observed in the sensorial tests
(Von frey hair test, formalin test and hot plate test). Microglial
quantiﬁcation and morphology was evaluated by immunoﬂuores-
cence through labeling Iba-1 protein in the motor cortex and
hippocampus, this quantiﬁcation showing similar results for both 5-
LO-/- and WT group.
MTU03-29
Conditional knockout of LKB1 from astrocytes increases
inﬂammatory activation and metabolic dysfunction:
effects on EAE disease
D. Feinstein1,5, S. Kalinin1, G. Meares2, S. Lin1, L. Pietruczyk1,
G. Saher3, K. Nave3, E. Benveniste4
1University of Illinois, Anesthesiology, Chicago, USA
2West Virginia University, Microbiology, Immunology and Cell
Biology, Morgantown, USA
3Max Planck Institute of Experimental Medicine, Neurogenetics,
Gottingen, Germany
4University of Alabama at Birmingham, Cell, Developmental, and
Integrative Biology, Chicago, USA
5Jesse Brown VA Medical Center, Research, Chicago, USA
The consequences of astrocyte metabolic dysfunction in EAE
disease are not well characterized. Liver Kinase B1 (LKB1) is a
ubiquitously expressed kinase involved in regulation of cell
metabolism, growth, and inﬂammation. We previously reported
that a single nucleotide polymorphism in the gene encoding LKB1
is a risk factor for multiple sclerosis (MS). We now examined the
consequences of LKB1 conditional knockout (cKO) from astrocytes
in the MOG peptide chronic MS model. While disease incidence
was similar, disease severity was worsened in cKO mice. RNAseq
analysis identiﬁed KEGG pathways enriched in cKO mice relating
to mitochondrial function, conﬁrmed by alterations in mitochondrial
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complex proteins and reductions in mRNAs related to astrocyte
metabolism. Enriched pathways also included major histocompat-
ibility class II genes, conﬁrmed by increases in MHCII protein in
spinal cord and cerebellum of cKO mice. We observed increased
presence of CD4+ Th17 cells and increased neuronal damage in
spinal cords of cKO mice, associated with reduced expression of
choline acetyl-transferase, accumulation of immunoglobulin-g, and
reduced expression of factors involved in motor neuron survival. In
vitro, LKB1-deﬁcient astrocytes showed reduced metabolic function
and increased inﬂammatory activation. These data suggest that
metabolic dysfunction in astrocytes, in this case due to LKB1
deﬁciency, exacerbates demyelinating disease by loss of metabolic
support and increase in the inﬂammatory environment.
MTU03-30
Digoxin regulates oligodendrocyte number, function, and
myelin structure
H. Titus, S. Miller
Northwestern University, Microbiology-Immunology, Chicago, USA
Demyelination and neurodegeneration are part of the pathology
in the CNS autoimmune disease of Multiple Sclerosis (MS). At
present, all clinical trials of potential myelin repair therapies have
failed. As MS is a chronic disease that often presents in young
adulthood, there is a need for both halting progression and repairing
existing damage. In a collaborative effort, the NIH library of oral
FDA approved drugs was screened for potential myelin repair
therapy candidates. The Na+/K+ ATPase inhibitor Digoxin was a top
candidate and our studies revealed it promoted an increase in the
oligodendrocyte cell lineage in vitro and in vivo in C57BL/6 mice as
well as in the LPC spinal cord model of demyelination/remyelina-
tion, in the non-T cell-mediated Cuprizone model of demyelination/
remyelination promoted a quicker restoration of myelin integrity in
the corpus callosum, and improved clinical score throughout the
autoreactive Th1/Th17 driven C57BL/6 Chronic experimental
autoimmune encephalomyelitis (EAE) time course. MS patients
currently have access to disease-modifying therapies that are global
immunosuppressants with limited efﬁcacy and a wide range of side
effects. Our lab is able to induce immune tolerance to selectively
target the immune system in relapsing-remitting (RREAE) and
chronic progressive (C-EAE) experimental autoimmune
encephalomyelitis murine models of MS using an i.v. infusion of
nanoparticles coupled with or encapsulating myelin peptides (Ag-
PLG) that prophylactically prevent disease and therapeutically stop
disease progression. Our hypothesis was that a combination of
selective immune regulation and myelin repair therapy is required to
effectively target disease course and severity in MS. Combination
therapy with PLG-MOG and Digoxin at peak of C-EAE disease
completely ameliorated clinical disease severity. These promising
pre-clinical ﬁndings steer toward future clinical trials using combi-
nation therapy in MS.
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MTU04-01
Role of acetamide analogue in arthritic rat model
Z. A. Razzak, Shabana. U. Simjee
International Center for Chemical and Biological Sciences ICCBS,
Dr. Panjwani Center for Molecular Medicine and Drug Research,
Karachi, Pakistan
Instruction: Rheumatoid Arthritis (RA) is considered as persis-
tent inﬂammation of multiple joints, however it may affect the other
parts of the body as well. Due to the production of matrix
metalloproteinases (MMPs) enzymes, destruction of extracellular
matrix (ECM) proteins occur. These MMPs are rate-limiting factor
in the degradation of collagen a major part of ECM. Autoimmunity
is also link along with inﬂammation and has an ample societal effect
in cost, disability, and productivity loss. Severity of disease can be
lessen but not completely cure by certain pharmacologic interven-
tions. The aim of this proposed study is to target the production of
MMPs to ﬁnd the new and potent and safe therapeutic moiety for the
treatment of RA.
Material and Method: In the present study collagen induced
arthritis (CIA) was develop on female rats. Severity of arthritis was
check by paw edema test, blood was collected for serum separation
and TNF, GSH, NO and PO were assayed. Brain samples are
processed to check gene expression proﬁling of certain inﬂamma-
tory markers on Real Time PCR.
Results and Conclusion: Based on our data, we found that the
group who were treated with Acetamide analogue shows signiﬁcant
decrease in paw edema. SH, NO, and PO assay results show
decrease in the level, by comparing treated and non-treated groups.
Hence we concluded that, Acetamide analogue has the potential
anti-inﬂammatory activity in joints. These results will be further
conﬁrmed by ELISA experiments speciﬁcally for MMPs and
immunohistochemistry of joints. In future, this will lead to new
drug development for rheumatoid arthritis.
MTU04-02
PI3K inhibition reduces mechanical allodynia and
sensitization of spinal TRPV1 in a model of paclitaxel-
induced neuropathy
P. Adamek1,2, M. Heles1,2, J. Palecek1
1Institute of Physiology of the Czech Academy of Sciences, Dept. of
Functional Morphology, Prague, Czech Republic
2Faculty of Science, Charles University, Dept. of Animal
Physiology, Prague, Czech Republic
Peripheral neuropathy is a major adverse effect of paclitaxel
chemotherapy. We have reported previously that paclitaxel
increased TRPV1 sensitivity to repeated capsaicin application via
TLR4-mediated mechanism. The results presented here describe the
role of phosphatidylinositol 3-kinase (PI3K) in the paclitaxel-
induced signaling between TLR4 and TRPV1. Neuropathy was
induced by a single application of Paclitaxel (Mylan, 8 mg/kg, i.p.)
in adult male mice C57BL/6. Mechanical allodynia was evaluated
by paw withdrawal threshold measurement. Whole-cell patch-clamp
recordings of miniature excitatory postsynaptic currents (mEPSC)
were made from superﬁcial dorsal horn spinal neurons. Paclitaxel-
induced robust mechanical allodynia was prevented for up to eight
days by PI3K antagonist wortmannin pretreatment in vivo. Both
in vitro and in vivo paclitaxel treatments enhanced capsaicin-evoked
responses recorded as an increased mEPSC frequency in dorsal horn
neurons. Acute co-application of PI3K antagonist wortmannin or
LY-294002 with paclitaxel attenuated this effect of paclitaxel. Acute
in vivo paclitaxel administration also increased phosphorylation of
Akt kinase, a marker of enhanced PI3K signaling, in rat L5 DRG
neurons. Wortmannin pretreatment prevented this increase in pAkt
expression. We showed that PI3K plays an important role in the
early development and maintenance of mechanical allodynia and in
the modulation of TRPV1 function after paclitaxel treatment. We
suggest that inhibition of PI3K may help alleviate pathological pain
in the paclitaxel-induced neuropathy. New data focused on pacli-
taxel-induced changes of inhibitory synaptic transmission will be
presented on site. Grant Support: Czech Science Foundation 18-
09853S, LQ1604 BIOCEV-FAR, BIOCEV CZ.1.05/1.1.00/
02.0109, RVO:67985823, GAUK 734218.
MTU04-03
Neuroprotective inﬂuence of luteolin and gallic acid on
cobalt-induced behavioural and biochemical alterations in
rats
A. Akinrinde, O. Adebiyi
University of Ibadan, Nigeria, Department of Veterinary Physiology
and Biochemistry, Ibadan, Nigeria
Cobalt (Co) intoxication arising from occupational exposures and
ion release from metal implants has been associated with neurolog-
ical alterations such as cognitive decline, incoordination and
depression. The present study evaluated the mechanisms of
neuroprotection by Luteolin (100 mg/kg) and Gallic acid
(120 mg/kg) in Wistar rats exposed to cobalt chloride (CoCl2) at
150 mg/kg for 7 consecutive days. Cognition, grip strength and
motor coordination were assessed with the Morris water maze,
hanging wire and Open Field tests, respectively. Rat’s whole brain
samples were processed for biochemical analyses of markers of
oxidative damage and acetylcholinesterase activity. Immunohisto-
chemistry was used to measure the immuno-reactivity of glial
ﬁbrillary acidic and calbindin D-28k proteins in brain tissues.
Results indicate that CoCl2 induced neuro-behavioural deﬁcits,
speciﬁcally producing decreased exploratory activities, increased
anxiety and signiﬁcant reduction in hanging latency. Co-treatment
with luteolin or gallic acid, however, restored these parameters to
values near those of normal controls. Moreover, Luteolin and Gallic
acid prevented CoCl2-induced increases in hydrogen peroxide,
malondialdehyde and nitric oxide in the brain, while increasing the
activities of acetylcholinesterase, glutathione S-transferase and
superoxide dismutase. Furthermore, Luteolin or Gallic acid treat-
ment produced increased astrocytic expression of glial ﬁbrillary
acidic protein (GFAP), with intense calbindin (CB) staining and
pronounced dendrites in the Purkinje cells. Taken together, luteolin
and/or gallic acid exerted protection against Co neurotoxicity by
restoring Ca2+ homeostasis, acetylcholinesterase and antioxidant
enzyme activities, while also inhibiting lipid peroxidation in the
brain.
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MTU04-04
Several disease-associated properties of the beta-amyloid
peptide are neutralized by its phosphorylation
E. Barykin1, I. Petrushanko1, S. Kozin1, V. Mitkevich1, S. Radko2, A.
Makarov1
1EIMB RAS, Laboratory of protein conformational polymorphism
in health and disease, Moscow, Russia
2IBMC RAS, Laboratory of transcriptomic analysis, Moscow,
Russia
Zinc-induced oligomerization of Ab represents a potential
seeding mechanism for the formation of neurotoxic Ab oligomers
and aggregates in Alzheimer’s disease (AD). Phosphorylation of Ab
by Ser8 (pS8-Ab), found in vivo, is localized inside the zinc-binding
domain of the peptide and may signiﬁcantly alter its zinc-induced
oligomerization and related pathogenic properties. Indeed, using
dynamic light scattering (DLC) and complementary methods we
have shown that phosphorylation by Ser8 dramatically reduces zinc-
induced aggregation of Ab, and moreover, pS8-Ab suppresses zinc-
driven aggregation of non-modiﬁed Ab in an equimolar mixture. We
have further analyzed the effect of pS8-Ab on the progression of
cerebral amyloidosis with serial retro-orbital injections of the
peptide in APPSwe/PSEN1dE9 murine model of AD, followed by
histochemical and immunohistochemical analysis of amyloid burden
in the hippocampus. Unlike the non-modiﬁed Ab that has no
inﬂuence on the amyloidosis progression in murine models of AD,
pS8-Ab injections reduced the number of amyloid plaques in the
hippocampus of mice by one-third. Recently shown inhibition of
Na+,K+-ATPase activity by Ab is prevented by phosphorylation of
the peptide. We showed that the binding of Ab to Na+,K+-ATPase
creates a seed for Ab oligomerization, which leads to the inhibition
of Na+,K+-ATPase. Such Na+,K+-ATPase-based oligomerization is
not observed for pS8-Ab. Moreover, the presence of Na+,K+-
ATPase in solution hastens the zinc-dependent aggregation of Ab;
the aggregation of pS8-Ab in presence of Na+,K+-ATPase does not
change. Thus, several AD-associated pathogenic properties of Ab
are neutralized by its phosphorylation.
Supported by RSF grant #19-74-30007.
MTU04-05
Modulation of the hyaluronan-based extracellular matrix
in mouse models of epilepsy
A. Blondiaux1, S. Jia2, R. Frischknecht3,1, A. Fejtova4, A. Dityatev2,
E. Gundelfinger1, C. Seidenbecher1
1Leibniz Institute for Neurobiology, Neurochemistry and Molecular
Biology, Magdeburg, Germany
2German Center for Neurodegenerative Diseases DZNE, Molecular
Neuroplasticity, Magdeburg, Germany
3University of Erlangen-Nuremberg, Biology, Erlangen, Germany
4Erlangen University Clinic, Molecular neurobiology, Erlangen,
Germany
The composition of the brain extracellular matrix (ECM) can
affect neuronal activity via changes to neuronal properties. In turn,
neuronal activity regulates the ECM composition. This balance is
disrupted in epilepsy as neuronal activity is not properly regulated.
We hypothesize that there is a correlation between the severity of
epileptic phenotypes and the composition and integrity of the
hyaluronan-based ECM. This ECM consists of proteoglycans (like
brevican or aggrecan), which bind to hyaluronan with the help of
link proteins (like HAPLN1) and glycoproteins (like tenascins).
To investigate this correlation, we use new models of epilepsy:
three mouse lines, mutant for the presynaptic scaffolding protein
Bassoon (Bsn). In the same animals, we recorded EEGs and
extracted the forebrain to quantify ECM proteins in different sub-
cellular fractions, including synaptosomes.
We show that lack of functional Bsn causes frequent seizures in
adult mice. A survival study suggests that epilepsy could be present
already in early life. Interestingly, some ECM proteins are correlated
with seizure parameters. Brevican strongly correlates with seizures,
making it a protein of interest for further analysis.
Our work suggests that the ECM composition in the epileptic
brain may be of interest for diagnostic purposes and as a potential
therapeutic target.
This project has received funding from the European Union’s
Horizon 2020 research and innovation programme under the Marie
Sklodowska-Curie grant agreement No 642881.
Work in the authors labs is funded by the DFG (SFB779 to A.D.,
R.F, C.S., E.G.).
MTU04-06
Impaired synaptic vesicle recycling in a rat model of
fragile X syndrome
K. Bonnycastle, P. Kind, M. Cousin
University of Edinburgh, Centre for Discovery Brain Sciences,
Edinburgh, United Kingdom
Fragile X syndrome (FXS) is a leading monogenic cause of
intellectual disability, autism spectrum disorder, and epilepsy. It
results from the loss of the fragile X mental retardation protein
(FMRP). Although historically considered a disorder of the
postsynapse, there is evidence for presynaptic defects in mouse
models of FXS, including accelerated synaptic vesicle (SV)
recycling and an increased number of SVs in the recycling pool.
Due to this, we aimed to characterise SV exocytosis and endocytosis
through clathrin-mediated endocytosis (CME) and activity-depen-
dent bulk endocytosis (ADBE) in a novel rat model of FXS. We
hypothesise that a deﬁcit in SV recycling may be an important
feature of the presynaptic phenotype in Fmr1/y rats. Using live-cell
imaging in hippocampal neurons, we observed that the rate of CME
was not altered in Fmr1/y compared to wildtype littermates at either
low frequency or high frequency stimulation. Interestingly, there
were fewer nerve terminals undergoing ADBE, the predominant
endocytosis mode during elevated neuronal activity, in Fmr1 KO
hippocampal neurons compared to WT. Additionally, using electron
microscopy, we observed fewer bulk endosomes in Fmr1 KO nerve
terminals although the number of SVs was unchanged across
genotypes. These results taken together suggest insufﬁcient SV
endocytosis in this model. This SV endocytosis deﬁcit could in turn
lead to neurotransmission failure which may, in part, underlie the
deﬁcits observed in FXS.
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MTU04-07
Regulation of KCNQ genes as a mechanism underlying
epileptogenesis
R. Butler-Ryan
University of Leeds, Faculty of Biological Sciences, Leeds, United
Kingdom
Epilepsy is a common and debilitating neurological disorder
which is often associated with ion channel dysfunction. The M-
current released by Kv7 voltage-gated potassium channels helps to
control hyperexcitability within the neuron, and mutations in the
KCNQ genes encoding this channel result in a form of epilepsy. An
insult such as an initial seizure can alter gene expression patterns
and cell function which drives the neuron toward hyperexcitability
and epileptogenesis, making the individual more susceptible to
further seizures. Organotypic hippocampal slice cultures provide a
convenient method for development of an epileptogenic model
which retains a high degree of structural and functional similarity to
the brain in vivo. They also provide an easy medium for applying
treatments and analysing the effects through various techniques.
Presented are details surrounding the technicalities of developing a
robust organotypic system for this type of work, and data showing
successful adenoviral infection for manipulation of gene expression
in the organotypic hippocampal cultures. Previous research has
shown the KCNQ2 and KCNQ3 genes encoding the Kv7 channel
subunits to be downregulated by the transcription factors REST, but
this mechanism is not well understood. Using adenoviral gene
transfer, electrophysiology, qRT-PCR and immunohistochemistry,
current work is focussing on elucidating this mechanism to highlight
key areas for therapeutic targeting to prevent epileptogenesis in
people who have suffered an initial brain trauma.
MTU04-08
Ibogaine downregulates CREB1 and GRIA1 mRNA
expression in the dorsal hippocampus
T. Calvey1, J. Woolf1, C. Dickens2
1University of the Witwatersrand, Anatomical Sciences,
Johannesburg, South Africa
2University of the Witwatersrand, Internal Medicine,
Johannesburg, South Africa
The glutamatergic system of the hippocampus plays a central role
in learning and memory of drug-related associations. Ibogaine is an
African psychedelic medicine that has shown promise in treating
substance use disorder (SUD) and opioid withdrawal. As ibogaine is
a NMDA receptor antagonist, many of its therapeutic effects may be
due to its ability to modulate the glutamatergic system.
The aim of this research was to assess changes in GRIA1 and
CREB1 mRNA expression in the dorsal (dHPC) and ventral (vHPC)
hippocampus during withdrawal from chronic morphine adminis-
tration with and without ibogaine treatment.
Male Sprague-Dawley rats were divided randomly into 6 test
groups of n = 10 for chronic morphine administration (daily
morphine sulphate 10 mg/kg s.c. for 10 days), 3 day withdrawal
from chronic morphine administration, ibogaine HCl (single i.p.
50 mg/kg), chronic morphine with ibogaine and the relevant saline
control groups. Upon termination, right dHPC and vHPC were
dissected for qPCR analysis.
Ibogaine reduced CREB1 expression in dHPC relative to control
(p = 0.051). A highly signiﬁcant reduction in GRIA1 expression
was found in dHPC of the ibogaine treatment group relative to saline
control (p = 0.003). Differences in GRIA1 expression between
dHPC and vHPC were highly signiﬁcant. No signiﬁcant differences
in expression were found between withdrawal groups and combined
morphine-ibogaine treatment.
The results indicate that ibogaine decreases CREB1 and GRIA1
mRNA expression in the dHPC which highlights a novel mecha-
nism of action in treating SUD and opioid withdrawal. The lack of
any signiﬁcant changes in CREB1 and GRIA1 expression in
combination morphine-ibogaine treatment highlights the role of the
mu-opioid receptor in glutamatergic regulation.
MTU04-09
Beneﬁcial effects of the regulation of miRNAs by dimethyl
fumarate via NRF2 in tauopathies
S. C. Sa´nchez1,2,3, I. Lastres-Becker1,2,3
1Centro de Investigacion Biomedica en Red sobre Enfermedades
Neurodegenerativas CIBERNED, Biochemistry, Madrid, Spain
2Instituto de Investigacion Sanitaria La Paz IdiPaz, Neuroscience,
Madrid, Spain
3Instituto de Investigaciones Biomedicas Alberto Sols UAM-CSIC,
Biochemistry, Universidad Autonoma de Madrid, Madrid, Spain
miRNAs regulate gene expression controlling physiological and
pathological processes. Redox stress can alter miRNA biogenesis
and processing pathways, suggesting an involvement of the
transcription factor NRF2, master regulator of redox homeostasis.
We ﬁrst assessed whether NRF2 could modulate miRNA biogen-
esis. Bioinformatics analysis revealed antioxidant response elements
in the promoters of miRNA processing proteins. This was corrob-
orated in vitro showing that the main miRNA processing proteins
were modulated in a NRF2-dependent way. Then, we determined
whether treatment with dimethyl fumarate (DMF), an NRF2
inducer, is able to modulate miRNA expression and its potential
therapeutic value in tauopathies. For this, we performed luciferase
activity assays using the 3’UTR-NRF2-LUC reporter. Next, we
performed a microarray assay to determine which miRNAs were
altered by TAU overexpression and if this effect could be reversed
by DMF treatment, in a murine model of tauopathy. It was observed
that the overexpression of TAU increases the levels of miR-142-3p/
5p and DMF treatment is capable of reversing this effect.
Bioinformatic analyses show that the miR-142-3p/5p is involved
in the processing pathways of RNA binding and regulation of its
stability and vesicle-mediated and intracellular transport. One of the
main genes that regulates miR-142 is staufen1 and 2, implicated in
synaptic plasticity and memory formation, of great relevance in the
pathological processes associated with TAU. Taken together, our
study suggests that the modulation of miRNAs by regulation of
NRF2 by DMF treatment is an effective therapeutic target for the
treatment of tauopathies.
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MTU04-10
Radiation exposure induces acute trafﬁcking of excitatory
and inhibitory receptors in cultured hippocampal neurons
C. Cronkite
Baylor College of Medicine, Department of Biochemistry and
Molecular Biology, Houston, USA
Radiation-induced cognitive impairment (RICI) is a well-
characterized consequence of cranial radiation therapy for brain
tumors that includes chronic learning disability, executive dysfunc-
tion, and behavioral and mood disorders. Interestingly, a single
radiation insult can lead to chronic and progressive neuropsychiatric
sequelae, suggesting that there are long-term changes in neuronal
function from a single inciting event. While most research into RICI
has focused on the effects of radiation on neural progenitor cells,
recent work in our lab has shown that there are structural and
functional changes in dendritic spines minutes after a radiation
insult. Dendritic spines are highly dynamic structures that are able to
respond to activity, inducing long lasting changes in synaptic and
neuronal function. For example, high activity leads to reinforcement
of synaptic transmission through an increase in surface expression of
receptors, and these changes are mediated primarily by NMDA
receptor activity. We have been able to visualize the acute
trafﬁcking of NMDA and GABA receptors after radiation in
dissociated hippocampal cell cultures by fusing the pH-sensitive
GFP derivative superecliptic pHluorin to obligatory receptor
subunits. Additionally, we have used NMDA receptor inhibitors
speciﬁc for localization and receptor subtype in order to determine
the activity dependence of these changes. Through serial live
imaging, we have shown that NMDA and GABA receptors are
differentially trafﬁcked following a radiation insult in an NMDA
receptor activity-dependent manner. Additionally, radiation leads to
neurotoxic transcriptional changes through the inactivation of CREB
that can be prevented by the administration of the extrasynaptic
NMDA receptor inhibitor memantine. Together, these ﬁndings
suggest that radiation leads to acute changes in synaptic function
that in turn adversely and chronically affect neuronal health.
MTU04-11
A glucocorticoid receptor-dependent mechanism of bile
acid action with therapeutic impact in polyglutamine
disease
J. D. Silva1,2, S. Duarte-Silva1,2, A. Neves-Carvalho1,2, C. Soares-
Cunha1,2, J. Correia1,2, G. Nogueira-Goncalves1,2, S. Oliveira1,2, A.
Teixeira-Castro1,2, P. Maciel1,2
1University of Minho, School of Medicine, Braga, Portugal
2ICVS/3B’s, Neurosciences, Braga/Guimar~aes, Portugal
Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant
neurodegenerative disorder caused by a polyglutamine expansion
within the protein ataxin-3, leading to protein dyshomeostasis and
ultimately neuronal demise. Clinically, it is characterized by gait
imbalance, with a mid-life onset. No directed treatments are
currently available for this invariably fatal disease. In this work
we tested bile acids as potential therapeutic agents for SCA3, since
these molecules have been shown to be neuroprotective in other
conditions. Using a C. elegans model of SCA3 we observed that
tauroursodeoxycholic acid (TUDCA) was the most efﬁcient bile
acid in improving the animals’ motor phenotype. A signiﬁcant
improvement was also observed in a pre-clinical trial using
CMVMJD135 mice: chronically treated mice showed markedly
improved performance motor behavior tests, reduced neuropathol-
ogy and neuroinﬂammation markers. Using the C. elegans SCA3
model, we dissected the mechanism of action of this drug.
Surprisingly, we observed that the effect of TUDCA was indepen-
dent of its canonical nuclear receptor, the farnesoid X receptor
(FXR), but fully dependent on the glucocorticoid receptor (GR).
Moreover, GR protein levels were markedly decreased in the
CMVMJD135 mouse model, and fully recovered upon acute
treatment with TUDCA. Finally, and most importantly, we observed
a decrease in GR levels in the pons, a highly disease-affected brain
region, of SCA3 patients. In sum, we identiﬁed TUDCA, a drug
with a high translational potential, as a contender compound for the
treatment of SCA3, and propose a novel mechanism of action that
could be of interest in the future, including for other neuromuscular
disorders currently treated with glucocorticoids.
MTU04-12
Aberrant regulation of monoubiquitination via E3
ubiquitin ligase RNF20 confer Gbm cancer stem-like cells
survival and maintenance
K. Daun1, N. Morimura1, K. Nozaki2, K. Tanigaki3, S. Hitoshi1
1Shiga University of Medical Science, Integrative Physiology, Otsu,
Shiga, Japan
2Shiga University of Medical Science, Department of
Neurosurgery, Otsu, Shiga, Japan
3Research Institute, Shiga Medical Center, Moriyama, Shiga,
Japan
A quiescent slow-growing state of GSCs subpopulation in GBM
is thought to underlie the tumor propagation, drug resistance, and
relapse. However, the underlying mechanism of how epigenetic
modiﬁcation controls stemness features in GSCs remain poorly
understood. Therefore, we postulate that a strong relationship
between genetic changes with epigenetic modiﬁcation via RNF20
(E3 ubiquitin ligase) by monoubiquitinating histone H2B (H2Bub1)
may contribute to the maintenance of GSCs. We ﬁrst examined
whether RNF20 is expressed in GSCs lines. We conﬁrmed that the
RNF20-positive cells overlap with the cancer stem cells marker
CD133. We then established a clone which is stably over-expressing
RNF20 using the tetracycline-inducible system and designed two
shRNAs for RNF20 knockdown targeting at the coding region. The
H2Bub1 positively correlated with the level of RNF20. The RNF20
over-expression exhibit higher mRNA expression of stemness
(SOX2, OCT4) and CD133 markers while RNF20 knockdown
down-regulate SOX2. The proliferation rate of over-expressing
RNF20 cells is higher than the control. In contrast, the RNF20
knockdown has shown small morphological GBM spheres and
suppressed proliferation. Since GSCs exhibit speciﬁc gene expres-
sion signatures to control cell fate during differentiation, we
emphasize that RNF20 through H2Bub1 may involve in GSCs
differentiation. As a result, RNF20/H2Bub1 regulates GSCs differ-
entiation into astrocyte and oligodendrocyte. Moreover, RNF20
overexpression can enhance the therapeutic effect of Temozolomide
while RNF20 knockdown leads to Temozolomide resistance. Taken
together, our ﬁndings suggest that RNF20 is required as an
epigenetic regulator for maintenance of GSCs.
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Palmitate increases microglia-derived TNF-alpha levels
and impairs hippocampal insulin signaling
H. D. Melo1, G. Sd. Silva2, B. Melo1, J. Fortuna1, V. Coreixas1, S.
Ferreira1,3, F. D. Felice1,4,5
1Federal University of Rio de Janeiro, Institute of Medical
Biochemistry Leopoldo de Meis, Rio de Janeiro, Brazil
2Federal Institute of Education Science and Technology of Rio de
Janeiro, Department of Biochemistry, Rio de Janeiro, Brazil
3Federal University of Rio de Janeiro, Institute of Biophysics
Carlos Chagas Filho, Rio de Janeiro, Brazil
4Queen’s University, Centre for Neuroscience Studies, Kingston,
Canada
5Queen’s University, Department of Psychiatry, Kingston, Canada
Unhealthy diets are related to an increasing burden of metabolic
disorders worldwide, including type 2 diabetes (T2D) and obesity.
T2D and obese patients exhibit cognitive impairment and increased
risk of developing dementia. Elevated levels of free fatty acids in the
circulation is linked to peripheral insulin resistance, especially
saturated fatty acids (SFA), such as palmitate. Interestingly, brain
palmitate uptake is increased in obese patients, with a positive
correlation with aging. Thus, to understand how excessive levels of
SFAs could impact brain function, we investigate the impact of
palmitate, the most abundant circulating SFA, on the hippocampus,
important region for learning and memory. Interestingly, intracere-
broventricular infusion of palmitate led to microglial activation and
increased TNF-a levels in the mouse hippocampus. In addition,
palmitate reduced insulin expression and induced neuronal insulin
receptor substrate 1 (IRS-1) phosphorylation at multiple inhibitory
serine residues in primary hippocampal cultures. Importantly,
palmitate failed to cause insulin signaling impairment in the
presence of minocycline or inﬂiximab, which inhibits microglial
activation and neutralizes TNF-a, respectively. Altogether, our
results delineate a pro-inﬂammatory mechanism underlying the
deleterious effects of palmitate on neuronal insulin signaling, a
pathway centrally involved in the learning and memory.
MTU04-14
Neuropharmacological prospective of urena sinuata
(borss) l
T. Emran, Md. Atiar Rahman
BGC Trust University Bangladesh, Pharmacy, Chittagong,
Bangladesh
Urena sinuata (Borss) L. is a wild shrubby plant with some folk
medicinal use. To our knowledge, the biological importance of this
plant has not been investigated yet. The present study aimed to
determine the neuropharmacology, antinociceptive, anti-inﬂamma-
tory and antipyretic effects of the chloroform extract of Urena
sinuata leaves (CEUS) in rodents and to elucidate the possible
mechanism of antinociception involved with its acute toxicity and
phytochemical studies. Neuropharmacological activities of CEUS
were conducted by hole cross, open ﬁeld test, elevated plus-maze
test and thiopental induced sleeping time test. For the analgesic
activity of CEUS different methods like hot plate test, acetic acid
induced test, formalin-induced test, tail immersion test and gluta-
mate-induced nociception were used. Additionally, the possible
mechanism of nociception is identiﬁed by cyclic guanosine
monophosphate (cGMP) and ATP-sensitive K+-channel pathway
analysis. Carrageenan-induced rat paw edema and cotton pellet-
induced granuloma test also were used to detect anti-inﬂammatory
activity and brewer’s yeast induced pyrexia test for antipyretic
activity. The extract (200 and 400 mg/kg) was administered orally
60 min prior to subjection to the respective test. The results obtained
demonstrated that CEUS produced signiﬁcant (p < 0.05) neurophar-
macological, anti-inﬂammatory and antipyretic activity with low or
no toxicity. The extract also exerts antinociceptive response in all
the chemical and thermal-induced nociception models. Furthermore,
it involves cyclic guanosine monophosphate (cGMP) and ATP-
sensitive K+-channel pathway mediated antinociceptive effect.
These data show for the ﬁrst time that CEUS has signiﬁcant
neuropharmacological, anti-inﬂammatory and antipyretic effects
which appear to be related to the inhibition of the glutamatergic
system and rationalized the traditional use of the leaf in the
treatment of different types of inﬂammation in intestines and
bladder. Thus the leaves of Urena sinuata could be used in the
treatment of several types of inﬂammation in intestines and bladder.
MTU04-15
Glast activity is modiﬁed by acute manganese exposure in
bergmann glial cells
M. E. Lopez, L. C. R. Hernandez-Kelly, A. Ortega
Cinvestav, Toxicology, Mexico City, Mexico
Manganese (Mn) is an essential trace element, serving as a
cofactor for several enzymes involved in various cellular and
biochemical reactions. However, chronic overexposure to Mn from
occupational or environmental sources induces a neurological
disorder, characterized by psychiatric, cognitive, and motor abnor-
malities, known as manganism. Astrocytes, the most abundant non-
neuronal glial cells in the brain, play a critical role in glutamate
homeostasis. The ﬁne regulation of extracellular glutamate in the
brain is accomplished by two major glutamate transporters (GLT-1
and GLAST) that are predominantly expressed in astrocytes.
Excitotoxicity has been highlighted as a critical mechanism in Mn
neurotoxicity and is also involved in the pathology of multiple
neurodegenerative diseases including ALS, AD and PD. Recent
studies show that Mn accumulates in different brain regions,
including the cerebellum. Bergmann glial cells (BGC) are radial
glial cells prevalent in the adult cerebellum and represent the most
abundant glia within this structure. This characteristic localization is
related to their involvement in neurotransmitter uptake and turnover,
K+ homeostasis, lactate supply and pH regulation. Despite these
well-known facts, there is no evidence about the acute effect of Mn
exposure in BGC physiology. To this end, in this contribution we
focused on the molecular mechanisms induced by Mn affecting
GLAST in BGC. A time and dose-dependent increase in GLAST
activity was found upon acute Mn exposure. This augmentation
might be explained as a complex interaction between Mn and
GLAST since its maximal transport capacity was affected after Mn
exposure. This effect is accompanied by a reduced glucose uptake,
that in the long term could contribute to the transporter dysfunction.
These results strengthen the notion of the critical involvement of
radial glia in glutamatergic neurotransmission.
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The oligosaccharide portion of ganglioside GM1 as
mitochondrial regulator
M. Fazzari1, G. Lunghi1, E. D. Biase1, M. Audano2, N. Mitro2, S.
Sonnino1, E. Chiricozzi1
1University of Milano, Department of Medical Biotechnology and
Translational Medicine, Segrate, Italy
2University of Milano, Department of Pharmacological and
Biomolecular Sciences, Milano, Italy
Functional data and clinical studies suggest the existence of a
positive loop between the age-dependent GM1 deﬁciency and alpha-
synuclein (aS) accumulation determining the neurodegeneration
onset of sporadic Parkinson’s Disease (PD). This loop is triggered
by the plasma membrane GM1 deﬁciency, which leads to a failure
of trophic signaling and to the aS accumulation, increasing the
susceptibility to neuronal death. Recently we shed new light on the
molecular basis underlying GM1 effects highlighting that GM1
oligosaccharide (OligoGM1) directly binds TrkA receptor, trigger-
ing TrkA-MAPK pathway activation which leads to neuronal
differentiation and protection. Following its administration to
B4galnt1+/ PD mouse model, OligoGM1 was found to completely
rescue the physical symptoms, reduce aS aggregates and restore
tyrosine-hydroxylase neurons. Since the mitochondrial dysfunction
plays a central role in the exacerbation of nigrostriatal degeneration
in PD, we decide to evaluate the putative OligoGM1 mitochondrial
modulation in murine neuroblastoma cells, N2a. Following its
exogenous administration, proteomic analysis revealed an increased
expression of proteins involved in mitochondrial bioenergetics and
in oxidative stress protection. By biochemical studies we found that
OligoGM1 protects N2a cells from MPTP toxic effect as well as
from mitochondrial oxidative stress. Moreover, by immunoblotting
we identiﬁed an increased expression of TOM20/HtrA2 mitochon-
drial proteins, whose reduced expression has been associated with
PD. At functional level, we found increased basal and uncoupled
mitochondrial respiration following OligoGM1 administration.
Collectively our data indicate a possible role of OligoGM1 as
mitochondrial regulator that by inducing mitochondriogenesis and
enhancing mitochondrial activity could determine mitochondrial
restoration in PD neurons.
MTU04-17
Reductive reprogramming: a not-so-radical hypothesis of
neurodegeneration
T. Foley
University of Scranton, Chemistry, Scranton, USA
Free radical-mediated oxidative stress, neuroinﬂammation, and
excitotoxicity have long been hypothesized to contribute to the
progression of Alzheimer’s disease and other aging-related neu-
rodegenerative disorders (NDD). Among these phenomena, the
signiﬁcance of oxidative stress and, more generally, redox pertur-
bations, for NDD remain ill-deﬁned and unsubstantiated. Here, I
argue that (i) free radical-mediated oxidations of biomolecules can
be dissociated from the progression of NDD, (ii) oxidative stress
fails as a descriptor of cellular redox states under conditions relevant
to disease, and (iii) aberrant upregulation of compensatory reducing
activities in neural cells, resulting in reductive shifts in thiol-based
redox potentials, may be an overlooked and paradoxical contributor
to disease progression. In particular, I summarize evidence, from
in vitro studies, which supports the view that reductive shifts in the
extracellular space can occur in response to oxidant and inﬂamma-
tory signals and that these have the potential to reduce putative
regulatory disulﬁde bonds in exofacial domains of the N-methyl-D-
aspartate (NMDA)-subtype of glutamate-gated receptors as well as
other synaptic regulatory proteins, leading potentially to aberrant
increases in neuronal excitability and, if sustained, excitotoxicity.
Moreover, I provide data from my laboratory which establishes the
presence in the brain, in vivo, of disulﬁde bonds in the NMDA
receptor as well as other glutamate and non-glutamate-gated
receptors. All of these are potential targets of reductive stress. This
novel reductive reprogramming hypothesis of neurodegeneration
provides an alternative view of redox perturbations in NDD and
links these to both neuroinﬂammation and excitotoxicity.
MTU04-18
The role of monocarboxylate transporter-1 on cognitive
deﬁcits development during NAFLD
A. Hadjichambi1, P. Hosford2, L. Pellerin1
1UNIL, Department of Physiology, Lausanne, Switzerland
2UCL, Neuroscience, physiology and pharmacology, London, UK
Non-alcoholic fatty liver disease (NAFLD) is a major compli-
cation of obesity. Certain observations regarding NAFLD induced
neuropsychiatric alterations have been reported but mechanisms are
unknown. Monocarboxylate transporter-1 (MCT1) haploinsufﬁcient
mice, which resist high fat diet (HFD) induced hepatic steatosis
represent an interesting model. Using a mouse model of NAFLD
(HFD+high fructose/glucose in water [HF/HG]) we investigated the
development of cognitive deﬁcits and state of cerebral oxygenation
and cerebrovascular reactivity.
Behavioural tests (open ﬁeld/novel object recognition/forced
swimming test [FST]) were performed in mice fed control diet (NC;
WT/MCT1 + /- +NC) or HFD HF/HG (WT/MCT1 + /- +HFD HF/
HG) for 16 weeks. Baseline cortical PO2 and in response to
systemic hypercapnia (10% CO2) was monitored under anaesthesia
by a ﬂuorescence method. Microelectrode biosensors were used for
lactate measurements by cortical slices. EchoMRI was performed to
assess lean/fat mass.
Increased fat mass was observed in WT and MCT1 + /- mice on
HFD HF/HG compared to NC controls. Liver mass was only
signiﬁcantly higher in WT+HFD HF/HG mice compared to controls.
Behavioural tests revealed no signiﬁcant differences between groups
except for FST, which indicated a depression-related behaviour in
the WT+HFD HF/HG group compared to controls. This was not
observed with MCT1 + /-+HFD HF/HG mice. WT+HFD HF/HG
mice had a lower cerebral PO2 baseline and hypercapnia-induced
PO2 response compared to controls, while MCT1 + /- groups
remained unchanged. Tonic lactate release was unaltered between
all groups although the MCT1 + /-+HFD HF/HG group indicated a
decreased lactate tone trend.
Our results suggest that NAFLD is associated with a depression-
related behaviour and decreased cerebral PO2 baseline. MCT1
haploinsufﬁcient mice were resistant to the reported phenotypes,
suggesting a link between liver metabolism and neuropathophysi-
ological alterations.
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MTU04-19
Quantitative proteomic analyses of dynamic signalling
events associated with neuronal death in excitotoxicity
M. A. Hoque1,2,3, Nicholas. A. Williamson3, C.-S. Ang3,
J.S. Oakhill1, H.-C. Cheng2
1St Vincents Institute of Medical Research, Metabolic Signaling
Laboratory, Protein Chemistry and Metabolism, Fitzroy, Victoria,
Australia
2University of Melbourne, Department of Biochemistry and
Molecular Biology, Parkville, Victoria, Australia
3University of Melbourne, Bio21 Molecular Science and
Biotechnology Institute, Parkville, Victoria, Australia
Excitotoxicity, caused by over-stimulation or dysregulation of
ionotropic glutamate receptors (iGluRs), is a major pathological
process directing neuronal death in both acute and chronic
neurological disorders. The aberrantly stimulated iGluRs direct
massive inﬂux of calcium ions into the affected neurons, leading to
changes in expression and phosphorylation of speciﬁc proteins to
modulate their functions and direct their participation in the
signalling pathways that induce excitotoxic neuronal death. To
deﬁne these pathways, herein we utilised quantitative proteomic and
phosphoproteomic approaches to identify neuronal proteins associ-
ated with excitotoxic cell death. We identﬁed > 150 neuronal
proteins with signiﬁcant dynamic temporal changes in abundance
and/or phosphorylation levels at different time points (5-240 min)
following glutamate overstimulation in cultured primary cortical
neurons. Bioinformatic analyses predicted that many of them are
components of signalling networks directing defective neuronal
morphology and functions. Biochemical approaches conﬁrmed the
ﬁndings of the proteomic analysis for Erk1/2, GSK3 and Tau.
Bioinformatic analysis further predicted Akt, JNK, Cdk5, MEK,
CK2, Rock and SGK1 as the potential upstream kinases phospho-
rylating some of these perturbed proteins and biochemical studies
conﬁrmed our predictions. We also deﬁned > 40 signiﬁcantly
changed neuronal (phospho)proteins including CK2 and AMPK
that are downstream of neurotoxic GluN2B-containing extra-
synaptic NMDA receptors. Our predicted signalling networks and
signalling dynamics of neuronal protein kinases form the conceptual
framework for future investigation to deﬁne the spatial and temporal
organisation of cell signalling pathways governing neuronal death in
excitotoxicity.
MTU04-20
PPV-6 suppresses amyloid beta-induced cell cycle reentry
in differentiated primary cortical neurons
B.-Y. Hou, D.-I. Yang
National Yang-Ming University, Institute of Brain Science, Tainan,
Taiwan
Amyloid beta-peptide (Ab) is the main neurotoxic component of
senile plaque, which is the pathological hallmark of Alzheimer’s
disease. In addition, Ab is also known to trigger cell cycle reentry in
post-mitotic neurons followed by cell death. Many studies have
reported that polysaccharides from medicinal plants may carry
therapeutic potential in AD. However, the mechanisms underlying
polysaccharide-mediated inhibition of Ab neurotoxicity is still
unclear. Therefore, this study was designed to explore the neuro-
protective mechanisms of polysaccharides extracted from a peren-
nial vine (PPV-6). We hypothesized that PPV-6 may suppress cell
cycle reentry and subsequent cell death induced by Ab in the fully
differentiated post-mitotic neurons. To test this hypothesis, post-
mitotic primary cortical neurons were subjected to cotreatment with
Ab and PPV-6. Western blotting, immunocytochemistry, and ﬂow
cytometry were conducted to assess the extents of neuronal cell
cycle reentry. MTT assay was performed to determine cell viability.
Compared with Ab alone, cell viability and morphology were
recovered by cotreatment with PPV-6. Further, Ab-induced upreg-
ulation of G1-phase markers including cyclin D1 and phosphory-
lated retinoblastoma protein (pRb), G2-phase marker such as
proliferating cell nuclear antigen (PCNA), and mitotic marker
histone H3 phosphorylated at Ser-10 were all reversed by PPV-6.
Similar results were obtained with ﬂow cytometry. Taken together,
our ﬁnding indicated that the neuroprotective mechanisms of PPV-6
involve suppression of Ab-induced neuronal cell cycle reentry and
subsequent cell death.
MTU04-21
Mechanism underlying age of disease onset in familial
amyloid polyneuropathy (ATTR-FAP)
R. Ibrahim1, T.-Y. Yu3, C.-C. Chan2, J.-W. Tsai1
1National Yang Ming University, Brain Science, Taipei, Taiwan
2National Taiwan University, Physiology, Taipei, Taiwan
3Academia Sinica, Atomic and Molecular sciences, Taipei, Taiwan
Familial amyloid polyneuropathy (FAP) is a progressive neu-
rodegenerative and systemic disease caused by the deposition of
amyloid ﬁbrils of misfolded transthyretin (TTR) origin.
Although over 100 disease causing point mutations have been
identiﬁed in the TTR gene, the effects of different mutations are
highly variable reﬂected by heterogeneous phenotypes seen in
affected human. To understand these phenotypic differences, we
generated TTR mutants with different disease onsets and study their
amyloidogenic properties using cell lines, biophysical approaches
and Drosophila melanogaster as a model. We analysed secretory
patterns and cytotoxic potentials of TTR mutants in HEK 293 and
IMR-32 neuroblastoma cells respectively. Differential scanning
calorimetry (DSC) was also used to determine the stabilities of TTR
mutants. To model TTR associated amyloid disease, we employed
the Drosophila as a disease model. We generated transgenic ﬂies
overexpressing amyloidogenic TTR mutant variants and the wild-
type protein. We analysed the effect of mutant TTR on drosophila’s
climbing activity, and lifespan. Our results reveal differences in the
secretory efﬁciencies and stability of TTR mutants corresponding to
their age of disease onset in patients. Importantly, our data reveal
that stability of TTR monomers and their interaction with ER
chaperone GRP78 determines age of onset in ATTR-FAP. In our
Drosophila model, late onset TTR mutants results in shortened
lifespan while early onset TTR mutants result in earlier reduced
climbing activities mimicking phenotypes seen in human patients.
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MTU04-22
Involvement of mitochondria mediated oxidative stress
dependent cell signaling events and SYK tyrosine kinase
activation in tumor
A. Kanthasamy, S. Kanuri, H. Jin, V. Anantharam, A. Kanthasamy
Iowa State Univ., BMS, Ames, USA
Neuro-inﬂammation, mitochondrial dysfunction, and impaired
clearance of aggregate prone proteins are implicated in Parkinson’s
Disease (PD) pathogenesis; however, the mechanism by which
inﬂammatory mediators increase the vulnerability of dopaminergic
neurons to oxidative stress-induced apoptotic cell death remain
poorly characterized. Therefore, the goal of the present study was to
investigate the cell signaling events that underlie TWEAK induced
apoptotic cell death using an in vitro dopaminergic cell culture
model, N27 cells. Herein, we show that N27 cells express both
TWEAK and its receptor Fn14 and that TWEAK-elicited dose
dependent apoptotic cell death in N27 cells. Exposure of N27 cells
to TWEAK evoked dissipation of mitochondrial membrane potential
(MMP), suppression of GSH levels, activation of caspase-8 and 3
and concomitant up regulation of Phospho-Tau and Phospho-NF-kB
P65 levels. Moreover, these changes were accompanied by the down
regulation of Phospho-AKT, P-GSK3Beta (Ser9) and LC3 levels in
TWEAK treated dopaminergic neuronal cells. Intriguingly, upreg-
ulation of TWEAK was evidenced in MPP+ treated dopaminergic
neuronal cells. Likewise TWEAK was upregulated in the SNpc of
MPTP treated mice. Consistent with the role of TWEAK in the
induction of oxidative stress response, pretreatment of N27 cells
with varying concentration of quercetin, a bioﬂavanoid abrogated
TWEAK-induced apoptotic cell death. In a similar fashion NFkB
inhibitor, SN50 ameliorated TWEAK-induced loss of dopaminergic
cell viability. Together, these data suggest that TWEAK exerts
deleterious effects on dopaminergic neuronal survival via aberrant
activation of NF-kB and impaired mitochondrial function in an
oxidative stress dependent manner.
MTU04-23
Pre-ischemic administration of nutraceutical offers
neuroprotection against stroke injury by attenuating
mitochondrial dysfunction
P. Kaushik1, H. Tabassum2, S. Parvez1
1Jamia Hamdard, Department of medical elementology and
toxicology, New delhi, India
2Indian Council of Medical Research, Division of Biomedical
Sciences, New delhi, India
Stroke is the worldwide threat that causes death and disability in
adults. The dynamic nature of mitochondria is related to cellular
survival, growth and death. Previous literature have reported that
ischemic stroke (IS) reduces mitochondrial respiration, enhances
production of reactive oxygen species (ROS) and triggers apoptotic
cell death, suggesting a prominent role of mitochondria in IS
pathophysiology. The selected nutraceutical, PIP, has been reported
to have anti- inﬂammatory and anti-oxidant properties. Pre-
treatment of PIP has been found to be neuroprotective in IS. The
present study emphasises on the possible neuroprotective role of PIP
via mitochondria as therapeutic target for stroke treatment. After PIP
administration (10 mg/kg b.wt. once daily, p.o. for 15 days), the
male wistar rats underwent the tMCAO surgery. The right middle
cerebral artery was occluded for 1 h followed by 23 h of
reperfusion. Behavioural assessment was done after 24 h. The brain
samples for analysis of mitochondrial impairment were extracted
after behavioural assessment. The results showed that PIP signif-
icantly reduced the infarct volume, mitochondrial ROS and restored
complexes activity, mitochondrial membrane potential and cyto-
chrome c release, thereby, attenuated the mitochondrial wreckage.
Taken together, our results are the ﬁrst to demonstrate that PIP has
the potential to constrict the mitochondrial dysfunction in IS.
MTU04-24
Investigation of immune modulators produced by hipsc-
derived astrocytes from schizophrenic patients
P. L. Cardozo1, P. Trindade2, J. Alves-Silva3, L. Chicaybam4, M.
Bonamino4, S. Rehen2,5, F. Ribeiro1
1Federal University of Minas Gerais, Biochemistry and
Immunology, Belo Horizonte, Brazil
2D’or Institute for Research and Learning, National Laboratory of
Stem Cells, Rio de Janeiro, Brazil
3Federal University of Minas Gerais, Morphology, Belo Horizonte,
Brazil
4Cancer National Institute, Experimental Medicine Division, Rio de
Janeiro, Brazil
5Federal University of Rio de Janeiro, National Laboratory of Stem
Cells, Rio de Janeiro, Brazil
Schizophrenia (SCZ) is a neuropsychiatric disorder, caused by
genetic and environmental factors. Schizophrenic individuals exhibit
cognitive deﬁcits, positive (psychosis, hallucinations and delusions)
and negative symptoms (depression, avolition and anhedonia), as
well as reduced gray matter volume. Microanatomical analyses
suggest that this gray matter reduction is due to diminished dendritic
spine density, which likely happens as a result of exaggerated
synaptic pruning. Recently, it has been shown that the classical
complement cascade and CX3CL1/CX3CR1 pathway play a direct
role in this process, triggering synaptic engulfment by microglia. In
addition, astrocytes secrete cytokines capable of modulating the
complement cascade. Taking into account that pre-natal infection
acts as a risk factor for SCZ, this work aimed at analyzing
complement components, proinﬂammatory cytokines and CX3CL1
production employing induced pluripotent stem cells (hIPSCs)-
derived astrocytes from schizophrenic individuals after stimulation
with TNF-a. The results demonstrate that TGF-b3 and IL-1b
transcripts are altered in SCZ-derived astrocytes relative to healthy
control-derived (HC) astrocytes. In contrast, C3, C4 and CX3CL1
show similar mRNA expression patterns in both groups. Finally,
non-secreted CX3CL1 levels seems to be increased in SCZ
astrocytes, suggesting problems in the release of the soluble form.
Altogether, these results indicate that SCZ astrocytes produce
immunomodulators in a distinct manner compared to HC astrocytes.
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A transposon-mediated somatic mutagenesis screen
identiﬁes new genes associated with malformations of
cortical development
I.-L. Lu1,2, C. Chen3,5, C.-Y. Tung4, H.-H. Chen3,5, J.-P. Pan4, J.-W.
Tsai2
1Academia sinica, Institute of Biomedical Sciences, Taipei, Taiwan
2National Yang-Ming University, Institute of Brain Sciences, Taipei,
Taiwan
3Taipei Veterans General Hospital, Neurological Institute, Taipei,
Taiwan
4National Yang-Ming University, VYM Genome Research Center,
Taipei, Taiwan
5Taipei Veterans General Hospital, Department of Pediatrics,
Taipei, Taiwan
Malformations of cortical development (MCDs) are heteroge-
neous neurodevelopmental disorders that often result in epilepsy and
developmental delays in children. However, many genetic mutations
involved in MCD pathogenesis remain unidentiﬁed. To identify new
genes potentially involved in cortical development and the patho-
genesis of MCDs, we took advantage of forward genetic screening
by transposon somatic mutagenesis during brain development. Here
we developed a genetic screening paradigm by combining trans-
poson-based somatic mutagenesis with in utero electroporation in
the developing mouse cortex. We identiﬁed 33 potential MCD
genes, several genes have been previously implicated in neuronal
development and disorders. Consistent with the screening results,
functional disruption of these genes by RNA interference or using
CRISPR/Cas9 causes alterations in the distribution of cortical
neurons that resemble human cortical dysplasia. To verify potential
clinical relevance of these candidate genes, we analyzed somatic
mutations in brain tissue from patients with focal cortical dysplasia
type II (FCDII) and found mutations enriched in these candidate
genes. These results demonstrate that the approach is able to identify
potential novel genes involved in cortical development and MCD
pathogenesis.
MTU04-26
Hypoxia or nicotine- which is worse on the infant brain?
from neurotransmitters, growth factors, to apoptosis and
microglia
R. Machaalani
University of Sydney, Faculty of Medicine and Health, University of
Sydney, Australia
A respiratory hypoxic environment and cigarette smoke exposure
around babies have long lasting effects on the brain such as
decreased neuroprotection, decreased IQ, and long-term increased
addictive behaviours (cigarette smoke exposure). Extensive studies
of the effects of such exposures to the developing brain on the
expression of neurotransmitters, receptors, growth factors, markers
of apoptosis and microglia in the brain have been undertaken in our
laboratory over the past decade and will be presented herein. Our
results are from two brain tissue datasets: 1- infants who died
suddenly and unexpectedly, and 2- piglet models of intermittent
hypercapnic hypoxia (IHH) and postnatal nicotine exposure. Brain
tissue was subjected to immunohistochemistry for apoptotic markers
(caspase-3 & TUNEL), NMDA receptor 1, brain derived neu-
rotrophic factor (BDNF) and its receptor TrkB, serotonin receptor
1A (5HT1A), pituitary adenylate cyclase activating polypeptide
(PACAP) and its receptor PAC1, orexin, nicotinic acetylcholine
receptors (nAChRs) and microglia. Staining was quantiﬁed and
compared between exposures to control (non-exposures). We found
that across the studies, the IHH exposure induced greater expres-
sional changes than nicotine, and many changes equated between
the piglet models and the infant ﬁndings when stratiﬁed for hypoxia
related conditions of prone sleeping, bedsharing, and cigarette
exposure, including the syndrome of Sudden Infant death (SIDS).
These changes predominated in the brainstem medulla, a region
containing nuclei of importance in cardiac and respiratory regula-
tion.
MTU04-27
Sphingosine-1-phosphate signaling in stroke - a potential
role for astrocytes
H. Matuskova1,2, F. Matthes3, G. Petzold1,2, A. Meissner2,3,4
1DZNE, Neurovascular Diseases, Bonn, Germany
2University Hospital Bonn, Department of Neurology, Bonn,
Germany
3Lund University, Department of Experimental Medical Sciences,
Lund, Sweden
4Lund University, Wallenberg Centre for Molecular Medicine,
Lund, Sweden
Stroke is a leading cause of long-term disability worldwide. Due
to its complexity, treatment options are sparse. Recently, the
bioactive signaling molecule, phospholipid sphingosine-1-phos-
phate (S1P), has gained increasing attention in cardiovascular
disease due to its involvement in both vascular function and immune
cell responses. As astrocytes play a critical role in the injured brain,
we sought to determine a potential contribution of astrocytic S1P
signaling to a stroke disease progression. In a mouse model of
transient middle cerebral artery occlusion (MCAo), we ﬁrst
investigated the expression pattern of S1P-generating enzyme 1
(SphK1) and S1P receptor 3 (S1PR3) in response to ischemia in
wild type mice, followed by an analysis of gene expression in
astrocyte RiboTag transgenic mice. Additionally, the concentration
of S1P in plasma and brain samples by mass spectrometry was
analyzed to complement the data. 24 hours following MCAo, the
SphK1 mRNA expression signiﬁcantly increased in the ischemic
hemisphere. This effect was abolished 72 hours post MCAo,
indicative of a transient SphK1 response following ischemia.
Moreover, similar results were obtained from the analysis of the
astrocytic ribosome-associated mRNAs, suggesting a critical
involvement of astrocyte in the SphK1 response to ischemia.
Interestingly, the S1PR3 expression was markedly reduced
24 hours, as well as 72 hours post-ischemia in the contralateral
hemisphere, while astrocytic ribosome-associated mRNA revealed a
signiﬁcant S1PR3 upregulation in the ischemic hemisphere. In
conclusion, our ﬁndings point to an important astrocyte-speciﬁc
contribution in the activation of the S1P/S1PR3 signaling axis post-
stroke.
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Amyloid-beta alone induces changes in hippocampal
GABAergic synapses
M. Mayer1, Katalin. E. Sos1, Virag. T. Takacs1, Z. Bardoczi1, A.
Major1, B. Beres1, T. Szeles1, Takaomi. C. Saido2, T. Saito2, Tamas.
F. Freund1, G. Nyiri1
1Institute of Experimental Medicine, Laboratory of Cerebral Cortex
Research, Budapest, Hungary
2RIKEN Brain Science Institute, Laboratory for Proteolytic
Neuroscience, Wako, Japan
Alzheimer’s disease (AD) is a neurodegenerative disorder,
characterized partly by amyloid-beta (Ab) depositions in cortical
areas. Several transgenic mouse lines were created to examine the
effect of Ab, however, most of them employed strong non-speciﬁc
promoters to drive Ab expression. We used APP-NL-F mice that are
unique, as they express Ab driven by the natural promoter of
amyloid precursor protein (APP), the latter of which is a mutated
version of the human APP in this strain. We investigated subcellular
effects of Ab in the hippocampus of APP-NL-F mice. We found that
Ab alone caused typical plaque formation, glial activation and
malformation of neurites. It induced the formation of signiﬁcantly
larger synapses on axon initial segments of pyramidal cells and
caused impairment in natural anxiety in the elevated plus maze.
However, these mice lack some changes typical in AD model
animals, including the degeneration of septo-hippocampal choliner-
gic and parvalbumin positive pathways and changes in the number
of hippocampal parvalbumin and somatostatin positive interneurons.
These results suggest that upregulation of Ab expression alone can
induce changes in the inhibitory balance of hippocampal pyramidal
cells, which may contribute to disease progression during the
preclinical phase of AD.
MTU04-29
An implantable microelectrode array for simultaneous
in vivo recordings of glutamate, Gaba and neural activity
E. Mitricheva, R. Kimura, L. P. Mansilla, E. Krampe, A. Oeltermann,
N. Logothetis, Hamid. R. Noori
Max Planck Institute for Biological Cybernetics, Department of
Physiology of Cognitive Processes, Tuebingen, Germany
Glutamate and c-aminobutyric acid (GABA) are the most
common neurotransmitters in the central nervous system. By
exciting, inhibiting, and modulating neural elements and microcir-
cuits, these chemicals critically regulate brain information process-
ing and energy metabolism at different spatiotemporal scales.
However, the exact relationship between the extracellular concen-
tration of these molecules and emergence of speciﬁc patterns in
neuronal ensemble activity remains elusive. Partly this is due to the
fact that recording of the mean extracellular ﬁeld potentials (mEFP)
concurrently with a quantitative assessment of alterations in the
concentration of such neurochemicals are currently unavailable.
Here, we present a silicon-based implantable ultraﬁne microelec-
trode array (35 μm diameter) composed of several iridium-stabilized
electrochemical and electrophysiological contacts. The electrophys-
iological electrodes have an average impedance of 0.5 MΩ at
1 kHz. The amperometric electrochemical channels, divided into
two groups of glutamate- and GABA-responsive electrodes, show a
sensitivity of 0.39 nA/μM for glutamate and 0.38 nA/μM on the
adjacent channel for GABA. This novel multimodal microelectrode
was used to simultaneously monitor extracellular glutamate and
GABA concentrations, spikes, multi-unit neuronal activity (MUA)
and local ﬁeld potentials (LFP) in the lateral geniculate nucleus
(LGN) of anaesthetized rats (n = 5). Retinal stimulation with
ﬂickering monochromatic light, emphasizing the simplest form of
feedforward processing in thalamus, induced neuronal response
patterns in LGN that were highly correlated with the temporal
alterations in glutamate concentrations. GABA responses, while
similar in proﬁle to MUA and LFP recordings, were found to be
event-selective, suggesting network-level processes. Our ﬁndings
suggest that this multimodal method may greatly contribute into our
understanding of microcircuit organization, by reducing the inherent
ambiguity in the mEFP through neurotransmitter-release-tracking.
MTU04-30
Dysfunction of SV2A elicites dopaminergic hyperactivity
via interacting accumbal gabaergic neurons in rats
Y. Ohno, K. Tokudome, A. Ikari, Y. Iguchi, T. Sugahara, N.
Kunisawa, M. Kato, T. Serikawa, S. Shimizu
Osaka University of Pharmaceutical Sciences, Pharmacology,
Osaka, Japan
Synaptic vesicle protein 2A (Sv2A) regulates action potential-
dependent synaptic release of neurotransmitters in the brain. To
explore the role of SV2A in modulating CNS functions, we have
recently created SV2A-mutant (Sv2aL174Q) rats carrying a missense
mutation (L174Q) in Sv2a gene and demonstrated that the Sv2aL174Q
mutation disrupts synaptic GABA release and facilitates epilepto-
genesis (Sci. Rep., 6, 27420, 2016; Front. Pharmacol., 7, 210, 2016).
Here, we performed behavioral and neurochemical studies using
SV2A-mutant rats to clarify the role of SV2A in modulating
psychotic disorders. In SV2A-mutant rats, methamphetamine
(MAP)-induced hyperactivity was signiﬁcantly augmented as com-
pared to the control (F344) rats. Development of MAP reverse
tolerance (supersensitivity) with repeated treatments was also
enhanced by the Sv2aL174Q mutation. In addition, social isolation
stress-induced aggressive behaviors were signiﬁcantly enhanced in
SV2A-mutant rats. In vivo microdialysis study revealed that
dopamine release induced by high K+ or MAP was markedly
enhanced in SV2A-mutant rats, as compared to F344 rats. When
bicuculline (BIC, 100 μM) was applied to the nucleus accumbens
through the dialysis probe to block GABAA receptors, enhanced
dopamine release by the Sv2aL174Q mutation was reversed to the
control level. In addition, high K+-induced GABA release in the
nucleus accumbens was signiﬁcantly decreased in SV2A-mutant rats
compared to F344 rats. The present study shows that dysfunction of
SV2A by the Sv2aL174Q mutation augments the MAP susceptibility
and aggressive behaviors by enhancing dopamine release in the
nucleus accumbens. Our results suggest that SV2A play an
important role in regulating the vulnerability to psychotic disorders
via the SV2A-GABA interaction.
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Pilot human study to deﬁne the impact of vascular and
inﬂammatory risk factors in Alzheimer’s disease
F. Prestia1, P. Galeano1, M. Dalmasso1, E. Casta~no1, D. Politis2, S.
Kochen3, L. Brusco4, L. Morelli1
1Leloir Institute Foundation, IIBBA-CONICET, Buenos Aires,
Argentina
2HIGA, CONICET, Buenos Aires, Argentina
3El Cruce Hospital, CONICET, Buenos Aires, Argentina
4School of Medicine, UBA, Buenos Aires, Argentina
Clinical evidence suggests a leading role of vascular and
inﬂammatory risk factors in Alzheimer’s disease (AD). Angiogenic
factors, chemokines and pro-inﬂammatory cytokines were evaluated
in plasma of control (CTR, n = 20) and sporadic AD (n = 18)
patients recruited from hospitals in Argentina. Statistical compar-
isons were carried out by Student’s t or Mann-Whitney tests.
Moreover, cognitive performance was evaluated with the MMSE
test and, as expected, signiﬁcant differences were observed between
groups. Levels (pg/mL) of 41 analytes were determined by
multiplex ELISA (V-PLEX Human Biomarker kit-MSD Technol-
ogy). From the 41 analytes, 33 were detected in most of the patients
and signiﬁcant differences were observed in the levels of 16 of them
(GM-CSF; IL-16; VEGF; IL-8; TNFa; EOTAXIN; EOTAXIN3;
IP10; MDC; MIP-1a; MIP-1b; sVCAM1; Fit1; PIGF; VEGFA). It is
of note that IL-1b was only detected in AD patients. A discriminant
analysis performed with all of the data revealed that 81.6% of
subjects (AD: 83.3%; CTR: 80%) were correctly classiﬁed. To
determine whether APOe4, the most relevant genetic risk factor for
AD, was associated with particular analytes, AD patients were
divided into two groups: APOe4(+) and APOe4(-). GM-CSF was
the only analyte that was signiﬁcantly different between groups
(0.068  0.006 vs. 0.030  0.007). These results suggest that a set
of circulating vascular and inﬂammatory factors is able to discrim-
inate between AD and CTR patients, while further studies are
required to determine the relationship between genetic risk factors
and plasma biomarkers.
MTU04-32
Dysregulation of autophagy and stress granule-related
proteins in stress-driven tau pathology
J. Silva1, S. Rodrigues1, P. Gomes1, A. Takashima2, B. Wolozin3, I.
Sotiropoulos1
1Life and Health Sciences Research Institute, School of Health
Sciences, Braga, Portugal
2Gakushuin University, Department of Life Science, Tokyo, Japan
3School of Medicine, Boston University, Department of
Pharmacology & Experimental Therapeutics, Boston, USA
Consistent with suggestions that lifetime stress may be an
important AD precipitating factor, and knowing that imbalance in
neuronal proteostasis associated with Tau misfolding and aggrega-
tion is a common feature between AD and other Tauopathies, we
previously demonstrated that chronic stress and high glucocorticoid
(GC) levels induce accumulation of aggregated Tau; however, the
molecular mechanisms for such process remain elusive.Hereby, we
monitor a novel interplay between RNA-binding proteins (RBPs)
and autophagy has underlying mechanisms through which chronic
stress and high GC levels impact on Tau proteostasis precipitating
Tau aggregation. Using molecular, pharmacological and behavioral
analysis, we demonstrate that chronic stress and high GC trigger an
mTOR-dependent inhibition of autophagy, leading to accumulation
of Tau and cell death in P301L-Tau expressing mice and cells. In
parallel, we found that environmental stress and GC disturb cellular
homeostasis and trigger insoluble accumulation of different RBPs,
such as PABP, G3BP1, TIA-1 and FUS, shown to form Stress
granules(SGs) and Tau aggregation. Interestingly, using an mTOR-
driven pharmacological stimulation of autophagy (CCI-779) atten-
uated the GC-driven Tau and SG-related proteins accumulation, as
well as the related cell death, suggesting a critical interaction
between autophagy and SG response in chronic stress and GC
driven neurodegeneration. Moreover, in vivo, this compound also
reverted some of the previously observed behavioral deﬁcits, acting
as an anti-depressant and reverting short-term memory deﬁcit-
s.These studies provide novel insights into the RNA-protein
intracellular signaling regulating the precipitating role of environ-
mental stress and GC on Tau-driven brain pathology.
MTU04-33
Prenatal hypoxia-induced alterations are accompanied
with malfunction of glutamatergic system in rat
hippocampus
V. Stratilov1, O. Vetrovoy1,2, E. Tyulkova1
1Pavlov Institute of Physiology, Laboratory of regulation of brain
neuronal function, St.Petersburg, Russia
2St.Petersburg State University, Department of Biochemistry,
St.Petersburg, Russia
Prenatal hypoxia (PH) is one of the most common causes of
developing brain pathologies. This study was aimed to analyze the
characteristics of the glutamate system and behavior during early (2-
week), adult (3-month) postnatal ontogenesis and in the process of
aging (18-month) of rats subjected to hypoxic stress (5% O2, 3 h)
during 14-16 days of prenatal development. We have shown
progressive with age decrease in the amount of glutamate in the
hippocampus of rats subjected to PH, which is accompanied by a
decrease in the number of NeuN+ cells, as well as a decrease in
long-term memory and learning ability in the Morris water maze. A
gradual decrease in the amount of glutamate inversely correlates
with, apparently, a compensatory increase in the levels of mGluR1,
IP3R1 and polyphosphoinositides. At the same time, the use of
mGluR1 agonists normalizes the cognitive ability of rats subjected
to PH. 18-month animals subjected to PH demonstrate decreased
activity of liver glucose-6-phosphatase, the product of glucocorti-
coid-dependent transcription. This enzyme contributes to increase of
glucose blood level and thus to reaction of glutamate synthesis in the
brain. Glucocorticoid receptor levels, similarly, decrease with age in
rats subjected to PH. These results indicate a signiﬁcant contribution
of the dysfunction of the glutamatergic system to the formation of
early aging caused by PH. The mechanism of glutamatergic deﬁcit
can be glucocorticoid-dependent.
Scientiﬁc research was performed with involvement of the
Research park of SPbU Observatory of Environmental Safety
Center. The work was supported by RFBR grant no. 17-04-01118.
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Synapse formation and remodeling unveil a
glutamatergic/GABAergic imbalance in hippocampal
neurons in the VPA model of autism
M. Traetta1,2, M. Codagnone1,2, N. Uccelli1, S. Zarate1, A. Reines1,2
1Instituto de Biologıa Celular y Neurociencia, IBCN-UBA-
CONICET, Buenos Aires, Argentina
2Catedra de Farmacologıa, FFyB-UBA, Buenos Aires, Argentina
Autism spectrum disorders (ASD) are characterized by impair-
ments in social interaction and repetitive-stereotyped behaviors.
Although increased cortical excitatory-inhibitory (E-I) ratio has been
described in ASD patients, results in the hippocampus are not
conclusive. Using the valproic acid (VPA) model of ASD, we
reported in the hippocampus of VPA rats a reduction in the synaptic
marker synaptophysin along with an increased adhesive/non-
adhesive form expression ratio of the neural cell adhesion molecule
(NCAM). This study aimed to evaluate E-I balance, synapse
formation and remodeling in primary hippocampal neurons either
from VPA or control male pups. Synaptic markers were evaluated
by immunocytochemistry and western blot. At DIV14, hippocampal
neurons from VPA animals displayed a reduced dendritic tree
(reduced MAP-2 area), a reduced number of glutamatergic synapses
(decreased vGLUT puncta number and area) and NMDA receptor
clusters (decreased NR1 puncta number and individual puncta area)
but no changes in gabaergic synapses (conserved GAD-67 puncta
number). These neurons also exhibited reduced number of func-
tional synapses (FM4-64 labelling) which contained smaller vesic-
ular pools with preserved unloading kinetics; total NCAM
expression increased while its non-adhesive form (PSA-NCAM)
decreased. While in neurons from control animals glutamate
exposure (5 μM-3 min) induced an NMDA-dependent dendritic
retraction and synapse number reduction, neurons from VPA
animals only exhibited dendritic retraction. Our results indicate that
neurons from VPA animals form fewer glutamatergic synapses with
a more adhesive and resistant proﬁle to synaptic remodeling,
suggesting an underlying mechanism that would contribute to
reduced structural synaptic plasticity in the hippocampus.
MTU04-35
Short and long non-coding RNA interactions in trauma
and fatty liver disease
Y. Tzur
Hebrew university of Jerusalem, Biological chemistry, Kibbutz
Shamir, Israel
Trauma-related and metabolic impairments are notably linked,
but the underlying mechanisms are incompletely understood. Here,
we report that long non-coding RNAs and microRNAs (lncRNAs,
miRs) might have co-evolved to ameliorate trauma, metabolic
syndrome (MetS) and sepsis conditions. In diet-induced obese mice,
antisense AM132 oligonucleotide suppression of the trauma-
inducible miR-132 led to liver deregulation of MetS-associated
miRs including miR-122-5p and miR-26a-5p, which were down-
regulated in human fatty liver tissues. Both these miRs may be
targeted by the lncRNA MIAT, known to be deregulated in MetS,
myocardial and diabetic disorders. Supporting functional relevance,
we found MIAT upregulation in human fatty liver samples. Next,
we pursued miR-target associations in the web-available CAPSOD
transcriptomic dataset of human liver and blood cell biopsies from
sepsis and MetS patients compared to controls. Searching the 1,152
subjects’ CAPSOD dataset identiﬁed the sepsis-related histocom-
patibility antigen HLA-DRA and the brain-expressed pseudogene
PGOHUM-565 as targets of the primate-speciﬁc miR-608, compat-
ible with the reduced risks of both sepsis and trauma in human
carriers of single nucleotide polymorphisms interrupting miR-608-
target interactions. Our ﬁndings support causal involvement of
lncRNA-miR interactions in stress-related metabolic imbalances and
predict that these interactions might have provided survival
advantages to evolving primates in both contexts.
MTU04-36
Targeting FTD/ALS: udca prevents CHMP2B-intron5
induced neurodegeneration, revealing a novel drug target
for dementia research
C. Ugbode, R. West, S. Sweeney, F.-B. Gao
University of York, Biology, York, United Kingdom
Frontotemporal Dementia (FTD) is the second most prevalent
form of early-onset dementia. The pathological mechanisms driving
neuronal atrophy in FTD remain poorly understood and no
therapeutic interventions exist. The FDA approved drug Ursodeoxy-
cholic acid (UDCA), normally used to treat biliary cirrhosis, shows
both cytoprotective and anti-apoptotic activity, however it’s mech-
anism of action remains unknown. Mutations in the FTD gene
CHMP2B (CHMP2BIntron5) cause severe neurodegeration and
apoptosis. Our data shows UDCA can alleviate these neurodegen-
erative phenotypes and provides novel insights into the mechanism
of action of UDCA. Given that UDCA has just entered clinical trials
in Europe for the treatment of Amytrophic Lateral Sclerosis (ALS)
our data suggests that UDCA has a broader neuroprotective effect
across the FTD/ALS spectrum.Our lab has previously characterised
the effect of the mutant CHM2BIntron5 protein in both
Drosophila and mammalian neuron models. Ectopic expression of
CHMP2BIntron5 in cortical neurons causes dendritic collapse asso-
ciated with autophagosome accumulation. Transgenic mouse mod-
els expressing CHMP2BIntron5 globally or in forebrain neurons
display neurodegeneration and behavioural deﬁcits. Also prominent
are accumulations in p62 and ubiquitin positive inclusions in
neurons and glia, mirroring events in CHMP2BIntron5 and other
FTD/ALS (GRN, C9ORF72, MAPT) patient tissue. We show that
UDCA alleviates apoptotic cascades, dendritic collapse and synaptic
aberrations in both Drosophila and mammalian models of
CHMP2BIntron5 induced FTD. In addition, we identify a novel
“orphan” receptor as a potential target of UDCA and demonstrate
genetic manipulation of this receptor is sufﬁcient to alter
CHMP2BIntron5 associated phenotypes. UDCA represents a com-
pound with potential to be repurposed for the treatment of FTD
associated with the CHMP2BIntron5 disease causing mutation.
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Neurodevelopmental deﬁcits in human isogenic fragile x
syndrome neurons
K. Utami1, N. H. Skotte2, A. R.-F. Colaco2, N. A. B. M. Yusof1, B.
Sim1, X. Y. Yeo3, H.-G. Bae3, M. Garcia-Miralles1, C. Radulescu1,
S. Jung3,4, M. Mann2, M. Pouladi1,5
1Translational Laboratory in Genetic Medicine, Neurodegenerative
Disease Program, Singapore, Singapore
2Novo Nordisk Foundation Center for Protein Research, University
of Copenhagen, Proteomics and Signal Transduction,
Copenhagen, Denmark
3Singapore Bioimaging Consortium SBIC, A*STAR,
Neuromodulation and Neurocircuitry group, Singapore, Singapore
4Yong Loo Lin School of Medicine, Department of Physiology,
Singapore, Singapore
5Yong Loo Lin School of Medicine, Department of Medicine,
Singapore, Singapore
Fragile X Syndrome (FXS) is a neurodevelopmental disorder
caused by epigenetic silencing of FMR1 and loss of FMRP
expression. Here, we describe the generation of an isogenic human
pluripotent embryonic stem cell (hPSC) model of FXS. Using
CRISPR/Cas9 to introduce indels in exon 3 of FMR1 resulting in
complete loss of FMRP (FMR1KO), we show that FMRP-deﬁcient
neurons exhibit a number of phenotypic abnormalities, including
neurite outgrowth and branching deﬁcits, and impaired electrophys-
iological network activity as measured by multi-electrode arrays.
RNA-Seq and proteomic analysis of FMRP-deﬁcient neurons
revealed dysregulation of pathways related to neurodevelopment,
neurotransmission, and cell cycle. These changes were paralleled by
abnormal neural rosette formation and neural progenitor prolifera-
tion. Of note, our transcriptional and proteomic analyses identiﬁed
marked deﬁcits in a key enzyme involved in the metabolism of
catecholamines (such as dopamine) and that has been linked to a
number of neuropsychiatric disorders. Using isogenic FMR1KO
hPSCs as a model to investigate the pathophysiology of FXS in
human neurons, we reveal key neural abnormalities arising from
loss of FMRP, including some with potential for therapeutic
intervention.
MTU04-38
Recapitulation of familial multiple sclerosis mutation
leads to compromised myelin and susceptibility to
demyelination insult
A. Ziaei1, M. Garcia-Miralles1, C. Radulescu1, A. Silvin1, V.
Shaygannejad2, H. Bae1, N. Yusof1, C. F. Bardile1, H. Sidik1, L.
Dehghani2, C. Bonnard1, S. Jung1, B. Reversade1, F. Ginhoux1, M.
Pouladi1
1A*STAR, BMRC, Singapore, Singapore
2MUI, Neurology, Isfahan, Iran
Efforts are currently underway to uncover factors that trigger the
immune system in multiple sclerosis (MS). We sought to identify
multi-incidence MS-families for the discovery of genetic back-
ground susceptibility. In one such family, inactivating mutations in
ERMN gene was identiﬁed with complete segregation. Ermin is an
actin-binding protein found almost exclusively in central-nervous-
system myelin-sheath. Although Ermin has been predicted to play a
role in the formation and stability of myelin sheaths, this has not
been examined. Using Ermin knockout mice, we show that Ermin is
essential for myelin sheath integrity and normal saltatory conduc-
tion. Loss of Ermin caused non-compacted myelin sheath and
myelin fragmentation in electron microscopy imaging, supported by
an increase in QD9/MBP ratio, led to slower conduction velocity in
the CC and progressive neurological deﬁcits. RNA sequencing of
the CC revealed pathways related to axonal degeneration and
inﬂammation in aged Ermin-deﬁcient mice, which were conﬁrmed
by immunostaining showing increased axonal damage, microgliosis
and astrogliosis. In addition, we observed an increased level of
demyelinated-lesion responsive microglia population in the CC also
with a higher level of fragmented myelin phagocytosed by these
microglia. The inﬂammatory milieu and microstructural myelin
abnormalities were further associated with increased susceptibility
to demyelination in the experimental autoimmune encephalomyelitis
model of MS. We hypothesize this non-compact, fragmented myelin
and white matter inﬂammation can expose myelin proteins to the
immune system and make individuals susceptible to MS.
MTU04-39
Binding of ethanol in the C1 domain of presynaptic
munc13-1: A molecular dynamics simulation study
J. Das, Y. You
University of Houston, Department of Pharmacological and
Pharmaceutical Sciences, Houston, USA
Identifying molecular targets of alcohol and understanding the
molecular mechanism of alcohol actions are necessary to develop
effective therapeutics for Alcohol Use Disorder (AUD). Munc13-1
is a presynaptic protein involved in the vesicle priming and
neurotransmitter release in the brain. Our earlier studies identiﬁed
Glu-582 as the alcohol-binding residue in the activator (diacylglyc-
erol/ phorbol ester)-binding C1 domain of Munc13-1. Here we
describe a 250 ns molecular dynamics simulation study on the
interaction of ethanol and the activator-bound C1 domain of
Munc13-1 in the presence of varying concentrations of phos-
phatidylserine. Our results suggest that phorbol 13-acetate forms
fewer number of the hydrogen bond with the C1 domain in the
ethanol solvent than in water. Ethanol does not change the protein
structure signiﬁcantly and it forms hydrogen bonds with the Glu-582
at 45.61 ns. When Glu-582 was mutated to alanine, ethanol
molecules were not observed in the vicinity (5A) of Ala-582 at this
time point. This study is important in providing structural basis of
ethanol’s action in presynaptic proteins.
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Association between demethylation and differentiation of
neural cells by mammalian GCM1 and GCM2
A. Abdullah, Y. Hayashi, S. Fuke, T. Fuchigami, N. Morimura, N.
Koyama, S. Hitoshi
Shiga University of Medical Science, Integrative Physiology, Otsu,
Japan
Glial cells missing (Gcm) gene was discovered in Drosophila and
thought to act as binary switch in determining the fate of neuron and
glia. We reported that orthologs of gcm in mammals, Gcm1 and
Gcm2, were associated with Hes5 expression in neural precursor
cells (NPCs) of early embryos with active demethylation of Hes5
promoter (Hitoshi et al., 2011). To determine the differentiation fate
of Gcm1 or Gcm2 overexpressed NPCs, we performed in utero
electroporation (IUEP) to an embryonic brain at E14.5. Our results
showed that Gcm1 promotes differentiation of NPCs into GFAP and
S100b positive astrocytes 72 hours after IUEP. Gcm2 gene have
polymorphism in the coding region between C57B6 and ICR mice,
and IUEP of Gcm2 from ICR promotes differentiation of NPCs into
NeuN positive neurons, which were detected in the ventricular zone/
subventricular zone rather than cortical plate. We could not observe
any changes in the Gcm2 gene from C57B6. These results suggest
that Gcm2 from ICR has stronger function than C57B6. To
determine the association between these phenotypes and DNA
demethylation, we performed in vitro assay using Neuro2a cells. To
reveal the function of demethylation by Gcm genes, we performed
sanger-bisulﬁte sequencing analysis. Since the Gcm1-overexpres-
sing Neuro2a upregulated Vegfa expression, which have CpG
islands in the ﬁrst intron, we are analyzing it’s methylation
percentage. Because Vegfa intron 1 is already hypomethylated in
the control, we could not detect changes by Gcm1 overexpression.
Now we are looking for other candidate genes in appropriate cell
line and the best system to clarify the function of Gcm1 and Gcm2.
MTU05-02
HIF-1A inhibition impairs neurodifferentiation induced by
retinoic acid in SH-SY5Y cells
P. Brum, C. Girardi, C. T. Ribeiro, N. Somensi, J. C. Moreira, D.
Gelain
UFRGS, Department of Biochemistry, Porto Alegrr, Brazil
Several studies indicate hypoxia as a key player in neuronal stem
cell differentiation and proliferation. Low oxygen concentration
increases the survival and proliferation rate of neuronal precursors as
well as the differentiation to a dopaminergic phenotype when
compared to normal oxygen concentrations. Hypoxia leads to the
accumulation of the hypoxia inducible factor-1a (HIF-1a). As
in vitro studies have shown, there is a correlation between its up
regulation and the increase of neuronal markers. Therefore, HIF-1a
emerges as a possible regulatory step of dopaminergic differentia-
tion. This work aims to investigate the effects of the selective
inhibition of HIF-1a on the differentiation induced by retinoic acid
in human neuroblastoma cells from the SH-SY5Y lineage with the
purpose of elucidating its role in the dopaminergic differentiation.
siRNA reverse transfection was performed to inhibit the expression
of HIF-1a and was followed by a 7 days differentiation protocol
utilizing retinoic acid as a differentiation promoter. HIF-1a silencing
efﬁciency was assessed by western blot and RT-qPCR and
differentiation markers were analyzed by immunoﬂuorescence and
RT-qPCR. Neuron average length and total number of neurites per
cell were assessed utilizing NeuronJ. Our results indicate that HIF-
1a inhibition is capable of reducing the neuron-like phenotype, the
immunocontent, and the expression of neuronal markers indicating
the regulatory role of this transcription factor in neuronal differen-
tiation.
MTU05-03
Distribution, density, and morphology of peripheral
myeloid cells invading the murine brain during normal
postnatal development
M. Carrier1, M.-E. Robert1, J. C. Savage1, F. Geissmann2, M.-E.
Tremblay1
1Universite Laval, Axe neurosciences, Centre de recherche du CHU
de Quebec-Universite Laval, Quebec, Canada
2Memorial Sloan Kettering Cancer Center, Immunology Program,
New york, USA
Microglia are the resident immune cells of the brain that
exclusively derive from the embryonic yolk sac. During trauma or
disease, bone marrow-derived cells (BMDC) can also invade the
brain, inﬁltrating through the blood-brain barrier, to accomplish
neuroinﬂammatory roles. Preliminary result from our team showed
that these cells were present in the brain during normal develop-
ment, leaving the question of where and why they invade the brain
without insult. We have described at the ultrastructural level a new
phenotype of brain myeloid cells that is highly prevalent upon
chronic stress, aging, and neurodegenerative disease. Recently, we
also found these cells to be abundant during normal development.
These ‘dark microglia’ are tightly associated with blood vessels.
They also interact extensively with synapses, suggesting their
possible implication in the remodeling of neuronal circuits. To study
BMDC in the context of normal development and determine the
origin of dark microglia from the bone marrow or embryonic yolk
sac, this study was conducted using Flt3creRFPlox mouse model in
which BMDC are selectively labelled, without radiation or
chemotherapy that can affect the BBB permeability. The animals
were sacriﬁced under steady-state conditions at different postnatal
ages from birth until adulthood. Serial sections providing a non-
biased representation of the brain were then imaged with a slide
scanner to analyze the distribution, density, and morphology of
FLT3-positive cells across development. 3D electron microscopy
with immunostaining (array tomography technology) experiments
are now underway to determine the origin of dark microglia.
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ATOH1 requires primary cilia for the expansion of granule
neuron progenitors by modulating centriolar satellites
C.-H. Chang1,2,3, H. Shirvani4,5, M. Zanini4,5, W.-J. Wang6, J.-W.
Tsai3,7, O. Ayrault4,5
1Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan
2TIGP in Molecular Medicine, Academia Sinica and National Yang-
Ming University, Taipei, Taiwan
3Institute of Brain Science, National Yang-Ming University, Taipei,
Taiwan
4Institute of Curie, PSL Research University, Orsay, France
5Universite Paris Sud, Universite Paris-Saclay, Orsay, France
6Institute of Biochemistry and Molecular Biology, College of Life
Sciences, National Yang-Ming University, Taipei, Taiwan
7Brain Research Center, National Yang-Ming University, Taipei,
Taiwan
Development of the cerebellum requires the primary cilium to
allow the transduction of Sonic Hedgehog (SHH) signaling.
Besides, precise regulation of ciliogenesis ensures the proliferation
of cerebellar granule neuron progenitors (GNPs). By mosaic
manipulation of cerebellum through in vivo neonatal electroporation,
we report that Atoh1, a transcription factor required for GNPs
formation, controls the presence of primary cilia, maintaining GNPs
responsive to the mitogen SHH. Loss of primary cilia abolishes the
ability of Atoh1 to keep GNPs in proliferation. Taking advantage of
the in vitro GNP puriﬁcation, we show that Atoh1 promotes
ciliogenesis by transcriptionally regulating Cep131, which facilitates
centriolar satellite (CS) clustering to the basal body. Importantly,
ectopic expression of Cep131 counteracts the effects of Atoh1 loss
in GNPs by restoring proper localization of CS and ciliogenesis.
Moreover, Atoh1 enhances SHH signaling in GNPs by translocating
Smo within the primary cilium, thereby activating the downstream
effectors. This Atoh1-CS-primary cilium-SHH pro-proliferative
pathway is also conserved in SHH-type medulloblastoma, a
pediatric brain tumor arising from the GNPs. Together, our data
reveal the mechanism whereby Atoh1 modulates the primary cilium
functions to regulate GNP differentiation during cerebellar devel-
opment.
MTU05-05
A de novo mutation of CEP170 leads to neuronal
migration defects and human lissencephaly
N.-H. Chao1, Y.-S. Chang1, M.-H. Tsai2, J. Tsai1
1National Yang Ming University, Institute of Brain Science, Taipei,
Taiwan
2Kaohsiung Chang Gung Memorial Hospital, Department of
Neurology, Kaohsiung, Taiwan
During cortical development, postmitotic neurons migrate along
the radial ﬁber to organize the six-layered neocortex. In the process
of neuronal migration, centrosome moves ahead of the nucleus into
the leading process by the pulling forces of cytoplasmic dynein
through the microtubule network. Defects in neuronal migration
have been found to cause human brain disorder, lissencephaly
(smooth brain). Here we identiﬁed a de novo mutation in the
centrosomal protein CEP170 in a lissencephaly patient. CEP170 is
localized on the subdistal appendage of the mother centriole;
however, its role in brain development and how the mutation caused
lissencephaly are still unclear. To investigate the function of
CEP170 in migrating neurons, we delivered CEP170 shRNA into
the embryo mice by in utero electroporation to knock down CEP170
expression in progenitor cells. CEP170 dysfunction led to neuronal
migration delay and presented the abnormal morphology in their
leading process at postnatal day 6. The mutant CEP170 showed
decreased localization to the centrosomes in culture cells. Immuno-
precipitation also showed less interactions of CEP170 mutant with
CCDC120 and CCDC68, two proteins that have been shown to
recruit CEP170 to the subdistal appendage hierarchically. Since
CEP170 has been shown to play a key role in microtubule
organization, these results suggest that failure of CEP170 in
centrosomal localization may lead to migration defect. Our ﬁndings
reveal the role of CEP170 in cortical development and provide novel
mechanisms of the pathogenesis of lissencephaly.
MTU05-06
Acute and chronic neurological consequences of
neonatal zika virus infection in mice
I. N. D. O. Souza1, P. Frost1,2, J. Franca2, J. Nascimento-Viana1, R.
Neris3, C. Nogueira1, G. Neves2, L. Chimelli4, F. De-Felice5,6, S.
Ferreira5,7, I. Assunc~ao-Miranda3, C. Figueiredo1, A. D. Poian5, J.
Clarke1
1Federal University of Rio de Janeiro, Faculty of Pharmacy, Rio de
Janeiro, Brazil
2Federal University of Rio de Janeiro, Institute of Biomedical
Sciences, Rio de Janeiro, Brazil
3Federal University of Rio de Janeiro, Institute of Microbiology, Rio
de Janeiro, Brazil
4State Institute of Brain, Laboratory of Neuropathology, Rio de
Janeiro, Brazil
5Federal University of Rio de Janeiro, Institute of Medical
Biochemistry, Rio de Janeiro, Brazil
6Queen’s University, Department of Biomedical and Molecular
Sciences, Kingston, Canada
7Federal University of Rio de Janeiro, Institute of Biophysics, Rio
de Janeiro, Brazil
Prenatal Zika virus (ZIKV) infection is associated to several
birth defects. However, how ZIKV affects the developing brain long
term is poorly understood. This study investigates whether neonatal
ZIKV infection leads to neurological changes in immunocompetent
mice throughout their lifespan. For such, Swiss mice were infected
subcutaneously with a Brazilian ZIKV strain at P3. ZIKV-infected
group showed brain viral replication, persistent lower body weight
and mortality rates of ~60%. Cytokine expression indicated
extensive proinﬂammatory proﬁle, further characterized through
immunohistochemistry. Moreover, ZIKV caused postnatal micro-
cephaly and motor deﬁcits throughout the lifespan. During the acute
phase of infection, mice developed seizures, which were reduced by
TNF–a inhibition. During adulthood, ZIKV replication persisted
and the animals showed increased susceptibility to chemically
induced seizures, neurodegeneration and behavioural deﬁcits. Alto-
gether, we show that neonatal ZIKV infection has long-term
neurological complications in mice and that early inhibition of TNF-
a prevent the development of some chronic neurological abnormal-
ities.
© 2019 The Authors
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VPA treatment in neurosphere culture: an approach
towards in vitro modelling of autism
S. Dwivedi, Y. Perumal
Birla Institute of Technology and Sciences BITS- Pilani Hyderabad
Campus, Department of Pharmacy, Hyderabad, India
Autism Spectrum Disorder (ASD) is a complex neurodevelop-
mental disorder of early onset, highly variable in its clinical
presentation. Although animal models for autism already exist, but
gives little idea about the mechanism of disease progression during
brain development. In utero valproic acid (VPA) exposure in
rodents leads to behavioral phenotypic changes related to ASD in
their offspring. Therefore, we have tried similar approach of VPA
exposure to neurospheres (in vitro). We have investigated whether
direct VPA exposure on neurospheres may recapitulate the molec-
ular alterations seen in vivo. Neuronal precursor cells isolated from
time pregnant SD rats were allowed to generate free ﬂoating
neurosphere. Neurosphere were treated with VPA (0.5 mM, 1 mM
and 2 mM) for 7 days with daily observation. The neurospheres
were investigated for size and proliferation, LDH release, gene
expression and differentiation studies. VPA exposure in neuro-
spheres do not cause alteration in LDH release indicating no
cytotoxicity of VPA (up to 2 mM), however a decrease in
proliferation of neurospheres followed by disrupted differentiation
pattern, and signiﬁcant alteration in expression level of high risk
genes for autism was observed with 3 days of VPA treatment. We
have also observed the improvement in neurosphere proliferation
and differentiation by co-treatment of VPA with few herbal drugs,
which supports use of neurosphere for preliminary screening of
novel candidate molecules. This approach requires one or two
animals at a time, thus, reduces the number of animals in an
experiment. Although, our study gives an insight to understand the
mechanism of VPA induced molecular changes in ASD, still the
approach needs further exploration to validate utility of neuro-
spheres as a high throughput screening tool for target speciﬁc
molecules.
MTU05-08
Temporal changes in the brain in neonatal hydrocephalic
mice: structural and neurobehavioural ﬁndings
O. Femi-Akinlosotu1, A. Naicker2, T. Shokunbi1
1University of Ibadan, Department of Anatomy, Ibadan, Nigeria
2University of KwaZulu-Natal, Optics & Imaging Centre, Durban,
South Africa
3University of Ibadan, Department of Surgery, Ibadan, Nigeria
In hydrocephalus, there is accumulation of cerebrospinal ﬂuid in
the ventricles and subarachnoid space. The impact of this on
neurobehaviour and structure of cellular organelles of pyramidal
neurons and their synapses in neonatal hydrocephalic mouse brain
overtime are not fully understood.
Hydrocephalus was induced in day-old mice by intra-cisternal
injection of sterile kaolin suspension. The pups were tested for reﬂex
developments prior to sacriﬁce on postnatal days 7,14,21. Cortical
thickness and neuronal density in the sensorimotor cortex were
evaluated using hematoxylin and eosin and Nissl stains while
ultrathin stained sections were also assessed.
Surface righting reﬂex (3.08  0.48 vs 1.27  0.16;
2.49  0.10 vs 1.06  0.05) and cliff avoidance activities
(17.15  2.18 vs 10.50  2.00) were signiﬁcantly impaired in
hydrocephalic pups. The cortical thickness (μm) of hydrocephalic
mice was signiﬁcantly reduced on PND7 (2409  43.37 vs
3752  65.74), PND14 (2035  322.10 vs 4273  67.26) and
PND21 (1676  33.90 vs 4945  81.79) compared to controls.
Compared with age-matched controls (129.60  3.72 9 106 lm2;
230.0  44.1 9 106 lm2), the neuronal density of the sensori-
motor cortex in hydrocephalic mice was signiﬁcantly increased on
PND14 (157.70  21.88 9 106 lm2) and PND21 (373.20 
21.54 9 106 lm2). The TEM of the hydrocephalic mice brains
showed loss of structural integrity of cellular organelles and
depletion of synaptic junctions. The synaptic densities (per lm²
9105) of hydrocephalic mice were signiﬁcantly lower
(188.0  22.67; 120.0  21.68;72.0  0.66) than their age-
matched controls (336.0  37.09; 486.0  18.60; 600.0  17.61)
on days 7, 14 and 21 respectively.
The quantitative changes and ultrastructural ﬁndings seen in the
neuronal population of the hydrocephalic mice may provide
supportive data for the structural basis of the neurological disabil-
ities associated with neonatal hydrocephalus.
MTU05-09
A link between temporal competence and reprogramming
M. Fries1,2, P. Mattar1,3, M. Cayouette1,2
1IRCM, Cellular Neurobiology, Montreal, Canada
2University of Montreal, Molecular Biology, Montreal, Canada
3Ottawa Hospital Research Institute, Regenerative Medicine,
Ottawa, Canada
The production of desired cell types via cellular reprogramming
has generated intense interest among researchers. Many reprogram-
ming phenomena depend on transcription factors with unusual
potency, but it remains largely unclear why particular transcription
factors possess reprogramming activity while others do not. We
have previously shown that the transcription factor Ikzf1 encodes
the early competence of neural progenitors in the retina and
neocortex. Since Ikzf1 was sufﬁcient to expand the potential of
neural progenitors, we wondered whether the induction of compe-
tence shared properties with reprogramming. To test this idea, we
compared the activities of Ascl1 (Mash1) and Pou3f2 (Brn2) to
Ikzf1. Surprisingly, like Ikzf1, overexpression of Ascl1 or Pou3f2
reset the developmental clock of transfected progenitors, causing the
production of early-fate retinal ganglion cells at inappropriate
postnatal stages. The induction of ganglion cell production occurred
in opposition to the natural roles of Ascl1 and Pou3f2 in retinal
development, and was dependent on high-level overexpression.
Similarly, like Ascl1 and Pou3f2, when Ikzf1 was expressed in
ﬁbroblasts, they were directly reprogrammed to the neuronal fate.
These data demonstrate that artiﬁcial reprogramming phenomena
can also occur within lineages, perhaps by co-opting natural
programs for regulating neural progenitor potential. Our study also
points to the requirement for careful interpretation of gain-of-
function data in developmental studies.
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Glial cells missing 1 promote cell differentiation and
angiogenesis by growth factor expression
Y. Hayashi1, S. Fuke1, Y. Go2, A. Abdullah1, T. Fuchigami1, N.
Morimura1, N. Koyama1, S. Hitoshi1
1Shiga University of Medical Science, Integrative Physiology,
Shiga, Japan
2National Institutes of Natural Sciences, Exploratory Research
Center on Life and Living Systems, Aichi, Japan
Glial cell missing (gcm) plays a critical role in glial cell
development in Drosophila. Overexpression of Gcm1 in the
mammalian embryonic brain was shown to promote the differen-
tiation of neural precursor cells into astrocytes. On the other hand,
when the brain was injured, a lot of astrocytes proliferate and play a
key role in the repair. Here, we show that the Gcm1 was upregulated
in the brain 3 days after cold injury. To determine the function of
Gcm1, we performed in utero electroporation studies to overexpress
Gcm1 together with Gfp in neural precursor cells at E14.5 and
analyzed at E17.5. The Gcm1 signiﬁcantly promoted the emergence
of GFAP(+) and S100b(+) astrocytes. Next, we investigated the
differentiation into oligodendrocyte lineage cells by immunostaining
the Gcm1 electroporated brains. The number of Olig2(+) cells, an
oligodendrocyte lineage marker, increased both in GFP(+) and in
GFP(-) populations. In the Gcm1 electroporated brain at postnatal
day 14, a large number of cells positive for GST-p, a marker of
mature oligodendrocytes, were observed. These results suggested
Gcm1 overexpression promoted both astrocytic and oligodendro-
cytic differentiation in the embryonic brain. Furthermore, we also
noticed that Gcm1 overexpression resulted in robust angiogenesis.
Interestingly, the astrocytic differentiation and angiogenesis were
regulated by LIF, VEGFA, and VEGFC secretion. Thus, consider-
ing that brain injury requires gliogenesis and angiogenesis for the
repair, our results suggest that modiﬁcation of Gcm1 expression
could be a new therapeutic strategy for the perinatal brain injury.
MTU05-11
Nigella sativa oil ameliorates the effects of early weaning
on the cerebellum of wistar rats
R. Jaji-Sulaimon, M. Adekunle, I. Gbadamosi, G. Omotoso
University of Ilorin, Anatomy, Ilorin, Nigeria
Early weaning has become a common practice among nursing
mothers in different communities around the world and may be one
of the leading causes of neuronal degeneration. This study aimed at
investigating the effects of Nigella sativa oil (NSO) on the
cerebellum of early weaned Wistar rats. We hypothesize that NSO
will attenuate the effects of early weaning on the cerebellum of
wistar rats.
Rats were divided into normal weaned (NW) and Early Weaned
(EW) groups, weaned on post natal day (PND) 28 and 18
respectively and EW+NSO group, weaned on PND 18 and
administered 25 ml/kg NSO. Exploratory activities were tested
using the open ﬁeld test (OFT). All experimental animals were
sacriﬁced on PND 35. Cerebelli were processed for light micro-
scopy. We estimated levels of malondialdehyde (MDA), Glu-
tathione peroxidase (GPx) and Superoxide dismutase (SOD). Data
were analysed using one-way analysis of variance. All animals
received humane care in compliance with the regulations of the
University of Ilorin Ethical Review Committee and best interna-
tional practice.
Exploratory activities of the EW rats were signiﬁcantly pro-
nounced when compared to rats in the NW and EW+NSO groups.
Biochemical analysis showed that NSO ameliorated early weaning-
induced oxidative stress as indicated by increased GPx and SOD
levels in the NSO treated group. Lipid peroxidation was also
attenuated as evidenced by reduced expression of MDA. Early
weaning caused several alterations in cerebellar cytoarchitecture.
However, the group treated with NSO showed less alterations and a
uniform cytoarchitecture similar to the control NW group.
Data from this study showed that oral administration of NSO
attenuated early weaning- induced anxiety, cerebellar oxidative
stress and neural tissue damage.
MTU05-12
LIS1 alterations drive distinct epigenetic, post-
transcriptional & chromatin accessibility modes to
resolve lineage commitment
A. Kshirsagar, T. Olender, J. Hanna, O. Reiner
Weizmann Institute of Science, Department of Molecular Genetics,
Rehovot, Israel
LIS1 mutations and deletions have been associated with
Lissencephaly; a condition wherein the cerebral cortices of patients
assume smooth shape. The LIS1 protein is involved in several key
functions including cell proliferation and neuronal migration, and is
involved in the regulation of the molecular motor cytoplasmic
dynein and the cytoskeleton. Increase in the dosage of the LIS1 gene
also causes mild brain malformations and developmental delay.
During early development, following embryonic day 3.5, regulation
of RNA at the transcriptional and post transcriptional levels plays a
pivotal role in the regulation of pluripotency and differentiation.
Lis1 knockout mice are early embryonic lethal and the role of this
protein during early development together with its function in the
nucleus still remains to be elusive.
Immunostaining of mouse wild type blastocysts afﬁrmed that
LIS1 co-localizes predominantly in inner cell mass cells. Here, in
this study, LIS1 is detected in the nucleus of mammalian embryonic
stem cells in association with chromatin embedded proteins, and
most notably, chromatin modiﬁers, the RISC complex and splicing
factors. Multiomic studies using Lis1 mutant mouse ES cells
(mESCs) showed that LIS1 together with ribonucleoprotein com-
plexes physically associate with chromatin accessibility, alternative
splicing and non-coding RNA regulation. Further, LIS1 mutant
human embryonic stem cell (hESCs) lines were generated using
CRISPR/Cas9 genome editing. We developed a novel on-chip
platform to grow 3D cortical organoids from mutant hESCs and
modelled growth with reduced folding. Extra cellular matrix (ECM)
related genes were differentially expressed when wild-type and
LIS1 + /- organoids were compared at different growth stages.
Our study reveals novel molecular roles of LIS1 in ESCs and
during early stages of brain development, and provide a model
system to understand the crucial mechanism associated with
Lissencephaly.
© 2019 The Authors
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The function of KLF5 gene in adult brain
A. Kuroda1, T. Fuchigami1, N. Morimura1, Y. Hayashi1, N. Koyama1,
M. Ema2, S. Hitoshi1
1Shiga University of Medical Science, Integrativephysiology, Otsu,
Japan
2Shiga Medical University, Depart of Stem Cells and Human
Disease Models, Otsu, Japan
Klf5, one of the Kr€uppel-like factor (Klf) family genes, is an
ortholog of Drosophila melanogaster gene Kr€uppel. It is a
transcription factor involved in cellular differentiation or prolifer-
ation during mammalian development. Klf5 deﬁcient embryos are
lethal at blastocyst stage showing defective trophectoderm devel-
opment and implantation failure. Our previous data suggested that
Klf5 gene promotes the cell proliferation of neural precursor cells
(NPCs) in the developing mice brain. In this study, we analyzed the
function of Klf5 in adult NPCs. Adult neural stem cells (NSCs)
reside only in the subependymal zone (SEZ) and the subgranular
zone of the dentate gyrus (DG). In these regions, the adult NSCs,
which have the self-renewal and multipotent capabilities, are
maintained in quiescent state. To investigate roles of Klf5 in the
adult brain, Nestin-Cre::CAGstopKlf5 mice were generated, in
which neural precursor-speciﬁc recombination induces the Klf5
overexpression. We perform a neurosphere assay using cells derived
from the SEZ of Klf5 overexpressing mice’s brain. Contrary to our
expectation, the number of neurosphere was decreased. We
evaluated the incorporation of BrdU at DG and found that
incorporated BrdU was decreased in Klf5 overexpressing mice’s
brain. Klf5 overexpression mice showed small body weight and
behavioral abnormality. Now, we are trying to evaluate the
molecular mechanisms underlying these phenotypes.
MTU05-14
A hierarchy of beta-spectrins is required for maintenance,
but not assembly, of axonal sodium channels clustering
C.-H. Liu1, S. Ha2, R. Seo3, P. Mohler4, J. Noebels3, M.
Stankewich5, M. Rasband1,2
1Baylor College of Medicine, Program in Developmental Biology,
Houston, USA
2Baylor College of Medicine, Department of Neuroscience,
Houston, USA
3Baylor College of Medicine, Department of Neurology, Houston,
USA
4The Ohio State University College of Medicine, Departments of
Physiology and Cell Biology and Internal Medicine, Columbus,
USA
5Yale University, Department of Pathology, New Haven, USA
Highly-concentrated ion channels at axonal excitable domains
including axon initial segments (AIS) and nodes of Ranvier are
necessary to transmit action potentials. Cytoskeletal protein bIV-
spectrin is proposed to stabilize voltage-gated sodium (Nav)
channels at nodes, and bI-spectrin is reported to preserve this
function after losing bIV-spectrin. However, patients carrying bIV-
spectrin mutants showed epilepsy and intellectual disability, while
their peripheral sensory functions were intact, suggesting bI-spectrin
plays distinctive compensatory roles in the CNS and PNS.
Furthermore, the necessity of b-spectrins for Nav channels cluster-
ing at axons are unknown. To determine the function of b1 and b4-
spectrin in the nervous system, we generated mice lacking these
proteins in the CNS and PNS neurons, respectively. Mice lacking
both b1/b4-spectrin in PNS showed ataxia and impaired action
potential conduction. With increasing age, there was progressive
loss of nodal Nav channels. Losing b1-spectrin in the CNS showed
normal AIS integrity while losing b4-spectrin reduced Nav channel
intensity. Unexpectedly, b1-spectrin was only detected at the AIS of
parvalbumin interneurons in b4-spectrin deﬁcient mice. Mice
lacking both b1/b4-spectrin showed severe seizures. These data
suggest that b-spectrins are necessary to maintain Nav channels at
axonal excitable domains. Furthermore, b4-spectrin is the primary
stabilizer, while b1-spectrin performs secondary functions in a
context-dependent manner.
MTU05-15
Cannabidivarin, capsaicin and the multiple fates of neural
stem cells
D. Lourenco1,2, R. Soares1,2, R. Rodrigues1,2, A. Sebasti~ao1,2, S.
Xapelli1,2
1Instituto de Farmacologia e Neurocie^ncias, FMUL, Lisboa,
Portugal
2iMM - JLA, FMUL, Lisboa, Portugal
Adult neural stem/progenitor cells (NSPC) with multipotent and
self-renewing properties can be mostly found in two neurogenic
niches, the Subventricular Zone (SVZ) and the Dentate Gyrus (DG)
of the hippocampus. Cannabinoids have been shown to play pivotal
roles in different neurogenic stages, namely in differentiation and
maturation of NSPC. Cannabidivarin (CBDV), a non-psychoactive
phytocannabinoid, homolog of cannabidiol, with high afﬁnity for
the vanilloid receptor 1 (TRPV1), is a potential candidate for
therapeutic use. Therefore, we aimed at unravelling the role of
CBDV on SVZ postnatal neurogenesis. SVZ neurospheres were
prepared from C57BL/6J (WT) mice pups (P1-3) and were
incubated for 2 days with CBDV and Capsaicin (TRPV1 agonist),
according to the experimental condition. Three groups were tested:
1) control (no drugs); 2) CBDV (100 nM; 300 nM; 1 μM); 3)
Capsaicin (3 μM; 10 μM; 30 μM). Immunocytochemistry against
mature neurons (NeuN) and oligodendrocyte progenitor cells (NG2)
was used to evaluate the effect of CBDV and Capsaicin on cell
differentiation. Here we show that SVZ neurospheres treated for
2 days in vitro with 1 μM of CBDV have a tendency (p = 0.07) for
an increase in the number of NeuN-positive cells and a signiﬁcant
increase (p < 0.05) with 30 μM Capsaicin. Regarding NG2-positive
cells, only SVZ neurospheres treated with 10 μM Capsaicin showed
a tendency (p = 0.08) for an increase in number of oligodendrocyte
progenitor cells. These results show that CBDV and capsaicin have
differential effects on SVZ cell differentiation. This work will allow
determining, in vitro, whether the activation of TRPV1, trough
CBDV or Capsaicin, can modulate postnatal neurogenesis and will
be important for future brain repair strategies.
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Analysis of TRPC5 expression in developing retina
O. Mai, I. Yasuki, S. Koji
Gunma University Graduate School of Medicine, Department of
Molecular and Cellular Neurobiology, Maebashi, Japan
Transient receptor potential canonical 5 (TRPC5) is a non-
selective cation channel, which is activated by various stimuli.
TRPC5 suppresses axonal outgrowth through its activation in
hippocampal neurons. On the other hand, we previously reported
that transient receptor potential vanilloid 2 (TRPV2) promotes
axonal outgrowth in developing sensory neurons. Thus, opposing
effects of TRPV2 and TRPC5 might modulate sensory nerve growth
as a positive and a negative regulator, respectively.
In this study, we examined whether TRPC5 activation is involved
in axonal outgrowth as in the case of hippocampal neurons. We ﬁrst
determined the timing of TRPC5 expression using in situ hybridiza-
tion (ISH) with retinal tissue sections from E12.5 to adult. The
expression was not detected at E12.5, but started at E14.5. The
signal of TRPC5 mRNA became strong in differentiated cell layers
such as the ganglion cell layer from E16.5 to adult. By utilizing
double-immunostaining of TRPC5 and retinal cell type speciﬁc
markers for retinal ganglion cells (RGC), amacrine cells (AC),
bipolar cells (BP), horizontal cells (HC) and M€uller cells, we next
identiﬁed which cell type expresses TRPC5 protein. Consequently,
the protein expression was consistent with the mRNA expression
pattern, indicating that our ISH probe speciﬁcally detected TRPC5.
Among retinal cells, RGC and AC selectively expressed the TRPC5
throughout the development. Since the peak timing of RGC axonal
elongation is from E11.5 to P0, and TRPC5 expression started from
E14.5, we hypothesize that the TRPC5 activation regulates the RGC
axonal outgrowth during retinal development. Currently, we analyze
whether TRPC5 regulates axonal outgrowth in embryonic retinal
explants treated with TRPC5 antagonist. Possible mechanism of
TRPC5-regulated optic nerve growth during development will be
discussed.
MTU05-17
Cerebellar development and function in neonatal rats
following intrauterine and postnatal exposure to caffeine
F. Olopade1, T. Shokunbi1,2
1University of Ibadan, Department of Anatomy, Ibadan, Nigeria
2University of Ibadan, Department of Surgery, Ibadan, Nigeria
Caffeine is commonly consumed in pregnancy and also used
therapeutically in the management of apnea in preterm babies.
Moderate to high maternal consumption of caffeine is associated
with detrimental neurological effects in the newborn. However,
there is insufﬁcient information on its effects on the structural and
functional development of the cerebellum. This study investigates
the effect of perinatal caffeine consumption in rat dams, on
neurobehavioral and structural cerebellar development of their
offsprings.
Pregnant rats received 50 or 100 mg/kg day of caffeine (CAF50,
CAF100) by gavage throughout pregnancy and three weeks
postnatal while the controls had sterile water. Post-delivery, the
dams nursed their pups and after three weeks, the pups underwent
neurobehavioral tests: cliff aversion for sensorimotor reﬂex devel-
opment, negative geotaxis for motor coordination, and forearm grip
strength test for muscular strength. By serial sacriﬁce from Day 19
to 21, morphological assessment of the cerebellum’s development
was assessed by measuring the external granular layer (EGL)
thickness and the cellular density within the molecular layer.
Development of motor reﬂexes and coordination appeared
slightly earlier in CAF50 pups than controls, but signiﬁcantly
delayed in CAF100 pups. Muscular strength in CAF50 pups was
comparable to controls, but reduced in CAF100 pups. The EGL was
consistently thicker and number of transiting cells in the molecular
higher in CAF100 pups than controls, from Day 19-21.
High maternal caffeine consumption delays the migration of the
cells of the EGL into the granular layer and therefore retards the
development of this layer in their offsprings. We propose there is a
relationship between this developmental delay and retarded neu-
robehavioural functions observed.
MTU05-18
Cannabinoids, adenosine A2A receptors and postnatal
neurogenesis
R. Rodrigues1,2, A. Armada-Moreira1,2, F. Ribeiro1,2, A. M.
Sebasti~ao1,2, S. Xapelli1,2
1Instituto de Farmacologia e Neurociencias, FMUL, Lisboa,
Portugal
2IMM - JLA, FMUL, Lisboa, Portugal
Postnatal neurogenesis operates in specialized niches of the
mammalian brain in a process modulated by cannabinoid type 1 and
2 receptors (CB1R and CB2R). Recent evidence sheds light on the
interaction of adenosine A2A receptors (A2AR) with cannabinoid
receptors. Herein, we aimed at understanding the putative role of
A2AR on cannabinoid-mediated cell fate, cell proliferation and
neuronal differentiation of rat neonatal subventricular zone (SVZ)
and dentate gyrus (DG) neurospheres. CB2Rs or A2AR activation
was found to promote self-renewing divisions of DG cells.
Importantly, A2AR antagonist blocked the effect mediated by
CB2R activation, while CB1R or CB2R antagonists blocked A2AR-
mediated effect. SVZ cell proliferation was only affected by CB1R
activation, an effect blocked in the presence of an A2AR antagonist.
Although CB1R, CB2R or A2AR activation alone did not alter DG
cell proliferation, CB1R or CB2R co-activation with A2ARs
promoted a signiﬁcant increase in DG cell proliferation. Lastly,
CB1R and/or CB2R activation promoted SVZ and DG neuronal
differentiation, while A2AR activation only promoted DG neuronal
differentiation. In both cases, the proneurogenic effect mediated by
CB1R or CB2R agonists was blocked by an A2AR antagonist, while
in DG the A2AR-mediated actions on neuronal differentiation were
blocked by CB1R or CB2R antagonists. Taken together, our
ﬁndings suggest an interaction between the adenosinergic and
cannabinergic systems, cross-antagonism being evident, responsible
for controlling early stages of postnatal neurogenesis.
Acknowledgements: Supported by FCT, SFRH/BD/129710/2017
and iFCT, IF/01227/2015.
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MTU05-19
PI3K signalling in trans-resveratrol mediated prevention
of monocrotophos damaged neuronally differentiating
human stem cells
S. Singh, S. Jahan, A. B. Pant
CSIR-Indian Institute of Toxicology Research, Developmental
Toxicology Division, Lucknow, India
The role of Resveratrol(RV) as a neuroprotectant is well
recognized and cellular molecules involved in imparting the
physiological effect have been well illustrated. However, some
ambiguity still prevails as the speciﬁc receptor and downstream
signaling molecules are not yet clearly stated. So, we investigated
the signaling pathway(s) involved in its cellular protection in the
human umbilical cord blood mesenchymal stem cells (hUCB-
MSCs) derived neuronal cells. The mesenchymal stem cells were
exposed to various concentrations (10, 100, 1000 μM) of Monocro-
tophos (MCP), a known developmental neurotoxic organophosphate
pesticide, for a period of 24 h. The MAPK signaling pathways
(JNK, p38, and ERK) known to be associated with MCP induced
damages were also taken into consideration to identify the potential
connection. The biological safe dose of RV (10 μM) shows a
signiﬁcant restoration in the MCP induced alterations. Under the
speciﬁc growth conditions RV exposure was found to promote
neuronal differentiation in the hUCB-MSCs. The exposure of cells
to a speciﬁc pharmacological inhibitor (LY294002) of PI3K
conﬁrms the signiﬁcant involvement of PI3K mediated pathway in
the ameliorative responses of RV against MCP exposure. Our data
identiﬁes the substantial role of RV in the restoration of MCP
induced cellular damages, thus proving to have a therapeutic
potential against organophosphate pesticides-induced neurodegen-
eration.
MTU05-20
The role of NPRL2 and NPRL3 in neural development and
disorders
S.-Y. Yeh1, Y.-T. Liu2, J.-W. Tsai1
1National Yang-Ming University, Institute of Brain Science, Taipei
City, Taiwan
2Taipei Veterans General Hospital, Neurological Institute, Taipei
City, Taiwan
The neurodevelopmental disorder focal cortical dysplasia (FCD) is
the most common cause of medically refractory epilepsy in children.
Several genes have been identiﬁed to be involved in the pathogenesis
of this disease, including NPRL2, NPRL3 and DEPDC5, the
components of GATOR1 complex. GATOR1 complex acts as a
negative regulator of mTORC1 in mTOR signaling pathway, which
regulates cell growth, metabolism, autophagy, and proliferation.
Although mutations in these genes have been reported to cause FCD
and focal epilepsy, the functions of NPRL2/3 in neural development is
still not fully understood. To investigate the roles of NPRL2/3 in
cortical development, we delivered shRNA by in utero electropora-
tion (IUE) to knock down NPRL2/3 in neural progenitors of mouse
embryos. We found that NPRL2/3 knockdown during development
caused neuronal migration delay. Furthermore, we observed mor-
phological changes of dendritic spines in the NPRL2/3-knockdown
neurons in postnatal mice. Meanwhile, we identiﬁed potential novel
mutations on NPRL2 and NPRL3 in patients with focal epilepsy. To
study whether these mutations may cause neuronal defects, we
electroporated wild type or mutant NPRL2/3 into mouse embryonic
neural progenitors. However, expression of these mutants did not
cause apparent neural migration defects. Our study may help us
understand the roles of NPRL2/3 in neuronal development and
provide information for developing effective treatment to NRRL2/3-
related neural developmental disorders.
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MTU06-01
ATP-citrate lyase (ACLY) is a key element of brain energy
metabolism
L. Achanta1, D. Thomas2, G. Housley1, C. Rae1
1UNSW, SOMS, Sydney, Australia
2UNSW, MWAC, Sydney, Australia
ATP-citrate lyase (ACLY) is the key enzyme generating
cytosolic acetyl-CoA and oxaloacetate from citrate. Widely
expressed in the brain, its role in healthy brain energy metabolism
needs elucidation. We inhibited ACLY with BMS-303141 (3,5-
Dichloro-2-hydroxy-N-(4-methoxy[1,10-biphenyl]-3-yl)-benzene-
sulfonamide)), at 1 lM (IC50) and 10 lM applied to guinea pig
cortical brain tissue slices that were incubated with 2 mM [2,3-13C]
pyruvate, 2 mM [3-13C]lactate, or 0.25 mM [U-13C]b-hydroxybu-
tyrate (bOHB) for 60 minutes, or with 5 mM [1-13C]glucose alone,
or 0.5 mM [1,2-13C]acetate and 5 mM [1-13C]glucose for 90 min-
utes. The brain slices were extracted with methanol/chloroform,
lyophilised and reconstituted in D2O.
1H, {13C}-decoupled 1, and
{1H}-decoupled 13C NMR spectra were acquired from each sample
(N = 4). The resultant isotopomers and metabolite pools were
quantiﬁed. Inhibition of ACLY using 1.0 lM BMS-303141 with
pyruvate, lactate, or bOHB as substrates resulted in increased
incorporation of label into Krebs cycle intermediates and glycolytic
by-products, showing that normal ACLY activity results in a
signiﬁcant efﬂux of label from the Krebs cycle. When [1-13C]
glucose was the sole substrate, total metabolite pools and net ﬂux of
13C into Krebs cycle intermediates and the glycolytic by-products
lactate and alanine were signiﬁcantly reduced. This effect was
“rescued” by 0.5 mM [1,2-13C]acetate, where 1.0 lM BMS-303141
resulted in increased incorporation of label from both glucose and
acetate. BMS-303141 at 10 lM had limited further effects in all
cases, suggesting that the ability of the system to accommodate
further ACLY inhibition is limited. These results indicate that the
impact of ACLY activity on Krebs cycle ﬂux is signiﬁcant, although
it is currently not a part of most models of brain metabolism.
MTU06-02
Metabolic impairments in neurons and astrocytes derived
from human induced pluripotent stem cells of Alzheimer’s
disease patients
B. A. Garcı´a1, C. Salcedo1, P. Hyttel2, H. Waagepetersen1, K.
Freude2
1University of Copenhagen, Drug Design and Pharmacology,
Copenhagen, Denmark
2University of Copenhagen, Veterinary and Animal Sciences,
Copenhagen, Denmark
Metabolic impairments are one of the earliest cerebral pathogenic
events in Alzheimer’s disease (AD). In order to investigate the
underlying mechanisms of these metabolic alterations, we studied
cellular energy and amino acid metabolism in neurons and
astrocytes derived from human induced pluripotent stem cells
(hiPSC) obtained from AD patients and their respective CRISPR/
Cas9 gene edited controls or age-matched controls. Cultures of
hiPSC-derived neurons and astrocytes from AD patients and
isogenic or aged-matched controls were incubated with 13C-labeled
energy substrates, enrichment in metabolites was determined using
gas chromatography coupled to mass spectrometry, followed by
metabolic mapping and Western blot analyses. Mitochondrial
function was assessed via the Seahorse XFe96 Analyzer. AD
neurons displayed changes in enzymes associated with glutamine
and glutamate processing. Speciﬁcally, phosphatase-activated glu-
taminase (PAG) and aspartate amino transferase (AAT) were up
regulated in AD neurons. The observed increase of PAG resulted in
increased levels of glutamate converted from glutamine, which is
expected to trigger excitotoxicity, one of the early pathological
hallmarks in AD neurons. Similarly, increased levels of ATT
resulted in increased conversion of aspartate to oxaloacetate fuelling
the tricarboxylic acid cycle (TCA). Interestingly, a decreased
mitochondrial respiratory function was observed in AD hiPSC-
derived neurons, suggesting that an overactive TCA cycle might be
a compensatory mechanism. The metabolic studies of astrocytes
revealed increases in Lactate production, which could point towards
a compensatory mechanism to counteract the increased glutamate
levels secreted from AD neurons and thereby combatting excito-
toxicity.
MTU06-03
Menadione-mediated WST 1 reduction as indicator for the
metabolic potential of cultured astrocytes
E. Ehrke1, J. Steinmeier1,2, C. Protzel1, R. Dringen1,2
1University of Bremen, Centre for Biomolecular Interactions,
Bremen, Germany
2University of Bremen, Center for Environmental Research and
Sustainable Technology, Bremen, Germany
The water-soluble tetrazolium salt 1 (WST1) is frequently used as
indicator of the metabolic potential of cultured cells and to
determine cell viability. The presence of the membrane-permeable
electron cycler menadione caused an almost linear increase in WST1
formazan with maximal WST1 reduction in the presence of 0.5 mM
glucose that was not further stimulated by increasing glucose
concentrations up to 10 mM after 30 min, while hardly any reaction
was observed in the absence of glucose. Only the hexose mannose
was able to fully replace glucose as substrate for WST1 formazan
generation but not other sugars nor mitochondrial substrates.
Intracellular menadione reduction is catalyzed by a cytosolic
enzyme that uses efﬁciently both NADH and NADPH as electron
donor, indicated by similar KM- and vmax- values for both cofactors.
Accordingly, application of WST1 and menadione to astrocytes led
to rapid depletion of NADH and NADPH. The menadione-mediated
WST1 reduction was highly sensitive towards dicoumarol as
demonstrated for the enzyme in lysates by an inhibitor constant of
approximately 2 nM and by the half-maximal inhibition of the cell-
dependent WST1 reduction at around 45 nM dicoumarol. These
data demonstrate that the NAD(P)H:quinone acceptor oxidoreduc-
tase 1 (NQO1) is involved in cellular menadione reduction which in
turn facilitates extracellular WST1 reduction. Interestingly, the
amount of WST1 formazan generated matched well with the
decrease observed in the lactate release, suggesting that electrons
from glycolysis-derived NADH contribute to the menadione-
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dependent WST1 reduction. In conclusion, the menadione-depen-
dent WST1 reduction can be used as valuable tool to study the
metabolism of cultured brain cells.
MTU06-04
NNT is required for brain mitochondrial redox balance and
is highly expressed in nitric oxide synthase and
serotoninergic neurons
A. Francisco1, D. Engel1, J. Ronchi1, T. Figueira2, F. Rogerio1, A. de
Bem3, R. Castilho1
1University of Campinas, UNICAMP, Campinas, Brazil
2University of S~ao Paulo, USP, Ribeir~ao Preto, Brazil
3University of Brasılia, UnB, Brasılia, Brazil
Nicotinamide nucleotide transhydrogenase (NNT) is a protein
located in the inner mitochondrial membrane that catalyzes the
reduction of NADP+ at the expense of NADH oxidation coupled to
inward proton translocation from the intermembrane space to the
matrix. NNT is known to support NADPH-dependent processes
such as peroxide detoxiﬁcation and reductive biosynthesis. Consid-
ering the scarce knowledge about NNT roles in brain, we aimed at
investigating NNT activity, distribution and contribution to brain
physiology by using congenic mice carrying mutated Nnt alleles
from the C57BL/6J strain (Nnt/) or the wildtype Nnt (Nnt+/+).
Biochemical analyses of isolated brain mitochondria showed that the
lack of NNT resulted in lower total NADP+-reducing activity. In the
absence of NNT, a higher mitochondrial H2O2 production was
detected when the metabolism of respiratory substrates did not favor
the ﬂux through other mitochondrial NADPH sources or when the
respiratory chain was inhibited. Concerning the spatial distribution
of NNT in mouse brain, we observed a higher NNT expression and
activity in the pons with increased NNT labeling of neurons in raphe
and hindbrain nuclei. Most of the neurons exhibiting strong NNT
labeling were also endowed with enzymes involved in biosynthetic
pathways for 5-hydroxytryptamine and nitric oxide production,
which require NADPH. Behavioral evaluations showed NNT
absence is associated with impaired locomotor activity and depres-
sive-like behavior in aged mice, but not in adults. These results
indicate that NADPH from NNT activity has relevance for brain
mitochondrial redox homeostasis and neurotransmission.
MTU06-05
Integration of micrornaome and metabolomics to dissect
cerebral disease progression in X-linked
adrenoleukodystrophy
J. Singh, L. Poisson, S. Giri
Henry Ford Health System, Dept. of Neurology, Detroit, USA
Introduction: X-linked adrenoleukodystrophy (X-ALD) is a
progressive neurodegenerative disease caused by mutations in
peroxisomal ABCD1 gene. X-ALD males develop fatal cerebral
demyelinating disease (ALD) the mechanism for which remains
unknown. We took a novel multi-omics approach of untargeted
metabolomics and next generation sequencing (HiSeq) to ﬁnd
regulatory (microRNA) and active (metabolite) pathways underlying
the fatal neuroinﬂammation in ALD.
Methods: Postmortem brain tissue from healthy controls and
ALD patients were processed for microRNA (miRNA) and
metabolite extraction and analysis. Data analysis was performed
by “MetaboAnalyst 2.5” for GC-MS and Bioconductor for miRNA.
Results: Each measured miRNA and metabolite was screened
using appropriate ANOVA models. Thresholds for signiﬁcance were
set to control the estimated false discovery rate, per platform, at 5%.
We compared postmortem brain white matter of healthy controls
(CTL) with normal looking area (NLA) and periphery of plaque/
lesion (PLS) regions within the ALD brain white matter. Analysis of
variance (p < 0.05) and Post-hoc t-tests identiﬁed nineteen miRNA
and eleven metabolites that signiﬁcantly differed across the three
groups (control, NLA and PLS). Of the nineteen miRNA seventeen
were increased (PLS > NLA > CTL) and two were decreased (CTL
> NLA > PLS). Seven metabolites were upregulated (PLS > NLA >
CTL) and four were downregulated (CTL > NLA > PLS). We
calculated the Pearson’s correlation coefﬁcient between the expres-
sion of these nineteen miRNA and the metabolite intensities of
eleven metabolites for putative links between the global gene
expression modulators (miRNAs), and metabolites.
Conclusion: Our novel “transomic” modeling identiﬁes, for the
ﬁrst time, integrated miRNA and metabolite pathways underlying
demyelination in X-ALD.
MTU06-06
Axonal metabolic support and energy dynamics in active
white matter tracts
A. Trevisiol1, K. Kusch1, J. Hirrlinger2,1, Klaus. A. Nave1
1Max Planck Institute for Experimental Medicine, Neurogenetics,
Goettingen, Germany
2Carl-Ludwig-Institute for Physiology, Hirrlinger, Leipzig,
Germany
In white matter, axonal energy homeostasis critically depends on
glial support. Failure in glial-mediated delivery of metabolic
substrates into the axonal compartment results in axonal energy
deﬁcit and may anticipate the axonal degeneration described in
several myelin disorders and neurodegenerative diseases. In mice,
neuronal transgenic expression of an ATP-ﬂuorescent sensor
allowed us to visualize axonal energy content in acutely isolated
optic nerves while simultaneously performing electrophysiological
compound action potentials (cAP) recordings. The real-time mon-
itoring of activity-dependent axonal ATP revealed a strong corre-
lation between axonal energy metabolism and nerve conduction.
Further on, to determine possible metabolic consequences of myelin
defects we monitored ATP and cAP in Plp1null/y optic nerves.
Genetic ablation of Plp1, encoding a myelin membrane protein,
serves as a model of spastic paraplegia type-2, where an impaired
axo-glia unit leads to secondary axonal loss. We found that the
energy metabolism of myelinated axons of Plp1null/y optic nerves is
perturbed long before the onset of clinical symptoms and major
pathological changes. To understand further the role of oligoden-
droglia and myelin formation in the white matter energy balance, we
focused on the metabolic properties of spinal cord sensory ﬁbres
in vivo, following a long-term FLIM analysis in a model of MS
where we could determine the axonal metabolic changes induced by
demyelination and remyelination. The parallel monitoring of axonal
ATP and cAP is therefore a powerful tool to study white matter
metabolism and metabolic support mechanisms under physiological
conditions and in models of neurodegenerative disorders.
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MTU06-07
The neuroprotective role of 5-methoxyindole-2-carboxylic
acid in ischemic stroke injury in rat brain
L.-J. Yan
University of North Texas Health Science Center, Pharmaceutical
Sciences, Fort Worth, USA
This presentation summarizes our ﬁndings that 5-methoxyindole-
2-carboxylic acid (MICA) can serve as a chemical conditioning
agent in neuroprotection against stroke injury and the corresponding
underlying mechanisms. MICA is a reversible inhibitor of mito-
chondrial dihydrolipoamide dehydrogenase that is involved in
bioenergetics and metabolism. We performed both MICA precon-
ditioning and postconditioning in the rat brain using an ischemic
stroke model. For preconditioning studies, MICA (200 mg/kg body
weight) was mainly administered via diet intake for 4 weeks. For
postconditioning studies, MICA (also 200 mg/kg body weight) was
injected intraperitoneally at the onset of 24 h reperfusion following
1 h ischemia. Our results indicate that stroked animals treated with
MICA either in preconditioning or postconditioning studies showed
less brain infarction volume than that of vehicle-treated animals.
Common protective mechanisms in both MICA preconditioning and
postconditioning studies involve Nrf2 up-regulation of NQO1
expression, decreased oxidative stress, increased mitochondrial
membrane integrity, and decreased cell death. Our ﬁndings demon-
strate that MICA can produce an effective pre- and post-
conditioning effects in the ischemic brain of rat and the underlying
mechanism likely involves preservation of mitochondrial function,
upregulation of cellular antioxidative capacity, and attenuation of
oxidative stress.
© 2019 The Authors
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MTU07-01
Methyl jasmonate mitigates cognitive impairment and loss
of neuronal dendritic spines in the brain of chronically
stressed mice
O. Aluko1, A. Pignataro2, S. Umukoro1, M. Ammassari-Teule2
1University of Ibadan, Department of Pharmacology and
Therapeutics/Neuropharmacology, Ibadan, Nigeria
2National Research Council, Institute of Cell Biology and
Neurobiology, Rome, Italy
Morphological changes such as retraction of neuronal dendrites
and spine loss have been identiﬁed as a common consequence of
chronic stress on the brain. Methyl jasmonate (MJ) is a bioactive
compound and naturally occurring anti-stress plant hormone
previously reported with ameliorative effect against acute and
chronic stress in mice. This study investigated the effect of MJ on
cognitive impairment, dendritic spines, and density of mice
subjected to unpredictable chronic mild stress (UCMS).
Mice were chronically stressed for 10 days and intraperitoneally
treated with either vehicle or 50 mg/kg MJ. Thereafter, mice were
assessed for freezing time in fear conditioning test as a measure of
cognitive function. Dendritic morphology of brains using Golgi-Cox
staining procedure followed by Sholl analysis and immunohisto-
chemical expression of nrf2 and parvalbumin were also assessed.
Our results revealed that UCMS triggered a signiﬁcant increase in
freezing duration, a decrease in neuronal dendritic spine density,
intersection, and length of hippocampal CA1, basolateral amygdala,
and prefrontal cortex, with concomitantly increased nrf2 and
decreased parvalbumin expressions. MJ signiﬁcantly attenuated
UCMS-induced cognitive dysfunction, alterations in dendritic
arborization and protein expression, indicating less susceptibility
to stressors and increased neuronal communication.
Due to the safety proﬁle of MJ, it could have a therapeutic
outcome in stress-induced cognitive deﬁcits and neuronal alter-
ations. We are currently investigating the molecular mechanisms
underlying these effect using western blotting techniques for
quantiﬁcation of BDNF, HSP 70, CREB, and Glut1.
MTU07-02
The role of the orexin (hypocretin) system in context-
induced relapse to alcohol seeking
E. Campbell1, M. Hill1, N. Marchant2, A. Lawrence1
1Florey Institute of Neuroscience and Mental Health and The
University of Melbourne, Florey, Melbourne, Australia
2VU University Medical Center, Anatomy and Neurosciences,
Amsterdam, The Netherlands
Our lab has previously shown a role for orexin signalling via
OX1 receptors in cue-induced relapse to alcohol seeking following
extinction. However, one shortfall of extinction is that it is
experimenter-imposed, and does not model the negative conse-
quences of drug use. Thus, the current study assessed the role of the
orexin system in a model of context-induced relapse to alcohol
seeking following punishment-imposed voluntary abstinence.
Male iP rats were trained to self-administer 20% alcohol in
context A, where alcohol was available without consequence.
Subsequently, rats were then trained in a new context (B) where an
active lever press resulted in the delivery of an alcohol reward paired
with footshock. Footshock was delivered randomly on 50% of lever
presses. Shock intensity was increased across day until responding
for alcohol ceased, despite the ongoing availability of alcohol. Rats
were then tested with either vehicle or SB-334867 (5 mg/kg, ip) in
both contexts A and B.
Rats reliably self-administered alcohol in context A and volun-
tary abstinence was observed in context B. On relapse test, there was
a main effect of treatment [F(1,17) = 24.8, p < 0.0001] and a
treatment x context interaction [F(1,17) = 5.6, p = 0.03]. Vehicle-
treated rats showed relapse to alcohol seeking in context A
compared to context B. Pre-treatment with SB-334867 reduced
alcohol seeking.
The current study further implicates orexin signalling in alcohol
seeking using a preclinical model that may be more reﬂective of the
human experience. Ongoing studies will aim to identify the
anatomic loci for this effect.
MTU07-03
Single-cell RNA-SEQ of mouse nucleus accumbens
reveals a subtype of D1 medium spiny neurons
W. Chen1,2,3, R. Chen1,2,3, Mohamed. N. Djekidel1,2,3, A.
Bhattacherjee1,2,3, Luis. M. Tuesta1,2,3, Y. Zhang1,2,3
1Harvard Medical School, Department of Genetics, Boston, USA
2Boston Children’s Hospital, Program in Cellular and Molecular
Medicine, Boston, USA
3Howard Hughes Medical Institute, Boston Children’s Hospital,
Boston, USA
The nucleus accumbens (NAc) is the most important entry point
of the basal reward circuitry and has been suggested to play a crucial
role in motivational behaviors. However, our knowledge of its
cellular heterogeneity is surprisingly limited. Thus, we performed a
high-throughput single-cell RNA-seq (10X genomics) and revealed
an underestimated cellular complexity of the NAc. Our data revealed
a rich cellular heterogeneity of interneurons and medium spiny
neurons (MSNs) in the NAc and a tight relationship between
transcriptional features and spatial distribution in different neuron
subtypes. As a proof-of-concept, we focused on the MSNs and
found that the tachykinin 2 (Tac2)-positive neurons in the NAc is a
molecularly distinct subtype of D1-MSNs. To characterize the Tac2
clusters as a subtype of D1-MSNs, we combined multi-color FISH
(RNAscope) neuronal tracing and behavioral assays. We found that
Tac2 is selectively expressed in the Drd1+ MSNs but not in the
Drd2+ MSNs, and are preferentially projected to the midbrain. In
addition, using chemogenetic, we selected manipulated the Tac2
cluster and found that activation of the NAc Tac2 clusters
potentiated, while inhibition repressed cocaine sensitization. How-
ever, such manipulation had no obvious effects on anxiety- and
depression-related behaviors. Furthermore, we investigated the role
of the NAc Tac2 clusters in mediating reinforcement in a mouse
intravenous self-administration (IVSA) and found that inhibition of
the Tac2 clusters signiﬁcantly reduced cocaine intakes. Collectively,
our results suggested that Tac2 clusters in the NAc are a D1 MSN
subtype.
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Functional and molecular markers of vulnerability
towards stress in a rat model of PTSD
A. Datusalia, N. Sala, L. Musazzi, P. Maurizio
Universita degli Studi di Milano, Dipartimento di Scienze
Farmacologiche e Biomolecolari, Milan, Italy
Stressful events represent a major risk factor for the development
of neuropsychiatric disorders such as depression and PSTD.
Although genetic vulnerability may represent a moderating factor,
it is not clear what mechanisms address the individual responses
towards pro-adaptive or maladaptive course. Here we aimed to
investigate short/long-term cellular/molecular changes in the after-
math of acute stress to understand better the dynamics of the stress
response and identify key factors that may trigger stress-related
psychopathology. We adapted sucrose intake (SI) test to identify
foot shock (FS)-stress-induced anhedonic phenotype. Baseline
sucrose intake was established for 5 weeks in rats. Rats were
randomly assigned to FS-stress/control groups and subjected to FS-
stress. After 24 h in SI test, anhedonic animals (showing at least
25% within-subject decrease in SI) were classiﬁed as vulnerable
(FS-V), while others as resilient (FS-R). We demonstrated that FS-
stress increased basal glutamate release only in FS-V, while
depolarization-evoked glutamate release was increased in both FS-
V and FS-R. In Further, we observed signiﬁcant increase in the
nuclear expression of MR only in FS-R while GR expression
remains unaltered. Recent studies have demonstrated multiple roles
of miRNAs in governing functional and structural synaptic plasticity
as well as in pathophysiology of psychiatric disorders. Currently we
are investigating key miRNAs responsible for resilience and
vulnerable response after single acute stress episode and their target
genes at short- and long-term after stress. We have also investigated
plasticity related protein like ERK1/2, CREB etc. expression and
found increased nuclear translocation of pERK in FS-V rats. This
study results will help to identify key molecules associated with
stress-induced maladaptive (vulnerable) response and novel targets
for therapy of stress-related neuropsychiatric disorders.
MTU07-05
Neonatal nicotine exposure primes midbrain neurons to a
dopaminergic phenotype and increases adult drug
consumption
D. Dulcis1, B. Romoli1, I. M. Sandoval2, F. Manfredsson2, D. K.
Berg3, A. F. Lozada3, T. Hnasko4
1UCSD, University of California San Diego, Psychiatry, La Jolla,
USA
2Michigan State University, Translational Science & Molecular
Medicine, Grand Rapids, USA
3UCSD, University of California San Diego, Neurobiology, La
Jolla, USA
4UCSD, University of California San Diego, Neuroscience, La
Jolla, USA
Nicotine is a psychoactive substance that induces addiction
through neuroplasticity affecting the function of the Ventral
Tegmental Area (VTA) and dopamine release in the reward
circuitry. We have previously shown that altered neuronal activity
can change dopamine (DA) expression both in the developing and
adult brain. Here, we investigated the effect of neonatal nicotine
(NN) exposure on DA plasticity of VTA neurons.
Osmotic pumps were implanted in lactating mice to deliver 2 mg
nicotine/Kg/day to P2-P16 pups. Adult mice underwent nicotine and
ethanol 2 bottle-choice test. Brains were processed for tyrosine
hydroxylase and nuclear receptor related-1 protein (Nurr1) immuno-
histochemistry and in situ hybridization. Calcium spike activity was
measured via ex-vivo calcium imaging. We overexpressed Nurr1
and altered neuronal activity (DREADDs) in non-DAergic VTA
neurons using VGLUT2- & VGAT-cre mice.
NN exposure potentiated nicotine preference in adult (P90) mice,
increased nicotine-induced responses, induced ectopic Nurr1
expression within VTA glutamatergic neurons. Adult nicotine
exposure increased both the total number of DA neurons and DA
co-expression with glutamate in the VTA of NN-exposed mice.
Overexpression of Nurr1 induced an increase in nicotine preference
when paired to DREADDs-mediated activity boost. Downregulation
of Nurr1 in glutamatergic neurons revealed its expression is
necessary for non-DAergic neurons to acquire a dopaminergic
identity. These ﬁndings may provide a new critical link between
developmental exposure to drugs of abuse and adult vulnerability to
drug addiction.
This research was supported by the Tobacco-Related Disease
Research Program Grant #271R-0020.
MTU07-06
Rauwolﬁa vomitoria AFZEL. root bark extract adversely
affects behaviour and brain microstructures
M. Ekong
University of Uyo, Department of Anatomy, Faculty of Basic
Medical Sciences, Uyo, Nigeria
Rauwolﬁa vomitoria (RV) Afzel. is a medicinal plant of the
Apocynaceae family, widely used locally in the management of
psychiatry conditions. The plant is beneﬁcial, especially when
applied during diseased state, and as antipsychotics and antipyretics.
Adverse effects have also been ascribed, especially to its con-
stituents, reserpine and yohimbine. Thus, the present study evalu-
ated the effect the root bark extract has on some behaviour and brain
microstructures. Eighteen adult male Wistar rats of 220 g average
body weight, were divided into three groups (n = 6); control
(distilled water), 200 mg/kg and 400 mg/kg body weight of RV root
bark extract. The administration was orally and lasted seven days.
On day 8, the open ﬁeld and Morris water mazes tests, as well as test
for olfaction were carried out and the animals sacriﬁced. Their
brains were processed for histology and immunoreactivity. Results
showed that learning and memory were not affected, but there were
freezing, sedation, and inhibition of locomotion and olfaction. The
histology showed degenerative features in the olfactory bulb,
hippocampus, dentate gyrus and cerebellum. Immunohistochemi-
cally, neuron speciﬁc enolase (NSE) expression was increased in the
hippocampus and cerebellum of the 200 and 400 mg/kg RV groups;
dentate gyrus of the 200 mg/kg RV group; and olfactory bulb of the
400 mg/kg RV group. NSE expression was decreased in the
olfactory bulb of the 200 mg/kg RV groups and dentate gyrus of the
400 mg/kg RV group. Expressions of glial ﬁbrillary acidic protein
(GFAP) was increased in the olfactory bulb, hippocampus, dentate
gyrus and cerebellum of the 200 mg/kg RV group, but decreased in
the 400 mg/kg RV group, compared to the control. At these given
doses, RV may be deleterious to the brain; in cognitive behaviour
and microstructure, and these effects were dose dependent.
© 2019 The Authors
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MTU07-07
Double hit of perinatal stress evokes depressive behavior
and affects midbrain levels of dopamine, serotonin and
their metabolites
M. Ferraz, F. Rito-Costa, T. Ferraz, S. Pereira, M. Cavalheira, A. C.
Carvalho, U. Araujo
Universidade do Estado do Rio de Janeiro, Pharmacology and
Psychobiology, Rio de Janeiro, Brazil
Perinatal stress is a susceptibility factor for the development of
mental disorders, whose etiology is in possible changes in the
integrity or functionality of neurobiological circuits. The aim of our
study is to investigate the effects of double perinatal stress,
consisting of the association of prenatal hypoxia ischemia and short
maternal separation, on behavior depressive-like and levels of
dopamine, serotonin and their metabolites in basal midbrain.
Hypoxia Ischemia was induced by clamping the uterine arteries of
pregnant rats for 45 minutes, on the 18th day of gestation. The same
conditions were applied to form the SHAM group only without
clamping the arteries. Maternal separation was performed from the
ﬁrst to the sixth day of birth. The anxiety-like and depressive-like
behavior were analyzed by the open ﬁeld, plus maze, forced swim
and head shaking tests. Nociception response was evaluated by hot
plate test. Analysis of the serotonin, dopamine and their metabolites
contents in basal midbrain and prefrontal cortex were done by high
performance liquid chromatography. Data were compared with a
two-way ANOVA, expressed by mean  SEM. Double perinatal
stressed rats showed increase of depressive-like behavior and
mesencephalic serotoninergic hypoactivity. These results are con-
sistent with the hypothesis of increased vulnerability of the
serotonergic system for perinatal stress.
This work was supported by FAPERJ grants.
MTU07-08
The role of kinesin 1 isoform, KIF5B, in dendritic spine
plasticity
A. H. K. Fok, K.-O. Lai, J. Huang, C. S. W. Lai
The University of Hong Kong, School of Biomedical Sciences, Hong
Kong, Hong Kong
Regulation and localization of plasticity-related proteins (PrPs)
are important for proper synapse maturation and function. Kinesin 1
motor protein family is known to be important in carrying and
distributing PrPs and mRNAs in dendrites. The three members of
kinesin 1 family, namely KIF5A, B and C, were traditionally
thought to be functionally redundant. However, previous studies
found different phenotypes in knockout mouse models of each
kinesin 1 family member. It therefore suggests that each kinesin 1
member has speciﬁc functions. In order to test this hypothesis, a
KIF5B conditional knockout mouse model was generated, in which
CRE recombinase expression was driven by CaMKII promoter to
remove kif5b exon 2 endogenously. We used western blot and
immunohistochemical staining to conﬁrm the reduced protein level
of KIF5B in the conditional knockout mouse model, while there was
no signiﬁcant effect on other isoforms of the kinesin 1 family. We
also found that KIF5B conditional knockout mice had increased
protein level of PSD95, NR2B, and GluR2. Next, we performed a
series of behavioral tests to evaluate the cognitive functions of
KIF5B conditional knockout mice. We found that they showed no
signiﬁcant different in anxiety-related behaviors, but they showed
learning deﬁcits in auditory-cued fear conditioning, novel object
recognition test, three-chamber social interaction test, and Barnes
maze. To investigate the cause of behavior deﬁcit, we carried out
chronic two-photon intravital imaging. We found that KIF5B
conditional knockout mice showed an increase of dendritic spine
turnover rate over a 7-day observation period. We will further
investigate the role of KIF5B in learning-induced dendritic spine
plasticity by in vivo imaging.
MTU07-09
Adult hippocampal neurogenesis impairment at pre-
plaque stage in a transgenic rat model of Alzheimer’s-like
amyloid pathology
P. Galeano1, M. Dalmasso1, F. Prestia1, E. Casta~no1, C. Cuello2, L.
Santın3, L. Morelli1
1Institute Leloir Foundation, IIBBA-CONICET, Buenos Aires,
Argentina
2Department of Pharmacology and Therapeutics, McGill
University, Montreal, Canada
3School of Psychology, Malaga University-IBIMA, Malaga, Spain
The contribution of adult hippocampal neurogenesis (AHN)
impairment on cognitive decline in early Alzheimer’s disease (AD)
remains poorly understood. This can be ascribed to the technical
difﬁculties to measure AHN in post-mortem brains and patients.
Furthermore, most animal models of AD exhibit an aggressive
neuropathology at early age and harbor gene mutations and express
transgenes that disrupts AHN by pathways not directly involved in
AD pathology. To overcome some of these limitations, we studied
AHN at pre-plaque stage (6-month-old) in hemizygous (Tg+/-) and
homozygous (Tg+/+) McGill-R-Thy1-APP transgenic rats. This
model exhibits a much less aggressive neuropathology that never-
theless is associated with a marked cognitive impairment from early
age. Our results revealed that Tg+/+ rats showed a reduced number
of PCNA+ cells, DCX+ immature neurons and BrdU+/NeuN+
colabed neurons in dorsal and ventral dentate gyrus. Moreover,
dendritic arborization was less developed. AHN was not impaired in
Tg+/- rats, although dendritic arborization was slightly decreased.
On the other hand, both hemizygous and homozygous rats exhibited
spatial memory impairments in the Morris water maze. These results
suggest that: 1) AHN is dysregulated from the pre-plaque stage in
homozygous rats; 2) AHN impairment is dependent on APP
transgene copy numbers since hemizygous rats did not show it; 3)
Dysregulation of AHN is not directly associated with spatial
memory impairments since hemizygous rats exhibited spared
neurogenesis despite showing spatial memory deﬁcits. Funding:
International Society for Neurochemistry CAEN Grant and
Andalucıa TECH-ICE (PG), and PICT-2015-0285 (LM).
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MTU07-10
Selective long term memory impairment in transgenic
McGill-R-Thy1-APP rat model of Alzheimer´s disease
M. Habif1, F. Filippin1, D. Salas1, M. Cercato1, N. Colettis1, C.
Cuello2, E. Kornisiuk1, D. Jerusalinsky1
1IBCN - UBA/CONICET, Lab. of Neuroplasticity & Neurotoxins
LaNyN -, Buenos Aires, Argentina
2McGill University, Dept Pharmacology and Therapeutics,
Montreal, Canada
Memory impairment in early Alzheimer Disease (AD) is
hypothesised to rely on the initial increase in soluble Ab-oligomers,
potent neurotoxins altering synaptic plasticity.
McGill-R-Thy1-APP Wistar-transgenic (Tg) rats, bearing human
Amyloid Precursor Protein with Swedish and Indiana mutations of
familial AD, offer a singular opportunity for testing learning and
memory abilities at AD onset. Homozygous Tg rats show cognition
deﬁcits at 3 months; human Ab accumulates intra-neuronally from
ﬁrst postnatal week and develops extracellular amyloid pathology
by 6-9 months. Hemizygous Tg (He) show a more subtle phenotype
and do not develop extracellular plaques even at 20 months.
13 month old He rats and their wild type litter-mates (WT) were
left to freely explore an open ﬁeld (OF) for 5 min and tested 24 hr
later (long-term-memory, LTM); bi-dimensional exploration was
quantiﬁed, being signiﬁcantly lower in test than in training for both
groups.
Rats were then trained in a two object recognition task (OR); both
WT and He discriminated new vs. known object 1 hr later (short-
term-memory, STM), while He rats did not show LTM.
They were then trained in an inhibitory avoidance (IA) to a mild
foot-shock task. Latencies to go from an enlightened to a dark
compartment where they get the shock, were recorded. Test
latencies 24 hr later, were signiﬁcantly higher than training latencies
for WT, while remained unchanged for He.
Therefore, unlike WT, He evidenced deﬁcits in memory forma-
tion for object discrimination and for an associative memory
involving aversive and spatial components.
MTU07-11
Mesopontine cholinergic signaling inﬂuences stress
responses affecting behaviour
O. Kljakic1,2, H. Janickova2, K. Rosborough1,2, S. Raulic2, S.
Matovic2, R. Gros2, L. Saksida2,3, T. Bussey2,3, W. Inoue2, M.
Prado1,2,3, V. Prado1,2,3
1University of Western Ontario, Anatomy & Cell Biology, London,
Canada
2Robarts Research Institute, Schulich School of Medicine &
Dentistry, London, Canada
3Brain & Mind Institute, Schulich School of Medicine & Dentistry,
London, Canada
Pedunculopontine and laterodorsal tegmental nuclei (PPT/LDT)
are heterogenous brainstem structures that contain cholinergic,
glutamatergic and GABAergic neurons. Several neuropsychiatric
disorders have been associated with degeneration of the cholinergic
neurons in this brain region, however, the importance of PPT/LDT
cholinergic signaling for cognitive and non-cognitive functions is
poorly understood. Previous work suggested that PPT/LDT cholin-
ergic neurons play a role in attention and other forms of higher-level
cognition, however these studies used non-selective methods to kill
cholinergic neurons. To test the role of acetylcholine in higher-level
cognition, we selectively eliminated the vesicular acetylcholine
transporter (VAChT) in the PPT/LDT to generate mice that have
impaired cholinergic signaling without interfering with other
brainstem cell types and co-transmitted chemicals. We tested these
VAChT-deﬁcient mice using conventional and touchscreen-based
cognitive tasks and found that they had little to no impairments in
many cognitive functions, including attention, yet failed to perform
in the spatial and cued forms of the Morris water maze (MWM).
Interestingly, spatial memory and visual spatial learning were intact
in VAChT-mutants, but touchscreen performance was affected by a
stressor and mice had altered corticosterone levels after the MWM.
These results suggest that attention and many other cognitive
functions are not affected by the loss of PPT/LDT cholinergic
signaling, but an altered stress response can inﬂuence cognitive
performance in aversive tasks.
MTU07-12
Enhancing adult neuroplasticity by epigenetic regulation
of PV interneuron
M. L. Jolin1,2, B. Chattopadhyaya2, F. Dumouchel1,2, A. V. Varlan1,2,
G. D. Cristo1,2
1Universite de Montreal, Neurosciences, Montreal, Canada
2CHU Sainte-Justine, Research center, Montreal, Canada
Parvalbumin-positive cells (PV), the major source of GABAergic
inhibition in the brain, innervate hundreds of postsynaptic targets
with multiple perisomatic synapses. They are important for the
regulation of multiple cognitive functions and developmental
cortical plasticity. Although PV cell function is being explored
extensively, the mechanisms that control their development and
plasticity have not been entirely resolved. Molecular mechanisms
involved in synapse formation and strengthening include the
regulation of speciﬁc subsets of genes by epigenetic modiﬁcations.
Histone Deacetylase 2 (HDAC2) regulates excitatory synapse
plasticity and memory formation. However, whether and how
HDAC2 affects PV cell synapse development and brain plasticity is
unknown. Here, we show that HDAC2 is expressed by PV neurons.
In order to dissect its role in PV cell, we used the conditional KO
mice (PV_Cre;HDAC2lox/lox), which express Cre selectively in PV
cells after P14. We found that adult PV_Cre;Hdac2lox/lox mice show
enhanced fear memory extinction, along with a reduction of
perineural nets (PNN) around PV cells somas in the prefrontal
cortex and the basolateral amygdala as well as an increase in
perisomatic PV synapse remodeling after fear extinction. Finally,
the direct role of Hdac2 in PNN formation and PV cell synapse
plasticity will be tested by viral overexpression of Hdac2 in
prefrontal cortex of PV_Cre;Hdac2lox/lox mice. All together, our
work supports the model in which PV cells and PNN play a pivotal
role in brain plasticity and suggests that modulation of Hdac2, in
combination with behavioral therapy can improve the treatment of
post-traumatic stress disorder (PTSD).
© 2019 The Authors
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MTU07-13
In silico characterization and functional analysis of non-
synonymous polymorphisms present in gpm6a’s
extracellular coding regions
A. Leo´n, G. Aparicio, C. Frasch, C. Scorticati
Instituto de Investigaciones Biotecnologicas IIB-UNSAM-
CONICET, Laboratorio de Neurobiologıa Molecular y Celular, San
Martın, Argentina
Membrane glycoprotein M6a is mainly expressed in neurons of
the central nervous system and it is involved in neuronal plasticity.
M6a promotes neurite and axonal outgrowth, ﬁlopodia/spines
formation and synaptogenesis in primary neuronal cultures and
neuronal cell lines. Recently, altered expression or polymorphisms
in the human M6a gene have been associated with neurological
disorders such as schizophrenia, bipolar disorder, depression,
claustrophobia and Alzheimer’s disease. However, the molecular
mechanisms underlying the development of such pathologies remain
unknown. M6a, together with M6b and PLP/DM20, belongs to the
tetraspan proteolipid protein family. According to its structure, we
speculate that certain amino acids within M6a’s extracellular loops
mediate speciﬁc interactions with other proteins and those contribute
to its function. Thus, out of more than a hundred submitted entries,
we selected 13 non-synonymous SNPs from the NCBI dbSNP
database located at the coding sequence of GPM6a’s extracellular
loops (EC1 and EC2). The selected nsSNPs had to be validated by
frequency, cluster and/or 1000G. In silico analysis –using -Polyphen
and I-mutant 2.0- predicted that all nsSNPs might decrease protein
stability and have a moderate to strong functional damaging effect.
In the case of SNPs located in the EC1, none of them modify M6a
neuronal membrane distribution and topology, however, some of
them rs375144137 (G69E), rs370813625 (T71P) and rs747244424
(T76I) impair M6a neurite extension in N2a cell line. We speculate
that these variants blocked M6a´s neurite extension because of the
drastic single amino acid substitution (non polar to acid or basic
residue and polar to non polar) that might affect extracellular loops
interactions.
MTU07-14
Adult neurogenesis in the paleognathous birds: the
common ostrich (struthio camelus) and emu (dromaius
novaehollandiae)
P. Mazengenya, A. Bhagwandin, A. O. Ihunwo
University of Witwatersrand, Anatomical sciences - Faculty of
Health Sciences, Johannesburg, South Africa
Adult neurogenesis is a process occurring in varying magnitudes
in different species ranging from invertebrates to vertebrates. We
examined adult neurogenesis throughout the brains of the common
ostrich (Struthio camelus) and emu (Dromaius novaehollandiae)
using immunohistochemistry for the endogenous markers prolifer-
ating cell nuclear antigen, which labels proliferating cells, and
doublecortin, which stains immature and migrating neurons. The
distribution of PCNA and DCX labelled cells was widespread
throughout the brain of both species. The highest density of cells
immunoreactive to both markers was observed in the olfactory bulbs
and the telencephalon, especially the subventricular zone of the
lateral ventricle. The density of PCNA immunoreactive cells was
less exuberant in the telencephalon of the emu compared to the
common ostrich. Substantial numbers of PCNA immunoreactive
cells were observed in the diencephalon and brainstem, but DCX
immunoreactivity was weaker in these regions. PCNA and DCX
immunoreactive cells were observed in moderate density in the
cortical layers of the cerebellum of both species. Columns of
migrating cells were observed at three distinct points extending from
the lateral wall of the lateral ventricle into parenchyma of the
telencephalon at rostral levels in both species. The distribution of
putative proliferating cells and immature neurons in the brain of the
common ostrich and the emu is widespread, far more so than in
mammals, and compares with the neognathous birds, and suggests
that brain plasticity and neuronal turnover is an important aspect of
cognitive brain functions in these birds.
MTU07-15
Behavioral, cytoarchitectural, and neurochemical
changes in the offspring of methylazoxymethanol treated
in mice
O. Nakagawasai1, K. Takahashi1, W. Sakuma1, W. Nemoto1, T.
Odaira1, L. Jia-Rong1, H. Onogi2, L. K. Srivastava3, K. Tan-No1
1Tohoku Medical and Pharmaceutical University, Dept of
Pharmacology, Sendai, Japan
2Tohoku Fukushi University, Faculty of Health Science, Sendai,
Japan
3McGill University, Douglas Mental Health University Institute,
Montreal, Canada
Methylazoxymethanol (MAM) treated pregnant rats at gestation
day (GD) 17 has been shown to be a valuable animal model for
schizophrenia. However, this model is still not established in mice
models. To examine face, construct and predictive validities, we
observed behavioral, cytoarchitectural, and neurochemical changes
in the offspring of MAM treated mice. We found in contrast to a
single injection of MAM to dams at GD 15, 16 or 17, its daily
administration from GD 15 to 17 led to deﬁcits in prepulse
inhibition (PPI) of startle in the post-pubertal offspring. Moreover,
we observed behavioral deﬁcits such as increasing locomotor
activity to NMDA antagonist MK-801, working memory and social
interaction. These animals also showed a reduction of volume at the
prefrontal cortex (PFC) and hippocampus, and neuroanatomical
changes such as discontinuities and heterotopias in the hippocam-
pus. Atypical antipsychotic drugs clozapine, risperidone, and
aripiprazole, but not the typical drug haloperidol, reversed the
deﬁcit in PPI. Therefore, the treatment of pregnant mice with MAM
during GD 15-17 MAM offers a new procedure to research
neurobiological mechanisms involved in the pathogenesis of
schizophrenia.
MTU07-16
Expression of molecular signatures during long-term
memory consolidation, established by behavioural
tagging model
M. Naseem
Jamia hamdard university, Department of toxicology, Delhi, India
Memory is one of the most fundamental processes of brain and
learning and memory are one of those frontier areas of neurobiology
which attract us to investigate the intricacy of this process. Here we
aimed to investigate the general mechanism of “Behavioural
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Tagging” in long term memory (LTM) formation. Long term
potentiation (LTP) is a form of synaptic plasticity and it is
considered as a cellular model of learning and memory. One of the
LTP speciﬁc PRPs, PKM-f, is required for the formation of LTM as
well as for the maintenance of LTP. In our study, we have shown
that for the consolidation of LTM, in addition to LTP-speciﬁc PRPs,
synaptic tags are also required to interact with each other. In the
present study, we investigated the involvement of LTP-speciﬁc
PKM-f and learning tags within a critical time window, which are
required for the formation of LTM without affecting STM.
Behavioural tagging is an established model for the assessment of
some forms of learning and memory. Despite being studied for LTM
formation for many years, no studies investigated the role of PKM-f
in Behavioural tagging model. Hence, by using these two different
memories based tasks (Inhibitory avoidance and Novel object
recognition tasks), we observed how PKM-f activated by exposing a
novel arena after a weak training and led to the consolidation of
memory. These ﬁndings thus show how the process of behavioural
behavioural tagging activates LTP-speciﬁc PKM-f for the formation
of LTM.
MTU07-17
Antinociceptive effect of diminazene aceturate, an
angiotensin-converting enzyme 2 activator, in the mouse
formalin test
W. Nemoto, R. Yamagata, O. Nakagawasai, S. Michimata, K.
Nakagawa, K. Tan-No
Tohoku Medical and Pharmaceutical University, Department of
Pharmacology, Faculty of Pharmaceutical Sciences, Sendai, Japan
We have reported that intrathecal (i.t.) administration of
angiotensin (Ang) II into mice produces a nociceptive behavior
accompanied by the phosphorylation of p38 MAPK in the spinal
cord, which was mediated through AT1 receptors. In addition, both
the p38 MAPK phosphorylation and subsequent nociceptive
behavior were attenuated by the i.t. co-administration of Ang (1-
7), an N-terminal fragment of Ang II formed by angiotensin-
converting enzeme 2 (ACE2), that acted via Mas receptors.
However, the role of ACE2 on spinal nociceptive transmission
remains unknown. Therefore, in the present study, we examined the
effect of diminazene aceturate (DIZE), an ACE2 activator, on the
formalin-induced biphasic nociceptive behavior. When administered
i.t. 1 hr prior to the intraplantar injection of 2% formalin, DIZE
dose-dependently attenuated the nociceptive behavior during the
second phase, but not the ﬁrst phase. The inhibitory effect of DIZE
was prevented by i.t. administration of A779, a Mas receptor
antagonist. The i.t. administration of DIZE also dose-dependently
attenuated the Ang II-induced nociceptive behavior, which was
prevented by i.t. administration of A779. Although phosphorylation
of p38 MAPK was observed in the lumbar dorsal spinal cord after
the injection of formalin or Ang II, these phosphorylation were
attenuated by DIZE, which was inhibited by A779. In addition,
DIZE signiﬁcantly increased the ACE2 activity in the lumbar dorsal
spinal cord. These results suggest that DIZE attenuates the formalin-
induced nociceptive behavior during the second phase through the
increase in Ang (1-7) generated from Ang II by the activation of
ACE2 and subsequent inhibition of p38 MAPK phosphorylation via
Mas receptors.
MTU07-18
Pain behavioural response in plasmodium berghei-
induced malaria
A. Oyewole1, O. Akinola1, B. Owoyele1,2
1University of Ilorin, Physiology, Ilorin, Nigeria
2Massachusetts General Hospital & Harvard Medical School, Dept
of Neurology, Boston, US
Several forms of pain are reported by patients with Plasmodi-
umfalciparium and are mostly described as one of the symptoms for
malarial infection. Neural processes that inﬂuence pain perception in
malaria-infected persons and its contributions to malaria related
mortality are poorly understood. In the current studies, Plasmodium
berghei (Pb) infected Swiss mice exhibited attenuated behavioural
responses to noxious chemical without compromising the motor
function. This parasite-induced analgesia improved with increase
daily proliferation of erythrocyte stage Pb and it appeared to be
synergistically mediated by opioidergic (via l-opioid receptor) and
serotoninergic (via 5HT2A receptor) system. Systemic intersection
study among drugs of varying mechanisms capable of eliciting anti-
or pro- nociception showed little or no contribution of pain system
in malaria related death. Though there were mild morphological
changes in brainstem cells and Nissl substance of infected mice,
neural secretory activity (of serotonin, noradrenaline and ATPase)
was preserved. These results indicated that animal model for malaria
is not a potential model to unravel mechanism surrounding malaria
parasite-induced pain reported in human. This however is the ﬁrst
report demonstrating that malaria parasite causes analgesic-like
effects in mice.
MTU07-19
Lipid raft dynamics in adolescent brain: alcohol-stimulant
co-use
D. Rhoads, C. O’Shea, M. Telatin
Monmouth University, Biology, West Long Branch, USA
Co-use of alcohol and stimulants, including caffeine and
amphetamine, is a growing concern, particularly among adolescents
already prone to binge alcohol consumption. We are modeling
chronic co-use of alcohol and stimulants in adolescent Long-Evans
rats. Previous behavioral work in our lab has shown that chronic
administration of caffeine or amphetamine with alcohol resulted in
decreased severity of alcohol withdrawal symptoms. Alcohol
withdrawal is considered a hyperglutamatergic state. Regulation of
glutamate activity may occur in part through lipid raft structures.
The goal of the present study was to characterize glutamatergic
receptor components of lipid rafts as a way of determining if raft
dynamics were a target for alcohol-stimulant interactions. Adoles-
cent rats were fed ethanol, amphetamine, caffeine, or combinations
of ethanol and amphetamine or caffeine as part of a liquid diet.
Detergent-resistant membranes were isolated by ultracentrifugation
and raft fractions identiﬁed by Western blotting with the raft marker
ﬂotillin. Higher (HBR) and lower (LBR) buoyancy raft fractions
were identiﬁed. Compared to control rats fed liquid diet without
drug, there was a 2-3 fold increase in the LBR fraction from rats
consuming alcohol. Western blotting showed that this fraction was
rich in NMDA-subtype of glutamate receptors which may account
in part for upregulation of NMDA receptors during chronic alcohol
consumption. Other components of glutamatergic transmission
© 2019 The Authors
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(mGluR1 and 5; Homer) also appeared in raft fractions. When rats
consumed ethanol along with caffeine, there was no increase in the
LBR fraction. Similar results were obtained after co-consumption of
ethanol and amphetamine. Thus, a change in lipid raft dynamics was
correlated with alcohol withdrawal symptoms but not under
conditions where stimulant co-consumption attenuated withdrawal
severity. Lipid rafts may be a site wherein stimulants antagonize
adaptive responses of the brain to chronic ethanol.
MTU07-20
Comorbidity between stress and cocaine: role of coﬁlin in
nucleus accumbens during the acquisition of cocaine
self-administration
D. Rigoni1, Marıa. P. Avalos1, Andrea. S. Guzman1, M. Julieta
Boezio1, Liliana. M. Cancela1, F. Bollati1, M. Bisbal2
1Universidad Nacional de Cordoba, IFEC- CONICET.
Departamento de Farmacologıa, Facultad de Ciencias Quımicas,
Cordoba, Argentina
2Instituto de Investigacion Medica M. y M. Ferreyra, -, Cordoba,
Argentina
The development of addictive behavior is associated with
functional and structural plasticity in the mesocorticolimbic path-
way. Animal models have demonstrated that exposure to stress
predisposes to developing substance use disorders. Our laboratory
has shown that repeated stress alters the capacity of a subsequent
cocaine injection to modulate dendritic spine morphology and actin
dynamics. These ﬁndings demonstrate that the pharmacological
inhibition of actin polymerization in the nucleus accumbens (NA)
prevents stress cross-sensitization with cocaine and inﬂuences actin
cytoskeleton remodeling in the NA. Thus, the main goal of this
project is to evaluate the impact of the actin cytoskeleton in the
changes underling the facilitatory inﬂuence of stress in the
acquisition of cocaine self-administration (SA). For this purpose,
we have generated a lentivirus containing a short hairpin RNA
(shRNA) speciﬁc to coﬁlin, to inhibit its expression in NA, and
explore its function during the acquisition of cocaine SA. Thus,
Sprague dawley rats pre-exposed to chronic restraint stress, will be
administered intra-accumbens with shRNA of coﬁlin, and later they
will undergo surgery for implantation of catheters in the jugular vein
one week before SA sessions. Our results reveal that the inhibition
of coﬁlin prevents the stress-induced sensitization to cocaine and
reverts the facilitation of the acquisition of cocaine self-administra-
tion induced by stress, suggesting that coﬁlin regulation is crucial
for the stress-induced facilitation on the vulnerability to develop
cocaine addiction.
MTU07-21
Outgrowth of ﬁlopodia is associated with intracellular
trafﬁcking of GPM6A
N. Rosas, A. C. Frasch, B. Fuchsova
Instituto de Investigaciones Biotecnologicas/Universidad de San
Martın IIB-UNSAM, Laboratorio de Neurobiologıa, San Martın,
Argentina
Gpm6a is a neuronal membrane glycoprotein that functions in the
processes of neuronal development and its overexpression leads to
the extensive formation of ﬁlopodia. Neuropsychiatric disorders and
chronic stress exposure have been linked to the alterations in Gpm6a
expression levels or sequence. However, the mechanism of action of
Gpm6a is not clearly understood. Previously, we identiﬁed K250,
K255, and E258 in the C-terminal of Gpm6a as key functional
residues for the formation of ﬁlopodia. Subsequent bioinformatic
analysis revealed that K250, K255, and E258 are predicted as part of
sorting signals of transmembrane proteins. Colocalization assay
showed that deletion of the C-terminus diminishes the association of
Gpm6a with clathrin in hippocampal neurons implying involvement
of clathrin-mediated trafﬁcking events. Moreover, using ﬂow
cytometry we found that subtitution of K250, K255, and E258
with alanine diminishes the amount of Gpm6a on cell surface and in
case of K255 and E258 also leads to the lower amount of total
expressed protein. Here using confocal microscopy we analyze the
subcellular localization of the mutant forms of Gpm6a that fail to
induce ﬁlopodia formation. K250A and E258A display increased
intracellular accumulation of the protein and a preferential localiza-
tion to Lamp1-positive structures. To determine if K250, K255 and
E258 substitutions leads to an increased protein degradation we use
ﬂow cytometry to quantify the Gpm6a expression levels upon
treatment with different protease inhibitors. The localization of
Gpm6a mutants to LC3- and Calnexin- positive structures was also
evaluated.
MTU07-22
Convergence of reward and aversion processing in
nucleus accumbens medium spiny neuron subtypes
C. Soares-Cunha1,2,3, N. Vasconcelos2,3,4, B. Coimbra2,3,
A. V. Domingues2,3, N. Sousa2,3,5, A. J. Rodrigues2,3
1University of Minho, School of Medicine, Braga, Portugal
2Life and Health Sciences Research Institute ICVS, School of
Medicine, University of Minho, Braga, Portugal, School of
Medicine, Braga, Portugal
3ICVS/3B’s-PT Government Associate Laboratory, Braga/
Guimar~aes, Portugal, School of Medicine, Braga, Portugal
4Departamento de Fısica, Universidade Federal de Pernambuco,
50670-901 Recife, Pernambuco, Brazil, Departamento de Fısica,
Recife, Brazil
5Clinical Academic Center-Braga 2CA, NA, Braga, Portugal
Reward is as important as aversion for survival. Deﬁcits in
decoding rewarding/aversive signals are present in several neu-
ropsychiatric disorders, such as depression or addiction, emphasis-
ing the need to study the underlying neural circuits in detail.
The reward circuit, comprising projections from the ventral
tegmental area (VTA) to the nucleus accumbens (NAc) is crucial for
reward/aversion processing. Though the dominant view postulates
that NAc D1-MSNs convey reward and D2-MSNs encode aversion,
recent results challenged this view.
Here, we show that both MSN populations drive reward and
aversion, depending on their pattern of activation. These opposite
behaviors result from differential evoked electrophysiological
patterns in downstream targets, namely the ventral pallidum (VP)
and VTA. Brief MSN optogenetic stimulation of either D1- or D2-
MSNs elicited positive reinforcement, in line with the observed
decreased VP-to-VTA inhibitory tone, and increased VTA dopamin-
ergic activity. Prolonged activation of either MSN population drove
aversion, inducing distinct electrophysiological effects in these
target regions.
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In addition, we further show that distinct patterns of MSN
activation differentially inﬂuence cocaine-induced place preference.
In sum, we show that D1- and D2-MSNs bi-directionally control
reward/aversion, highlighting that more studies are needed to
understand how these two populations interact to modulate
behaviour.
MTU07-23
Mild ketogenic diet as promising approach for cognition
enhancement: medium-chain triglyceride supplement
improves memory in rats
A. Trofimov1, A. Schwarz2,1, D. Krytskaya1, V. Shavva3,1, E.
Veniaminova4, V. Sizoff1, A. Shcherbakova5,1
1Institute of Experimental Medicine, Pavlov Department of
Physiology, Saint Petersburg, Russia
2Sechenov Institute of Evolutionary Physiology and Biochemistry,
Multidisciplinary Laboratory of Neurobiology, Saint Petersburg,
Russia
3Karolinska Institute, Department of Medicine, Stockholm, Sweden
4Sechenov First Moscow State Medical University, Institute of
Molecular Medicine, Moscow, Russia
5Para Impacto, Department of Adaptive Learning, Tokyo, Japan
Ketogenic diet is known to be a viable approach for correction of
brain disorders. The strict ketogenic diet is difﬁcult to adhere to.
Search for an intervention both beneﬁcial and not too restrictive
appears important. Intermittent mild ketosis by using medium-chain
triglycerides (MCT: C8–C10) may be such intervention. The study
was aimed at the investigation of effects of MCT-enriched diet on
the memory of adult intact animals. Adult Wistar males kept on
standard diet (SD) were tested in Y-maze, Open ﬁeld, Object
recognition. Then, 2 groups were formed: MCT (chow excluded for
6 h/day, MCT intragastric, 2 ml/kg) and SD control (water intra-
gastric). After 2 weeks of diet, the tests were repeated, adding
Morris water maze. Statistics: rm-ANOVA, post hoc Sidak; Student’s,
Mann-Whitney, p < 0.05. In the Y-maze, MCT group demonstrated
better working memory: more spontaneous alternations compared to
control. In the Open ﬁeld, MCT animals showed decreased
exploration than SD when normalized to pre-diet trials, indicating
better memory of environment. No differences were found in the
Object recognition. In the probe trial of Morris water maze, MCT
animals spent more time in the target quadrant than SD group,
indicating better spatial memory. MCT-enriched diet is shown to be
a promising non-drug approach to improve cognitive functioning.
MTU07-24
Discovery of a key missing signaling between RHOA/
RHO-kinase and ras underlying spine enlargement and
LTP
M. Wu1, Y. Funahashi1, T. Takano2, D. Tsuboi1, R. Ahammad1, M.
Amano1, K. Kaibuchi1
1Nagoya University, Cell pharmocology, NAGOYA, Japan
2Duke University, Cell Biology, Duke, USA
The small GTPase RhoA and its downstream effector Rho-kinase
are considered as one of the key regulators in dendritic spine
formation and synaptic plasticity. However, how RhoA/Rho-kinase
signaling involved in modulating synaptic plasticity still remains
unknown. We have recently developed a phosphoproteomic analysis
method that uses afﬁnity beads coated with 14-3-3 proteins to enrich
phosphorylated proteins and established the kinase-associated neural
phosphosignaling (KANPHOS) database that provides the phos-
phorylated sites identiﬁed by our phosphoproteomic approaches.
Using the KANPHOS database, we identiﬁed SynGAP1, which is a
synaptic Ras-GTPase activating protein, as a novel Rho-kinase
substrate. In this study, we found that phosphorylation of SynGAP1
by Rho-Kinase increased its interaction with 14-3-3 but decreased
with PSD-95, which is a major scaffolding protein in the postsy-
naptic densities of dendritic spines. SynGAP1 was dispersed from
spines upon long-term potentiation (LTP) induction in cultured
neurons, and this dispersion depends on phosphorylation of
SynGAP1 by Rho-kinase. Moreover, we found that Rho-kinase
increased Ras and ERK activity through phosphorylation of
SynGAP1. Thus, the synaptic dispersion of SynGAP1 which
phosphorylated by Rho-kinase during LTP represents may be a
key signaling link element that transduces RhoA/Rho-kinase activity
to Ras-ERK signaling-mediated spine enlargement, AMPA receptor
(AMPAR) synaptic incorporation, and synaptic potentiation.
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Sensitive and stable quantitation of endogenous oxytocin
in mice using reduction/alkylation approach for elisa
S. Cherepanov, M. Gerasimenko, T. Yuhi, S. Yokoyama, H.
Higashida
Kanazawa University, Center for Child Mental Development,
Kanazawa, Japan
Oxytocin (OT) is a nonapeptide essential for the social brain.
Several studies have reported the ability of plasma OT levels to be a
neurological biomarker of autism, anxiety and other mental
disorders. One of the main methods of OT determination - is
immunosorbent assay (ELISA). Speciﬁcity of this method is
criticized. Matrix interference and binding of OT with plasma
albumins make data of direct determination doubtful. An established
way to solve this problem – is a measurement of only the free OT
fraction, employing solid phase extraction (SPE). However, SPE
required a signiﬁcant amount of plasma which made it difﬁcult to
use in research employing rodents.
Recently, Brandtzaeg group discovered reduction/alkylation
followed by proteins precipitation (RAPPT) method that enables
to save a sufﬁciently high amount of OT released from plasma
proteins as well as provide a reduction of matrix interference.
Importantly, the required volume of plasma is just 100 ll. This
method was implemented for the Mass Spectrometry platform.
We aim to adopt this approach for ELISA. We have performed
RAPPT prior to ELISA measurement using ICR mice plasma pool.
OT levels after RAPTT were lower than in diluted plasma, but
signiﬁcantly higher compared with SPE samples. RAPPT samples
demonstrate linearity within dilution, while samples after dilution
only - not. Protein precipitation only leads to a dramatic loss of OT
from the sample. This data indicated essential roles of RAPPT to
release OT from binding with plasma albumins. Finally, we
validated RAPPT sample treatment in comparison of plasma pools
of ICR and CD38KO mice (a model with disrupted central OT
release). Obtained data conﬁrmed lower levels of OT in CD38KO
plasma.
MTU08-02
Traumatic brain injury and risk of dementia: A
meta-analysis of cohort studies using real-world data
M. S. Hussain1, S. O. Rahman1, A. K. Najmi2
1Jamia Hamdard, Department of Pharmaceutical Medicine, New
Delhi, India
2Jamia Hamdard, Department of Pharmacology, New Delhi, India
Introduction: Published epidemiological studies found positive
association between TBI and dementia risk. However, there are
studies which found no association. So, this study is aimed to assess
the association between TBI and dementia risk.
Methods: Articles were retrieved from PubMed and Embase
database by running the keywords related to TBI and dementia till
February 2019. We included all the cohort studies which assessed
dementia risk due to TBI. Newcastle-Ottawa scale was used to
assess the study quality. The primary outcome of this study was to
compute the pooled dementia risk due to the TBI. Secondary
outcomes include dementia risk based on subgroups like dementia
subtypes, geographic region, and sex. Statistical analysis was
performed using Review Manager software.
Results: A total of sixteen articles qualiﬁed the inclusion criteria
and comprised of 5,429,711 patients with mean age of
62.28  11.4 years. Majority of the studies were of high quality.
Pooled relative risk found that TBI signiﬁcantly increased the
dementia risk with a relative risk (RR) of 1.61 (95% CI: 1.39 –
1.86), p < 0.00001. Subgroup analysis also revealed signiﬁcant
Alzheimer’s risk due to TBI with RR of 1.17 (95% CI: 1.12 – 1.22),
p < 0.00001. Studies conducted in US (n = 6) and other parts of the
world (n = 10) also found signiﬁcant dementia risk due to TBI with
RR of 1.54 (95% CI: 1.14 – 2.08), p = 0.005 and 1.67 (95% CI:
1.38 – 2.01), p < 0.00001. No signiﬁcant association was observed
with gender.
Conclusion: The ﬁnding of this study suggests that TBI is
signiﬁcantly associated with dementia as well as Alzheimer’s risk.
MTU08-03
Imoportance of the existence of salive proteins for stress
biomarkers founded by proteome after mental or physical
stress loading
S. Oshiro1, T. Kaburagi2, N. Nishiyama1, S.-y. Kadowaki1, T.
Suagasawa3, M. Morioka4
1Graduate School of Sports and Health Science, Daito Bunka
University, Cell Biology, Higashi-matsuyama, Saitama, Japan
2Graduate School of Sports and Health Science, Daito Bunka
University, Nutrition Science, Higashi-matsuyama, Saitama, Japan
3Graduate School of Comprehensive Human Science,University of
Tsukuba, Sportd Medicine, Higashi-matsuyama, Saitama, Japan
4RIKEN ACCC, Preventive Medicine and Applied Genomics Unit,
Tsukuba, Ibaraki, Japan
Saliva is a useful sample non-invasively and repeatedly collected
from body ﬂuid. Our objective in the present study is to ﬁnd salive
biomarker proteins for mental and/or physical stress for quality of
life. Quite recently, we investigated rat saliva marker proteins for
mental or physical stress by proteome using rat stress models. The
increased proteins by mental stress were subjected to liquid
chromatography-mass spectrometry/mass spectrometry (LC-MS/
MS). We detected the known enzymes and secretary proteins with
MW od 20-70 KDa in rat saliva proteins. Furthermore, we analyzed
the biomarkers for physical stress by proteome after tredmill
runnning loading to rats. After the separation by SDS-PAGE, the
increased proteins by physical stress were used for LC-MS/MS and
comprehensive proteome analysis (isobaric Tags for Relative and
Absolute Quantitation, iTRAQ). We might ﬁnd biomarkers for
mental and/or physical stress. In the present study, we discussed on
the importance of the existence of saliva proteins as stress
biomarkers of mental and/or physical stress loading to rats.
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Rage-associated serum markers along with motor and
cognitive clinical parameters as predictors of parkinson’s
disease
N. Somensi1, J. Gasparotto1, C. T. Ribeiro1, N. M. Soares2,4, A. C.
Panzenhagen1, J. C. F. Moreira1, A. Hilbig3,5, C. R. de Mello
Rieder2,4, D. P. Gelain1
1Universidade Federal do Rio Grande Sul, Bioquımica, Porto
Alegre, Brazil
2Universidade Federal do Rio Grande Sul, Cie^ncias Medicas, Porto
Alegre, Brazil
3Universidade Federal de Cie^ncias da Saude de Porto Alegre,
Neurologia, Porto Alegre, Brazil
4Hospital de Clinicas de Porto Alegre, Clınica Medica, Porto
Alegre, Brazil
5Santa Casa de Misericordia de Porto Alegre, Neurologia, Porto
Alegre, Brazil
Parkinson’s disease (PD) affects nearly 10 million people
globally. The course of disease is highly variable and there are no
established biomarkers with diagnostic value or predictive models.
The receptor for advanced glycation end products (RAGE) is crucial
in the propagation of inﬂammatory events, exerting a major role in
neuroinﬂammation and dopaminergic denervation. We evaluated the
correlation of inﬂammatory cytokines with RAGE agonists in
serum, in parallel with cognitive (MoCA) and motor/non-motor
(UPDRS) clinical parameters of PD. Blood samples were collected
from 51 cases and 37 controls. Serum parameters were measured by
Multiplex. PD-patients had increased concentration of serum
HMGB1 and decreased IL-1b, TNF-a, IL-8, RANTES and IL-6.
HMGB1 is correlated with other RAGE agonists, such as
nitrotirosine, 4-HNE, CML along with S100B, but when analyzed
together they do not predict the outcome. RANTES is negatively
correlated to MoCA and TNF-a and together they show to be good
predictors of PD. Although a-synuclein does not differ between
control and PD, it is positively correlated to TNF-a in PD, and
together they are factors that predict the disease. More parameters
should be developed in order to discover RAGE-associated potential
molecular markers that may aid in clinical diagnostic.
MTU08-05
Frontal theta asymmetry changes while watching
emotional ﬁlm clips and role of difference pair of frontal
electrodes
W. Suwannapu1, N. Kraiwattanapirom1, S. Prayoonsak2,
V. Siripornpanich1
1Institute of Molecular BiosciencesMB, Research Center for
Neuroscience, Mahidol University, Nakhonpathom, Thailand
2Faculty of Education, Educational Psychology and Guidance,
Mahasarakham University, Mahasarakham, Thailand
The brain hemispheric asymmetry has been hypothesized asso-
ciated with emotional processing related emotional valence. Amyg-
dala and prefrontal cortex are the important brain structures involved
in emotional processing. Frontal alpha (8.5-13 Hz) asymmetry
(FAA) has been received most attention to be a neuro-biomarker of
emotion, but the brain asymmetry on other spectral frequencies,
particularly in frontal theta (4.5-8 Hz) asymmetry (FTA), are needed
to be clariﬁed. This study aimed to investigate the FTA in response
to emotional clips and the inﬂuence of difference pairs of frontal
sites (F4/F3: medail-frontal vs. F8/F7: lateral-frontal). The partic-
ipant were 10 healthy females (aged 20-32 years; M = 25.80,
SD = 4.85). Two sets of emotional clips (4 clips per set) were used
to elicit target emotional states (sadness, fear, happiness, and
neutral). The FTA was calculated using the equation: ln[right]–ln
[left] theta power. The results found the signiﬁcantly decreased FTA
at F4/F3 pair in response to negative and neutral clips when
compared to resting-states. The signiﬁcant reduction of FTA among
types of emotional clips was obviously demonstrated at F4/F3 pair.
However, only one pair of emotional clip (fear and happiness) can
be revealed with FTA at F8/F7 pair. These ﬁndings indicated that
FTA can be used for studying emotional response, especially with
negative stimuli, and may be a valuable tool as a neuro-biomarker of
emotion apart from the FAA. However, the selection of frontal
electrode pairs is important. The FTA between medial-frontal
electrodes seem to be sensitive with emotional response than the
FTA between lateral-frontal sites.
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Effects of garlic constituents in a rat model of reserpine-
induced depression
Khushboo, B. Sharma
University of Allahabad, Biochemistry, Allahabad, India
Commonly available chemical drugs used for nervous system
disorders have various unfavorable side effects. Due to this, herbal
medicines are being prescribed as an alternative therapy. In the
present study, we have investigated the effect of antidepressant and
neuroprotective effect of garlic extract against reserpine-induced
depression in the rat model. Rats were divided into four groups: 1)
control, 2) reserpine, 3), reserpine with garlic extract and 4)
reserpine with ﬂuoxetine. The forced swimming test was used to
evaluate the antidepressant activity of garlic extract. The levels of
antioxidant enzymes including SOD, GST and CAT and some
metabolic enzymes such as LDH and MDH were signiﬁcantly
decreased in depressed rat brain. The levels of serotonin and
acetylcholinesterase activity were also altered which suggested the
abnormal dopamine cycle in the brain. A histological study shows
signiﬁcant malformations in brain parts. Reserpine-induced a
signiﬁcant increase in the immobility time of rats in the forced
swimming test and treatment with garlic extract ameliorated the
reserpine-induced changes. Reserpine-induced reduction in brain
marker enzymes was improved using garlic extract. Also, it reduces
the MDA level in the brain. The study suggests the antidepressant
activity of garlic extract against the reserpine-induced depression.
MTU09-02
Potential effects of genistein on human amniotic
mesenchymal stem cells for cholinergic neuronal
differentiation
M. Ahmad-Mahidi1, W. Thangnipon1, T. Phermthai2, S.
Julavijitphong2
1Institute of Molecular Biosciences, Research Center for
Neuroscience, Nakhon Pathom, Thailand
2Faculty of Medicine Siriraj Hospital, Department of Obstetrics and
Gynecology, Bangkok, Thailand
Alzheimer’s disease (AD) is an irreversible neurodegenerative
disorder that worsens without receiving proper treatment. AD is
widely known for causing dementia but it is also characterized by
loss of cholinergic neurons and high production of reactive oxygen
species (ROS). Mesenchymal stem cells (MSCs) became a recent
area of interest as a treatment of AD, because under speciﬁc
conditions MSCs can differentiate into cholinergic neurons. Previ-
ous studies have shown that pretreating amniotic ﬂuid mesenchymal
stem cells with an antioxidant called N-benzylcinnamide (PT-3)
aided in preventing cell death during cholinergic neuronal induction.
In the present study, human amniotic mesenchymal stem cells
(hAMSCs) were retrieved with consent after full-term labor and
prepared for cell culture (PSC5 cells). Additionally, phytoestrogens
with antioxidative properties are also an upcoming candidate for the
treatment of AD as low estrogen was found to be related to AD
progression. Genistein (GEN), an isoﬂavone, binds to estrogen
receptor a and even more estrogen receptor b (ERa and ERb) and it
is present in some legumes such as soy beans and red beans. GEN
was found to be beneﬁcial to the nervous system because of its
estrogen-like properties but at the same time possessed low
oncogenicity. Treatment of PSC5 cells with GEN for 48 h showed
that it was able to protect cells from cell death via cell viability assay
(MTT), and decreased the amount of ROS production measured by
ROS assay.
MTU09-03
DY-9836 AS calmodulin inhibitor ameliorates cognition via
inhibiting nitrosative stress and NLRP3 signaling in mice
model of BCAS
M. M. Ahmed1,2, W. Rui2,3, Y. Yi-Xuan2, S. Andleeb1, X. Juan2,
I. Ch1, K. Fukunaga4, Y.-Z. Du2, S. Nh. Shah1, F. Han2
1Bahauddin Zakariya University, Faculty of Pharmacy, Multan,
Pakistan
2Zhejiang University, College of Pharmaceutical Sciences,
Hanghzhou, China
3Ningxia Medical University, Department of Pharmacology,Key
Laboratory of Ministry of Education in Fertility Preservation and
Maintenance, Yinchuan, China
4Tohoku University, Department of Pharmacology,Graduate School
of Pharmaceutical Sciences, Sendai, Japan
Vascular dementia (VaD) is a heterogeneous brain disorder or
which there are no effective approved pharmacotherapy available.
The aim is to elaborate the effect of calmodulin inhibitor, DY- 9836,
and its loaded nano drug carrier system on cognitive impairment and
gain a better understanding of the protective mechanisms in mice
with bilateral carotid artery stenosis (BCAS). DY- 9836 (0.5 or
1 mg/kg) or DY-9836 (0.25 mg/kg)-encapsulated polysialic acid-
octadecylamine (PSA-ODA) micelles (PSA- ODA/DY) were given
to BCAS mice for 4 weeks. Administration of DY- 9836 or PSA-
ODA/DY reduced escape latency in space exploration and working
memory test compared with vehicle group. Vehicle treated mice
showed reduced phospho- CaMKII (Thr286/287) levels in the
hippocampus, whereas partially restored by DY- 9836 (1 mg/kg) or
PSA- ODA/DY (0.25 mg/kg) treatment. In accordance with the
pharmacological proﬁle of DY- 9836 observed during behavioral
studies, experimental molecular and biochemical markers induced
by CAS, such as protein tyrosine nitration, Nod- like receptor
protein 3 (NLRP3), caspase- 1, and interleukin- 1b, were reduced by
DY- 9836 and PSA- ODA/DY treatment.This study discloses the
novel therapeutic potential of DY-9836, and its encapsulated
nanodrug delivery system signiﬁcantly enhanced the cognitive
function in mice model of Vascular dementia.
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Kolaviron mitigates rotenone-induced behavioural
incompetence and nigrostriatal degeneration
I. Awogbindin
University of Ibadan, Ibadan Nigeria, Molecular Drug Metabolism
and Toxicology Laboratory, IBADAN, Nigeria
Parkinson’s disease (PD) is the most prevalent movement
disorder. Currently, therapies are palliative with associated irre-
versible behavioural incompetence. Here, we investigated the ability
of kolaviron (KV), an anti-inﬂammatory agent, to rescue nigrostri-
atal damage and redo-inﬂammation in rats exposed to rotenone
(ROT). Aged rats exposed to 11 days of rotenone intoxication were
treated with KV either concurrently or for 18 days (7 days of pre-
treatment prior 11-day concurrent ROT-KV treatment). ROT-
exposed rats lost weight appreciably and travelled less distance
with reduced speed, decline efﬁciency to maintain a straight path,
enhanced freezing, increased immobile episodes and poor hole
recognition. The motor incompetence was attributed to enhanced
nigrostriatal degeneration and increased alpha synuclein formation.
ROT resulted in reduced tyrosine hydroxylase (TH) intensity in
substantia nigra (SNc; 50%) and striatum (75%), and depletion of
SNc TH-positive cells (50%). ROT intoxication signiﬁcantly elicited
reactive species production, induction of striatal antioxidant system
and damage to biomolecules. ROT increased COX-2 expression,
myeloperoxidase activity and secretion of striatal inteleukine-6 (IL-
6), IL-1b and tumour necrosis factor (TNF-a). KV treatment
reversed the rotenone-associated locomotor impairment, exploratory
deﬁcits and motor/neuromuscular incompetence. KV-treated rats
showed improved capacity to maintain efﬁcient gait with minimal
rigidity and enhanced coordination. KV pre-treatment preserved
more than 70% striatal dopaminergic terminal and 75% SNc TH-
positive neurons. KV signiﬁcantly attenuated ROT-induced neuro-
biochemical imbalance, altered antioxidant defence system, reduced
DJ-1 secretion, neuroinﬂammation and enhanced striatal inﬁltration
of CD45R+ cells. Taken together, kolaviron treatment mitigated the
molecular processes and pathological features associated with PD
via mechanisms related to its antioxidant and anti-inﬂammatory
properties. Thus, kolaviron may be beneﬁcial in the management of
PD.
MTU09-05
Adenosine A1 and A2A receptors modulation by
atorvastatin: neuroprotective and antidepressant-like
effects
L. B. Binder1, F. K. Ludka2, N. F. Marques1, L. C. Constantino1, C. I.
Tasca1
1Universidade Federal de Santa Catarina, Departmento de
Bioquımica, Florianpolis, Brazil
2Universidade do Contestado, Curso de Farmacia, Canoinhas,
Brazil
Adenosinergic system is involved in key neuromodulatory
processes. The purpose of this study was to evaluate the modulation
of this system on neuroprotective and antidepressant-like effects of
atorvastatin. Adults male Swiss mice received an acute administra-
tion of atorvastatin (0.1 or 0.01 mg/kg, p.o.). CHA (0.05 mg/kg, i.p,
A1R agonist) or DPCPX, (2 mg/kg, i.p. A1R antagonist) was
administered 30 min before atorvastatin. Animals received dipyri-
damole (0.1 μg/site, i.c.v, adenosine transport inhibitor) or
SCH5621 (0.05 mg/kg, i.p., A2AR antagonist) 45 min after ator-
vastatin. Mice were subjected to tail suspension test (TST) and open
ﬁeld test (OFT), 1 h after Atorvastatin. For ex vivo evaluations mice
received sub-effective atorvastatin for 7 days, once a day (10 mg/
kg). Hippocampal slices were pre-incubated with DPCPX (250 nM)
or SCH5621 (SCH, 100 nM) and subjected to glutamate toxicity
protocol (10 mM) for 1 hour and cellular viability was evaluated.
The coadministration of atorvastatin and CHA produced an additive
effect, reducing the immobility time in TST. DPCPX administration
prevented the immobility time reduction induced by an effective
dose of atorvastatin. Similarly, atorvastatin antidepressant-like effect
was blocked by SCH administration. To evaluate adenosine
transport, dipyridamole was administrated but no alterations were
observed in TST and OFT. In neuroprotective ex vivo evaluations,
atorvastatin treatment prevented glutamate-induced cellular viability
decrease, however, pre-incubation with DPCPX, or SCH prevented
atorvastatin effect. This set of results suggests a dependence on A1R
and A2AR activation for the antidepressant-like and neuroprotective
atorvastatin effects, as well as, a correlation between these
mechanisms.
MTU09-06
Aging-induced neurodegeneration in relation to brain
regional Ab deposition, locomotor and cognitive function:
role of carnosine
S. Banerjee
Jadavpur University, Pharmaceutical Technology, Kolkata, India
Aging develops positive association of biological disability to the
stress related physiological conditions to culminate into the risk of
disease with the deterioration of different antioxidant system.
Carnosine, an endogenous antioxidant dipeptide biomolecule pre-
sent in different tissues including brain. The present study focuses
on central amyloid beta (Ab) and carnosine in relation to
neurodegeneration, locomotor activity (LA) and cognitive function
(CF) in young (4 months) and aged (18 and 24 months) male albino
Wistar rats. Results revealed that aging signiﬁcantly (1) enhanced
brain regional Ab deposition (as plaque) in the order of hippocam-
pus > cerebral cortex > hypothalamus > pons-medulla, without its
any existence in cerebellum in spite of having its (Ab) highest level
among the brain regions, (2) reduced (a) steady state level of
carnosine and neuronal cell count of the brain regions studied and
(b) LA and CF. Carnosine (2.0 μg/Kg/day, i.t for 21 consecutive
days) attenuated this aging-induced (a) brain regional increase of Ab
levels and plaques along with their neuronal cell loss and reduction
in endogenous carnosine level, (b) decrease in LA and CF towards
the results that were observed in young rats. Thus it may be
concluded that (a) aging-induced up regulation of brain regional Ab
in association with their reduction in carnosine content may be
correlated with the neurodegeneration and down regulation of both
LA and CF, (b) carnosine attenuated the above mentioned aging-
induced changes in brain regulated behavior, possible by in vivo up
regulation of antioxidant system.
Supported by DST-SERB, New Delhi, India and ICMR, New
Delhi, India.
© 2019 The Authors
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The characterisation of oligodendrocytes derived from
IPSC from als patients harbouring point mutations in the
TDP-43 gene
S. Barton1,2,3, D. Magnani2,3, B. Selvaraj2,3,4, M. Livesey2,4,5, E.
Cleary3, N. Vasistha3, K. Burr2,3,4, D. Story2,3,4, R. Carter6, N.
Morton6, G. Hardingham2,4,5, D. Wyllie4,5, S. Chandran2,3,4
1Florey Institutes, University of Melbourne, Melbourne, Australia
2Euan MacDonald Centre for MND, University of Edinburgh,
Edinburgh, UK
3UK DRI, University of Edinburgh, Edinburgh, UK
4Centre for Discovery Brain Sciences, University of Edinburgh,
Edinburgh, UK
5Centre for Cardiovascular Science, University of Edinburgh,
Edinburgh, UK
TDP-43 pathology is common to > 95% of ALS patients and has
been identiﬁed in glia, including oligodendrocytes. Oligodendro-
cytes have two main roles in the brain, which are myelination and
providing metabolic support and both are critical for maintaining
neuronal health and function. The effect of TDP-43 pathology on
oligodendrocyte function remains unknown. We derived oligoden-
drocytes from induced pluripotent stem cells (iPSC) from patients
harbouring separate point mutations in the TDP43 gene, namely
G298S and M337V. We investigated the effect of these mutations
on oligodendrocyte TDP-43 subcellular localization, cell morphol-
ogy, and function. Using advanced CRISPR-Cas9 technology we
generated an isogenic control line for comparison and also generated
oligodendrocytes from an unrelated control. We assessed cellular
development and morphology as well as metabolic capacity of
diseased oligodendrocytes compared to controls using a ‘disease in a
dish’ approach. For the ﬁrst time, we demonstrated pathogenic TDP-
43 protein mislocalization in iPSC-derived oligodendrocytes that
was not present in the isogenic control or unrelated control. Despite
this TDP-43 pathology, the oligodendrocytes did not have a
developmental or morphological deﬁcit and there was no effect of
the TDP43 mutations on the oligodendrocytes’ metabolic capacity.
MTU09-08
Intranasal delivery of insulin for the restoration of memory
signaling in Alzheimer disease
M. Bhargava2,1
1Himalayan University, Pharmacy, Kanpur, India
2GTB Hospital, R&D, Kanpur, India
Alzheimer’s disease(AD), a form of dementia, is progressive,
degenerative brain disease characterized by marked atrophy of
cerebral cortex and loss of cortical and sub-cortical neurons.
Weakening of insulin receptor signaling is involved in ageing-
related brain degeneration like AD. Objective of study is to develop
delivery-system to overcome BBB by employing novel, non-
invasive approach via nasal route i.e. delivery of antibody appended
Insulin encapsulated carrier, PEGylated nanoparticle coated with
chitosan to facilitate nasal absorption for efﬁcient transfer to brain.
PEGylated-PLGA nanoparticles were prepared by modiﬁed Double
Emulsiﬁcation method and coated with chitosan by freeze drying.
Characterization was done by FTIR, NMR and in-vitro parameters.
In-vivo study comprised biodistribution in various organs and
ﬂuorescence microscopy, estimation of Anti-Ab antibody, PET-
Imaging of Brain, Hemolytic Toxicity studies, Histopathology of
Nasal Mucosa and Brain with periodic Blood Glucose Level
Monitoring. Degree of hemolysis showed PEGylated(PEG-NP’s)
and chitosan coated nanoparticles(cPEG-NP’s) were less toxic.
Blood glucose monitoring indicates reduction in blood glucose level
in cPEG-NP’s. Biodistribution assessment suggests nanoparticles
showed maximum availability at olfactory bulb entrance. Chitosan
coating increased CSF availability of drug even at initial period of
administration. Uptake study shows intense ﬂuorescence in brain
revealing higher uptake of nanoparticles. These studies highlight
possible biological signiﬁcance of cPEG-NP’s for delivery to brain.
Results from various studies suggest nanoparticles are effective
delivery system for targeted delivery of insulin in brain for extended
period. Coating with chitosan elicits associated beneﬁts in addition
to prolonging uptake via intranasal route. This project may provide
sound platform towards employment of this modiﬁed nanopartic-
ulate carrier for brain delivery of proteins and peptides towards
intranasal delivery of insulin for restoration of memory signaling in
Alzheimer patients.
MTU09-09
Novel molecular-genetic probe for visualizing protein
aggregation in neurodegenerative diseases by 3d electron
microscopy
D. Boassa1, J. Hu1, S. Phan1, M. Mackey1, R. Ramachandra1, S.
Adams2, J. Ngo3, M. Ellisman1
1University of California San Diego, Neuroscience, La Jolla, USA
2University of California San Diego, Pharmacology, La Jolla, USA
3Boston University, Department of Biomedical Engineering, Boston,
USA
We engineered a protein-fragment complementation assay for
detecting and localizing protein aggregates associated with neu-
rodegenerative diseases, including the homomeric aggregation of
alpha-synuclein (aSyn) and tau proteins. This tool was built by
bisection of miniSOG, a ﬂuorescent ﬂavoprotein derived from the
light, oxygen, voltage (LOV)-2 domain of Arabidopsis phototropin.
When brought together by interacting proteins, the fragments
reconstitute a functional reporter that permits tagged protein
complexes to be visualized by ﬂuorescence light microscopy, and
then by standard as well as “multicolor” electron microscopy (EM)
via the photooxidation of 3-3’-diaminobenzidine and its derivatives.
Unlike previous EM-compatible PCAs, the split-miniSOG frag-
ments are relatively small, and display low afﬁnity for each other,
minimizing perturbation of the native dynamics of the tagged
interacting partners. These experiments show the general utility of
the system for detection of spatial organization of molecular
complexes in mammalian cells at nanometer resolution. Using
tagged monomers of aSyn, we carried out correlative analyses and
observed the self-aggregation of the protein within neuronal cells for
the ﬁrst time. Applying 3D EM and electron tomography, we
observed both straight and twisted aSyn ﬁlaments with a diameter
ranging from 4 to 15 nm. In dendrites of expressing neurons, these
aggregates were contained in membrane-limited organelles, fusing
to the plasma membrane and suggesting release to the extracellular
compartment. We further extended the split miniSOG proximity
indicator/protein aggregation detection strategy to Tau proteins. This
approach allows to clearly visualize how the aggregation occurs in
the context of the intracellular milieu.
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Proteomic proﬁling of exosomes derived from brain
microvascular endothelial cells under hypoxia: Potential
role in remyelination
A. Campero-Romero1, E. Rıos-Castro2, A. Cardenas-Rivera1,
Luis. B. Tovar-y-Romo1
1Universidad Nacional Autonoma de Mexico, Instituto de Fisiologia
Celular, Molecular Neuropathology, Mexico City, Mexico
2IPN-CINVESTAV, Unidad de Genomica, Proteomica y
Metabolomica, Mexico City, Mexico
Brain endothelium plays critical roles in the modulation of
responses to injury, such as regulation of blood-brain barrier
dynamics, neuroinﬂammatory processes, and reperfusion after
stroke, and the molecular characterization of exosomes released
by endothelial cells might enable the identiﬁcation of adaptive
signaling responses to stress. Here we proﬁled the protein content of
brain microvascular endothelial cells (BMEC)-derived exosomes
shed by primary BMEC harvested from adult rat brains that were
subjected to 6 h of hypoxia followed by 18 h of recovery. We also
charactrized exosomes released by BMEC cultured under normoxic
conditions. Exosome molecular signatures and structure were
conﬁrmed by transmission electron microscopy, NanoTracking
assays and the presence of exosome markers. Proteomic analyses
were carried out with ESI-IMS-MS. We identiﬁed 262 high-quality
hits with BMEC features such as molecules involved in focal
adhesion, prostaglandin synthesis, and integrin signaling and
molecular regulators that target recovery mechanisms after an injury
to the CNS such as remyelination. We tested the potential of
BMEC-derived exosomes to restore lisophosphatidylcholine-
demyelinated corpus callosum in the rat, and we found that
intracerebral injection of these extracellular vesicles improved the
rate of remyelination as compared to non-treated animals. The
proteomic characterization of extracellular vesicles released by
BMEC under hypoxic stress enabled us to discover the participation
of vascular endothelium in repairing processes like remyelination
that could constitute new therapeutic targets to repair brain damage.
This work was supported by DGAPA-PAPIIT grant IN226617.
MTU09-11
Agathisﬂavone binds to estrogen and retinoic receptors
and drives remyelination in a demyelination-induced
model
M. M. Carneiro1,2, F. Pieropan2, A. Rivera2, L. Oliveira3,
M. S. Junior3, C. Souza1, A. Butt2, S. Costa1
1Federal University of Bahia, Department of Biochemistry and
Biophysics, Salvador, Brazil
2University of Portsmouth, School of Pharmacy and Biomedical
Sciences, Portsmouth, United Kingdom
3State University of Feira de Santana, Department of Health, Feira
de Santana, Brazil
Myelin dysfunction plays a signiﬁcant role in the pathogenesis of
various neurodegenerative diseases. Therefore, there is a critical
need to develop more effective therapies for demyelinating disor-
ders. Here, we have examined the protective effect of the ﬂavonoid
agathisﬂavone (FAB 5 and 10 μM) in the lysolecithin (LCT) model
of demyelination, in mouse cerebellar slice organotypic culture.
Treatment with LCT (0.5 mg/mL) resulted in signiﬁcant
demyelination, determined by loss of MBP immunostaining, and a
signiﬁcant increase in PLP1-DsRed+ mature oligodendrocytes and
NG2 + oligodendrocyte progenitor cells (OPCs). Treatment with
FAB signiﬁcantly increased MBP immunostaining and the number
and proliferation of OPCs. In addition, LCT induced astrogliosis
(GFAP immunostaining) and microglial proliferation
(IBA1 + Ki67 + ), as well as a shift in microglia to a more
inﬂammatory phenotype (M1/M2 ratio: CD16/32 + /CD206 + ).
These astroglial and microglial changes were reverted by FAB,
which also reduced Tnfa, Il1b and Nos2 and increased Arg1, Tgfb
and Acvr1b expression, as determined by RT-qPCR. Molecular
docking analysis demonstrated intermolecular interactions between
FAB and a/b-estrogen receptors (ERa/b), retinoic acid receptors
(RAR), and a/c retinoic X receptors (RXRa/c), which are involved
in myelination and neuronal survival. Furthermore, blockade of ERa
reduced FAB-induced promotion of remyelination. Together these
ﬁndings provide evidence that FAB has a signiﬁcant protective
effect against demyelination and implicates ER, RAR and RXR in
these effects. Supported by CAPES/CNPq (SLC), BBSRC/MS
(AMB), MS (FP).
MTU09-12
Hippocampus metabolic changes and memory
impairment in mice under high fat-sucrose diet for
4 months are reversed by normal diet
A. G. Serrano1, J. Duarte1
1Lund University, Experimental Medical Science, Lund, Sweden
2Lund University, Wallenberg Centre for Molecular Medicine,
Lund, Sweden
Type 2 diabetes (T2D) increases dementia risk through mecha-
nisms that not fully understood. Brain metabolic dysregulation plays
a role in T2D-induced memory dysfunction. We investigated the
potential for reversibility of brain metabolic alterations and memory
impairment in male and female C57BI6/J mice fed a high-fat and
high-sucrose diet (HFHSD) that develop T2D. Age matched control
mice were fed a 10%-fat diet (CD). Diabetic mice were exposed to
HFHSD (60%-fat, plus 20% sucrose in drinking water) for
6 months. A group of mice under HDHSD for 4 months was
reversed to CD for 2 months (RD). Metabolic proﬁles in hippocam-
pus and cortex were measured longitudinally by magnetic resonance
spectroscopy (MRS) at baseline, and after 4 and 6 months. Memory
performance was assessed at 6 months using object relocation and
novel object recognition tasks. HFHSD-fed mice developed over-
weight, glucose intolerance and insulin resistance, which recovered
to control values after diet reversing (all p < 0.01, RD vs. HFHSD).
HFHSD-fed mice showed poor memory performance in object
recognition tasks (both p < 0.001 vs. CD), but not mice in RD. At
4 months of HFHSD, the hippocampal metabolic proﬁle showed a
prominent increment in taurine concentration (p < 0.01 vs. base-
line). This change persisted at 6 months in HFHSD mice (p < 0.01
vs. baseline), but recovered to baseline levels in RD mice (p < 0.05
vs. HFHSD). Metabolic changes were not observed in cortex. We
conclude that HFHSD leads to T2D and T2D-induced memory
impairment, and increased hippocampal taurine concentration. T2D
and brain alterations were all reversed upon dietary switch from
HFHSD to a regular diet.
© 2019 The Authors
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Ascorbic acid augments nicotine neuromodulatory roles
in transferrin-mediated cortico-hippocampal
neuropathology in wistar rats
I. Gbadamosi, O. Olayemi, G. Omotoso
University of Ilorin, Anatomy, Ilorin, Nigeria
Controlled activation of nAChRs in invivo model of neurode-
generation is a remarkable way of combatting molecular aberrations
in Alzheimer’s. Nicotine, being an allosteric modulator of these
receptors, exacerbates production of reactive species thereby
compromising its candidacy as a drug target for the management
of Alzheimer’s disease. We characterized the behavioral outcome
and molecular ﬁngerprints in transferrin-mediated neuroinﬂamma-
tion while exploring the potentials of nicotine in mitigating
molecular aberrations in the presence of ascorbic acid,
Following due ethical approval, ﬁve groups (A-E) of Wistar rats
(n = 8/group) were used for this study. Group A was treated with
distilled water daily for 8 week. Transferrin-mediated neuroinﬂam-
mation was achieved in groups B-E through daily oral infusion of
100 mg/kg of AlCl3 for four weeks. Groups C-E were then post
treated with ascorbic acid (100 mg/kg daily), nicotine (10 mg/kg
daily) and nicotine (10 mg/kg daily) + ascorbic acid (100 mg/kg
daily), for four weeks. Following behavioral assessments, prefrontal
cortex (PFC) and hippocampus were prepared for biochemical
analyses, histology and immunohistochemistry.
Nicotine+ascorbic acid signiﬁcantly reversed reduction of/work-
ing memory, cognitive decline and special memory dysfunction.
These correlated with nicotine-dependent modulation of TfP-1
expression that was complemented by signiﬁcant reversal of neural
oxidative and nitrosative stress by antioxidant properties of ascorbic
acid. Furthermore, nicotine+ascorbic acid treatment regimen further
inhibited neural dysfunction within PFC and hippocampus correlat-
ing with increased glucose-6-phosphate dehydrogenase. Nissl
staining and immunohistochemical proﬁling of thin sections
corroborated roles of nicotine+ascorbic acid in reversing AlCl3-
induced neuropathology.
Summarily, we have showed the role of ascorbic acid in
enhancing nicotine neuromodulatory activities in transferrin-
mediated behavioral decline and molecular aberration in the frontal
cortex and hippocampus of Wistar rats.
MTU09-14
Cholinergic regulation of plaque pathology in Alzheimer’s
disease knock-in mouse models
L. German-Castelan1,2, T. Saito3, T. Saido3, M. Prado1,2,4,
V. Prado1,2,4
1Western University, Neuroscience, London, Canada
2Robarts Research Institute,, London, Canada
3RIKEN Brain Science Institute,, Wako-shi, Japan
4Western University, Physiology/Pharmacology, London, Canada
Cholinergic deﬁciency is characteristic of many neurodegenera-
tive disorders including Alzheimer’s disease (AD). Decreased levels
of the vesicular acetylcholine transporter (VAChT) have been
detected in AD patients, and previous work suggested that
cholinergic deﬁciency increase AD-like pathology in mouse models.
In humans, plaque pathology has been linked to the loss of VAChT;
however, whether changes in VAChT have a causal relationship
with plaque accumulation is unknown. To study this aspect of AD,
we crossed a humanized APP-knock-in mouse carrying 3 AD-
associated mutations (AppNL-G-F/NL-G-F) with mice overexpressing
VAChT using a BAC transgene. We analyzed the number and area
populated by Ab-plaques in the cortex, as well as Iba1 marker (for
microglia) and GFAP (for reactive astrocytes). Our preliminary
results show a signiﬁcant decrease in the number of reactive
astrocytes and the number of microglia associated with plaques at
2 months of age. Likewise, cortical plaque area was signiﬁcantly
decreased at 2 months, but not at 3 or 6 months. Remarkably, we
observed a sharp decrease in the levels of VAChT in AppNL-G-F/NL-G-
F-VAChT-BAC mice at 6 months, effectively reducing the overex-
pression of VAChT. Accordingly, AppNL-G-F/NL-G-F mice presented
age-decreased VAChT levels at 3 and 6 months when compared to
2-months-old. Moreover, elimination of cortical VAChT increased
the number of plaques in AppNL-F/NL-F mice, a humanized model
with less aggressive pathology. These results suggest a causal
relationship between cholinergic tone and plaque accumulation in a
humanized AD mouse model and that amyloid plaques can interfere
with cholinergic tone by decreasing VAChT levels.
MTU09-15
Nickel-induced developmental neurotoxicity in c. elegans;
neuronal degeneration, altered behaviour, and increased
SKN-1 activity
O. Ijomone1,2, M. Miah2, G. Akingbade1, H. Bucinca2, M. Aschner2
1Federal University of Technology Akure, Human Anatomy, School
of Health & Health Technology, Akure, Nigeria
2Albert Einstein College of Medicine, Molecular Pharmacology,
New York City, USA
Globally, environmental and occupational exposures to heavy
metals are an increasing health concern. Nickel (Ni) is one of such
metals and has extensive industrial applications. Importantly there is
no known physiological role for Ni in humans and other mammals.
Brain damage has been severally implicated in Ni overexposure
however, published reports are relatively limited. Here, we inves-
tigated speciﬁc neuronal susceptibility in a C. elegans model of
acute nickel neurotoxicity. Wild-type C. elegans and worms
expressing GFP in several neuronal subtypes were treated with
NiCl2 at the ﬁrst larval (L1) stage. Our results show signiﬁcantly
increasing degeneration of cholinergic, dopaminergic and GABAer-
gic neurons with increasing Ni concentration in worms expressing
GFP for these neuronal subtypes. Also, signiﬁcant functional
changes in locomotion and basal slowing response assays reﬂected
impaired cholinergic and dopaminergic neuronal function respec-
tively. Interestingly, a signiﬁcant effect on number of worms
exhibiting shrinker phenotype indicated that function of D-type
GABAergic neurons of C elegans may be speciﬁcally attenuated
while the RME subset of GABAergic neurons is unaffected. GFP
expression due to induction of glutathione S-transferase 4 (gst-4), a
target of Nrf2 homolog skn-1, was increased in VP596 (Pgst-4::
GFP; Pdop-3::RFP) worms highlighting increased SKN-1 activity
and consequently, Ni-induced oxidative stress. RT-qPCR veriﬁed
upregulation of this expression of skn-1 immediately after exposure.
These data suggest that developmental Ni exposure impairs
cholinergic, dopaminergic and GABAergic neurotransmitter sys-
tems, probably via the generation of oxidative stress. Further studies
are ongoing to unravel molecular mechanisms involved in Ni
neurotoxicity using C. elegans model.
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Isolation and neuroprotective effect of ethyl acetate
fraction of terminalia macroptera leaf
L. Ior1,2,3, S. Negri2, I. Scambi3, O. Sunday1, F. Guzzo2, A. Sagay1
1University of Jos, Pharmocology, Jos, Nigeria
2University of Verona, Plant Biotechnology, Verona, Italy
3University of Verona, Neuroscience, Biomedicine, and Movement
Sciences, Verona, Italy
4University of Jos, Department of Obstetrics and Gynecology, Jos,
Nigeria
Neurodegeneration is a process involved in both neuropatholog-
ical conditions and brain ageing. It is known that brain pathology in
the form of cerebrovascular and neurodegenerative disease is a
leading cause of death all over the world. No effective treatment for
these neurodegenerative diseases has been developed yet. Oxidative
stress-mediated neurodegeneration is one of the key pathophysio-
logical factors involved in these diseases. This study is aimed at
investigating the neuroprotective effect of the ethylacetate fraction
of Terminalia macroptera leaf and its isolates on SH-SY5Y
neuronal cells. The ethylacetate fraction of T. macroptera leaf was
subjected to solid phase extraction and preparative high-perfor-
mance liquid chromatography (HPLC) to yield several polyphenolic
compounds. We examine the neuroprotective effects of the
ethylacetate fraction and the polyphenols isolated from it against
hydrogen peroxide (H2O2)-induced cytotoxicity in SH-SY5Y cells.
The results revealed that the ethylacetate fraction of T. macroptera
showed the most favorable antioxidant activity in scavenging free
radicals compared to the isolates such as Gallic acid, chebulagic
acid, Quercetin-3-O-glucoside, chebulinic acid, vitexin, and ellagic
acid. Component elucidation revealed that the ethylacetate fraction
of T. macroptera is a rich source of phenolic compounds, especially
ﬂavonoids and tannins. The ethylacetate fraction of T. macroptera
has the potential to be a novel neuroprotective agent to be
considered in nutraceutical products for preventing oxidative-related
disorders. Further investigation is necessary to verify the neuropro-
tective efﬁcacy and mechanisms in vivo.
MTU09-17
Cnestis ferruginea ameliorates kainic acid-induced status
epilepticus in rats: role of neuroinﬂammation and
oxidative stress
I. Ishola, A. James, E. Ojo, O. Afolayan, O. Adeyemi
University of Lagos, Pharmacology, Therapeutics and Toxicology,
Idi-Araba, Nigeria
We have earlier reported anticonvulsant of Cnestis ferruginea
root extract (CF), hence, this study aimed to investigate the
mechanism underlying the protective effects of CF on kainic acid
(KA)-induced excitotoxicity in the rat hippocampus. Intraperitoneal
injection of KA (10 mg/kg) caused seizures and increased the
expression of neurotoxic markers, immediate early genes such as
cyclooxygenase 2 (COX-2), cfos, brain-derived neurotrophic factor
(BDNF), and heat shock protein 70 (hsp70) and a delayed response
gene (inducible nitric oxide synthase (iNOS)), which were
measured at 6 and 72 h after KA injection, respectively, in the
hippocampus. Pretreatment or post-treatment of mice with CF
(400 mg/kg, p.o.) delayed the onset of KA-induced seizure as well
as reduction in seizures score. KA increased c-Fos (transynaptic
marker for neuronal activity) immunoreactivity in DG, CA1, and
CA3 hippocampal regions which was attenuated by pre- and post-
treatment of mice with CF. Moreover, CF treatments reduced KA-
induced expression of COX-2, BDNF, and iNOS mRNA. Intraperi-
toneal injection of KA produced signiﬁcant deﬁcit in the antiox-
idant enzyme activities (GSH, superoxide dismutase (SOD) and
catalase) when compared with the vehicle. However, pre- treatment
and reversal with CF 400 mg/kg produced a signiﬁcant enhance-
ment of antioxidant enzyme activities suggestive of radical
scavenging effect. Findings from this study showed that CF
treatment suppresses KA-induced hippocampal injury through
attenuation of excitotoxicity, neuroinﬂammation and enhancement
of antioxidant defense mechanisms. Thus, suggest the beneﬁcial
effects of CF on the treatment of excitotoxicity-induced status
epilepticus.
MTU09-18
Biochemical and behavioral evidence for
neuromodulatory properties of ellagic acid against
D-galactose neurotoxicity in mice
D. Khatri
Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research,
Department of Pharmacology, Pune, India
Introduction: Ellagic Acid is a non-ﬂavonoid polyphenolic
compound found in different berries, mango, areca nut, walnut,
green tea, and other fruits, food, and beverages as well as in wine. It
has been reported to show different biological activities such as free
radical scavenger, antidiabetic, antiangiogenic and antimelanogenic
effects, and reduced heart infarction incidence and oxidative liver
and kidney damage.
Objective: The aim of the present study was to investigate the
protective effects of oral Ellagic acid against motor dysfunction,
striatal oxidative stress and mitochondrial deﬁcit induced by D-
galactose in mice.
Methods: Male mice were divided into different treatment
groups. D-galactose (100 mg/kg s.c.) was given for 42 days to
induced neurodegeneration. Chronic (6 weeks) oral administration
of Ellagic acid was given at three different doses (50, 100, 200 mg/
kg) to ﬁnd out neuroprotective effect. The neuroprotective effect
was evaluated in term of behavioral (learning, memory and motor
coordination) and biochemical (Lipid peroxidation, Nitrite (NO)
level, AChE activity, Advanced glycation end products). Anti-
oxidant enzyme estimations were also performed on, reduced
glutathione (GSH), Superoxide dismutase (SOD), Catalase (CAT)
activity. Mitochondrial Complex activity was performed on mice
brain mitochondria for Complex-I (NADH dehydrogenase), Com-
plex-II (succinate dehydrogenase activity) and Complex-III (MTT
ability) activity.
Results: Chronic (6 weeks) oral administration of Ellagic acid at
three different doses (50, 100, 200 mg/kg) was found to provide a
signiﬁcant neuroprotective effect in a dose-dependent manner in
terms of reversing behavioral, biochemical, anti-oxidant and mito-
chondrial damage induced by D-galactose.
Conclusion: The results suggest that Ellagic acid has neuropro-
tective activity against D-galactose induced neurodegeneration. The
present ﬁndings provide a rationale for the uses of Ellagic acid in
neurodegenerative disorders.
© 2019 The Authors
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Neuroprotective effects of kynurenic acid analogue
against secondary cascades of traumatic brain injury in
mice
N. Khatri1, S. Kumar2, A. Datusalia2,3, S. Sharma1
1Guru Jambheshwar University of Science & Technology,
Pharmaceutical Sciences, Hisar, India
2National Brain Research Centre, -, Gurugram, India
3University of Milan, Pharmacology & Biomolecular Sciences,
Milan, Italy
Traumatic brain injury (TBI) is a major cause of fatality and
disability across worldwide. Apart from, acute injury, secondary
injury cascades such as oxidative stress, mitochondrial dysfunction,
excitotoxicity, neuronal cell death etc. are detrimental factors for the
life-long disability. Despite many efforts, limited progress has been
made towards the development of pharmacological interventions to
reduce the effects of TBI. The neuroprotective effects of Kynurenic
acid are counterbalanced by 3-hydroxyanthranilic acid which is
another neurotoxic metabolite of indoleamine-2,3-dioxygenase
pathway. Here, we hypothesize that secondary injury cascade can
be rescued by elevating neuroprotection via kynurenic acid. In
current study, we had investigated the effect of kynurenic acid
amide analogue (KAA; BBB permeable) against the secondary
cascade after TBI in mice.Our data showed signiﬁcant increase in
mitochondrial dysfunction at 6 h and which persisted even after
72 h of injury. However, cell death of cortical neurons was evident
after 24 hours post-injury. Animals (Swiss albino mice, 25-30 g)
administered with Kynurenic acid amide analog (KAA, blood brain
barrier permeable, NMDA receptor antagonist) (100, 200 and
400 mg/kg, i.p) 30 minutes after injury showed a dose dependent
neuroprotective effect on mitochondrial dysfunction (complex-I, II
& IV activities), oxidative stress. KAA also improved neuronal
survival and neurological function signiﬁcantly. KAA (100 mg/kg)
were found effective at on long-term treatment (i.e. 72 hr to
21 days’ time point). Overall,our data shows that KAA promotes
neuroprotection against TBI-induced secondary cascade and
improve neurological functions in mice model of TBI.
MTU09-20
Neuregulin 1 deﬁciency in dorsal root ganglia and dorsal
roots in friedreich ataxia
A. Koeppen1,2, A. Travis1, J. Qian2, J. Mazurkiewicz3
1VA Medical Center, Research Service, Albany, USA
2Albany Medical College, Pathology, Albany, USA
3Albany Medical College, Neuroscience and Experimental
Therapeutics, Albany, USA
Friedreich ataxia (FA) is an autosomal recessive ataxia that in the
vast majority of cases is due a homozygous guanine-adenine-
adenine (GAA) trinucleotide repeat expansion in intron 1 of the
frataxin gene. The complex pathological phenotype includes atrophy
of the dentate nucleus, hypoplasia and inﬂammatory destruction of
dorsal root ganglia (DRG), spinal cord hypoplasia and degeneration
of dorsal spinal columns and dorsal spinocerebellar tracts, myelin
deﬁciency in dorsal roots (DR) and sensory peripheral nerves,
concentric cardiac hypertrophy or dilated cardiomyopathy, and
destruction of pancreatic beta cells. Neuregulin 1 type III (NRG1
[III]) is a critical signaling protein for the myelination of dorsal roots
and sensory peripheral nerves. Systematic immunohistochemical
visualization of NRG1 conﬁrmed paucity and smallness of NRG1-
reactive DR axons, and a severe lack of myelination. NRG1 (III)
signaling to Schwann cells occurs by binding to ErbB2-ErbB3
heteromers. An antibody to ErbB2 revealed abundant reaction
product in DR of FA. Ventral spinal roots in FA displayed normal
large NRG1 (III)-reactive axons, myelinated ﬁbers, and abundant
ErbB2 in Schwann cells. We conclude that lack of myelination in
DR in FA is due to insufﬁcient NRG1 (III) in DRG neurons and
downstream ﬁbers. The role of frataxin deﬁciency in this mechanism
is unknown.
Supported by Friedreich’s Ataxia Research Alliance.
MTU09-21
Lead aggravates the diabetic-induced neurodegeneration
and neuro-protecting effect of C. carandas
A. Kumar, R. Singh, B. Sharma
University of Allahabad, Department of Biochemistry, Allahabad,
India
Diabetes, an unresolved metabolic disorder and lead contamina-
tion are prevalent problems in contemporary society. Previously,
reported suggest that either diabetes or lead exposure resulted in
neurodegeneration in male rats. The aim of this study was to
evaluate whether diabetic rats exposed to lead demonstrate a higher
degree of neurotoxicity, inﬂammation and neurodegeneration when
compared with lead-exposed control rats. And the neuroprotective,
anti-inﬂammatory and antioxidant activity of C. carandas con-
stituents were also evaluated. Diabetes was induced by injecting a
single dose of streptozotocin (40 mg/kg body weight). Control and
diabetic rats were exposed to lead through oral gavage for a period
of 21 days and assessed for neuro-inﬂammatory markers and
oxidative endpoints. Signiﬁcant reduction in brain antioxidant
enzyme activity, membrane proteins and ion channels including
Acetylcholinesterase, Na+-K+ ATPase levels and glutathione levels
were observed in diabetic rats with an elevation in levels of
superoxide anions, hydrogen peroxides, lipid peroxidation. Mild
histopathological malformations were observed in the brain of the
diabetic rats. TNF-a, IL-6 transcripts and nuclear factor-jB
expression were increased in the diabetic rat brain. Similar oxidative
and neurotoxicity was observed in lead-exposed control rats.
Further, lead-exposed diabetic rats showed additional deterioration
in hippocampal and inﬂammation end points and noteworthy
elevation in oxidative toxicity suggesting that treatment with lead
exacerbates neurotoxicity in streptozotocin-induced diabetic rats.
The ameliorative efﬁcacy of the aqueous extract of C. Carandas was
analysed in diabetic rat exposed to lead. The study shows the
signiﬁcant neuroprotective and anti-inﬂammatory activity of the
extract.
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HSP90 co-chaperone stress inducible phosphoprotein-1
is necessary for chaperone activity and neuronal
resilience during aging
R. Lackie1,3, F. Beraldo2,3, R. Gros2,3, J. Fan3, V. Martins4,
V. Prado2,3, M. Prado2,3
1University of Western Ontario, Neuroscience, London, Canada
2University of Western Ontario, Phys/Pharm, London, Canada
3Robarts Research Institute, Molecular Medicine, London, Canada
4A.C. Camargo Hospital, Molecular&Cell Biology, S~ao Paulo,
Brazil
Stress inducible phosphoprotein 1 (STI1) is a co-chaperone of the
Hsp70-Hsp90 machinery and can be secreted by cells such as
astrocytes. In the extracellular space, STI1 interaction with prion
protein (PrPC) results in pro-survival signaling and neurotrophic
effects. Deletion of STI1 in mice is lethal and STI1 haplo-sufﬁcient
neurons are less resilient to stress. Recent in vitro work has
implicated Hsp90 in regulating cellular senescence, a phenotype
seen in aging. It remains unknown how reduced STI1 levels affects
chaperone machinery function in vivo and cellular resilience during
aging. To overcome the difﬁculty of studying STI1 in vivo due to
embryonic lethality of STI1 KO mice, we generated a mouse line
with a hypomorphic Stip1 allele that produces a partially functional
protein (reduced by 80%). These mutant mice have a signiﬁcant
decrease in Hsp90 client proteins and a subset of Hsp90 co-
chaperones, suggesting that STI1 acts as a major regulatory node.
Moreover, they present age-dependent hippocampal neuronal loss,
and consequent memory deﬁcits in the Morris water maze. To
determine whether STI1 is required for normal aging in a cell
autonomous or non-cell autonomous way we are currently gener-
ating neuronal and astrocyte selective STI1 mutant mice. Prelim-
inary results from aged mice with STI1 knocked down in astrocytes
revealed no memory impairment or hippocampal neuronal loss.
Overall, our work will test whether STI1 is important for
maintaining brain cell viability during aging and how its function
in the chaperone machinery may maintain proteostasis.
MTU09-23
Physical exercise during pregnancy prevents cognitive
impairment induced by amyloidb in adult offspring rats
C. Matte, C. P. Klein, J. B. Hoppe, A. B. Saccomori, J. P. Sagini,
M. S. Crestani, P. M. August, R. M. Hozer, M. Grings,
B. Parmeggiani, G. Leipnitz, P. Navas, C. G. Salbego
UFRGS, Biochemistry, Porto Alegre, Brazil
Alzheimer’s disease (AD) is the main aging-associated neurode-
generative disorder and is characterized by mitochondrial dysfunc-
tion, oxidative stress, synaptic failure, and cognitive decline. It has
been a challenge to ﬁnd disease course-modifying treatments.
However, several studies demonstrated that regular physical activity
and exercise are capable of promoting brain health by improving the
cognitive function. Maternal lifestyle, including regular exercise
during pregnancy, has also been shown to inﬂuence fetal develop-
ment and disease susceptibility in adulthood through fetal
metabolism programming. Here, we investigated the potential
neuroprotective role of regular maternal swimming, before and
during pregnancy, against amyloid-b neurotoxicity in the adult
offspring. Behavioral and neurochemical analyses were performed
14 days after male offspring received a single, bilateral,
intracerebroventricular (icv) injection of amyloid-b oligomers
(AbOs). AbOs-injected rats of the sedentary maternal group
exhibited learning and memory deﬁcits, along with reduced
synaptophysin, brain-derived neurotrophic factor (BDNF) levels,
and alterations of mitochondrial function. Strikingly, the offspring
of the sedentary maternal group had AbOs-induced behavioral
alterations that were prevented by maternal exercise. This effect was
accompanied by preventing the alteration of synaptophysin levels in
the offspring of exercised dams. Additionally, offspring of the
maternal exercise group exhibited an augmentation of functional
mitochondria, as indicated by increases in mitochondrial mass and
membrane potential, a-ketoglutarate dehydrogenase, and cyto-
chrome c oxidase enzymes activities. Moreover, maternal exercise
during pregnancy induced long-lasting modulation of fusion and
ﬁssion proteins, Mfn1 and Drp1, respectively. Overall, our data
demonstrates a potential protective effect of exercise during
pregnancy against AbOs-induced neurotoxicity in the adult off-
spring brain, by mitigating the neurodegenerative process triggered
by Alzheimer-associated AbOs through programming the brain
metabolism.
MTU09-24
Effect of melatonin on methamphetamine (meth)induced
alteration of app cleaving enzymes related to Alzheimer’s
disease
C. Nopparat
Mahidol University, Research center for Neuroscience,
Nakhonpathom, Thailand
Methamphetamine (METH) is an addictive drug, which has been
found to cause neurotoxicity to central nervous system through
multiple mechanisms. METH abusers are likely to develop
Alzheimer’s disease (AD) and suffer cognitive disabilities as well
as alterations in brain chemistry as the pathological cascade
observed in AD brains, however, the underlying mechanism of
METH-induced Alzheimer’s disease remains unknown. Melatonin,
hormone is mainly produced by pineal gland plays critical rule in
physiological function and brain protective effect. In this study we
aimed to investigate the effect of METH on amyloid precursor
protein (APP) cleaving enzymes and its upstream pathway in
Alzheimer’s disease pathway and to determine the protective effect
of melatonin on METH-induced Alzheimer’s disease. SH-SY5Y cell
lines and Male Wistar rats are used to investigate the effect of
METH on APP cleaving enzymes and upstream pathway likes
GSK3-b. Our results showed that METH signiﬁcantly increased the
b- and c-secretase, amyloidogenic protein marker. On the contrary
METH decreased the a-secretase, non-amyloidogenic biomarker
protein. These effects of METH are prevented by pretreatment with
melatonin. The result in this study suggested that METH induced
the production of amyloid peptide and melatonin exerted it
protective effect on METH-induced Alzheimer’s disease pathway.
© 2019 The Authors
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Assessment of the mechanism of actions of bacopa
ﬂoribunda on amyloid beta 1-42-induced Alzheimer’s
disease in male wistar rats
M. Omotola1, H. Oni1, B. Owoyele2
1Afe Babalola University, Ado-Ekiti, Physiology/Neuroscience, Ado-
Ekiti, Nigeria
2University of Ilorin, Kwara State, Physiology, Ilorin, Nigeria
This study aimed at assessing the effects of Bacopa Floribunda
(BF) leaves’ extracts on hippocampal changes Amyloid beta 1-42
(Ab)-induced Alzheimer’s disease. A single bilateral dose (4 μg/μl/
site) of Ab (1-42) was injected into the lateral ventricles using a
stereotaxic apparatus while BF (200 mg/kg) was given orally for
21 days. Forty eight (48) adult male Wistar rats (170-220 g) were
randomly divided into eight groups (n = 6). Group A received
intracerebroventricular (ICV) injection of normal saline, Group B
received ICV injection of Ab alone, Groups C and D received only
Ethanolic and Aqueous extracts of BF respectively, Groups E and F
were post-treated with Ethanolic and Aqueous extracts of BF
respectively after receiving ICV injection of Ab, Groups G and H
were pretreated with Ethanolic and Aqueous extracts of BF before
the Ab ICV injection. Rats were subjected to Y-maze and Novel
Object Recognition tests and sacriﬁced by cervical dislocation.
Twenty-four hours after the last administration, rats were sacriﬁced
and brain tissues excised. The hippocampus was removed and some
were assayed for the levels of glutamate, acetylcholinesterase, Na+ -
k+ ATPase activities and Amyloid beta deposition using ELISA kits,
while the rest were processed for histology using Hematoxylin &
Eosin (H&E) and nissl body stain. Data were analyzed using One-
way ANOVA followed by a post-hoc test and expressed as Mean 
SEM. Results showed that BF was able to reverse some perturba-
tions caused by Ab (1-42)-induced Alzheimer’s disease as evident in
changes in the hippocampal levels of acetylcholinesterase, Na+ - k+
ATPase and glutamate in the different treatment groups.
MTU09-27
Ameliorative potentials of bryophyllum pinnatum on
kianic acid induced temporal lobe epilepsy in models
J. Owolabi, O. Fabiyi, J. Olanrewaju, S. Olatunji, A. Odubanjo
Babcock University, Nigeria, Department of Anatomy, Ilishan-
Remo, Nigeria
Bryophyllum pinnatum is reportedly used in managing epilepsy
in African folk medicine, albeit without signiﬁcant empirical or
experimental evidences. Effects of aqueous leaf extract of bryophyl-
lum pinnatum (AEBP) on the kainic acid induced epileptic activities
in the temporal lobes was studied using Wistar rats. Twenty-ﬁve
(n = 25) adult male Wistars (average weight = 135 g) which were
randomly divided into 5 groups. Group A was the control group, and
only fed ad libitum; Group B was administered Kainic acid only to
induce epilepsy; Group C was ﬁrst administered kainic acid to
induce epilepsy and thereafter bryophyllum pinnatum (300 mg/kg/
day) to observe its ameliorative properties; Group D was admin-
istered ketogenic diet (1 kcal/ml/day) after inducing epilepsy with
kainic acid and Group E was administered the anti-epileptic
carbamazepine (100 mg/kg/day) following initial administration of
kainic acid to induce epilepsy. Epilepsy was induced with 10 mg/kg
of kainic acid in every instance and conﬁrmed and observed using
the Racine scale. After treatment for 21 days, behavioural
observations on memory and cognition were carried out using the
Barnes mazes. Animals were sacriﬁced, and the temporal lobe
cortex and hippocampus tissues were processed for histological and
immunohistochemistry studies using the hematoxylin and eosin,
Nissl stain and glia acidic ﬁbrillary acid proteins techniques.
Neurotransmitters- glutamate, serotonin and dopamine activities
were assayed in brain homogenates. Histological and histochemical
evidences on neurons and astrocyte morphologies and special
distribution, astrocyte reactions, cortical histological integrity,
neurotransmitters activities showed that bryophyllum pinnatum
had potentials to ameliorate epilepsy and the effects with signiﬁcant
relative to carbamazepine and ketogenic diet. It also signiﬁcantly
ameliorated behavioural aberrations attributable to epilepsy
[p ≤ 0.05]. This plant’s aniti-epilepsy potentials should be explored
further.
MTU09-28
Cloﬁbrate, A PPAR-a agonist mitigated sodium ﬂuoride-
induced neuro-inﬂammation, oxidative stress and motor
incoordination
A. Oyagbemi, O. Adebiyi, B. Ogunpolu, O. Falayi, K. Adigun
University of Ibadan, Department of Veterinary Physiology and
Biochemistry, University of Ibadan,, Ibadan, Nigeria
Fluoride is an environmental contaminant that is present in air,
water and soil. It is commonly added in minute quantity to drinking
water, toothpaste, and mouth rinses to prevent tooth decay.
Epidemiological ﬁndings have demonstrated that exposure to
ﬂuoride induced neurodevelopmental toxicity, developmental neu-
rotoxicity and motor disorders. The neuroprotective effect of
cloﬁbrate, a Peroxisome Proliferator-Activated Receptor alpha
(PPAR-a) agonist was investigated in the present study. Forty-male
Wistar rats were used for this study and were randomly grouped into
ten rats per group as control, sodium ﬂuoride (NaF) alone
(300 ppm), NaF plus Cloﬁbrate (250 mg/kg) and sodium ﬂuoride
plus Lisinopril (10 mg/kg), respectively, for seven days. Sodium
ﬂuoride was administered in drinking water while Cloﬁbrate and
Lisinopril was administered by oral gavage. Markers of neuronal
inﬂammation and oxidative stress, acetylcholinesterase (AchE)
activity and neurobehavioral (Hanging wire and Open Field) tests
were performed. Immunohistochemistry was performed on brain
tissues and were probed with Glial ﬁbrillary acidic protein (GFAP),
Ionized calcium binding adaptor molecule 1 (Iba1) and cerebellar
Ca2+ binding protein calbindin D-28k (CB). The results showed that
NaF signiﬁcantly increased makers of oxidative stress, neuro-
inﬂammation and inhibited AchE activity. Immuno-staining
revealed reactive astrocytes, microgliosis, loss of dendritic spines
and arborisation in Purkinje cells in rats administered only NaF.
Neurobehavioral results showed that co-treatment of NaF with
Cloﬁbrate improved muscular strength, locomotion, reduced anxiety
as well as signiﬁcant reduction in astrocytic count. Altogether, co-
treatment of NaF with either Cloﬁbrate or Lisinopril demonstrated
neuroprotective effect by mitigating neuronal inﬂammation, oxida-
tive and motor incoordination. Hence, Cloﬁbrate is a novel drug
candidate against neurodegeneration and motor disorders.
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Norvaline, a novel Alzheimer’s disease-modifying agent
B. Polis, A. Samson
Bar-Ilan University, Medical School, Safed, Israel
Alzheimer’s disease (AD) is an irredeemable chronic neurodegen-
erative disorder and the predominant cause of dementia. The disease
progression is associated with amyloid plaques’ deposition and
neuroﬁbrillary tangles’ formation in the brain, yet clinical dementia is
the end stage of the enduring pathology. Recent evidence points to
severe characteristic metabolic dysfunction as a leading cause and
hallmark of AD that is apparent decades prior to the disease
manifestation. State-of-the-art metabolomics studies prove that com-
plex arginine and branched-chain amino acids (BCAAs) metabolism
disturbances accompany AD. Lower plasma valine levels are
associated with accelerated cognitive decline, and, conversely, an
increase in valine concentration is associated with reduced risk of AD.
We administered an arginase inhibitor norvaline, which is an
uncommon non-proteinogenic BCAA and a valine’s isoform,
chronically to a mouse model of AD. A set of immunohistochem-
istry, proteomics, and transcriptomics assays was applied to evaluate
the neuroprotective effect of the substance and identify the
biological pathways activated by the treatment.
The results verify that norvaline reverses the cognitive decline in
the AD mice. The neuroprotective effect is associated with
signiﬁcantly reduced hippocampal arginase levels and diminished
amyloidosis. Moreover, the treatment moderates the rate of Tau
protein phosphorylation, alleviates microgliosis and apoptosis.
Additionally, we disclose the treatment-associated increase in the
hippocampal expression levels of synaptic plasticity-related pro-
teins, expression levels of cytosolic branched-chain amino acid
aminotransferase, and an activation of several, involved in cell
survival and neuroplasticity, biological pathways.
The data suggest that norvaline is a potent arginase inhibitor and
modulator of glutamate metabolism. The substance possesses
various modes of action, which improve the symptoms of AD and
even interfere with its pathogenesis. Therefore, norvaline presents a
promising neuroprotective molecule with manifold biological
potentials that might be tailored for the treatment of a range of
neurodegenerative disorders.
MTU09-30
Antibody-based therapeutic approach to target TDP-43
proteinopathy
S. Pozzi1, S. S. Thammisetty1, P. Codron2, R. Rahimian1,
K. V. Plourde1, J. Kriz1,3, C. Gravel1,3, J.-P. Julien1,3
1CERVO Brain Research Centre, Axis integrative neuroscience and
experimental therapies, Quebec city, Canada
2MITOVASC Institute, MitoLab Unit, Angers, France
3Laval University, Psychiatry and Neuroscience, Quebec city,
Canada
TAR DNA-binding protein 43 (TDP-43) is a DNA/RNA binding
protein mainly localized in the nucleus of cells. In pathological
conditions, TDP-43 mislocalizes and aggregates in neuronal cyto-
plasm forming hyperphosphorylated, fragmented and ubiquitinated
inclusions which impair its physiological functions. This condition
is called TDP-43 proteinopathy and can be primarily observed in
amyotrophic lateral sclerosis (ALS) and frontotemporal degenera-
tion (FTD) cases. TDP-43 has two RNA-recognition domains
(RRM1 and RRM2) both involved in relevant aspects of the protein
function. Different studies had highlighted the involvement of the
RRM1domain in TDP-43 proteinopathy. Through the RRM1
domain, indeed, TDP-43 can interact with p65, the main subunit
of NF-KB, inducing a hyperactivation of the factor which ultimately
lead to increased neuroinﬂammation and neuron toxicity. Moreover,
the RRM1 domain is a sensitive target for detrimental effects, such
as oxidation and misfolding, that eventually induce TDP-43
proteinopathy. We generated a monoclonal antibody against the
RRM1 domain of TDP-43 with the aim of reducing pathological
events mediated by this protein portion. Viral-mediated delivery into
the CNS of a single chain antibody, derived from the antigen
binding fragment of the monoclonal antibody, in mutant TDP-43
mice was found to reduce cognitive and motor impairments as well
as to decrease TDP-43 cytoplasmic mislocalization, aggregation and
neuroinﬂammation. These observations support the feasibility of an
immunotherapeutic approach to mitigate TDP-43 pathology in ALS
and FTD.
MTU09-31
Pioglitazone reversed hippocampal insulin resistance in
an amyloid-beta ﬁbrils induced animal model of
Alzheimer’s disease
S. O. Rahman1, S. Parvez2, B. P. Panda3, A. K. Najmi1
1Jamia Hamdard, Pharmacology, New Delhi, India
2Jamia Hamdard, Toxicology, New Delhi, India
3Jamia Hamdard, Biotechnology, New Delhi, India
Backround: Complications of Alzheimer’s disease (AD) have
made the development of its therapeutic intervention quite a
challenging task. Numerous studies have supported the hypothesis
that central insulin resistance plays a signiﬁcant role in AD. Serine
phosphorylation of Insulin Receptor Substrate-1 (IRS-1) has been
found to be a contributing factor in neuronal insulin resistance.
Pioglitazone (PIO) is a peroxisome proliferator-activated receptor
gamma (PPAR-c) activator, known for its signiﬁcant antidiabetic
functions, has also demonstrated neuroprotective actions.
Methods: In the present study, AD was induced by i.c.v
administration of Amyloid-b (1-42) ﬁbrils in Wistar rats. After
7 days of recovery, rats were treated with 10 mg/kg and 20 mg/kg
of PIO orally for 28 days. Behavioral analysis was done in the last
week of our experimental study. On the 36th day, rats were sacriﬁced
and their hippocampus was separated from the whole brain, then
homogenized and stored for biochemical estimations.
Results: PIO signiﬁcantly reversed the cognitive and memory
impairment, as assessed by the Morris water maze test, in Ab (1-42)
ﬁbrils infused Wistar rats. PIO also signiﬁcantly attenuated Ab (1-
42) level, IRS-S307 activity, GSK-3b activity, TNF-a level, AChE
level, nitrite level and oxidative stress in the hippocampus.
Histopathological evaluation, done through H&E and Congo red
staining, also demonstrated neuroprotective and anti-amyloidogenic
effects of PIO in the hippocampus.
Discussions: Our study concludes the protective action of
pioglitazone against hippocampal insulin resistance and Alzheimer’s
disease complications, supporting the potential role of hippocampal
insulin resistance targeting against the AD.
© 2019 The Authors
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Stress-induced inhibition of 82-KDA choline
acetyltransferase nuclear translocation
A. Rai, O. Ojiakor, H. Arora, J. Rylett
Western University, Robarts Research Institute, London, Canada
Decreased function of basal forebrain cholinergic neurons
(BFCNs) in Alzheimer’s disease (AD) causes cognitive deﬁcits.
Choline acetyltransferase (ChAT) is a key enzyme in cholinergic
neurons that synthesizes acetylcholine (ACh). The M-ChAT tran-
script of human ChAT gene encodes both cytoplasmic 69- and
nuclear 82-kDa isoforms of ChAT. We reported that expression of
82-kDa ChAT in neural cell nuclei alters expression of several
genes, including some involved in regulation of APP metabolism.
Necropsy human brain shows nuclear localization of 82-kDa ChAT
in cholinergic neurons, with subcellular distribution changing in
aging and mild cognitive impairment and AD with reduced levels of
82-kDa ChAT in nucleus and increased levels in cytoplasm. Being a
cysteine-rich protein, 82-kDa ChAT is susceptible to cellular and
oxidative stress. Our studies reveal that exposure of SH-SY5Y
neural cells to beta-amyloid or oxidative stress reduces 82-kDa
ChAT levels in nucleus. We have also characterized homodimer-
ization of 82-kDa ChAT through bimolecular ﬂuorescence comple-
mentation assay. Our results show nuclear localization of 82-kDa
ChAT homodimers in control neural cells, whereas stressed cells
exhibit perinuclear aggregate formation, which may lead to the
observed decrease in nuclear localization. Due to primate-speciﬁc
expression of 82-kDa ChAT and inaccessibility of human brain
neurons, we produced BFCNs from human induced pluripotent stem
cells (hiPSCs) as a model. We veriﬁed differentiation of iPSCs to
BFCNs by monitoring expression of cholinergic phenotypic markers
and functional parameters, such as ChAT, choline uptake and ACh
synthesis. Importantly, 82-kDa ChAT is expressed in these BFCNs
and located in nuclei. Taken together, we have demonstrated a
possible mechanism for modulation of nuclear translocation of 82-
kDa ChAT in stressed cells and developed a model for study of 82-
kDa ChAT in human neurons.
MTU09-33
Cassia tora reverses Ab1-42 aggregation in vitro and
conveys multiple neuroprotective effects in aluminium-
induced ad rats
S. K. Ravi1, R. B. Narasingappa2, C. G. Joshi1
1Mangalore University, Biochemistry, Mangalore, India
2University of Agriculture Sciences, Biotechnology, Bangalore,
India
Alzheimer’s disease is a progressive neurodegenerative disorder
characterized by the presence of neuritic plaques and neuroﬁbrillary
tangles and its multifactorial nature calls for multi-target-directed
approaches for therapeutic treatment. This study is ﬁrstly aimed at
determining the effects of Cassia tora methanolic fraction (MECT)
on Ab1-42 aggregation in vitro. Secondly, it evaluates the effects on
aluminium-induced neurobehavioral and neuropathological changes
in vivo in rats. MECT was prepared and tested for its ability to
prevent and/or reverse Ab1-42 aggregation by measuring thioﬂavin-
T ﬂuorescence and by transmission electron microscopy. For in vivo
experiments, AlCl3 was administered orally for 60 consecutive days
in the absence or in the presence of MECT. Behavioural were
employed for neurobehavioral assessment. Then, biochemical
assays measuring acetylcholinesterase activity and oxidative stress
as well as examination of the expression levels of pro-inﬂammatory
cytokines and BDNF in the hippocampus and frontal cortex were
performed. Finally, histopathological assessment of neuronal health
in the CA1 and CA3 regions of the hippocampus by cresyl violet
staining was carried out. MECT inhibits Ab1-42 aggregation from
monomers and oligomers and disintegrates pre-formed Ab1-
42 ﬁbrils. Moreover, MECT dose-dependently improves the
cognitive and behavioural impairments observed in alu-
minium-treated rats. Furthermore, the extract alleviates
AChE hyperactivity as well as oxidative stress and inﬂam-
mation observed in the hippocampus and the cerebral cortex
of aluminium-treated animals Finally, MECT precludes
aluminium-induced neuronal collapse. Our study reveals that
the methanolic extract of Cassia tora is able to prevent most
of the AD-related events and therefore stands as a promising
mild and natural anti-AD multi-target compound.
MTU09-34
Rage inhibition reduced neuroinﬂammation and
dopaminergic neurodegeneration in a long-term response
to LPS systemic inﬂammation
C. Ribeiro, J. Gasparotto, C. Girardi, P. Brum, D. Peixoto,
J. C. Moreira, D. Gelain
Universidade Federal do Rio Grande do Sul, Departamento de
Bioquımica, Porto Alegre, Brazil
Neuroinﬂammation is one of the major contributors to the
progressive loss of dopaminergic (DA) neurons in Parkinson’s
disease (PD). The receptor for advanced glycation endproducts
(RAGE) has been demonstrated as an important mediator of
neurodegeneration triggered by inﬂammation. In this study, we
investigated the effect of RAGE inhibition in a long-term response
to systemic inﬂammation in Wistar rats induced by a single dose of
lipopolysaccharide (LPS, 5 mg/kg, i.p.). The multimodal RAGE
blocker, FPS-ZM1, was administrated to selectively inhibit RAGE
either intraperitoneally (1 mg/kg, i.p.) one hour before LPS injection
or intracranially (40 lg per rat, i.n.) two months after LPS injection.
Immunostaining of Iba-1 and GFAP demonstrated that LPS
modulates microglia and astrocyte in the substantia nigra (SN)
15 days, 30 days, 6 months and 10 months after injection. By
contrast, 10 months after LPS injection both FPS-ZM1 administra-
tions reduced glial activation, suggesting that RAGE mediates the
neuroinﬂammation resulted from systemic stimulus. In addition,
immunostaining of RAGE and TH demonstrated a progressive
increase of RAGE in the SN, which is accompanied by DA neurons
loss. FPS-ZM1-induced RAGE inhibition also reduced DA neurons
loss, showing a neuroprotective effect of FPS-ZM1 against LPS
insult. Overall, our results indicate RAGE as mediator of neuroin-
ﬂammation and DA neurodegeneration triggered by LPS systemic
inﬂammation. Therefore, RAGE inhibition has a potential applica-
tion in neuroprotective therapies for PD and associated disorders.
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Anthranilate sulfonamides attenuate oxidative stress in
human neuronal cells
W. Ruankham1, W. Suwanjang2, V. Prachayasittikul1,
S. Prachayasittikul3, K. Phopin1,2
1Mahidol University, Clinical Microbiology and Applied
Technology, Bangkok, Thailand
2Mahidol University, Center for Research and Innovation, Bangkok,
Thailand
3Mahidol University, Center of Data Mining and Biomedical
Informatics, Bangkok, Thailand
Oxidative stress is associated with neuronal damage which is
considered to be a risk factor for pathogenesis and development of
neurodegenerative diseases (NDs) including Alzheimer’s disease
(AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis
(ALS), Huntington’s disease (HD), and others. Thus, antioxidant
therapy is a plausible strategy to delay NDs progression. Recently,
anthranilic acid and sulfonamides have been reported to possess
anti-inﬂammatory and antimicrobial activities. However, the under-
lying molecular mechanisms of anthranilic sulfonamide hybrids
against oxidative damage have not been fully elucidated. In this
study, hybrids of anthranilic sulfonamide incorporating benzenesul-
fonyl chlorides and anthranilic acid were synthesized, and neuro-
protection properties of the compounds against H2O2-induced
oxidative stress in neuronal cells were also investigated by using
MTT assay, carboxy-H2DCFDA assay, ﬂow cytometry, and western
blotting. Both cell viability and reactive oxygen species (ROS)
assays showed that pretreatment with anthranilate sulfonamides
effectively attenuated H2O2-stimulated cytotoxicity and ROS pro-
duction. Surprisingly, these synthesized compounds promoted
antiapoptotic protein (BCL-2) and triggered Sirtuin (SIRT1) signal-
ing pathways in human neuronal cells. Moreover, the binding
interaction of anthranilate sulfonamides to SIRT1 protein targets is
elucidated and characterized by an in silico molecular docking.
Taken together, anthranilate sulfonamides might act as sirtuin-
activating compounds which are novel therapeutic candidates for
NDs.
MTU09-36
Chlorogenic acid protects against MPTP induced
neurotoxicity in parkinsonian mice model via its
anti-apoptotic activity
S. Singh, S. Rai, H. Birla, W. Zahra, A. Rathore, H. Dilnashin,
S. Singh
Banaras Hindu University, Varanasi, India, Biochemistry,
Varanasi, India
Parkinson’s disease (PD) being one of the most common
neurodegenerative disease is primarily caused by the degeneration
of dopaminergic (DA) neurons in the substantia nigra pars compacta
of the midbrain. Studies have been conducted in various models
including, cell cultures, animal models along with post-mortem
brain studies on human bodies to reveal the role of apoptosis in the
neuronal cell death in PD. The studies have proven to determine
treatment for symptomatic relief but till date, no cure has been
identiﬁed for PD. Although in the past few years, studies have been
correlating neuroprotective effects of chlorogenic acid (CGA) to
neurodegenerative diseases and thus, various PD models have been
established to study its treatment therapy. With a similar objective,
we aimed to study the effect of CGA, a natural polyphenolic
compound, in MPTP-induced mice model of PD. On CGA
supplementation, signiﬁcant motor coordination and the antioxidant
defense has been observed in contrast with MPTP-injected mice.
Furthermore, the improved tyrosine hydroxylase expression inside
the nigrostriatal region in CGA-treated mice supports the neuro-
protective effect of CGA. Here, 1-methyl-4-phenylpyridinium
(MPP+) ion insult in the DA neurons were protected by CGA by
reversing aberrant expression of apoptotic markers (Bcl-2, Bax, and
Caspase-3). After CGA supplementation, the activity of pAkt1 was
promoted, which has further inhibited the apoptosis of DA neurons.
In Real-time PCR analysis, CGA treatment after MPTP intoxication
showed reduced expression of IL-1b, IL-2, and IL-6; the pro-
inﬂammatory cytokines. These studies have concluded that against
MPTP-intoxication, CGA has offered the neuroprotective effect
through its anti-apoptotic activity.
MTU09-37
Role of glutamate dependent signalling pathways during
Alzheimer disease and diabetes
N. Singla, A. Shukla, R. Sandhir
Panjab University, Department of Biophysics, Chandigarh, India
Worldwide, epidemiological ﬁndings have revealed that the
prevalence of Alzheimer Disease (AD) is more prominent in
Diabetes Mellitus (DM) affected individuals. The relationship
between neurodegeneration and metabolic disorder is still unclear,
which makes them a public health concern. The present study was
designed to investigate the role of glutamate dependent signaling
pathways during AD and DM. Female Wistar rats weighing 180-
200 g were divided into three groups viz: Normal control, Ab (1-42)
treated (AD model) and Streptozotocin treated (DM model). All the
treatments were continued for a total duration of one month. A
signiﬁcant decline in the learning and memory was observed in AD
and DM animals when compared to the normal control animals. The
levels of neurotransmitters c-aminobutyric acid and glutamate were
also found to be signiﬁcantly increased in the cerebrum and
cerebellum of AD and DM animals in comparison to controls. On
the contrary, activities of proteins regulating glutamate metabolism
viz: glutamate synthetase, glutamate alpha decarboxylase and
glutamate dehydrogenase were found to be signiﬁcantly decreased
in brain of AD and DM animals as compared to controls. The
protein expression of glycogen synthase kinase-3, glial ﬁbrillary
acidic protein and amyloid precursor protein were also elevated in
brain samples of AD and DM animals in comparison to control
group. The brain sections of diabetic animals showed similar
alterations in the neurohistoarchitecture as that of AD brain sections.
Hence, the present study reveals that glutamate dependent signalling
pathways plays a vital role in diabetes induced Alzheimer Disease.
© 2019 The Authors
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MTU09-38
Neurotoxic implications of rotenone induced alpha-
synuclein conformers
T. Srivastava1,2, S. Devi1,2, M. Chaturvedi1,2, S. Priya1
1Indian Institute of Toxicology Research,Lucknow, System
toxicology and health risk assessment group, Lucknow, India
22Academy of Scientiﬁc and Innovative Research AcSIR, CSIR-IITR
Campus, Lucknow, India
Genetic mutations and environmental factors are believed to
initiate the pathogenesis and aggregation of a-synuclein (a-syn),
linked to Parkinson’s disease (PD) and other synucleinopathies.
However, initiation of a-syn unfolding, structural alterations and
aggregation upon environment exposure events are still obscure.
Here, we studied rotenone-a-syn interactions as rotenone; a
pesticide is known to induce the a-syn aggregation. We also
characterized the initial events in a-syn misfolding. The study of
aggregation kinetics was done with Thioﬂavin T assay, Circular
dichroism and Transmission electron microscopy suggested that
rotenone increased the rates of aggregation with initial structural loss
and ﬂuctuations at amino acid level in a-syn and form seeds with
distinct structural morphology. For rotenone induced a-syn con-
formers we further performed cytotoxicity studies using MTT assay,
AnnexinV apoptosis assay and found them cytotoxic for neuronal
cells. The mechanistic study through DCFDA Assay and JC1 assay
has been shown that these rotenone exposed a-syn seeds did not
cause the oxidative stress but depolarized the mitochondrial
membrane potential which results in cell death. In brief we found
that rotenone induced a-syn aggregation by affecting the initiation
of misfolding events and these aggregated species cause cellular
toxicity by altering the mitochondrial membrane potential. Implica-
tion of these ﬁndings suggests that may be environmental exposure
also leads to seeds formation which are cytotoxic and remain
dormant till further exposure or favourable conditions and have
capability to induce the disease at later stages.
MTU09-39
Nickel-induced neurodegeneration in the hippocampus,
striatum and cortex; an ultrastructural insight, and the
role of caspase-3 an
O. Sunday1, I. Omamuyovwi2, O. Joshua1, A. Michael4, N.
Thajasvarie5
1Babcock University, Neuroscince Unit, Department of Anatomy
Babcock University, Ilisan-remo, Nigeria
2Federal University of Technology Akure, Department of
Anatomical Sciences, Akure, Nigeria
3Babcock university, Neuroscince Unit, Department of Anatomy
Babcock University, Ilisan-remo, Nigeria
4Albert Einstein College of Medicine, Department of Molecular
Pharmacology, New York, USA
5University of KwaZulu-Natal, Optics and Imaging Centre, Durban,
Durban, South Africa
Human overexposure to nickel (Ni) emanating from the increas-
ing application of Ni compounds in modern technology is a major
public health concern. Nickel has been shown to be teratogenic,
immunotoxic, genotoxic and carcinogenic. The current knowledge
on Ni neurotoxicity is still relatively limited. We have previously
demonstrated that Ni treatment alters cognitive and locomotor
behaviors, induces oxidative stress and neurodegeneration in brains
of rats. In this study, we examine the ultrastructural changes to
neurons in the hippocampus, striatum and cortex of the brain
following Ni treatment, as well as attempt to delineate the roles for
caspase-3 and a-synuclein in Ni-induced neurodegeneration. Rats
were treated with either saline, 10 or 20 mg/kg of nickel chloride for
4 weeks via oral gavage. Electron microscopy analysis revealed
ultrastructural alterations in neurons of the hippocampus, striatum
and cortex following Ni treatment. Mitochondria structural integrity
within neurons were markedly compromised. We also detected
elevated caspase-3 activity in hippocampus and striatum, as well as
verexpression of a-synuclein in the cortex following Ni treatment.
Our study demonstrates that mitochondria are a key target in Ni-
induced neurodegeneration. Additionally, we implicate apoptotic
pathway via caspase-3 action as the executioner and perturbation of
a-synuclein expression in Ni-induced neurodegeneration.
MTU09-40
The role of tau phosphorylation at the AT8 pathological
site in brain development
D. Tuerde1,2, K. Furusawa1, T. Takasugi1, T. Kimura1, S. Ishigaki2,
K. Ando1, S.-i. Hisanaga1, G. Sobue2
1Tokyo metropolitan university, Department of Biological Sciences,
Hachioji, Japan
2Nagoya University Graduate School of Medicine, Department of
Neurology, Nagoya, Japan
Tau is a microtubule (MT)–associated protein, which stabilizes
MTs in axons of neurons, contributing the structural support of
neuronal network in healthy brains. In contrast, in Alzheimer’s
disease (AD) brains, tau is phosphorylated around 40 sites and
forms aggregates called neuroﬁbrillary tangles, which are supposed
to cause neurodegeneration. Among many pathological phosphory-
lation sites, the AT8 site is particularly interesting because the site
used for diagnosis of AD but also is phosphorylated during early
brain development. However, it is not completely understood yet
how the AT8 reactivity is generated in AD brain and contributes to
AD development. We reported that the AT8 site was highly
phosphorylated in fetal mice brains, and dephosphorylated at around
postnatal day 14 when the neuronal circuit is established. We found
hypothyroidism delayed not only brain development but also
dephosphorylation at the AT8 site, indicated their direct relation-
ship. Here, we examined localization of phosphorylated tau and
non-phosphorylated tau at AT8 site in neurons and found that AT8
phospho-tau was present highly in the cell body and AIS region and
less in distal axons. In contrast, non-phosphorylated tau at AT8 site
was absent in AIS region and found highly in distal axon. We
introduced wild-type (WT) human tau or AT8 site mutants, either
Ala or Glu, in tau-knockdown neurons and found that 2E and WT,
but not 2A human tau induced axon extension. Thus, axon
development requires tau phosphorylated at AT8 site. This is the
physiological role of the AT8 phosphorylation in tau, but would also
provide important information on AD development.
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Neuroecotoxicology: effects of environmental heavy
metal exposure on the brain of african giant rats
I. Usende1, J. Olopade1, M. Bentivoglio2
1University of Ibadan, Veterinary Anatomy, Ibadan, Nigeria
2University of Verona, Neuroscience, Biomedicine and Movement
Sciences, Verona, Italy
Introduction: Increased exploitation of minerals has led to
pollution of environments. Information on brain effects of such
exposure is limited. Due to its exploratory activities, the African
giant rat(Cricetomys gambianus) provides a unique model for
ecotoxicological research to determine levels of animal and human
exposure to different environmental pollutants. The aim of the
present study is to unravel neuropathological features of this animal
sampled from agro-ecological zones of Nigeria.
Materials and methods: With ethical approval, the animals were
collected in the ﬁeld in three Nigerian regions according to
previously determined data on heavy metal exposure: mangrove
forest (high vanadium, selenium); woodland savanna (high lead,
selenium, zinc); rain forest (low levels of heavy metals). Immunoﬂu-
orescence and Immunohistochemical analyses were conducted,
focusing on different neuronal cell types sensitive to oxidative
stress.
Results: Interesting results were obtained concerning orexin-A
and melanin concentrating neurons of lateral hypothalamus and
dopaminergic neurons of substantia nigra pars compacta (SNC).
Stereological cell counts of tyrosine hydroxylase cells showed a
signiﬁcant loss (-41.8%) of SNC dopaminergic neurons in the
animals exposed to vanadium (mangrove), and (-50.7%) in those
exposed to lead (woodland savanna), compared to those from rain
forest zone. Similarly, a signiﬁcant loss (-39.9% and -40.8%
respectively) of parvalbumin-containing interneurons in the cingu-
late cortex has been documented in same animal groups compared to
those of rain forest.
Conclusion: These perhaps are the ﬁrst “neuroecotoxicological”
ﬁndings in distinct neuronal cell groups. The implications of these
ﬁndings are highly relevant for human population living in these
areas, not only in Nigeria but also in similarly polluted areas
elsewhere in the world.
MTU09-42
Muscarinic acetylcholine receptors in alcohol use
disorder
L. Walker1, C. Niki1, A. Lawrence1, V. Perreau1, B. Alice2,
P. Rueda2, C. Langmeed2, C. Lindsley3, C. Jones3
1Florey Institute of Neuroscience and mental health, Behavioural
neuroscience, Melbourne, Australia
2Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy
and Pharmaceutical Sciences, Melbourne, Australia
3Vanderbilt Center for Neuroscience Drug Discovery, Departments
of Pharmacology and Chemistry, Nashville, USA
Despite the large socioeconomic burden of alcohol use disorders
(AUD), therapeutic treatment options are limited. Basic neuro-
science has identiﬁed a number of targets that contribute to alcohol
reward craving and relapse; however few of these successfully
translate to human populations. AUDs are characterised by a
transition to compulsive alcohol seeking, which is hypothesized to
involve a shift from ventral to dorsal striatum. In addition, a medial
to lateral shift in the dorsal striatum is implicated in the transition
from goal-directed to habitual alcohol seeking. Muscarinic acetyl-
choline receptors (mAChRs) are potential targets for AUD
treatment as they are expressed within the mesocorticolimbic
reward system, including dense expression in the dorsal striatum.
Here they modulate dopamine and glutamate release, which may
regulate reward processing. To assess the role of mAChRs in AUD,
we ﬁrst conducted genome-wide RNA sequencing in the caudate/
putamen of 10 human alcoholics and 10 healthy controls and
concurrently examined mAChR expression in the corresponding
regions in rat (dorsolateral and dorsomedial striatum) following
chronic alcohol consumption/withdrawal using qPCR. Next we
examined the role of select mAChR subtypes in alcohol consump-
tion and seeking using selective allosteric modulators. Finally, we
probed the role of speciﬁc mAChR subtypes in the dorsal striatum
in alcohol consumption and seeking. Collectively, our data show
that mAChRs are potential novel target pharmacotherapies for the
treatment of AUD.
MTU09-43
Alteration of dopaminergic behaviors in a parkinson’s
disease model through P2x4R modulation by ivermectin
A. Warnecke1, Moon. S. Kang1, L. Halbers1, Micheal. W. Jakowec2,
D. L. Davies1
1University of Southern California, School of Pharmacy, Los
Angeles, USA
2University of Southern California, Neurology Keck School of
Medicine, Los Angeles, USA
Dopamine is a key neurotransmitter within the brain that plays a
role in the mesolimbic pathway (associated with reward-based
behavior) and the nigrostriatal pathway (which is associated with
motor control and reward-based cognition). The ability to modify
dopaminergic activities within these pathways provides a potential
target for the treatment of dopaminergic disorders. Ivermectin
(IVM), a P2X4 receptor (P2X4R) positive modulator, has been
shown to reduce alcohol consumption in mice and alter L-Dopa
induced rotational behavior in the 6-hydroxydopamine (6-OHDA)
model. P2X4R knockout mice showed reduced rotational behavior
changes (+/- IVM) further implicating P2X4Rs and IVM. To further
investigate the effects of IVM on L-Dopa enhancement, I tested
additional behaviors linked to the striatum of the medial forebrain
bundle in unilaterally lesioned mice via 6-OHDA stereotaxic
injection. Following lesion conﬁrmation (via amphetamine [5 mg/
kg] challenge) mice were subjected to a battery of behavioral tests to
evaluate motor coordination, anhedonistic behavior, learning and
memory. IVM (5 mg/kg, I.P.) was administered 8 hours prior to L-
Dopa injection (5 mg/kg S.C.) and mice were observed while
performing on the rotarod, sucrose preference test or novel object
recognition test. L-Dopa and IVM+L-Dopa altered performance on
rotarod tests and novel object recognition tests. We found IVM + L-
Dopa was able to alter signiﬁcantly motor coordination and
produced a trend in altering learning and memory and anhedonistic
behavior in a Parkinsonian mouse model. Overall, these initial
ﬁndings further illustrate IVM’s potential importance as a potential
adjunct therapy for Parkinson’s disease.
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MTU10-01
Axonal trafﬁcking of L1CAM in cortical neurons
J. Gallardo1,2, A. Luarte1,2, C. Gonzalez1,2, A. Couve1,2,
J. Sierralta1,2
1Universidad de Chile, Biomedical Neuroscience Institute BNI,
Santiago, Chile
2Universidad de Chile, Neuroscience Department, Santiago, Chile
Introduction: Neurons are highly polarized cells with two
distinct compartments, somato-dendritic and axonal. The mainte-
nance of this polarity depends mainly on axonal proteome. There is
increasing evidence supporting that axons and dendrites can
autonomously synthesize and export transmembrane (TM) proteins
through a local secretory pathway. Although in CNS axons it has
been well described the presence of endoplasmic reticulum (ER), the
presence or functionality of a Golgi-like structure has been poorly
described. Recent evidence showing axonal proteins with immature
N-glycosylation in the neuronal surface suggests a Golgi-indepen-
dent route. Here we study L1-cell adhesion molecule (L1CAM), an
axonal TM protein that contributes to the outgrowth and pathﬁnding
of the growth cone, and which delivery is not fully understood. We
hypothesize that the trafﬁcking of L1CAM from axonal ER to
plasma membrane (PM) is Golgi-independent in cortical neurons
axons.
Methods: We isolated the axonal compartment of cultured
embryonic cortical neurons (E18) using microﬂuidic chambers. To
synchronize ER export of L1CAM, we used an ER retention/release
system based on FM4/DD. Disruption of ER to Golgi trafﬁcking
was achieved with Golgicide-A (GCA) and Brefeldin-A (BFA). WB
analysis and glycosidases treatment was performed to study
L1CAM N-glycosylation.
Results: L1CAM was locally exported from the axonal ER to
PM. Axonal trafﬁcking was resistant to GCA, but sensitive to BFA.
There is a differential N-glycosylation proﬁle in axonal and somato-
dendritic compartments.
Conclusions: L1CAM can be locally exported in cortical axons
but a BFA-resistant Golgi trafﬁcking is necessary. Our results
suggest that there is a contribution of Golgi-like structures in local
local delivery of L1CAM to axonal PM.
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MTU11-01
Oligodendrocyte progenitor cell diversity in the healthy
brain
R. Beiter, M. Wall, C. Rivet-Noor, D. Rosen, A. Fernandez-
Castaneda, E. Schumann, A. Gaultier
University of Virginia, Department of Neuroscience, Charlottesville,
USA
Oligodendrocyte Progenitor Cells (OPCs) make up 2-8% of the
adult brain and remain proliferative throughout life. Historically, a
majority of the OPC ﬁeld has focused on the their role as a
progenitor pool for mature oligodendrocytes, but recent literature
has begun to explore the idea that the population of OPCs
maintained in the adult brain encompasses multiple diverse
subpopulations that may have roles beyond that of producing
oligodendrocytes. OPCs have been shown to maintain neuronal
health in the hypothalamus and play an integral role in both
depression and a mouse model of multiple sclerosis. Further
elucidation of both the molecular and functional diversity of OPCs
will potentially reveal novel functions for this cell type and provide
evidence for the production of new therapeutics for diseases in
which OPCs may be implicated. To address the question of overall
molecular diversity of OPCs in the adult brain, we have performed
single-cell sequencing of PDGFRa-reporter positive cells from the
brains of adult mice. Based on unbiased clustering, we have
preliminarily identiﬁed 4 populations of OPCs. Go Term analysis of
these clusters reveals signiﬁcant enrichment of genes related to a
variety of functions, including regulation of dendrite development,
cytokine-mediated signaling pathways, and regulation of response to
oxidative stress. Ongoing work includes validation of OPC clusters
using immunoﬂuorescent techniques to detect transcripts of genes
speciﬁcally enriched in each OPC cluster. This work provides an
overview of the transcriptional state of adult OPCs during home-
ostasis, as well as a foundation for future investigation into novel
functions of OPCs. Identiﬁcation of subpopulations of OPCs may
have important implications for diseases in which OPCs may be
playing a signiﬁcant role.
MTU11-02
Lysosomal function and dysfunction in astrocytes
L. Civiero
University of Padova, Department of Biology, Padova, Italy
During neurodegenerative diseases (NDs), astrocytes become
reactive and engulf and degrade dead cells as well as protein
aggregates via the lysosomal pathway. As a consequence, lysosomal
impairment in these cells interferes with astrocyte function and
contributes to the onset and the disease progression of NDs. In PD,
astrocytes participate to the clearance of neuronal-released a-syn
toxic species. LRRK2 is a kinase that impinges on the lysosomal
pathway in different tissues (PNAS 2014, BBRC2016) and alter-
ation of LRRK2 kinase activity in neurons is associated with PD
(Front Mol Neurosci 2017, J Neurochem 2015). Of note, LRRK2 is
highly expressed in glial cells and mutated LRRK2 might impact on
astrocyte functionality. My research aims to deﬁne pathological
implications of mutated LRRK2 in the phagycotysis/lysosomal
pathways in astrocytes and imply whether targeted therapies focused
on restoring astrocytes degradative capacity might be a route for
drug intervention in PD.
MTU11-03
Myelin breakdown favors mycobacterium leprae survival
in schwann cells
B. D. S. Mietto1,2, B. J. Souza2, P. Sammarco-Rosa2,
M. C. V. Pessolani2, F. A. Lara2, E. N. Sarno2
1Institute of Biological Sciences, Biology Department, Juiz de Fora,
Brazil
2Oswaldo Cruz Institute, Leprosy Department, Rio de Janeiro,
Brazil
Leprosy neuropathy is a chronic disorder caused by the infection
of the peripheral nerve by the intracellular pathogen mycobacterium
leprae (M leprae). Schwann cells are remarkable in supporting
Mycobacterium leprae persistence in the nerve. While M leprae
binding to myelinated Schwann cells has been implicated in
demyelinating phenotype, what exactly role M leprae plays during
myelin breakdown and clearance are not entirely clear. Here, we
provided strong evidence of close interaction of M leprae and
degenerating myelin proﬁles in vitro and in vivo. We also observed
accelerated myelin breakdown and clearance in infected Schwann
cells that was accompanied by reduced expression of myelin-related
genes in vitro and in vivo. Furthermore, this increased myelin
breakdown was associated with the upregulation of autophagic
myelin destruction in Schwann cells in vitro and in nerve biopsies.
Finally, when we blocked myelin degradation by pharmacological
inhibition of JNK/c-Jun pathway in Schwann cells, we drastically
reduced M leprae viability in the host cell. Overall, these results
provided novel evidence of the ability of M leprae in advancing
myelin breakdown to beneﬁt its persistence intracellulary in
Schwann cells.
MTU11-04
DAAM2 antagonizes VHL to modulate oligodendrocyte
differentiation and remyelination after white matter injury
X. Ding1,2,4, J. Jo2,4, C. Cristobal2,3,4, Y. Qi2,4, S.-H. Yoo5,
H. K. Lee1,2,4
1Baylor College of Medicine, Program in Developmental Biology,
Houston, USA
2Baylor College of Medicine, Department of Pediatrics and
Neuroscience, Houston, USA
3Baylor College of Medicine, Integrative Molecular and Biomedical
Science Program, Houston, USA
4Texas Children’s, Jan and Dan Duncan Neurological Research
Institute, Houston, USA
5The University of Texas Health Science Center at Houston,
Biochemistry and Molecular Biology, Houston, USA
White matter injury (WMI), or loss of myelinating oligoden-
drocytes (OLs) results in devastating neurological disorders, such
as hypoxic ischemic encephalopathy in neonates and multiple
© 2019 The Authors
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sclerosis in adults. Despite the robust regenerative capacity of
OLs, myelin repair under pathological conditions have been
unsuccessful. Indeed, lesions of patients are found populated with
stalled OL precursors, highlighting the need of deciphering
inhibitory cues. Previously, we identiﬁed a novel gene Daam2
that suppresses OL differentiation and WMI repair. Meanwhile,
Yuen et al. reported that HIF arrests OL maturation. Upon Daam2
overexpression during tumorigenesis, we observed a signiﬁcant
reduction of VHL, a well-known ubiquitin-ligase targeting HIF,
leading to the hypothesis that Daam2 suppresses OL differenti-
ation and WMI repair by antagonizing VHL functions. Using
genetic mouse models and OL cultures, we discovered a
functional antagonizing relationship between Daam2 and VHL
during development, which is conserved in lysolecithin-induced
demyelination and hypoxia-induced hypomyelination mouse mod-
els. Lastly, Daam2 promotes VHL ubiquitin-proteasomal degra-
dation under the regulation of targeting E3 ligase, the direct
manipulation of which is sufﬁcient to alter OL differentiation
in vitro. Importantly, human expression data indicates promising
therapeutic prospects. Together, we propose Daam2-VHL as a
novel regulatory mechanism for OL differentiation and a potential
therapeutic target for WMI.
MTU11-05
NG2 glia are vulnerable at breaches of the blood brain
barrier during secondary degeneration following
neurotrauma
M. Fitzgerald1,3,2, T. Clarke1, C. Bartlett2, E. Denham1
1Curtin University, Curtin Health Innovation Research Institute,
Nedlands, Australia
2The University of Western Australia, School of Biological Sciences,
Nedlands, Australia
3Perron Institute for Neurological and Translational Science,
Sarich Neurosciences Research Institute Building, Nedlands,
Australia
Blood brain barrier disruption accompanies secondary degener-
ation, both adjacent to and remote from a primary injury, and leads
to increased neuroinﬂammation and damage. NG2 + glia are an
integral component of the blood brain barrier, and encompass both
pericytes and oligodendrocyte precursor cells. However it is not yet
known if oxidative damage to NG2 + glia occurs to a greater degree
at sites of blood brain barrier breach than sites where the barrier is
intact, thereby perhaps contributing to secondary degeneration. Here
we use the partial optic nerve transection model of secondary
degeneration in adult female rats and semi-quantify 8-hydroxy
deoxyguanosine (8OHdG) immunoreactivity as an indicator of
oxidative damage to DNA in NG2 + glia and glial ﬁbrillary acidic
protein (GFAP) + astrocytes, together with Immunoglobulin G
immunoreactivity as an indicator of blood brain barrier breach.
8OHdG immunoreactivity was increased 1 day after injury in both
NG2 + glia and GFAP+ astrocytes surrounding blood vessels
(p ≤ 0.001). However, only in NG2 + glia surrounding vessels,
was 8OHdG immunoreactivity higher at sites of blood brain barrier
breach than where the barrier was intact (p ≤ 0.01). Ethynyldeox-
yuridine labelling of proliferating cells demonstrated that the
percentage of proliferating NG2 + cells around RECA+ blood
vessels was increased after injury (p ≤ 0.05), whereas the percent-
age of proliferating RECA+ endothelial cells did not increase at this
time point. Thus, NG2 + glia may be particularly vulnerable to
oxidative damage at sites of blood brain barrier breach, associated
with a proliferative response.
MTU11-06
Effects the remyelination-promoting antibody rHIgM22 on
sphingolipid metabolism in primary cultured glial cells
S. Grassi, S. Prioni, L. Cabitta, S. Sonnino, A. Prinetti
University of Milan, Department of Medical Biotechnology and
Translational Medicine, Segrate Milano, Italy
Recombinant human IgM22 (rHIgM22) binds to myelin and
oligodendrocytes (OLs) and promotes remyelination in mouse
models of multiple sclerosis. Literature suggests that rHIgM22
recruits a multimolecular complex formed by Lyn, integrin avb3
and PDGFRa, triggering Lyn activation and promoting oligoden-
drocyte precursor cells (OPCs) survival and proliferation. However,
its exact mechanism of action remains to be elucidated.
We have shown the involvement of different sphingolipids in
rHIgM22 binding at the cell surface, suggesting that reorganization
of lipid membrane microenvironment might be relevant in its
biological activity.
Thus, we assessed the effect of a 24 hours, single dose treatment
with rHIgM22 on sphingolipid metabolism in cultured rat mixed
glial cells (MGC), OPCs and OLs. The treatment had no signiﬁcant
effects on the lipid pattern of MGC. However, in OPCs and OLs it
determined an increase in the levels of gangliosides GD3 and GM3,
both known for their ability to interact with and modulate the
activity of different growth factor receptors.
In addition, rHIgM22 determined a reduced activity of the acid
sphingomyelinase (ASMase), with a consequent reduction of
ceramide (Cer) generation. Ceramide generated by the action of
ASMase represents an important pro-apoptotic signal, but also
potent regulator for the organization of sphingolipid-rich signaling
platforms. Remarkably, genetic deﬁciency or pharmacological
inhibition of ASMase effectively protect against demyelination
and other detrimental effects in MS models.
Altogether, our results support the notion that rHIgM22 protec-
tive effects might be mediated by alterations of lipid-dependent
membrane organization and/or signalling in different cell types
present in the nice of MS lesions.
MTU11-07
In vivo activation of microglial Gi signalling using
chemogenetics
A. Hogan-Cann1,2, D. Sakae2, M. Maksoud1,2, V. Ostapchenko2, W.-
Y. Lu1,2, M. Prado1,2, V. Prado1,2
1University of Western Ontario, Neuroscience, London, Canada
2Robarts Research Institute, Schulich School of Medicine &
Dentistry, London, Canada
Microglia, the immune cells of the central nervous system,
survey their surroundings and respond to external stimuli to
maintain homeostasis in the brain. To do this, microglia express
an array of receptors that allow them to receive and respond to
signals from neighboring cells. Many of these receptors are G
protein-coupled receptors, which regulate a variety of microglial
functions through different signalling pathways. Gi receptors have
been shown, for example, to modulate microglial phagocytosis and
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chemotaxis. We have generated mice expressing Gi (hM4Di)
Designer Receptors Exclusively Activated by Designer Drugs
(DREADDs) selectively in microglia. These mutated muscarinic
receptors no longer respond to their endogenous ligand acetylcholine,
but they can be activated by clozapine-N-oxide (CNO) and other
compounds at doses that are inert at other receptors. These mice
therefore allow for the selective activation of microglia Gi signalling
in vivo without simultaneously affecting receptors on neurons or
astrocytes. Activation of microglial Gi DREADDbyCNO initiates Gi
intracellular signalling pathways in DREADD-expressing microglia.
Remarkably, activation of Gi signalling, via CNO injection, does not
affect baseline behavior. Furthermore, chronic activation of micro-
glial Gi signalling in mice does not appear to alter the expression of
pro-inﬂammatory cytokines in the brains of LPS-injected mice.
Lastly, phagocytic activity of primary microglia is not affected by
activation of this pathway. Taken together, our results suggest that
speciﬁc activation of Gi signalling in microglia is possible and
appears to have no negative consequences in healthy mice.
MTU11-08
Dissecting the role of DAAM2 during astrocyte
development and associated disease
J. Jo1, K. Ung3, G. Liu3, X. Ding1,3, B. R. Arenkiel2,3, H. K. Lee1,2,3
1Baylor College of Medicine, Neurological Research Institute at
Texas children’s hospital, Pediatrics-Neurology, Houston, USA
2Baylor College of Medicine, Neuroscience program, Houston, USA
3Baylor College of Medicine, Develpmental Biology program,
Houston, USA
Astrocytes play a vital role in CNS physiology including
synaptogenesis and formation of functional blood-brain-barrier.
Consequently, astrocytes are associated with numerous neurological
disorders and malignancies. However, the molecular mechanisms
that control astrocyte development, diversity, and dysfunction
remain poorly deﬁned. Development of cell lineages follows a
sequential series of differentiative steps, culminating with the
differentiation of lineage-speciﬁc progenitors into mature popula-
tions that execute speciﬁc physiological functions. While the
paradigm of stepwise lineage differentiation is much appreciated
in neuronal and oligodendrocyte lineages, the intermediate steps of
astrocyte lineage remain unclear. Therefore, unraveling mechanisms
regulating astrocyte development and homeostasis will provide
critical insight into the pathology and treatment of multiple
neurological disorders. While we discovered previously that Daam2
suppresses oligodendrocyte differentiation during development and
repair, how Daam2 operates during astrocyte development remains
completely unknown. Here, we found that astrocyte-speciﬁc loss of
Daam2 results in abnormal astrocyte maturation and alterations in
synaptogenesis followed by the aberrant neuronal activity. Addi-
tionally, loss of Daam2 enhanced inﬂammatory responses in
photothrombotic stroke model, suggesting critical functions of
Daam2 in astrocyte development and tissue repair. To decipher how
Daam2 suppresses astrocyte maturation, we performed screening
and identiﬁed NBCe1, Na+/HCO3
 cotransporter as an inverse
functional regulator of Daam2 in astrocyte development. Together,
these studies elucidate the mechanistic link between Daam2 and its
associated genes during astrocyte development and may provide
new, tractable pathways of undeﬁned intermediated astrocyte
lineage in CNS development as well as associated injury repair.
MTU11-09
Acute toxicity after uptake of copper oxide nanoparticles
in glial cells
A. Joshi1,2, K. Jog1, R. Dringen1,2
1University of Bremen, Center for Biomolecular Interactions,
Bremen, Germany
2University of Bremen, Center for Environmental Research and
Sustainable Technology, Bremen, Germany
Copper oxide nanoparticles (CuO-NPs) have been known for their
high cell toxic potential. However, interferences by copper ions in
CuO-NPpreparationshavebeenahurdle in the investigationofspeciﬁc
nanoparticle-mediated toxicity. In order to distinguish between the
adverse effects exhibited by CuO-NPs and ionic copper that was
present in the CuO-NP preparation, we have applied the membrane-
impermeable copper chelator bathocuproine disulfonate (BCS) in a
molar ratio of 20% of total copper, in order to chelate the ionic copper
extracellularly released from the CuO-NPs. Physicochemical charac-
terization of CuO-NPs revealed that the presence of BCS did not alter
their size or surface charge. Application of CuO-NPs induced a time-,
concentration- and temperature-dependent copper accumulation and
severely compromised cell viability in C6 glioma cells and primary
astrocytes. These consequences were not altered in the presence of
BCS, while the tremendous copper accumulation and severe toxicity
found upon application of ionic copper was prevented. The observed
impairment of cell viability correlated well with the increase in the
speciﬁc cellular copper content forboth typesof copper species applied
andwasonlyobserved for conditionswhere the speciﬁc cellular copper
contents exceeded 30 nmol copper per mg protein. The copper-
induced toxicity to glial cells was accompanied by an increase in the
generation of reactive oxygen species, which was partially prevented
by BCS in copper ion-treated glial cells. In conclusion, the application
ofBCSallows to clearly distinguish between adverse effects caused by
extracellular CuO-NPs and copper ions, and demonstrates that intact
CuO-NPs are taken up and impair the viability of glial cells.
MTU11-10
Potentiation of adult oligodendrogenesis as a candidate
target for ms therapy
J. Mateus1,2, M. Gomes1,2, R. Soares1,2, S. Paulo1,2, A. Chora2, A.
Sebasti~ao1,2, S. Xapelli1,2
1Instituto de Farmacologia e Neurociencias, FMUL, Lisboa,
Portugal
2IMM-JLA, FMUL, Lisboa, Portugal
Oligodendrocytes, the myelinating cells of the Central Nervous
System (CNS), are generated upon differentiation of oligodendrocyte
precursor cells (OPCs), which possess proliferative and migratory
capabilities and are present in the CNS postnatally. Under patho-
logical conditions such as in Multiple Sclerosis (MS), there is a
depletion of oligodendrocytes, but OPCs present in the brain
parenchyma or derived from subventricular zone (SVZ) neural stem
cells (NSCs) can differentiate, migrate and partially remyelinate the
lesioned areas. Herein, we aimed at characterizing the MS mouse
model, experimental autoimmune encephalomyelitis (EAE), as well
as the process of adult oligodendrogenesis. Behavioural tests were
performed to evaluate motor function. Cellular differentiation was
assessed by immunohistochemistry for bromodeoxyuridine (BrdU)
colocalization with oligodendrocytic markers in brain regions of
interest. Western blot and ELISA assays were used for myelin
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protein levels and inﬂammatory cytokine quantiﬁcation. Results for
EAE model characterization suggested that motor impairment is
proportional to the clinical score. Moreover, an increase in the levels
of the pro-inﬂammatory cytokine TNFa (n = 5, p < 0.01), and a
tendency for increased IL-1b were observed in EAE mice. Impor-
tantly, a tendency for increased BrdU+ cells in the SVZ, corpus
callosum (CC) and cerebral cortex (CT) was observed, accompanied
by a signiﬁcant increase in NG2 + BrdU+ cells in the CC of EAE
mice (n = 3, p < 0.05), hinting at the migration of precursor cells
from the SVZ to the CC. Altogether, this work allowed the
characterization of the oligodendrogenesis process and of the EAE
model throughout time, supporting future studies involving the
modulation of adult oligodendrogenesis as a putative therapy for MS.
MTU11-11
Age-related changes in astrocytes contribute to synapse
loss and dysfunction
I. Matias1, L. Diniz1, L. Neves1, A. P. Araujo1, D. Vonk2,
J. Middeldorp2, E. Hol2, F. Gomes1
1Federal University of Rio de Janeiro, Institute of Biomedical
Sciences, Rio de Janeiro, Brazil
2University Medical Center Utrecht, Dept Translational
Neuroscience, UMC Utrecht Brain Center, Utrecht, Netherlands
Aging is associated with synaptic deﬁcit and cognitive decline.
Several evidences have shown the role of astrocytes in synaptic
function during brain development and diseases, although there is
still a lack of evidence on their involvement in age-related cognitive
decline. Here we investigated the phenotype and function of
astrocytes in aging. We used hippocampal tissue from young (2-3
months) and aged (~21 months) C57Bl/6 mice for in vivo analysis.
We also established an in vitro model for astrocyte senescence, in
which cultures were maintained for 30-35 days in vitro (DIV)
(senescent astrocytes) or 7-10 DIV (control astrocytes). We
observed a ~90% reduction in synaptic density in the hippocampal
dentate gyrus of aged mice. The GFAP immunostaining revealed
astrocyte hypertrophy and decreased levels of synaptogenic factors
in dentate gyrus of aged mice. Senescent astrocytes cultures showed
a reactive phenotype, based on LCN2 immunostaining. The ACM
from these cells presented a decreased capacity to support neurite
outgrowth and synaptogenesis on neuronal cultures, possibly due to
a signiﬁcant reduction in synaptogenic factors expression and
secretion. Our results point to a key role of changes in astrocyte
phenotype and function to the age-related synaptic loss and
dysfunction. The protocols of this study were approved by the
Committee for Animal Research of the Federal University of Rio de
Janeiro and the University Medical Center Utrecht. Support: CNPq,
CAPES, FAPERJ, Ministerio da Saude, ZonMW Memorabel.
MTU11-12
Altered myelinic nanochannel integrity modulates ALS
disease progression in SOD1 mutant mice
A. Mot, P. Dibaj, U. Gerwig, I. Tzvetanova, M. Denk-Lobnig,
W. M€obius, S. G€obbels, K.-A. Nave
Max Planck Institute of Experimental Medicine, Department of
Neurogenetics, G€ottingen, Germany
Amyotrophic lateral sclerosis (ALS) is a highly debilitating and
fatal disease characterized by the progressive loss of motor neurons.
The mechanisms leading to disrupted oligodendroglial support of
motor neurons in ALS are poorly understood. To investigate this, we
ﬁrst conﬁrmed that selective removal of oligodendroglial mutant
SOD1-G37R expression delays disease onset, prolongs survival, and
improves motor performance. Given the recently discovered novel
role of oligodendrocytes in supplying nutrients to neurons via a
system of nanometer-wide cytoplasmic channels, we utilized
immuno electron microscopy and found that mutant SOD1 is
present within paranodal loops and the inner periaxonal tongue. This
raises the intriguing possibility that SOD1 aggregates within these
nanochannels could perturb the motor-driven transport of transporter
proteins (i.e. MCT1) within oligodendrocytes and disrupt the free
diffusion of nutrients from the oligodendrocyte to the motor neuron.
To investigate the role of perturbed myelinic nanochannel integrity
as a potential mechanism leading to impaired oligodendroglial
metabolic support of motor neurons in ALS, we crossed mutant
SOD1-G93A mice with mice lacking expression of CNP, a protein
that keeps myelinic nanochannels open by preventing excessive
myelin membrane compaction. Double SOD1-G93A and CNPnull
mutants show reduced survival and worsened neurological scores.
Decreased frequency of myelinic nanochannels in CNPnull mice
could accelerate ALS disease progression in double mutants by
further limiting the transport of nutrients from the oligodendroglial
compartment to the axonal compartment. These data provide novel
insights into the mechanisms leading to impaired oligodendroglial
support of motor neurons in ALS.
MTU11-13
The innate capacity of MS oligodendrocytes to produce
efﬁcient myelinating oligodendrocytes
S. Mozafari1, L. Starost2, B. Manot3, B. Garcia-Diaz1, D. Roussel1,
L. Ottoboni4, M. Ehrlich2, M.-C. Angulo3, G. Martino4, T.
Kuhlmann2, A. B.-V. Evercooren1
1Sorbonne University, INSERM U1127, CNRS, UMR 7225, Institut
du Cerveau et de la Moelle epiniere ICM, Paris, France
2University Hospital M€unster, Institute of Neuropathology, Max
Planck Institute for Molecular Biomedicine, M€unster, Germany
3Universite Paris Descartes, Laboratory of Neurophysiology and
New Microscopies, INSERM U1128, Paris, France
4San Raffaele Scientiﬁc Institute, Institute of Experimental
Neurology -DIBIT 2, Division of Neuroscience, Milan, Italy
Multiple Sclerosis (MS) a neuroinﬂammatory demyelinating
disease, could result either from extrinsic activation of the immune
system or a process initiated intrinsically by primary cytodegener-
ation of neuroglia. Whether failed remyelination in MS results from
the incapacity of the MS oligodendroglia to function properly, or
from environmental cues is still at debate. MS oligodendrocytes are
not easily accessible. The induced pluripotent technology constitutes
a powerful tool to generate MS oligodendroglia. We showed that
transplantation of iPS-derived oligodendrocytes in adult
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demyelination condition results in excellent integration and func-
tional remyelination of host axons. Here, we ask whether MS
oligodendrocytes exhibit a primary blockade or behave as efﬁciently
as the healthy control cells.
We transplanted Human iPS-oligodendroglia from RRMS
patients and their siblings in the developing brain and spinal cord
of Shiverer:Rag2/ mice and sacriﬁced mice at 4, 8, 12, 16 and
20 weeks-post-transplantation to evaluate their fate and functional
properties as myelin-forming cells.
Data showed that MS oligodendroglia survive, vastly dis-
tribute/migrate over time and differentiate efﬁciently in myelin-
forming cells generating compact myelin within the murine brain
and spinal cord as efﬁciently as healthy controls. Transcallosal
conduction velocities were signiﬁcantly delayed in non-grafted
shiverer mice compared to the wild-type mice but rescued in the
grafted mice.
Our data suggest the innate capacity of MS cells to produce
efﬁcient myelinating oligodendrocytes. The chimeric mouse-human
glial network could be a target as a preclinical model for drug
screening of promyelinating compounds for personalized therapy in
MS. SM is beneﬁciary of an ECTRIMS fellowship. Support by the
International Progressive MS Alliance Grant #: PA-1604-08492.
MTU11-14
Function of microglia and the exosomes content are
inﬂuenced by the origin of cells
A.-N. Murgoci1,2, K. Mallah2, S. Aboulouard2, I. Fournier2, M.
Salzet2, D. Cizkova1,2,3
1Institute of Neuroimmunology SAV, Center of Regenerative
Medicine, Bratislava, Slovakia
2Univ. Lille, Inserm, U-1192, Laboratoire PRISM, Lille, France
3University of Veterinary Medicine and Pharmacy in Kosice,
Department of Anatomy, Histology and Physiology, Kosice,
Slovakia
Microglia cells are key players of the cross-talk between the
nervous and immune systems. In present study we used a
combination of proteomic and systemic biology analyses to
demonstrate that neonatal microglial cells derived from cortex and
spinal cord expressed different phenotypes upon the physiological
or pathological conditions. Primary cells were isolated from
neonatal rat cortex and spinal cord. For proteomic analyses of
microglia cells, the proteins were extracted with RIPA buffer and
processed using FASP and nanoHPLC-MS/MS analyses. Functional
analyses, including neurite outgrowth and glioma proliferation
analysis in 3D spheroid cultures, were performed to test biological
activity of cortex microglia exosomes compared with spinal cord
microglia exosomes. The results highlight variability in protein
production on both cellular and exosome levels. Bioinformatics data
reveal for proteins extracted from cortex microglia anti-inﬂamma-
tory and neurogenesis/tumorigenesis characteristics, while for
proteins isolated from spinal cord microglia involvement in the
inﬂammatory response. In vitro assays indicate that the microglia
located at different CNS areas reveal differential biological
functions through released vesicles. While exosomes from both
microglia sources enhanced growth of DRGs axons, only the spinal
microglia vesicles signiﬁcantly attenuated glioma proliferation. The
results show that exosomes produced by two different sources of
microglia do not have the same pattern nor the same biological
functions. Thus, microglia function is dependent on its cellular
microenvironment which conditions its phenotype. Supported by
APVV 15-0613, ERANET Axon Repair, INSERM, SIRIC-
ONCOLille Grant-DGOS-Inserm 6041aa.
MTU11-16
Role of coronin-1a in human fetal brain derived astrocyte
physiology and activation in HIV-1 neuropathogenesis
H. S. Pandey, P. Seth
National Brain Research Centre, Cellular and Molecular
Neuroscience, Gurgaon, India
One of the major challenges of neuroAIDS ﬁeld is lack of apt
model to study HIV-1 neuropathogenesis. This prompted us to
develop a well-characterized Human Fetal Brain-derived Neural
Precursor cell (hNPCs) culture system. We maintain hNPCs as
multipotent stem cells and differentiate neurons and astrocytes for
our studies. In HIV/AIDS, astrocytes cause indirect damage to
neuron that culminates into neurocognitive deﬁcits. Cellular and
molecular mechanisms for astrocyte activation are unclear, hence
requires extensive explorations. Recent reports using rat model
system, suggest coronin-1a is important for cognitive abilities.
Coronin-1a, an actin-binding protein, is associated with important
cellular processes such as cell migration, phagocytosis, morpho-
genesis, cellular trafﬁcking, cytokinesis etc. However, role of
Coronin-1a in astrocyte physiology is underexplored. Using hNPCs
model, we attempted to investigate the role of Coronin-1a in
modulation of astrocytic function by neurotoxic HIV-1 protein Tat.
Our studies reveal that HIV-1 Tat can modulate Coronin1A
expression in astrocytes. Interestingly, knockdown of coronin-1a
resulted in altered physiological features, such as decreased calcium
ﬂux, altered PLCy1, and ERK1/2 phosphorylation patterns in ATP
stimulated astrocytes. Having observed its role in Calcium signaling,
we were curious if it also contributes to HIV-1 Tat-induced
astroglial activation. Knockdown of this protein alleviates the HIV-1
Tat-induced astrocyte activation marked by measuring the levels of
Glial ﬁbrillary acidic protein (GFAP), cytokine, and glutamate
release. These results provide novel insights into the ﬁeld of
neuroAIDS by identifying important roles of Coronin-1a in
modulation of astrocyte physiology and pathophysiology.
Research Fellowship to HSP by CSIR, New Delhi and ﬁnancial
support from NBRC core funds to PS is greatly acknowledged.
MTU11-17
Treatment of experimental allergic encephalomyelitis
(EAE) by the metabotropic receptor agonist chpg, reduces
disease progression
T. Planas-Fontanez1,2, A. D. Stefano2, T. Sullivan2, Y. Huang2, C.
Dreyfus2
1Rutgers University, Toxicology, Piscataway, USA
2Rutgers Robert Wood Johnson Medical School, Neuroscience &
Cell Biology, Piscataway, USA
Previous studies demonstrated that a metabotropic glutamate
receptor (mGluR) agonist, ACPD (1-amino-1,3-dicarboxycyclopen-
tane), is able to reverse deﬁcits in brain-derived neurotrophic factor
(BDNF) and myelin protein levels following injury in a cuprizone
model of demyelination. Group I mGluRs (mGluR1 and mGluR5)
were localized to astrocytes and effects of ACPD were found to be
dependent upon the production of BDNF by these cells. Recent
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work indicates that similar effects are elicited by an intraperitoneal
injection of the Group I mGluR agonist, CHPG (2-chloro-5-
hydroxyphenylglycine). In this study, we tested whether CHPG
could reverse clinical signs in EAE mice immunized with myelin
oligodendrocyte glycoprotein (MOG). CHPG (20 mg/kg, injected
every other day) delayed MOG-induced EAE, and ameliorated
clinical signs when treatment was initiated after mice developed
hindlimb paralysis. This effect was accompanied by reversal in the
loss of BDNF and myelin proteins in the lumbar spinal cord.
Moreover, preliminary data revealed increased colocalization of
mGluR5 with GFAP+ astrocytes within lesioned sites, with rare
colocalization with Iba1 + activated microglia, or CD11b+ micro-
glia and macrophages, suggesting that astrocytes or microglia may
be targets of CHPG action. In contrast, no colocalization of the
receptor with CD4 + T-helper cells, CD45R+ B-cells, or Ly-6 g+
neutrophils was observed, suggesting that peripheral immune cells
do not express mGluR5 at early or late stages of disease. Future
studies will be performed to deﬁne the cellular mechanisms
underlying the effects of CHPG on glial cells and continue to
explore the potential of metabotropic agonists as targets for treating
demyelinating diseases. Supp. NMSS RG4257B4/1 and NIH RO1
NS036647.
MTU11-19
Regulation of microglial aktivity by Gq-DREADD mediated
signalling
D. Sakae1,2,3, A. Hogan-Cann11,2,3, W. Binning1,2,3, V.
Ostapchenko1,3, M. Maksoud1,3, W.-Y. Lu1,3, W. Inoue1,3, V.
Prado1,2, M. Prado1,2
1Robarts Research Institute, Neuroscience, London, Canada
2University Of Western Ontario, Schulich School of Medicine &
Dentistry, London, Canada
3University of Western Ontario, Pharmacology and Physiology,
London, Canada
G protein coupled receptors (GPCR) are widely expressed across
different cell types in the brain. They can act through Gq, Gs or Gi
signaling which have been shown to regulate several functions in
microglial cells. Microglia are the resident immune cells of the
central nervous system. They have an important role responding to
injury, infections and removing damaged cells and cross talk to
neurons via a number of GPCRs. How activation of Gq-mediated
signaling in microglia regulate some of its critical functions in vivo
is poorly understood, because neurotransmitter receptors are located
in all different cell types in the brain. To address this question, we
generated a microglia Gq-DREADD (Designer Receptors Exclu-
sively Activated by Designer Drugs; hM3Dq) mouse line. hM3Dq is
a mutated muscarinic receptors type 3 that no longer responds to
acetylcholine, but is activated by clozapine-N-oxide (CNO) and
similar compounds. We conﬁrmed in this mouse line that hM3Dq is
expressed only in microglia and that CNO increases intracellular
calcium concentrations only in Gq DREADD microglia, indicating
Gq pathway activation. Treatment with CNO also increased
phagocytosis of ﬂuorospheres by Gq DREADD microglia. In vivo,
chronic activation of hM3Dq by CNO (ip) does not affect baseline
behaviour, however it decreased LPS-induced sickness behaviour
and the upregulation of inﬂammatory cytokines mRNA in the brain.
Our results show that hM3Dq-speciﬁc microglia mice can be a
useful tool to understand how microglia GPCR-signaling modulates
its activity in vivo.
MTU11-20
Deletion of glial ABCA1 causes glaucoma-like optic
neuropathy
Y. Shinozaki1, K. Namekata2, K. Kashiwagi3, N. Ohno4,5,
T. Segawa6, S. Koizumi1
1University of Yamanashi, Dept. Neuropharmacol., Grad. Sch.
Med., Yamanashi, Japan
2Tokyo Metr. Inst. Med. Sci., Vis. Res. Project, Tokyo, Japan
3University of Yamanashi, Dept. Ophtalmol, Grad. Sch. Med.,
Yamanashi, Japan
4Natl. Inst. Physiol. Sci., Dev. Neruobiol. Bioinfo., Aichi, Japan
5Jichi Med. Univ., Div. Anat., Tochigi, Japan
6University of Yamanashi, Cent. Life. Sci. Res., Yamanashi, Japan
Glaucoma is second leading cause of blindness worldwide which
is characterized by damages or degeneration of retinal ganglion cells
(RGCs). Although an elevated intraocular pressure (IOP) is the main
risk factor, it has become apparent that many other factors are
involved in the etiology of glaucoma. Among genetic risk factors,
single nucleotide polymorphism (SNP) of ABCA1 gene has been
identiﬁed as the risk for glaucoma from large scale genome wide
association studies (GWAS). However, its pathogenic mechanisms
are totally unclear. To clarify this, we raised three issues to be
revealed. First, it is unclear whether or not ABCA1 affects IOP.
Second, it is undermined which of gain-of-neurotoxicity or loss-of-
function of ABCA1 causes glaucoma. Third, it is unknown which
type of cells contributes to glaucoma. We analyzed conventional
ABCA1 knockout (KO) mice and found that IOP was not changed.
We also found that ABCA1 was highly enriched in astrocytes of
ocular tissues. To further elucidate the role of astrocytic ABCA1, we
generated astrocyte-speciﬁc ABCA1 knockout (cKO) mice. The
cKO mice showed signiﬁcant increase in the number of apoptotic
RGCs and reduction in visual function at middle-age (12 months
old). Taken together, our data showed that (1) ABCA1 has no impact
on IOP; (2) loss-of-function of ABCA1 is involved in glaucoma; and
(3) ABCA1 in glial cells contributes to pathogenesis of glaucoma.
MTU11-21
Studying the role of dark microglia in early postnatal
development in CX3CR1-deﬁcient mice
M.-K. St-Pierre, F. Gonzalez-Iba~nez, S. Belhocine, M. Carrier,
D. Gosselin, M.-E. Tremblay
CRCHU de Quebec-Universite Laval, Molecular Medicine, Qc,
Canada
Dark microglia (DM), a recently discovered microglial pheno-
type, has been associated with ultrastructural alterations caused by
oxidative stress, as well as down-regulation of microglial homeo-
static proteins like CX3CR1.These cells were shown to be abundant
in mouse models of psychiatric and degenerative diseases, as well as
in normal post-natal development. DM were observed in brain
regions like the hippocampus, were associated with an upregulation
of cd11b and appear to be involved in synaptic modulation.
Although DM can be identiﬁed by electron microscopy due to their
electron dense cyto- and nucleoplasm, the impossibility to study
these cells with other techniques has left many questions unan-
swered. Our goal is to identify a marker that labels these cells
selectively, in order to analyze their molecular signature, regional
density, localization, morphology and ultrastructure in a myriad of
pathologies. The putative DM marker’s speciﬁcity was assessed
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using correlative immunocytochemical light and electron micro-
scopy. Furthermore, series of brain sections providing a non-biased
representation of the brain of young male and female CX3CR1-
deﬁcient mice (postnatal day 14 and 21), a model where synaptic
dysfunction can be seen, were imaged using a slide scanner to reveal
their distribution. Our results revealed that DM are found in
unexpected regions in the grey (e.g. striatum) and white matters (e.g.
arbor vitae of the cerebellum). Moreover, we found that only some
DM were positive for our marker, suggesting that multiple DM sub-
populations co-exist. Their close association with myelinated axons
in the white matter suggest a new potential role for these cells.
Further studies will be carried out to investigate DM’s role in the
white matter of young mice.
MTU11-22
Menadione induces rapid radical formation and
MRP1-mediated gssg export in rat astrocytes
J. Steinmeier, R. Dringen
University of Bremen, Biology/Chemistry, Bremen, Germany
Menadione (2-methyl-1,4-naphtoquinone) is a derivative of
vitamin K and takes part in redox cycling, thereby generating
reactive oxygen species (ROS) in cells. In brain, astrocytes defend
themselves and also neighbouring cells against xenobiotics and
toxins using an efﬁcient antioxidant defence system. To test for
adverse consequences of menadione on brain cells, primary
astrocyte cultures were treated with menadione for up to 6 h.
Concentrations of up to 30 μM menadione did not affect viability or
cellular glutathione redox state. In contrast, 100 μM menadione
caused a quick impairment in lactate release and a delayed increase
in extracellular lactate dehydrogenase activity, demonstrating
metabolic impairment and loss in membrane integrity, respectively.
Already within 5 min after exposure, 100 μM menadione caused
formation and cellular accumulation of glutathione disulﬁde (GSSG)
which was accompanied by an increased ROS-staining, clearly
indicating oxidative stress. The intracellular GSSG accumulation
was followed by an export of GSSG that was prevented by MK571,
an inhibitor of the multidrug resistance protein 1 (Mrp1). In glucose-
deprived cells glutathione oxidation and ROS formation were
already observed for lower concentrations of menadione compared
to glucose-fed cells, most likely due to a lack in NADPH
regeneration by the pentose phosphate pathway. Co-incubation of
astrocytes with dicoumarol, an inhibitor of the menadione-reducing
enzyme NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1), did
not prevent menadione-induced ROS formation nor GSSG accu-
mulation. These data demonstrate that in primary astrocytes
menadione rapidly induced NQO1-independent ROS production
and GSH oxidation to GSSG which is followed by a Mrp1-mediated
export of GSSG.
MTU11-23
Autotaxin, a regulator of oligodendrocyte differentiation
during remyelination
E. Suarez1, Fatemah. S. Afshar1, Karen. M. Gorse1, Wouter. H.
Moolenaar2, J. L. Dupree1, B. Fuss1
1Virginia Commonwealth university, Anatomy, Richmond, USA
2Netherlands Cancer Institute, Division of Cell Biology, Amsterdam,
The Netherlands
Autotaxin (ATX), also known as ectonucleotide pyrophos-
phatase/phosphodiesterase 2(ENPP2) or phosphodiesterase-Ia (PD-
Ia)/ATX, is a secreted glycoprotein primarily known for its
enzymatic lysophospholipase D (lysoPLD) activity, which generates
the lipid signaling molecule lysophosphatidic acid (LPA). LPA, in
turn, exerts its functions through activation of a family of G protein-
coupled receptors (GPCRs), the so-called LPA receptors. In our own
studies, we identiﬁed ATX as a protein that is released by cells of
the oligodendrocyte (OLG) lineage and functions via two mecha-
nisms to drive OLG differentiation. Initially, we uncovered that
ATX, via its C-terminally located modulator of oligodendrocyte
remodeling and focal adhesion organization (MORFO) domain,
promotes the establishment of a complex and expanded process
network by post-migratory, premyelinating OLGs. More recently,
we focused on ATX’s lysoPLD activity and found that the ATX-
LPA axis promotes the expression of genes well-known to be
associated with the earlier stages of OLG differentiation via, at least
in part, the modulation of histone deacetylation. Studies undertaken
in the developing zebraﬁsh substantiated a critical role of ATX in
regulating OLG differentiation during development. Interestingly,
there is evidence for reduced levels of ATX in the central nervous
system (CNS) parenchyma in the major demyelinating disease in
humans, Multiple Sclerosis. Here, we show that, similarly, ATX
levels are reduced during toxin-induced demyelination. In addition,
we present, data that support a role of OLG-derived ATX in
regulating OLG differentiation not only during development but
also after toxin-induced demyelination.
MTU11-24
Comparison of molecular signatures of OLIG2-lineage
astrocyte and GFAP-positive astrocyte using laser
microdissection
K. Tatsumi, A. Isonishi, S. Takemura, T. Tanaka, A. Wanaka
Nara Medical University, Anatomy & Neuroscience, Kashihara,
Japan
Our lineage tracing study using Olig2CreER; Rosa-CAG-LSL-
eNpHR3.0-EYFP (Olig2 CreER; YFP) transgenic mice revealed that a
subpopulation of Olig2-lineage mature astrocytes (Olig2-astrocytes)
distributed widely but unevenly in the adult brain; regions rich in
Olig2-astrocytes tended to lack GFAP-positive astrocytes (GFAP-
astrocytes). Even within a single brain nucleus, Olig2-astrocytes and
GFAP-astrocytes occupied mutually exclusive territories. External
globus pallidus (GPe) is one of the representative nuclei. Interest-
ingly, brain nuclei rich in Olig2-astrocytes tended to strongly
express GABA-transporter 3 (GAT-3) in astrocytes and vesicular
GABA transporter (vGAT) in neurons, suggesting that Olig2-
lineage astrocytes may be involved speciﬁcally in inhibitory
neuronal transmission by forming tripartite synapses.
To compare molecular signatures of the two kinds of astrocytes,
we applied laser microdissection to the GPe in combination with
© 2019 The Authors
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immunohistochemistry. The method enabled us to differentially
collect two types of astrocytes from a single section of the GPe,
where the territories of Olig2- and GFAP-astrocytes were intermin-
gled. Feeding tamoxifen-containing chow for 1 week to adult
Olig2CreER; YFP mice successfully enhanced recombination and
subsequent YFP ﬂuorescence. Brain sections were then labeled with
anti-GFAP antibody and Alexa 594-labeled secondary antibody. We
dissected out YFP-expressing cells with bushy morphologies
(Olig2-astrocyte) and Alexa 594-labeled star-like cells (GFAP-
astrocyte) from single sections. mRNAs from each type of astrocytes
were isolated and subjected to molecular comparison using qPCR.
Consistent with our previous report, Olig2-astrocytes expressed
lower GFAP mRNA than GFAP-astrocytes. The RT-qPCR analyses
further showed that Olig2-astrocytes expressed higher level of GAT-
3 gene than GFAP-astrocytes. These results strongly suggest that
Olig2-astrocytes constitute a distinct subpopulation of astrocytes
subsidiary to inhibitory GABAergic transmission.
MTU11-25
Parallel S1P receptor signalling synergise to induce
neuroprotective signalling
C. Tran1,2, S. Humphrey3, B. Heng4, J. Teo2, H. Stefen1, A. Don2,5
1UNSW, School of Medical Science, Sydney, Australia
2Centenary Institute, Lipid Signalling and Neurochemistry, Sydney,
Australia
3University of Sydney, School of Life and Environmental Science,
Sydney, Australia
4Macquarie University, Faculty of Medicine and Health Sciences,
Sydney, Australia
5University of Sydney, NHMRC Clinical Trials Centre, Sydney,
Australia
Sphingosine 1-phosphate (S1P) is an essential lipid metabolite
with potent vasculoprotective and neuroprotective properties. S1P
signals through its own family of ﬁve G-protein coupled receptors,
S1P1-S1P5, activating intracellular pathways that regulate prolifer-
ation, differentiation, and survival. The multiple sclerosis drug
Fingolimod is a potent S1P receptor agonist that causes lymphope-
nia. However, recent research has also established direct neuropro-
tective properties of Fingolimod on astrocytes in multiple
neurodegenerative paradigms including Alzheimer’s and Parkin-
son’s disease. In this study, we show S1P upregulates brain-derived
neurotrophic factor (BDNF), leukaemia inhibitory factor (LIF),
platelet-derived growth factor B (PDGFB), and heparin-binding
EGF-like growth factor (HBEGF) in astrocytes but not neurons, and
S1P is a much more potent inducer than Fingolimod. Accordingly, in
an in vitromodel of neuronal excitotoxic cell death, S1P signiﬁcantly
attenuates apoptosis whilst Fingolimod does not. Speciﬁc antagonists
of S1P1 and S1P2 both inhibited neurotrophic gene induction in
response to S1P, indicating simultaneous activation of both receptors
is required. Phosphoproteomic analysis, siRNA, and Western
blotting showed that S1P2 signals through Ga13, RhoA, Jun and
Yap to drive neurotrophic gene expression. Fingolimod does not
activate S1P2, explaining why it does not promote signiﬁcant
neurotrophic gene expression in astrocytes. Supplementing Fin-
golimod with a constitutively active G13 boosts expression of
neurotrophic factors. These results demonstrate that S1P utilises dual
signalling pathways from independent receptors to maximise neu-
rotrophic gene expression and protection against excitotoxicity.
MTU11-26
Striatin-3 is a novel glial RAC1 effector
M. Weaver1,2, C. Berti3, L. Frick2,4, M. Palmisano5, M. Pellegatta6,
S. Ferguson7, C. Namba8, M. Selbach9, F. Paul9, L. Wrabetz2,4,
L. Feltri2,4
1SUNY Buffalo, Neuroscience, Buffalo, USA
2SUNY Buffalo, Hunter James Kelly Research Institute, Buffalo,
USA
3New York University, Pathology, New York, USA
4SUNY Buffalo, Biochemistry, Buffalo, USA
5AstraZeneca, Medical Affairs, Basiglio, Italy
6San Raffaele Scientiﬁc Institute, Experimental Neurology, Milan,
Italy
7SUNY Buffalo, Pharmaceutical Sciences, Buffalo, USA
8Meharry Medical College, Medicine, Nashville, USA
9Max Delbr€uck Center, Biochemistry, Berlin, Germany
During development, Schwann cells undergo extensive cytoskele-
tal reorganization as they insert cytoplasmic extensions into axon
bundles to sort, ensheath, and myelinate axons. Similarly, following
peripheral nerve injury there is extensive actin polymerization around
Schmidt-Lantermann incisures as Schwann cells differentiate into a
repair phenotype. Both processes are regulated by Rac1. Our lab
previously demonstrated that Rac1 activation during development is
driven by engagement of b1 integrin with laminins and is essential for
radial sorting. Therefore, we performed a proteomic screen to look for
novel Rac1 effectors in peripheral nerves and identiﬁed striatin-3
(Strn3) as a candidate. Initial in vitro data suggests that Strn3
knockdown in SCs decreases their ability to adhere to various
substrates including axons and reduces proliferation. We are devel-
oping a mouse model with ablation of Strn3 speciﬁcally in Schwann
cells along with a Strn1/3 double Schwann cell knockout. Addition-
ally, we have found that Strn3 may be highly expressed in axons at
nodes of Ranvier and in oligodendrocytes. Therefore, we are also
developing mouse models with speciﬁc ablation of Strn3 in neurons
or oligodendrocytes to characterize the functional signiﬁcance of
Strn3 in axons and myelinating glia of the central nervous system.
MTU11-27
Presentation of acute motor deﬁcit and subsequent
recovery following internal capsule demyelination in mice
R. Yamazaki
Gerogetown University, Department of Biology, Washington DC,
USA
Multiple sclerosis (MS) is a chronic inﬂammatory demyelinating
disease of the CNS characterized by progressive remyelination
failure and accumulated motor disability. However, whether
remyelination promotes motor recovery remains unclear. Here, we
compared the effect of experimental demyelination with focal
ischemia induction in the internal capsule (IC), a white matter region
associated with motor impairment in MS and stroke, on motor
behavior in mice. First, to induce the demyelination, we injected
lysolecithin (LPC) into right side IC using stereotaxic technique. At
7 days post lesion (dpl), demyelination was observed in the IC by
immunoﬂuorescence staining and FluoroMyelin. Next, to examine
whether this model affects motor function, we performed adhesive
tape removal test, cylinder test, wire hang test and ladder walking
test. IC-demyelinated mice reduced motor function in mice at 7 dpl.
Further, we demonstrated that demyelination of right IC signiﬁ-
cantly impaired both left forelimb and left hindlimb motor function.
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Moreover, these mice exhibited motor deﬁcit until 14dpl, but
regained motor function by 28dpl, corresponding with reduced
inﬂammation, decreased axonal dystrophy, and increased oligoden-
drocytes in lesions. By contrast, injection of endothelin-1 (ET1) into
the IC, which is known to induce white matter infarct, displayed
lasting motor deﬁcit, which is accompanied by persistent inﬂam-
mation and axonal dystrophy, and reduced oligodendrocytes in
lesions. These results demonstrate that IC demyelination induces
acute motor deﬁcit and subsequent motor recovery through
remyelination, and suggest that inﬂammation resolution and the
restoration of axonal integrity may be required for successful
remyelination and motor recovery. Therefore, IC demyelination is a
tractable model for assessing the inﬂuence of remyelination on
motor behavior, and may be used to complement future drug screens
for the identiﬁcation of compounds for promoting remyelination.
MTU11-28
Guanosine and guanine can differently modulate
sumoylation in rat cortical astrocytes
C. Zanella, G. Poluceno, C. Tasca, H. Cimarosti
UFSC, Pharmacology, Florianopolis, Brazil
SUMOylation is a posttranslational protein modiﬁcation that can
participate in endogenous protective mechanisms, and defective
SUMOylation is observed in a diverse array of neurological
disorders. Guanosine and its metabolite guanine, two endogenous
molecules from the purinergic system, also play physiological and
protective roles in different disorders. Here we investigated whether
guanosine and/or guanine can modulate SUMOylation. Primary
cortical astrocytes (14 days in vitro) were treated with guanosine
and guanine (1, 10, 100, 300 or 500 μM) for 1 h and 6 h. Data from
Western blotting labelling were obtained from the whole membrane
signal always divided by its respective loading control (GAPDH).
One-way ANOVA followed by Neuman-Keuls post hoc test was used
to analyze the data. Global SUMO-2/3-ylation increased two-fold in
astrocytes treated for 1 h with guanosine (10 - 500 μM, n = 4).
Conversely, guanine (at 500 μM, n = 4) decreased global SUMO-2/
3-ylation in astrocytes treated for 1 h. SUMO-2/3 levels go back to
control levels in astrocytes treated with guanosine (10 - 500 μM,
n = 4) for 6 h, however treatment with guanine (at 500 μM, n = 4)
for 6 h caused a signiﬁcant increase in SUMO-2/3 levels. To our
knowledge this is the ﬁrst report where molecules from the
purinergic system are shown to be modulating SUMOylation.
These are promising results that raise several questions concerning
the functional consequences of this modulation for cellular protec-
tion.
MTU11-29
Ionotropic mechanism of NMDA receptor-mediated
calcium ﬂuxes in cultured mouse astrocytes: is it
modulated by neurons?
K. Skowron´ska, J. Albrecht
Mossakowski Medical Research Centre, Polish Academy of
Sciences, Neurotoxicology, Warsaw, Poland
It is well established that activation of NMDA receptors
(NMDAR) in cultured rodent astrocytes triggers calcium ﬂuxes. In
rat astrocytes the ﬂuxes involve calcium derived from both
extracellular and intracellular compartments, reﬂecting ionotropic
or metabotropic mechanisms, respectively. Here we analyzed the
two mechanisms in cultured mouse astrocytes and the role of
neuronderived factors in the process. Cultured mouse cortical
astrocytes were treated with 100 lM NMDA and changes in the
intracellular calcium concentration ([Ca2+]i) were measured with
the ﬂuorescent calcium indicator, Fluo-3-AM. The NMDA-depen-
dent ﬂuxes were absent in the presence of a NMDAR channel
blocker MK-801 and in cultures with silenced NMDAR subunit
GluN1 (siGluN1), but were not altered by incubation with blockers
of: i) IP3 receptor (xestospongin C), ii) ryanodine receptor
(ryanodine) and iii) mGluR5 (MPEP). The results indicate that the
mechanism by which NMDAR in mouse astrocytes exclusively
mobilize extracellular, but not intracellular calcium, reﬂecting
ionotropic mechanism. The ionotropic nature of the ﬂuxes was not
altered by preincubation of astrocytes with a medium derived from
cultured neurons, indicating that neuron-derived soluble factors are
neutral to the process. Evaluation of the calcium ﬂuxes in astrocytes
co-cultured with neurons are under way to assess whether direct cell
contact between astrocytes and neurons plays a role in establishing
the nature of astrocytic calcium ﬂuxes. Supported by National
Science Centre of the Republic of Poland (NCN), grant no 2017/27/
N/NZ3/02819.
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MTU12-01
DTI found structural altercations induced by long-term
optogenetics stimulation of striatal medium spiny
neurons
Y. Abe, K. Tanaka
Keio University School of Medicine, Neuropsychiatry, Tokyo, Japan
Striatal medium spiny neurons (MSNs) control motor function.
Hyper- or hypo-activity of MSNs coincides with basal ganglia-
related movement disorders. Based on the assumption that lasting
alterations in neuronal activity lead to structural changes in the
brain, understanding these structural alterations may be used to infer
MSN functional abnormalities. To infer MSN function from
structural data, understanding how long-lasting alterations in MSN
activity affect brain morphology is essential. To address this
question, we conducted a proof-of-concept study using mice that
express channelrhodopsin-2 (ChR2) only in the MSNs. We utilized
ex vivo diffusion tensor imaging (DTI) for comprehensive visual-
ization of structural alterations. One-week optogenetic stimulation
was conducted to the hemispheral dorsal striatum (dStr) of mice
which express a ChR2-YFP in MSNs. As a result, a rotation
behavior induced by optogenetics stimulation to the MSNs was
impaired after one-week stimulation. The stimulation decreased
fractional anisotropy (FA), reﬂecting structural alterations of axons
and myelin, in the ipsilateral dStr, motor cortex (M), and substantia
nigra reticular (SNr), compared with the contralateral side. Histo-
logical approach using a super-resolution microscopy showed the
smaller diameters of YFP positive axons and dendrites of MSNs. In
addition, the diameters of myelin proteolipid protein (PLP) positive
axons were smaller and PLP positive myelination was thinner in
dStr, M, and SNr. These structural changes were approved by
observation with an electron microscopy and were highly correlated
with the DTI-FA change. These results indicated that the long-term
activation of dStr MSN, resulting in motor dysfunction, altered
structures of MSNs and myelinated neurons of the MSN-related
circuit. This combinatorial study provides a useful tool to under-
stand the causal relationship with functional and structural alter-
ations.
MTU12-02
Involvement of the gut microbiome-brain microglia axis in
a maternal high-fat diet mouse model of
neurodevelopmental disorders
M. Bordeleau1,2, C. Bolduc1, G. Luheshi2, M.-E. Tremblay1
1CRCHU de Quebec - Universite Laval, Neuroscience, Quebec,
Canada
2Douglas Mental Health University Institute, Psychiatry, Montreal,
Canada
A high-fat diet (HFD) during pregnancy and/or nurturing is
associated with an increased risk of neurodevelopmental disorders in
the offspring. Previous results in mice revealed that maternal HFD
(mHFD) leads to the development of behavioral abnormalities,
including stereotypic and repetitive movements, caused by a gut
dysbiosis, which promoted altered neuronal network activation. The
gut microbiome may inﬂuence brain development by altering
microglia, the immune cells that regulate the formation of neuronal
circuits. However, these effects on microglia and their consequences
on the brain and behavior remain largely undetermined. We
hypothesized that a dysbiosis of the gut microbiota caused by a
mHFD could alter microglial function leading to an imbalance of
excitatory/inhibitory neuronal input relevant to known behavioral
deﬁcits. To test this hypothesis, female mice received a HFD (rich in
saturated and unsaturated fats) for 4 weeks before breeding until
weaning of their litter. Offspring’s behavior was assessed during
adulthood, which identiﬁed increased repetitive movements.
Another cohort of animals was sacriﬁced at 30 days of life to
collect brain and gut tissues. The microbiome will be analyzed by
sequencing of 16S RNA. To assess changes in neuronal circuits and
their interactions with microglia, a triple immunostaining will be
performed to label excitatory synapses (Vglut1/Homer1) or
inhibitory synapses (vGAT/gephyrin) in addition to microglia
(IBA1) among the hippocampus and amygdala, two regions
involved in the glutamatergic circuit. This project will help to
understand the link between gut dysbiosis caused by mHFD and the
pathogenesis involving microglia and excitatory/inhibitory imbal-
ance of neurodevelopmental disorders.
MTU12-03
Microglia contribute to the loss of inhibitory synapses in
chronic toxoplasma gondii infection
G. Carrillo1, T. Glausen2, J. Teamer1, Z. Boone1, I. Blader1, M. Fox1
1Virginia Tech, Fralin Biomedical Research Institute, Roanoke,
USA
2University at Buffalo, Department of Microbiology and
Immunology, Buffalo, USA
Schizophrenia is a complex and heterogeneous neurological
disorder associated with debilitating cognitive impairment, acquisi-
tion of positive symptoms (hallucination and psychosis), and loss of
behaviors that are normally present in healthy individuals (apathy
and social withdrawal). Evidence from both human patients and
rodent models suggest that schizophrenia-associated behaviors
result from alterations in the assembly and function of inhibitory
synapses, including inhibitory axo-somatic synapses. In addition to
genetic causes (such as those examined with genetic mouse models)
environmental factors can both increase the risk of schizophrenia
and alter inhibitory circuit function in the brain. One such
environmental factor is infection with Toxoplasma gondii, an
intracellular protozoan parasite that infects over one-third of the
human population worldwide. We previously discovered abnormal-
ities in inhibitory synapse organization and function in chronically
Toxoplasma-infected brains. Here, we sought to test whether chronic
infection speciﬁcally alters axo-somatic inhibitory synapses. We
performed ultrastructural analysis of inhibitory axo-somatic
synapses in the CA1 region of mouse hippocampus and in layer
V of cerebral cortex using Serial Block Face Scanning Electron
Microscopy. In parasite-infected brains we discovered a signiﬁcant
reduction of inhibitory axo-somatic synapses in CA1 and neocortex.
Interestingly, we observed a dramatic ensheathment of neuronal
somas in these regions by microglia-like cells in Toxoplasma-
infected brains. These ﬁndings were further corroborated with in situ
hybridization for Syt1 (a marker for neuronal somas) coupled with
immunohistochemistry to visualize phagocytic microglia. Thus, we
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not only identiﬁed a signiﬁcant reduction in axo-somatic synapses in
parasite-infected brains, but our data suggests a role for microglia in
inhibitory synapse loss.
MTU12-04
Quetiapine reverses the malfunctions in the behaviour
and the neuron-microglia protein systems of prenatally
LPS-treated offspring
K. Chamera, M. Szuster, E. Trojan, A. Basta-Kaim
Institute of Pharmacology Polish Academy of Sciences, Department
of Experimental Neuroendocrinology, Krakow, Poland
The risk of developing schizophrenia appears to be a serious
threat for an adult offspring of mothers exposed to prenatal insults
during pregnancy. The immunological aspect seems to indicate the
importance of systems controlling neuron-microglia interactions,
including chemokines and clusters of differentiation. The study was
designed to examine: 1) an inﬂuence of the changes induced by the
prenatal treatment with lipopolysaccharide (LPS) on the behaviour
and protein levels of CX3CL1, CX3CR1, CD200, CD200R in the
hippocampus and the frontal cortex of adult offspring rats; 2) an
impact of 14-day-treatment with quetiapine on above-mentioned
aspects. Every other day from the 7th day of pregnancy, rats were
injected with LPS. 3-month-old male offspring were subjected to the
behavioural examination (the PPI test). Afterwards, rats were treated
with quetiapine for 14 days. The PPI test was performed again and
animals were sacriﬁced to dissect hippocampi and frontal cortices.
CX3CL1, CX3CR1, CD200 and CD200R levels were measured
using ELISA assays. The results of the PPI test showed disturbances
in the prepulse inhibition in LPS adult offspring. These changes
were normalized after 14-day injections of quetiapine. Prenatal
administration of LPS disrupted homeostasis of CX3CL1-CX3CR1
and CD200-CD200R systems in the examined brain areas and the
treatment with quetiapine had a normalizing effect on part of these
aspects. Prenatal exposure to lipopolysaccharide causes schizophre-
nia-related changes in adult offspring rats. The behavioural alter-
nations are followed by disturbances in the protein systems. The
antipsychotic drug – quetiapine exerts a positive effect on examined
aspects. Nevertheless, the matter raised in the presented summary
requires further research. Funding: grant no. 2015/19/B/NZ7/02394,
NCN, Poland.
MTU12-05
Alpha-synuclein oligomers enhance astrocyte-induced
synapse formation through TGF-b1 signaling in
parkinson’s disease model
L. Diniz, I. Matias, A. P. Bergamo, M. N. Araujo, F. B. Arag~ao, S. V.
Alves-Leon, J. M. de Souza, D. Foguel, C. P. Figueiredo, C. Braga,
L. Rom~ao, F. Gomes
UFRJ, Institute of biomedical sciences, Rio de Janeiro, Brazil
Parkinson’s disease (PD) is characterized by selective death of
dopaminergic neurons in the substantia nigra, nigrostriatal pathway
degeneration, increase of glutamatergic synapses in the striatum and
aggregation of a-Synuclein. Evidence suggests that oligomeric
species of a-Synuclein (aSO) are the genuine neurotoxins of PD.
Whereas several studies support the direct neurotoxic effects of aSO
on neurons, their effects on astrocytes have not been directly
addressed. Astrocytes are essential to several steps of synapse
formation and function, including secretion of synaptogenic factors,
control of synaptic elimination and stabilization, secretion of neuro-
gliomodulators, and modulation of extracellular ions and neuro-
transmitters levels in the synaptic cleft. Here, we showed that aSO
induce astrocyte reactivity and enhanced the synaptogenic capacity
of human and murine astrocytes by increasing the levels of the
known synaptogenic molecule, transforming growth factor beta 1
(TGF-b1). Moreover, intracerebroventricular injection of aSO in
mice increased the number of astrocytes, the density of excitatory
synapses, as well as TGF-b1 levels in the caudate-putamen of
injected animals. Inhibition of TGF-b1 signaling impaired the effect
of the astrocyte conditioned medium on glutamatergic synapses
in vitro and striatal synapse formation in vivo; whereas addition of
TGF-b1 protected dopaminergic neurons against synapse loss
triggered by aSO. Together, our data suggest that aSO have
important effects on astrocytic functions, and describe TGF-b1 as a
new endogenous astrocyte-derived molecule involved in the
increase of striatal glutamatergic synaptic density present in early
stages of PD.
MTU12-06
Unraveling the role of SUMOylation in peripheral
myelination
L. Frick1, Y. Poitelon2, V. Matafora3, A. Bachi3, L. Wrabetz1,
M. L. Feltri1
1University at Buffalo, HJKRI, Buffalo, USA
2Albany Medical College, DNET, Albany, USA
3Institute of Molecular Oncology Foundation, FIRC, Milano, Italy
The mechanisms that govern myelination in the peripheral
nervous system are not completely understood. Post-translational
modiﬁcations of proteins are necessary for peripheral myelination,
and malfunction of these pathways leads to neuropathies. Whether
SUMOylation, covalent attachment of Small Ubiquitin-like Modiﬁer
(SUMO) proteins to the substrate, is involved in the formation of
myelin and/or in the pathophysiology of peripheral neuropathies is
not known. We have recently identiﬁed SUMO2 as a novel protein
that may be involved in the early interaction between axons and
Schwann cells. In the pseudopod system, Schwann cells are cultured
on a porous surface, and stimulated to extend pseudopods towards a
neuronal membrane preparation. One of the proteins found in the
proteome of Schwann cell pseudopods is SUMO2, along with 10
immediate neighbors in the interactome. Using a prediction
algorithm, we evaluated which of the proteins found in the
pseudopods have SUMO interaction motifs (SIMs) and/or
SUMOylation sites. Interestingly over 85% of those proteins have
either SIMs or SUMOylation sites: 67% of proteins may be
SUMOylable, 58% of the proteins may interact with SUMO through
SIMs. Proteins involved in cytoskeleton organization represent the
major category of enriched proteins bearing SIMs and/or SUMOyla-
tion sites, and proteins related to regulation of cellular component
organization are the most signiﬁcantly enriched in pseudopods.
Pharmacological modulation of SUMOylation and gene targeting of
SUMO proteins affect myelination in vitro. Our current research is
focused on the role of SUMOylation, its substrates, and SUMO2 in
Schwann cell function and peripheral myelination. The discovery of
SUMO targets will contribute to understanding the mechanisms of
PNS development and demyelinating pathologies.
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MTU12-07
Circuit-specialized transcriptional control of astrocytes
contributes to learning and memory
A. Y.-S. Huang1,2, J. Woo2, D. Sardar2, B. Lozzi2, C.-C. J. Lin2,
D. Felice3, A. Paulucci4, B. Deneen1,2,3
1Baylor College of Medicine, Program in Developmental Biology,
Houston, USA
2Baylor College of Medicine, Center for Cell and Gene Therapy,
Houston, USA
3Baylor College of Medicine, Department of Neuroscience,
Houston, USA
4MD Anderson Cancer Center, Department of Genetics, Houston,
USA
Astrocytes are abundant in the brain with diverse functions that
contribute to brain homeostasis. However, whether astrocytes in
different regions of the brain exhibit specialized characteristics is
largely unknown. Here, in order to understand region-speciﬁc
transcriptional regulation of astrocytes, we knocked out NFIA, a
transcription factor pivotal to inducing gliogenesis, in four different
regions of the adult mouse brain. We found that NFIA regulated
great amount of genes in the hippocampus but only minimal amount
of genes in other brain regions. Loss of NFIA in adult astrocytes
resulted in aberrant morphology with fewer, shorter processes in the
hippocampus. NFIA-deﬁcient hippocampal astrocytes had reduced
proximity to neurons, impaired detection of neurotransmitters, and
reduced intracellular calcium activity. These astrocytic defects were
associated with impaired long-term potentiation (LTP) and learning/
memory deﬁcits in astrocytic NFIA knockout mice. Our ﬁndings
have identiﬁed the ﬁrst region-speciﬁc transcriptional mechanism
that regulates adult astrocyte morphology and function, and provide
further insight into the contribution of astrocytes to learning and
memory.
MTU12-08
New neurons reach and regenerate stroke-injured brain
tissue by clearing a path through glia
N. Kaneko1, V. Herranz-Perez2, T. Otsuka3, H. Sano3, N. Ohno4,3,
H. B. Nguyen3, T. Q. Thai3, A. Nambu3, Y. Kawaguchi3,
J. M. Garcıa-Verdugo2, K. Sawamoto1,3
1Nagoya City University Graduate School of Medical Sciences,
Department of Developmental and Regenerative Biology, Nagoya,
Japan
2Universidad de Valencia, Laboratory of Comparative
Neurobiology, Valencia, Spain
3National Institute for Physiological Sciences, Division of Cerebral
Circuitry, System Neurophysiology, Neurobiology and
Bioinformatics, and Neural Development and Regeneration,
Okazaki, Japan
4Jichi Medical University, Department of Anatomy, Shimotsuke,
Japan
New neurons are continuously generated by the neural stem cells
in the ventricular-subventricular zone (V-SVZ) even in the adult
brain. After brain injury, the immature new neurons (neuroblasts)
migrate toward the lesion. However, the ability of the mammalian
brain to regenerate neuronal circuits for functional recovery is quite
limited. By time-lapse imaging and immunohistochemistry using a
mouse model for ischemic stroke, we showed that neuroblast
migration is restricted by astrocytes, a major population of glial
cells, activated in response to tissue damage in and around the
lesion. To migrate through the meshwork of the astrocytic processes,
the neuroblasts secrete a diffusible protein Slit1 to disrupt the actin
cytoskeleton in reactive astrocytes that express its receptor, Robo2.
By enhancing the Slit1-Robo2 signaling, V-SVZ-derived neurob-
lasts transplanted into the post-stroke brain could migrate closer to
the lesion. Some of these cells matured into neurons possessing
morphological and electrophysiological properties of the striatal
projection neurons lost by stroke. They were efﬁciently integrated
into the neuronal circuit, resulting in functional recovery in the post-
stroke mice. These results suggest that the positioning of new
neurons is critical for functional neuronal regeneration in stem/
progenitor cell-based therapies for brain injury.
MTU12-09
The role of astrocytes in memory: focus on pattern
separation
C. Kramar, V. Ostapchenko, O. R. Ghosh-Swaby, V. Prado,
M. Prado, T. Bussey, L. Saksida
University of Western Ontario, Robarts Research Institute,
Department of Physiology and Pharmacology, Schulich School of
Medicine & Dentistry, London, Canada
Pattern separation (PS), a cognitive function thought to depend
on adult born neurons (ABNs) in the dentate gyrus (DG), involves
the transformation of representations of distinct features into unique,
less overlapping representations, helping to minimize memory
interference. As it has recently been shown that astrocytes play a
leading role in helping ABNs to integrate and function in DG
networks, we hypothesized that astrocytes themselves could play a
role in regulating PS. We manipulate astrocytes by expressing
excitatory DREADDs speciﬁcally on astrocytes by crossing
GlastcreERT2-mice with ﬂoxed hM3-Gq-DREADD-mice. We surgi-
cally implant cannulas into the DG of each mouse, allowing us to
directly inject clozapine-n-oxide (CNO), or vehicle. We conﬁrm the
expression and co-localization of DREADDs on astrocytes, and a
lack of DREADDs expression on ABNs or mature neurons. We also
validated the functionality of the DREADDs by performing in vitro
experiments with astrocytic cultures from these animals and
measuring Ca+ levels after CNO induction. We have two main
approaches for the study of PS: Spontaneous Location Recognition
(SLR); and the touchscreen-based Location Discrimination (LD)
task. These tests are the same ones used to reveal a role for ABNs in
PS. We found that activation by CNO of the excitatory Gq-
DREADDs on the astrocytes of the DG region improved PS
performance in both the SLR and LD tasks.
The ﬁnding that selective astrocyte manipulation can robustly
and selectively improve memory function provides compelling
evidence for the importance of astrocytes in cognition, and
introduces astrocytes as a novel target for intervention in neurode-
generative and neuropsychiatric diseases affecting memory.
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MTU12-10
Speciﬁc deletion of neuronal MCT2 or astrocytic MCT4
disturbs the hippocampus-dependent acquisition of
information
C. Netzahualcoyotzi, L. Pellerin
University of Lausannne, Department of Physiology, Lausanne,
Switzerland
The astrocyte-neuron lactate shuttle (ANLS) hypothesis proposes
that neuronal glutamatergic activity leads in astrocytes to a large
increase in the production of lactate, which is released in the
extracellular space through the monocarboxylate transporter 4
(MCT4) to be taken by neurons via MCT2 and used as an energy
substrate to sustain neurotransmission. Lactate released by astro-
cytes has been suggested to be necessary for working memory.
Further, it was demonstrated that MCT1, 2 and 4 are required for the
formation of a non-spatial, long-term (24 h) memory and in the
expression of plasticity genes. In the present work, we used for the
ﬁrst time the Cre-lox technology to induce the speciﬁc deletion of
MCT2 in neurons and MCT4 in astrocytes of the dorsal hippocam-
pus to evaluate their requirement for different behavioral tasks. Our
results show that the deletion of either MCT2 or MCT4 does not
alter innate behavior, but only the acquisition of new information.
The short-term storage of information was normal, but long-term
memory was signiﬁcantly affected. However, if the exposition to the
new information (training) is sufﬁciently repeated, it is possible to
ﬁnally acquire the data and their retrieval in such case is normal. Our
results suggest that lactate transport is a critical step in the
acquisition of new information, either in the astrocytes or in the
neurons. This could be related to the metabolic coupling proposed
by the ANLS. Our data also indicate that intense training sessions
can induce compensatory responses to overcome MCT deﬁciencies.
Hence, we propose that the ANLS facilitates the acquisition of new
hippocampus-dependent information.
MTU12-11
Volume electron microscopy of the white matter in the
hereditary demyelinating disease model
N. Ohno1,2, T. Q. Thai2, H. B. Nguyen2, Y. Sui2, K. Ikenaka2
1Jichi Medical University, Department of Anatomy, Shimotsuke,
Japan
2National Institute for Physiological Sciences, Division of
Neurobiology and Bioinformatics, Okazaki, Japan
The connections of neurons are dependent on axons, long
neurites which are enriched in the white matter. Many of the axons
are ensheathed in the white matter by myelin, and the myelin
ensheathment divides axons into structurally and functionally
distinct domains. Myelin supports salutatory conduction and
maintenance of axonal integrity. Volume electron microscopic
imaging of the white matter has recently started providing structural
information for the better understanding of physiology and pathol-
ogy of the white matter. For example, the distribution and
morphology of organelles in axons were changed by demyelination
in the white matter, and it was suggested that such alterations are
beneﬁcial for axonal functions and survival. Among them, mito-
chondria associated membranes (MAM), physical connections
between mitochondria and endoplasmic reticulum, are critical for
cellular functions such as Ca2+ signaling, lipid transport. Disruption
of the connection has been implicated in mitochondrial dysfunction,
which has been proposed as a major contributor of axonal
degeneration in diseases of myelin. However, the changes and roles
of these juxtapositions are still unclear in demyelinated axons. In
this study, we investigated three-dimensional ultrastructural changes
of axonal MAM in chronic demyelination, using the serial block-
face scanning electron microscopy and a mouse model of chronic
demyelination caused by extra-copies of proteolipid protein. The
results suggest that modulations of MAM as well as mitochondria
are caused by chronic loss of myelin, and that such organelle
changes are involved in the pathophysiology of hereditary myelin
diseases.
MTU12-12
NG2 GLIA-speciﬁc KIR4.1 knockout as a tool to
understand the impact of neuron-glia synaptic signaling
G. Seifert1, A. Timmermann1, A. Boehlen1, M. Skubal1, A. Bilkei-
Gorzo2, A. Zimmer2, R. Jabs1, F. Kirchhoff3, C. Steinh€auser1
1University of Bonn, Institute of Cellular Neurosciences, Bonn,
Germany
2University of Bonn, Institute of Molecular Psychiatry, Bonn,
Germany
3University of Saarland, Molecular Physiology, CIPMM, Homburg,
Germany
NG2 glia in grey matter receives direct synaptic input from
glutamatergic and GABAergic neurons. During development, NG2
glia upregulate Kir4.1 channels. To test if Kir currents regulate the
efﬁciency of synaptic activation of NG2 glia, we used NG2-
CreERT2 knock-in mice to selectively ablate the Kir4.1 gene upon
tamoxifen administration.
Mutant NG2 glia, deﬁcient of Kir currents, displayed a more
positive resting potential and increased membrane resistance in
comparison to control NG2 glia. Monitoring responses upon
Schaffer collateral stimulation revealed similar EPSC amplitudes
in Kir-deﬁcient NG2 glia compared to control cells. Moreover,
mEPSP amplitudes were enhanced and the time constant of voltage
decay was prolonged in Kir4.1 deﬁcient glial cells. To investigate
the impact of Kir4.1 deletion in NG2 glia on neural signaling, ﬁeld
potentials were recorded in the hippocampus after stimulation of
Schaffer collaterals. Long term potentiation (LTP), induced by theta-
burst stimulation, was signiﬁcantly impaired in the hippocampal
CA1 region of mice with NG2 glia-targeted Kir4.1-deﬁciency.
Despite impaired LTP, Kir4.1-deﬁcient mice showed increased
novelty preference in the object location recognition test, and
improved new partner preference in the partner recognition test. In
the hippocampus, NG2 glia-targeted deletion of the Kir4.1 gene
entailed an upregulation of MBP protein 8 weeks after tamoxifen
injection. These ﬁndings show that Kir4.1 channels in NG2 glial
cells regulate their excitability, inﬂuence myelination and are
important for proper hippocampal synaptic plasticity and behavior.
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MTU12-13
Muscarinic acetylcholine receptors regulate the
expression of KIR4.1 channels and BDNF in cultured
mouse astrocytes
S. Shimizu1, M. Kinboshi1,2, Y. Nakamura1, N. Oda1, A. Ikeda2, Y.
Ohno1
1Osaka University of Pharmaceutical Sciences, Department of
Pharmacology, Osaka, Japan
2Kyoto University, Department of Epilepsy, Movement Disorders
and Physiology, Graduate School of Medicine, Kyoto, Japan
Astrocytes are the most abundant glial cells and regulate neuronal
excitability by maintaining ion homeostasis, metabolizing neuro-
transmitters and secreting neuroactive substances. Recent evidence
illustrates that astrocytic brain-derived neurotrophic factor (BDNF)
expression is speciﬁcally modulated by inwardly rectifying potas-
sium (Kir) channel subunit Kir4.1 channel, which mediate the
spatial potassium buffering function of astrocytes (Front. Mol.
Neurosci., 10, 408, 2017; Int. J. Mol. Sci., 19, 3313, 2018). In the
present study, we investigated the effects of acetylcholinergic agents
on mRNA expression of Kir4.1 and BDNF in primary cultured
mouse astrocytes in order to explore the neural factors inﬂuencing
on the Kir4.1-BDNF system. Treatment of astrocytes with acetyl-
choline (ACh, 3-30 μM) signiﬁcantly inhibited Kir4.1 expression
and increased BDNF expression in a concentration-related manner.
Both inhibition of Kir4.1 and enhancement of BDNF expression by
ACh (10 μM) were antagonized by muscarinic ACh receptor
antagonist atropine (3 μM), however, the nicotinic ACh receptor
antagonist mecamylamine (30 μM) showed no effects. In addition,
inhibition of Kir4.1 expression by ACh was signiﬁcantly antago-
nized by the selective muscarinic ACh M1 antagonist pirenzepine
(10 μM), which also inhibited acetylcholine-enhanced BDNF
expression. The present results strongly suggest that ACh inhibits
Kir4.1 channel expression and increases BDNF expression via
activation of muscarinic ACh M1 receptor in astrocytes.
MTU12-14
Anti-inﬂammatory effect of carbon monoxide on the
neuron-microglia communication
N. Soares1, C. Queiroga1, H. Vieira1,2
1CEDOC - NOVA Medical School, Universidade NOVA de Lisboa,
Cell Death and Disease, Lisbon, Portugal
2Instituto de Biologia Experimental e Tecnologica, iBET, Oeiras,
Portugal
Microglia, the ‘resident immunocompetent cells’ of the central
nervous system (CNS), are key players in innate immunity and
tissue homeostasis. However, dysfunctional microglia contributes
heavily to the creation of a toxic inﬂammatory milieu, a common
driving force for the pathophysiology of several CNS disorders.
Thus, strategies have been postulated to tackle exacerbated tissue
inﬂammation by modulation of microglial function. Carbon monox-
ide (CO) is an endogenous gaseous molecule, produced by the
degradation of free haem. Long considered a catabolic waste
product, it has now emerged as a player in neurobiology, having
shown neuroprotective properties in in vivo and in vitro models. We
aimed at studying CO as a modulator of microglial reactivity,
focusing on its communication with neurons by limiting inﬂamma-
tion and consequently providing neuroprotection. For this, we used a
BV2 microglia-CAD neuron cell line conditioned media protocol.
Treating LPS-activated BV2 microglia with CO limited expression
and secretion of inﬂammatory cytokines (TNF-alpha, NO). Neurons
subsequently challenged with inﬂammatory media displayed high
cell death and dysfunction levels. This is partially reverted whenever
microglia is pre-treated with CO, indicating the gas promotes
neuroprotection in a non-cell autonomous mode. Likewise, CO
stimulated the expression of neuronal glycoprotein CD200 and its
microglial receptor CD200R1 via PPAR-c transcription factor. The
CD200-CD200R1 axis is involved in the ﬁne regulation of
microglial function, and we are elucidating how CO-driven
modulation of this tight contact alters cell function, fate and
homeostasis. Altogether, this is a stepping stone to understand CO’s
impact on novel cell-cell regulatory mechanisms.
MTU12-15
Retinal inputs signal through astrocytes to recruit
interneurons into mouse visual thalamus
R. D. Somaiya1, J. Su1, N. Charalambakis2, A. Monavarfeshani1,
U. Sabbagh1, W. Guido2, M. Fox1
1Virginia Tech, Fralin Biomedical Research Institute, Roanoke,
USA
2University of Louisville , Anatomical Sciences and Neurobiology,
Louisville, USA
The lateral geniculate complex includes a number of retinore-
cipient thalamic nuclei that play important roles in receiving,
processing, and relaying image- and non-image forming visual
information. Recent studies have revealed that neonatal innervation
of these regions by retinal ganglion cell axons play an instructive
role in the postnatal development and maturation of thalamic
circuits. For example, surgical or genetic removal of retinal inputs at
birth impairs the recruitment of local GABAergic interneurons into
visual thalamus. Here we sought to identify the mechanisms that
underlie retinal input-dependent interneuron migration into visual
thalamus. Focusing on this, we ﬁrst explored transcriptomic changes
in neonatal mouse visual thalamus lacking retinal input. Using
microarray analysis and in situ hybridization (ISH), we discovered
that the expression of Fibroblast Growth Factor 15 (FGF15) in
visual thalamus is dependent upon the retinal inputs. To test whether
FGF15 was required for interneuron recruitment into visual
thalamus, we examined thalamic development in Fgf15-/- mutant
mice. In these mutants, we observed a signiﬁcant reduction in
GABAergic interneurons both by ISH and by crossing these mutant
mice to Gad67-GFP reporter mice. We hypothesized that retinal
inputs induced FGF15 expression in retinorecipient neurons. To test
this, we performed ISH to detect Fgf15 mRNA in reporter mice that
label distinct populations of cells in visual thalamus. Surprisingly,
our data revealed that FGF15 is generated by thalamic astrocytes
and not neurons, suggesting a novel role for astrocytes in thalamic
development. Taken together, these results suggest the existence of
novel axon-glia-neuron signaling pathway that underlies subcortical
visual circuit formation.
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MTU12-16
High fat diet promotes cognitive impairment,
neuroinﬂammation and decreased hippocampal
plasticity: role of microglial exosomes
A. Vinuesa1, M. Bentivegna1, G. Calfa2, F. Filipello3, C. Pomilio1,
A. Gregosa1, J. Presa1, M. Matteoli3, J. Beauquis1, F. Saravia1
1Institute of Biology and Experimental Medicine IByME, Biological
Chemistry, Buenos Aires, Argentina
2IFEC-CONICET, Pharmacology, Cordoba, Argentina
3Humanitas Clinical and Research Center, Pharmacology, Milan,
Italy
Western dietary habits including high fat foods are increasingly
represented in juvenile populations, and constitute one of the factors
that affect brain health, potentially leading to long lasting effects.
The aim of this study was to assess the impact of an early exposure
to a high fat diet (HFD) on mouse hippocampal plasticity. C57BL/6J
male mice were exposed to HFD for 6 weeks since weaning.
Glucose and IL1b levels were found to be higher in serum of HFD
mice, without overweight. In the hippocampus, neuroinﬂammation
was evidenced by Iba1+ cells reactivity and increased expression of
TNFa and IL1b in HFD group, which also exhibited a strongly
reduced neurogenic capability: decreased Ki67+ cells and immature
DCX+ neurons in the SGZ of the dentate gyrus. We also found a
reduced proportion of mature Dil-labeled dendritic spines from CA1
neurons and diminished levels of the scaffold protein Shank2,
suggesting a defective connectivity. Moreover, HFD mice exhibited
spatial memory alterations in the novel object location recognition
test. To study whether microglia could be mediating HFD-
associated neuronal changes, primary microglia was incubated with
palmitate, a saturated fatty acid present in HFD. Palmitate induced a
proinﬂammatory proﬁle as shown by secreted cytokine levels and
exosome-like extracellular vesicles that were able to induce an
immature dendritic spine phenotype in primary GFP+ hippocampal
neurons, in line with the in vivo ﬁndings. These results provide
novel data concerning microglia-neuron communication and high-
light that fat excess during an early period of life could negatively
impact on hippocampal plasticity in a neuroinﬂammatory context,
where microglia-derived exosomes could be directly implicated.
MTU12-17
Astrocytic insulin-like growth factor-1 protects neurons
against excitotoxicity
P. Zheng, B. He, W. Tong
Shanghai Pudong New area People’s Hospital, Neurosurgery,
Shanghai, China
Background: Exogenous insulin like growth factor-1 (IGF-I) is
known to be neuroprotective in animal models with brain insults,
while it can also cause hyperexcitability in rodents. In this regard,
the role of endogenous IGF-1 in brain responses to brain insults like
excitotoxicity, a common pathology in brain injuries remains
elucidated. Here, we investigated the potential role of cell-speciﬁc
endogenous IGF-I in the kainic acid (KA) -induced degeneration of
the neurons.
Methods: KA was given to primary cultured cortical neurons and
co-cultured astrocytes were added as a supportive system. We
evaluated the cell proliferation rate, IGF-1 level in different groups
and applied the PCR-Chip assay to explore the downstream of IGF-
1. In addition, we applied the viral transfer of astrocytic IGF-1 to
rodents treated with KA and assessed the associated molecular
marker and behavioural outcomes in these rodents.
Results: We found KA induced increased cell death and hyper-
phosphorylated tau in neurons; co-cultured astrocytes could prevent
these pathologies, and this rescuing effect was abrogated with
blockade of the astrocytic IGF-1 with AG1024 (IGF-1R inhibitor).
PCR-Chip assay identiﬁed that astrocytic IGF-1 could decrease the
p-GSK-3 at Thy 216 in neurons treated with KA and this effect was
abrogated with AG1024 as well. In addition, in vivo study showed
that gene transfer of astrocytic IGF-1 decreased p-tau and cognitive
dysfunction in KA mice.
Conclusion: Our results show astrocytic IGF-1 exhibit neuropro-
tective properties in neurodegenerative processes in the CNS.
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MTU13-01
Identiﬁcation of the antigen recognized in vitro by
RHIGM22, a remyelination-promoting human monoclonal
antibody
L. Cabitta1, S. Grassi1, S. Prioni1, L. Mauri1, M. G. Ciampa1,
Y. Zorina2, S. Sonnino1, A. Prinetti1
1Universita di Milano, Dipartimento di biotecnologie mediche e
medicina traslazione, Segrate, Italy
2Acorda Therapeutics, Inc, Ardsley, NY, USA
Recombinant human IgM22 (rHIgM22) binds to myelin and
oligodendrocytes (OLs), and promotes remyelination in models of
multiple sclerosis. rHIgM22 preferentially reacts with sulfatide-
positive (O4+) OLs, and its binding is abolished in brain slices from
Cst (-/-) mice, suggesting its binding requires the presence of a
product of cerebroside sulfotransferase. However, literature suggests
that cell populations lacking sulfatide expression, such as microglia
and oligodendrocyte precursor cells, are responsive to rHIgM22,
thus the identity of the antigen recognized by this antibody remains
to be elucidated.
We tested the binding of rHIgM22 to puriﬁed lipids and lipid
extracts from various sources using TLC immunostaining and
surface plasmon resonance (SPR) with lipid monolayers. Our results
show that IgM22 binds to sulfatide and lysosulfatide in vitro, while
it does not bind to other myelin sphingolipids. In addition, rHIgM22
also reacts with phosphatidylinositol, phosphatidylserine and phos-
phatidic acid, present in lipid extracts from various sources,
including CST ko mice brains, mixed glial cultures, isolated
astrocytes and microglia.
These data suggest that sulfatide at the OLs surface might be
important for the binding of rHIgM22 to these cells. On the other
hand, its ability to bind some glycerophospholipids could explain
the biological responses elicited by rHIgM22 in cells lacking
sulfatide expression. The in vitro reactivity of rHIgM22 suggests
that binding of rHIgM22 to intact cells might require a complex
molecular arrangement, and, in particular, sulfatide and other
membrane lipids might be part of the functional rHIgM22 antigen
localized at the cell surface.
MTU13-02
Gender-speciﬁc changes to sphingolipid metabolism may
sensitise the aging brain to neurodegeneration and
Alzheimer’s disease
T. Couttas1,2, N. Kain2, C. Tran1,2, Z. Chatterton1,2,3, J. Kwok3,
A. Don3
1The Centenary Institute, Lipid Metabolism and Neurochemistry
Laboratory, Sydney, Australia
2UNSW Sydney, Prince of Wales Clinical School, Sydney, Australia
3Sydney University, Sydney Medical School, Sydney, Australia
The major risk factors associated with Alzheimer’s disease (AD)
are age and inheritance of the e4 allele of the APOE gene, which
encodes the lipid transporter protein, Apolipoprotein E (ApoE). This
suggests a key involvement of lipid transport and metabolism in AD.
Sphingolipids, are a class of lipids that exhibit alterations at the
prodromal stages of AD, in both brain tissue and serum. Our study
investigated sphingolipids as a function of age and APOE genotype in
neurologically normal subjects, aged 65 and over. Lipids were
quantiﬁed from the hippocampus of post-mortem tissue (n = 80) using
mass spectrometry. Signiﬁcant changes to sphingolipids were
observed as a function of age, and were gender-speciﬁc. Females
had a pronounced decline in the sphingosine-1-phosphate:sphingo-
sine ratio (p = 0.0020). In contrast, males exhibited increases in
ceramides, sulfatide and sphingomyelin (p < 0.005). No association
between lipids and APOE genotype was identiﬁed. Previous literature
has demonstrated AD is associated with a decline in cerebral glucose
utilisation, potentially caused by a loss of insulin receptors at synaptic
membranes of the cerebral cortex and hippocampus. Ceramide is a
pro-apoptotic lipid implicated as a driver of of insulin resistance in
metabolic tissue, whereas S1P is associated with increased glucose-
stimulated insulin secretion. In the age of precision medicine, there is
a need to discern whether risk factors and etiology of AD differs
between genders. Our results establish gender-speciﬁc differences in
sphingolipid metabolism in the aging human brain, which may
contribute to a pro-neurodegenerative phenotype.
MTU13-03
Correlation of plasma omega fatty acid index with alpha
power during working memory in acute mild traumatic
brain injury
A. Fonteh1, X. Arakaki1, K. Csator1, E. Amini2, S. Thomas3,
R. Goldweber3, M. Harrington1
1Huntington Medical Research Institutes, Neurosciences, Pasadena,
USA
2USC, Marshall School of Business, Los Angeles, USA
3HMH, Emergency Department, Pasadena, USA
We explored the relationship between alpha power during
working memory (WM) processing and the plasma levels of n-3/
n-6 polyunsaturated fatty acids (PUFA) in acute mTBI to understand
mechanisms and to discover biomarkers of injury. Brain challenges
using 0-back and 2-back WM tests were administered within 5 days
post-injury with simultaneous electroencephalography (EEG) from
21-head sensors. Plasma unesteriﬁed and esteriﬁed PUFAs were
quantiﬁed using gas chromatography/mass spectrometry. The pro-
portions of n-3, n-6, the n-3/n-6 ratio, and the n-3 index were
determined and correlated with alpha power for all six brain regions.
Esteriﬁed n-6 PUFAs negatively correlated with 0-back alpha wave
power in the frontal, left temporal, and occipital brain regions while
unesteriﬁed n-3 negatively correlated with the central brain region of
mTBI participants. Esteriﬁed n-3/n-6 ratio positively correlated with
0-back alpha power of all six brain regions while esteriﬁed n-6
negatively correlated with 2-back alpha power of all brain regions.
In contrast, the esteriﬁed n-3/n-6 ratio positively correlated with 2-
back alpha power in all six brain regions. N-3 and n-6 fatty acids did
not correlate with alpha power in the controls. Our studies reveal
brain region-speciﬁc correlations of 0-back and 2-back alpha
frequency with plasma PUFAs in acute mTBI, but not in controls,
suggesting that changes in plasma omega-3/6 proﬁle underlie
abnormal brain functions during WM challenge at the early phase of
mTBI. Therefore, restoring the n-3 PUFA index may enhance
prognosis by normalizing alpha power disturbance in mTBI.
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Neuroprotective sphingosine 1-phoshate is essential for
amyloid formation, oligodendrocyte survival and
cognitive function in AD
M. Lei1, J. Teo1, T. Couttas1, L. Ittner2, A. Ittner2, T. Karl3, A. Don1
1Centenary Institute, The University of Sydney, ACRF,
Camperdown, Australia
2UNSW, School of Medical Sciences, Kensington, Australia
3Western Sydney University, School of Medicine, Campbelltown,
Australia
Sphingosine 1-phosphate (S1P) is a potent vasculo- and neuro-
protective signalling lipid that promotes neurotrophic growth factor
expression and pre-synaptic acetylcholine and glutamate release.
S1P is synthesized primarily by sphingosine kinase 2 (SphK2) in the
brain. We recently demonstrated pronounced loss of S1P, and
SphK2 activity, early in Alzheimer’s disease (AD) pathogenesis.
Using human female hippocampal tissue samples from neuropatho-
logically normal donors, we recently showed that S1P levels decline
with age (r = -0.5, p = 0.002), leading us to speculate that loss of
S1P sensitizes to AD development. To test whether SphK2
deﬁciency synergises with amyloid beta (Ab) in promoting AD,
SphK2 knockout (SphK2-/-) mice were crossed to the J20 mouse
model of familial AD amyloidosis.
Suprisingly, SphK2 deﬁciency reduced Ab content, plaque
burden and reactive astrocyte immunoreactivity in J20 mice.
Reduced Ab was associated with signiﬁcant improvements in
hypersynchronous activity and cross-frequency coupling measured
by hippocampal electroencephalography. Despite reduced amyloid
burden, SphK2-deﬁcient J20 mice exhibited severe hypomyelination
in the hippocampus and cortex, hippocampal atrophy and signiﬁcant
deﬁcits in the Y-maze and social novelty memory tests, when
compared to the J20 or SphK2-/- strains.
In summary, endogenous S1P, synthesized by SphK2, is reduced
with ageing and AD pathogenesis, yet required for Ab formation.
However, memory deﬁcits and myelin loss and hippocampal
volume in J20 mice were exacerbated on a SphK2-/- background,
indicating that age-dependent SphK2 depletion promotes neurode-
generation and urging consideration of oligodendrocyte attenuation
as a potential enforcer of neurodegeneration in AD.
MTU13-05
Evidence that human glioma cells form pregnenolone via
a CYP11A1-independent pathway
Y. C. Lin, V. Papadopoulos
University of Southern California, Department of Pharmacology &
Pharmaceutical Sciences, Los Angeles, USA
The term “neurosteroids” refers to steroid hormones, such as
pregnenolone, synthesized and acting in brain. In peripheral
steroidogenic tissues, pregnenolone is formed from cholesterol by
the cytochrome P450 11A1 enzyme. This conversion involves two
hydroxylations at C22 and C20 of cholesterol followed by cleavage
of the side chain between C20-22 to form pregnenolone and
isocaproic aldehyde. Although pregnenolone is found in the brain,
protein expression of CYP11A1 has been difﬁcult to detect. We
found extremely low levels of CYP11A1 mRNA in human glioma
cells but no protein expression. Therefore, we investigated the
ability of human glioma cells to synthesize pregnenolone in a
CYP11A1-independent manner. Unlike testicular and adrenal
cortical cells, treatment of glioma cells with the CYP11A1 inhibitor
DL-aminoglutethimide or the non-speciﬁc CYP inhibitor ketocona-
zole did not inhibit pregnenolone production by glioma cells.
Pregnenolone synthesis can be increased with addition of the
substrates 22R-, 22S-, and 20a-hydroxycholesterols suggesting the
involvement of a desmolase activity although the enhanced
pregnenolone formation was not blocked by DL-aminoglutethimide
or ketoconazole. These data suggest that glioma cells can produce
pregnenolone independently of CYP11A1 activity. CYP enzymes
are monooxygenases generating free radicals, so we examined
whether this alternative pathway involves reactive oxygen species
(ROS). Although high doses of DL-aminoglutethimide and keto-
conazole increased pregnenolone production by glioma cells, only
ketoconazole increased cellular ROS. Addition of the antioxidant
Trolox, an analog of vitamin E, did not change pregnenolone
production despite blocking ketoconazole’s effect on increasing
cellular ROS. Treatment with hydrogen peroxide also did not have a
signiﬁcant effect on pregnenolone production. Taken together these
results suggest that human glioma cells form pregnenolone via a
CYP11A1- and ROS-independent pathway.
MTU13-06
Hexa-associated GM2 gangliosidosis in a family of wild
boars
S. Prioni1, L. Cabitta1, S. Grassi1, S. Sonnino1, V. Bertani2, A. M.
Cantoni2, A. Corradi2, V. Jagannathan3, C. Dr€ogem€uller3
1University of Milan, Dep. of Medical Biotechnology and
Translational Medicine, Milano, Italy
2University of Parma, Department of Veterinary Science, Parma,
Italy
3University of Bern, Institute of Genetics, Vetsuisse Faculty, Bern,
Switzerland
Gangliosidosis are inherited lysosomal storage disorders caused
by defective activity of a lysosomal hydrolase required for
ganglioside catabolism, resulting in the intra-lysosomal accumula-
tion of undegraded metabolites. The molecular mechanisms linking
the lysosomal accumulation to the pathology are still obscure. We
report on a novel form of GM2 gangliosidosis in wild boar (Sus
scrofa). Three littermate wild boards, from a free ranging farm,
presented neurological signs (dysmetria, ataxia, quadriplegia and
lateral decubitus) at 6 months of age. Viral, bacterial and toxico-
logical analysis were performed to exclude possible exogenous
causes of symptoms. Animals were euthanized at approximately one
year of age. Necropsy revealed in all affected animals reduced
consistency of cerebral and cerebellar parenchyma. Histology
revealed enlarged foamy neurons, with diffusely severely vacuolated
cytoplasm in brain, cerebellum, spinal cord, peripheral ganglia and
retina. EM revealed the presence in neurons of numerous lysosomes,
ﬁlled by membranous material. Biochemical studies revealed the
presence of an elevate amount of GM2 ganglioside, conﬁrming the
diagnosis of GM2 gangliosidosis. In addition, genetic analysis
revealed the presence of a recessively inherited missense variant
(p.Arg499Cys) in the hexosaminidase subunit alpha (HEXA) gene
located within the GH20 hexosaminidase superfamily domain of the
encoded protein. In man and other species, pathogenic HEXA
variants are known to be associated with the disease. In conclusion,
this HEXA-associated form of GM2 gangliosidosis, described for
the ﬁrst time in wild boars, is thus very similar to human disease.
© 2019 The Authors
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MTU14-01
Expression of FMRFamide and GFSKLYFamide peptides
in holothuria scabra: Implication for the neuroendocrine
system
A. Ajayi1, B. Withyachumnarnkul2
1Kogi State University, Anatomy, Anyigba, Nigeria
2Mahidol University, Anatomy, Bangkok, Thailand
Neuropeptides are key mediators of physiological processes in
animals and a considerable amount of information has been
accumulated on their diversity and functions across phyla.
FMRFamide-related peptides are a large collection of neuropeptides
found in invertebrates and vertebrates. They are identiﬁed by the
possession of a C-terminal -RFamide amino acid sequence and are
often coded for by multiple genes. Echinoderms are of phylogenetic
importance to chordates in that they are deuterostomes. The sea
cucumber, Holothuria scabra is a high-premium tropical echino-
derm species that is overexploited globally and may be in imminent
danger of extinction in some areas. Conservation of this species and
its amenability to culture is however hampered by our limited
knowledge of its biology, including the neurohormonal system. In
this study, FMRFamide peptide, a cardioactive neuropeptide ﬁrst
isolated in a mollusk and GFSKLYFamide peptide, an Echinoderm
SALMFamide were investigated for their presence in H. scabra. We
used indirect immunoﬂuorescence technique with confocal micro-
scope and dot immunoblot assay utilizing polyclonal antisera raised
against FMRFamide and GFSKLYFamide peptides. Both FMRFa-
mide- and GFSKLYFamide-immunoreactivity were demonstrated to
be widely distributed in H. scabra tissues, such as the radial nerve
cord, body wall, intestines and coelomic ﬂuid. This underscores the
potential physiological roles of these peptides, which might be
working as neurotransmitters and neuromodulators in this species.
MTU14-02
Promoting endogenous photoreceptor regeneration in the
mammalian retina
C. Boudreau-Pinsonneault1, M. Fries3,2, A. Javed3,2,
M. Cayouette2,3,1
1McGill University, Department of medicine, Montreal, Canada
2Institut de recherches cliniques de Montreal, Cellular
neurobiology, Montreal, Canada
3Universite de Montreal, Department of medicine, Montreal,
Canada
Regenerating the retina using endogenous stem cells is a
promising therapy for vision restoration. While ﬁsh M€uller glial
cells (MG) can regenerate the retina, this natural ability was lost in
mammals. Recently, however, some genetic manipulations in mouse
MG were found to trigger neuron production, but it remains
unknown whether MG can generate cone photoreceptors, which are
essential for high acuity vision. Interestingly, MG have a similar
gene expression proﬁle to late-stage retinal progenitors, and our
previous work identiﬁed temporal identity factors that can repro-
gram late progenitors to produce early-born cones. We hence
hypothesized that these factors might reprogram MG into cone-
producing progenitors. We co-electroporated Cre-dependent
constructs into GlastCreERT;RosaYFPﬂ/ﬂ retinal explants, which
express CreERT speciﬁcally in MG, allowing expression of genes of
interest and cell lineage tracing with the YFP reporter. Of the 21
combinations tested, one was able to reprogram MG into immature
cones. MG-derived cells migrated to where cones normally reside,
downregulated glial markers, started expressing the cone marker
RxRg and adopted a cone-like morphology. These factors were also
sufﬁcient to reprogram MG to immature cones in vivo in the adult
mouse retina, and into more mature cones under certain culture
conditions. It remains to be determined whether these cells are
functional, but this work suggests that stimulating cone production
from endogenous glia might represent a new therapeutic opportunity
for retinal degeneration.
MTU14-03
Inner hair cell and neuron degeneration contribute to
hearing loss in a DFNA2-like mouse model
C. Carignano1, E. Barila1, E. Rıas1,2, L. Dionisio1,2, E. Aztiria1,2, G.
Spitzmaul1,2
1Instituto de Investigaciones Bioquımicas de Bahıa Blanca , INIBIBB,
Bahıa Blanca, Argentina
2Universidad Nacional del Sur UNS, Departamento de Biologıa,
Bioquımica y Farmacia (DBByF), Bahıa Blanca, Argentina
DFNA2 is a progressive deafness caused by mutations in the
voltage-activated potassium channel KCNQ4. Hearing loss develops
with age from a mild increase in hearing threshold to profound
deafness. The ﬁrst phase starts around 10-15 years old, progressing
to the last phase by the age of 70. Studies using transgenic mice for
Kcnq4 expressed in a mixed background demonstrated the impli-
cation of outer hair cells (OHCs) at the initial phase. However, it
could not explain the last phase mechanisms of the disease. Genetic
backgrounds are known to inﬂuence disease expressivity. To
unmask the cause of profound deafness phenotype, we backcrossed
Kcnq4 knock-out allele to the inbred strain C3H/HeJ and investi-
gated inner and outer hair cell and spiral ganglion neuron (SGN)
degeneration across lifespan. In addition to the already reported
OHC death, C3H/HeJ strain also exhibited inner hair cell (IHC) and
SGN death. We tracked the spatiotemporal survival of cochlear cells
by plotting cytocochleograms and neuronal counts at different ages.
Cell loss progressed from basal to apical turns with age for both hair
cells. Interestingly, the time-course of cell degeneration was
different for each cell-type. While for OHCs it was already present
by week 3, IHC and neuronal loss started 30 weeks later. We
established that OHC loss kinetics slowed down from basal to apical
regions correlating with KCNQ4 expression pattern determined in
wild-type mice. Our ﬁndings indicate that KCNQ4 plays differential
roles in each cochlear cell-type impacting in their survival ability.
IHC and SGN neuron death generates severe hearing loss that could
be associated to the last phase of DFNA2.
156 Journal of Neurochemistry © 2019 International Society for Neurochemistry, J. Neurochem. (2019) 150 (Suppl. 1), 73--161
© 2019 The Authors
MTU14-04
Copper uptake and toxicity in cerebellar granular neurons
after application of copper ions or copper oxide
nanoparticles
K. Faber1,2, R. Dringen1,2
1University of Bremen, Center for Biomolecular Interactions
Bremen, Bremen, Germany
2University of Bremen, Center for Environmental Research and
Sustainable Technology, Bremen, Germany
Copper is essential for brain cells as cofactor of various enzymes.
Nonetheless, disturbances of copper homeostasis are known to cause
oxidative stress and neurological disorders. However, there is only
little known on copper uptake and metabolism in neurons. To
investigate copper uptake in neurons we have used cerebellar
granule neuron-rich primary cultures as model system. The low
basal copper content increased strongly after application of copper
chloride in a time and concentration-dependent manner, reaching
values of up to 40 nmol copper per mg protein after exposure to
100 μM copper chloride for 30 min. Exposure of neurons to copper
chloride in the presence of ascorbate increased cellular copper
contents more than 7 times which was accompanied by severe
toxicity. Correlation of cellular copper contents with cell viability
revealed that speciﬁccopper values of above 30 nmol copper per mg
protein were accompanied with a strong loss in cell viability. Copper
accumulation and copper-induced toxicity was prevented by the
application of the copper chelators bathocuproine disulfonate and
tetrathiomolybdate, whereas the application zinc ions, known copper
transport competitors, did not lower neuronal copper uptake.
Comparison of neuronal copper accumulation after application of
copper chloride or copper oxide nanoparticles showed that cellular
copper contents after incubation with 100 μM copper chloride was
33 % lower than after incubation with the same concentration of
copper oxide nanoparticles. These results demonstrate that copper
uptake in neurons is prevented by copper chelators and accelerated
by ascorbate which leads to an imbalance of cellular copper
homeostasis that severely damages neurons. Moreover, copper
accumulation was also observed after application of copper oxide
nanoparticles but the mechanisms involved in the uptake need to be
further elucidated.
MTU14-05
Targeting mitochondrial dynamics by environmental
toxicant bisphenol-A in the rat hippocampus
S. Goyal1,2, A. Tandon1,3, S. J. Singh1,2, J. Shankar4,
R. K. Chaturvedi1,2
1CSIR-Indian Institute of Toxicology Research, Systems Toxicology
and Health Risk Assessment Group, Lucknow, India
2Academy of Scientiﬁc and Innovative Research AcSIR, CSIR-Indian
Institute of Toxicology Research Campus, Lucknow, India
3Babu Banarasi Das University, BBD City, Department of
Biochemistry, Lucknow, India
4CSIR-Indian Institute of Toxicology Research, Advanced Imaging
Facility, Lucknow, India
This study summarized the neuronal demise following Bisphe-
nol-A (BPA) exposure linked impaired mitochondrial biogenesis
and dynamics in rat brain hippocampus. Mitochondria are known
for their multiple essential cellular functions beyond ATP produc-
tion/ energy transduction, impacting most of the areas of cell
biology and related mitochondrial medicines in brain. Most of the
proteins that help in mitochondria biogenesis (formation of healthy
mitochondria) and regulate their dynamics (ﬁssion/fusion) are
encoded in nucleus. BPA is a known xenoestrogen, found in
consumable plastics and causes neuronal apoptosis after chronic
exposure in the rat hippocampus and linked cognitive deﬁcits. Any
pathogenesis in mitochondria is responsible for impaired mitochon-
drial dynamics and biogenesis, which is directly associated with
cognitive impairment. In this study, we have investigated the gene
expression and protein levels of parental factors of mitochondrial
biogenesis (PGC1a, TFAM etc.) and dynamics (DRP-1, MFN-1/2)
after BPA exposure in the adult rat hippocampus and in NSC
derived neuronal culture. Our result showed reduced protein levels
of PGC1a, TFAM, while imbalanced dynamics showed through
excessive ﬁssion protein DRP-1. Beside this, our study also
investigates the regulatory circuitry and inter-linked events involved
in both mitochondrial dynamics and biogenesis. With this, our work
holds promising in understanding the role of BPA induced
mitochondrial pathophysiology that may give new therapeutic
targets to neurodegenerative disorders.
MTU14-06
Metabolic proﬁles of the synthetic cannabinoid,
athpinaca, in human liver microsomes with isomeric
discrimination
K. Kitaichi1, N. Kadomura1, T. Matsuhisa1, T. Kinoshita1, M. Soda1,
E. Kohyama2, T. Chikumoto2, H. Nagai2, T. Ito1,2
1GIfu Pharmaceutical University, Laboratory of Pharmaceutics,
Department of Biomedical Pharmaceutics, Gifu, Japan
2Gifu Prefectural Research Institute for Health and Environmental
Sciences, Department of Drug and Housing Hygiene, Gifu, japan
The illegal use of synthetic cannabinoids (SCs) has become a
serious problem worldwide. To promote further research of SCs,
precise discrimination of SCs and their metabolites from their
isomers and derivatives in human biological specimens is needed.
Here, we aimed to develop a method to speciﬁcally detect SCs and
their structural isomers and to investigate SC metabolic proﬁles in
human liver microsomes (HLMs). ATHPINACA isomer 1 and 2
were incubated with HLMs at designated time points up to 3 hrs.
LCMS-IT-TOF data from resulting samples were analyzed by ESI
positive/negative mode. The product ion spectra of parent SCs
obtained from the protonated molecules revealed a clear difference
between the two isomers, likely due to the stability of the resulting
adamantyl cation—although chromatography showed similar reten-
tion times for both parent compounds. Both parent SCs were quickly
metabolized with half-lives of approximately ﬁve min. 14 metabo-
lites in isomer 1 and 12 metabolites in isomer 2 were annotated. The
major metabolizes were di-hydroxylated isomer 1 and mono-
hydroxylated isomer 2, suggesting that hydroxylation of the
adamantyl moiety is likely the major metabolic pathway of
ATHPINACA isomers. This is the ﬁrst report to characterize the
metabolism of ATHPINACA and its adamantyl positional isomer.
The information about differences in the product ions of the parent
compounds or their major metabolites is useful for discriminating
between the two isomers in forensic cases and pharmacokinetic/
pharmacodynamic studies.
© 2019 The Authors
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MTU14-07
L-theanine inhibits the proliferation of neural cell lines via
an L-glutamine transporter SLC38A1
S. Maeda1, Y. Watanabe1, S. Araki1, T. Sudo1, S. Yoshikawa1,
M. Shibata1, A. Yamamuro1, Y. Ishimaru1, Y. Yoshioka1, T. Kinjyo2,
N. Kuramoto2, Y. Yoneda3
1Setsunan Univ., Pharm. Sci./Pharmacotherap., Hirakata, Japan
2Setsunan Univ., Pharm.Sci./Mol. Pharmacol., Hirakata, Japan
3Osaka Univ., Grad. Sch. of Dent./Pharmacol., Suita, Japan
L-Theanine (g-glutamylethylamide) is an amino acid contained in
green tea leaves with structural analogy to glutamine and is
suggested to be taken up into cells mediated by a glutamine
transporter Slc38a1. Recently, the oral intake of L-theanine is
expected to suppress anxiety, sleep disturbance, and cognitive
impairment. Some reports showed that L-theanine possesses anti-
cancer activities against some cancers. Here, it was investigated
whether L-theanine inhibits cell proliferation and its mechanism is
via Slc38a1. The cell proliferation rate was measured by MTT
method, and the cell viability was measured by propidium iodide
staining. Expression of the amino acid transporter was carried out by
real time RT-PCR method. L-Theanine inhibited cell proliferation in
mouse motor neuron cell line (NSC-34), mouse neuroblastoma cell
line (Neuro 2A) and human neuroblastoma cell line (SH-SY5Y) in a
concentration- and time-dependent manner. However, it had little
effect in human brain glioblastoma cell line (U-251 MG), mouse
astrocyte cell line (C8-D1A), mouse brain endothelial cell line
(bEnd3) and human umbilical vein endothelial cells (HUVEC).
There was a positive correlation between the L-theanine-dependent
inhibition of cell proliferation and the expression level of Slc38a1
mRNA (r2 = ~0.66). Therefore, it was suggested that in these neural
cell lines, the suppressive effect on cell proliferation was caused by
L-theanine which was taken up into the cells via Slc38a1.
MTU14-08
Agrin as a presynaptic differentiation inducer and its
proteolytic regulation
M. Oentaryo, C. W. Lee
The University of Hong Kong, School of Biomedical Sciences, Hong
Kong, Hong Kong
Agrin, a heparan sulfate proteoglycan molecule, has been well
studied for its critical role in promoting acetylcholine receptor
(AChR) clustering during postsynaptic differentiation at the neuro-
muscular junction (NMJ). A previous study also suggested that agrin
regulates growth cone guidance in spinal neuron cultures; however,
the functional roles of agrin and its proteolytic regulation in
presynaptic differentiation remain unclear. Matrix metallopro-
teinases (MMPs) play critical functions in the remodeling of
extracellular matrix (ECM) proteins to control cell migration and
motility. Interestingly, membrane-type 1 MMP (MT1-MMP) and
secreted MMP-3 have previously been shown to extracellularly
cleave agrin that affect synaptic structures. Using Xenopus primary
cultures, this study aims to investigate how agrin and its proteolytic
regulation by MMP activity spatio-temporally modulate presynaptic
differentiation at developing NMJs. Firstly, local application of
agrin spatially induces the clustering of mitochondria and synaptic
vesicles, two well-known presynaptic markers, along the neurites.
The ﬁndings indicated that agrin is an effective presynaptic
differentiation inducer. Secondly, pharmacological inhibition of
MMP activity or reduced expression of MT1-MMP signiﬁcantly
inhibited agrin-induced presynaptic differentiation. We next
observed that agrin is spatially enriched at nerve-muscle contact
sites, which is coupled with ECM degradation and nerve-induced
AChR clustering in nerve-muscle co-cultures. Since agrin is usually
secreted globally along the neurites, localization of agrin at synaptic
sites inferred that MMP proteolytic activity cleaves agrin that is
present in extra-synaptic regions. Lastly, MMP inhibitors or
morpholino-mediated MT1-MMP knockdown also inhibited agrin
deposition and the formation of nerve-induced AChR clusters at
synaptic sites. Taken together, our results demonstrate a previously
unappreciated role of agrin in presynaptic differentiation and the
regulatory role of MT1-MMP in this process.
MTU14-09
Estrogen-deﬁciency induced cognitive impairment: role of
HB-EGF/EGFR signaling in autophagy and neuronal
apoptosis in hippocampus
R. Pandey1,2, N. Chattopadhyay3, Rohit. A. Sinha4,
S. Bandyopadhyay1,2
1CSIR-Indian Institute of Toxicology Research, Developmental
Toxicology Laboratory, Systems Toxicology & Health Risk
Assessment Group, Lucknow, India
2Academy of Scientiﬁc and Innovative Research AcSIR , CSIR-IITR
campus, Lucknow, India
3CSIR-Central Drug Research Institute, Department of
Endocrinology, Lucknow, India
4Sanjay Gandhi Postgraduate Institute of Medical Sciences,
Department of Endocrinology, Lucknow, India
Estrogen deﬁciency in post-menopausal condition promotes
hippocampal neuronal apoptosis and learning-memory impairment.
However, the underlying mechanism remains uninvestigated. Since
excessive autophagy promotes the self-digestion of cells while
growth factor signaling promotes cell survival pathway. So, we
hypothesized their participation in estrogen deﬁciency-induced
learning-memory impairment, and for this, the ovariectomized
(OVX) rat model was used. We observed that estrogen deﬁciency
induces autophagy in hippocampal neurons marked by increased
LC3-II, Beclin-1, ATG7, ATG5/12 and autophagosomes along with
decreased p62 levels. In addition, autophagy regulators p-AKT/
AKT, p-mTOR/mTOR and p-ULK1/ULK1 were down-regulated in
OVX rats. Further, we observed mitochondrial localization within
the autophagosomes along with decreased VDAC and COXIV
levels in OVX rats indicating mitochondrial loss during estrogen
deﬁciency. On investigating up-stream effectors molecules, we
identiﬁed down-regulated HB-EGF, along with decreased EGFR
activation in OVX rats suggesting its role during estrogen
deﬁciency. We observed that 17b-estradiol or HB-EGF treatment
restores autophagy markers, autophagy regulators as well as
mitochondrial loss. We ﬁnally correlated our observation with
neuronal apoptosis and learning-memory impairment. We observed
that HB-EGF or autophagy inhibitor, 3-MA treatment not only
inhibited OVX-induced apoptosis of hippocampal neurons but also
restored learning-memory performances, assessed through Y-Maze
and Passive avoidance tasks. Thus, our study highlighted the
involvement of HB-EGF/EGFR signaling in mitochondria-asso-
ciated autophagy in estrogen deﬁciency which leads to neuronal
apoptosis and learning-memory impairment in estrogen-deﬁcient
females.
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MTU14-10
Characterization of vascular changes in the regenerating
optic nerve
B. Rangel1, L. Benowitz2,3,4, Sd. Lima2,3,4, V. ibeiro- Resende1
1Federal University of Rio de Janeiro, Institute of Biophysics Carlos
Chagas Filho, Rio de Janeiro, Brazil
2Harvard University, Departament of Neurosurgery, Boston, USA
3Harvard University, F.M. Kirby Neurobiology Center, Boston,
USA
4Harvard University, Departament of Ophthalmology at Harvard
Medical School, Boston, USA
The vascular and the nervous systems are highly branched
networks that are functionally and physically interdependent during
development. Vascular patterning and neural wiring share some
guidance cues and receptors. Most recently this relationship has also
been investigated in the peripheral nervous system (PNS) regener-
ation. In the PNS, nerves and blood vessels often run in parallel and
endothelial cells play an important role on guiding the formation of
the bands of B€ugner and serving as a scaffold for regrowing axons.
Here, we used the optic nerve crush (ONC) model with a
combinatorial treatment that stimulates retinal ganglion cells
(RGCs) growth after injury. Our results show that in control
animals that didn’t receive treatment for regeneration, there was a 2-
fold change in the total number of blood vessels 7 days after crush,
compared to a unlesioned nerve. Moreover, there were more blood
vessels at 0,5 mm after the crush site than in distal parts of the
nerve. The combination of treatments promoted extensive regener-
ation of RGCs and increase in survival. Interestingly, the increased
regeneration throughout the nerve is not followed by an increase in
the number of blood vessels. There is no difference in the total
number of blood vessels 2 weeks after crush between animals that
received the combined treatment for regeneration and control
animals. This study provides interesting insights into role of blood
vessels in the regeneration of an adult CNS` tissue.
MTU14-12
Effects of prenatal ischemic hypoxia on cardiovascular
risk and rat behavior
T. Silva
State University of Rio de Janeiro, Pharmacology and
psychobiology department, Rio de Janeiro, Brazil
Perinatal stress has been associated with increased susceptibility
to affective disorders. Hypertension is a chronic disease that
fundamentally compromises the balance of vasodilatory and vaso-
constricting mechanisms, causing damage to the organs irrigated by
them. There are enough evidences showing a relation between
mental and cardiovascular diseases, suggesting that depression
could be a risk factor to acute myocardial infarction and cardiovas-
cular mortality. In the present study, we investigated whether there
is an association between prenatal hypoxia ischemia, depression and
late cardiovascular disease. Ischemic hypoxia was induced by
clamping the uterine arteries of pregnant rats (Wistar) for 45 min-
utes, on the 18th day of gestation. Same conditions were applied to
the pregnant rats to form the SHAM group, only without the uterine
arteries clamping. Analyzes of serotonin, dopamine and their
metabolites contents in basal midbrain were performed by the
High- performance liquid chromatography technique. Morphometric
analyses was also studied in aortas and hearts tissues. Oxidative
stress was studied by the balance between anti-oxidants enzymes
and the damage in proteins by carbonylation and immunohis-
tochemetry for 8-isoprostane. The animals were also submitted to
systemic arterial pressure measurement using the noninvasive
method of caudal plethysmography. The mesenteric artery was
isolated to study the performance of the vascular reactivity induced
by vasoconstrictors and vasodilators. Data were statistically ana-
lyzed using one-way ANOVA and student t test. These results are
consistent with the hypothesis of increased vulnerability of the
serotonergic system for perinatal stress and the physiological
changes in the cardiovascular system before hypertension is
established. Although not hypertensive, hypoxic animals are more
likely to develop hypertension at older ages than control groups.
This work was supported by CNPq, CAPES and FAPERJ grants.
MTU14-13
Cellular and molecular mechanism of bisphenol-a (BPA)
mediated effect(s) on protein quality control in the rat
hippocampus
S. J. Singh1,2, A. Tandon1,3, S. Goyal1,2, J. Shankar4, N. Arjaria4, R.
K. Chaturvedi1,2
1CSIR-Indian Institute of Toxicology Research, System Toxicology
and Health Risk Assessment Group/Developmental Toxicology
Division, Lucknow, India
2Academy of Scientiﬁc and Innovative Research AcSIR, CSIR-Indian
Institute of Toxicology Research Campus, Lucknow, India
3Babu Banarasi Das University, Department of Biochemistry,
Lucknow, India
4CSIR-Indian Institute of Toxicology Research, Advanced Imaging
Facility, Lucknow, India
Widespread uses of plastic products containing BPA, well known
xenoestrogen, have hazardous health impact. In present study, we
have investigated the effect(s) of BPA on neurogenesis and protein
quality control in rat brain hippocampus. For experimental exam-
ination Wistar rats were orally administered BPA (40 & 400 μg/kg
body weight) during gestation and postnatal periods. Expression of
genes and protein levels were analysed by qRT-PCR and western
blotting, respectively. To study proteins localization, immunohisto-
chemical and ultrastructural studies were performed by immunoﬂu-
orescence and transmission electron microscopy studies in vitro and
in vivo. Results suggested that exposure of BPA in neural stem cells
(NSCs) culture derived from rat brain hippocampus showed reduced
proliferation and differential potential. Furthermore, we have
observed that BPA exposure induces generation of autophagic ﬂux
as a protective response in neuronal cells. Electron microscopy
analysis revealed that BPA exposure induced generation of
autophagosomes and autolysosomes. Moreover gene and protein
expression analysis depicts an altered protein quality control in the
BPA exposed rat brain hippocampus. Our ﬁnding suggests that BPA
exposure not only decreases NSCs proliferation and neuronal
differentiation, but also increases neurodegeneration, autophagy &
apoptosis both in-vitro and in-vivo. Therefore altered protein quality
control might be responsible for BPA induced defects in cognitive
function in the rat brain.
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Quercetin modulates neuronal activity of the RAT arcuate
nucleus
R. Srisawat, N. Nontamart
Suranaree University of Technology, Institute of Science, Nakhon
Ratchasima, Thailand
Quercetin, an important ﬂavonoid found in fruits and vegetables,
possesses antioxidant, anti-inﬂammatory, and anti-obesity activities.
However, there is no evidence to suggest anti-obesity effects of
quercetin through central effects, especially for the hypothalamic
brain regions that play an importance role in regulation of energy
balance. Hence,This study investigated the effects of quercetin on
neuronal activity in the hypothalamic food intake regulating areas
including the arcuate nucleus (ARC), the ventromedial hypothala-
mus (VMH), and the dorsomedial of hypothalamus (DMH) and also
investigated the effects of quercetin on activity of neuropeptide
(NPY) neuron of the ARC in male Wistar rats. Rats orally received
vehicle and quercetin (100, 200, 400 mg/ml/kg) for 30, 60, 90 and
120 min. Brains were ﬁxed and sectioned. Free-ﬂoating sections
were subjected to Fos, NPY and Fos/NPY immunohistochemical
staining. The highest number of Fos+ neurons/area were found in
the ARC in the rats treated with 100 mg/ml/kg of quercetin for
120 min. In the ARC, there was signiﬁcantly more number of Fos+
neurons/area in quercetin treated group than vehicle-treated group.
Number of Fos+ neurons/area in the VMH in quercetin treated
group was signiﬁcantly lower than in vehicle-treated group. Number
of Fos+ neurons/area in the DMH were not different between
quercetin and vehicle treatments. Fos+/NPY+ neurons/area, and the
ratio and percentage of Fos+/NPY+ neurons to total number of
NPY+ neurons in the ARC induced by quercetin were signiﬁcantly
lower than vehicle-treated group. The results suggested that
quercetin may involve in the regulation of food intake and energy
homeostasis by activate neurons in the ARC and inactivate neurons
in the VMH. Quercetin may exert anti-obesity effect by inactivating
NPY/AGRP neurons and activate POMC/CART neurons in the
ARC.
MTU14-15
Curcumin inhibits bisphenol-a (BPA) mediated rat
hippocampal de-myelination via notch signaling
A. Tandon1,2, S. J. Singh1, M. Gupta1, N. Singh2, S. Goyal1, J.
Shankar3, N. Arjaria3, R. K. Chaturvedi1
1CSIR-Indian Institute of Toxicology Research, System Toxicology
and Health Risk Assessment Group/Developmental Toxicology
Laboratory, Lucknow, India
2Babu Banarasi Das University, Department of Biochemistry,
Lucknow, India
3CSIR-Indian Institute of Toxicology Research, Advanced Imaging
Facility, Lucknow, India
Xenoestrogen BPA is component of plastic materials such as
feeding bottles and food cans. Previously, we have shown adverse
effects of BPA on myelination. The aim of this study is to
understand mechanistic action of curcumin against BPA induced
alterations in hippocampal myelination. BPA (40 lg/kg b.w,
peroral) and curcumin (20 mg/kg b.w, intraperitoneal) were
administered to rats from postnatal day (PND) 21-90. Curcumin
treatment after BPA exposure improved immunoreactivity of
ﬂuoromyelin, Olig2+/MBP+ and MBP+/NF+. It also signiﬁcantly
increased number and size of oligospheres, augmented number of
A2B5+/PCNA+ (proliferation), MBP+/CNPase+ (differentiation), b-
III tubulin+/MBP+ (myelination) cells and up-regulated expression
and levels of myelin protein. We studied the effect of curcumin on
canonical Notch pathway, which is essential for maintenance of
oligodendrocyte progenitors (OPCs). In-silico studies predicted
interaction of BPA and curcumin with Notch1, Hes1 and Mib1.
Curcumin treated BPA exposed groups exhibited signiﬁcantly
enhanced gene expression and protein levels of Notch pathway
markers. Notch pathway inhibition via Notch1 siRNA and DAPT
resulted in further signiﬁcant decline in number of OPCs in BPA
exposed group as compared to BPA alone group. OPCs number was
not ameliorated after curcumin treatment in Notch inhibited groups
indicating notch mediated neuroprotective action of curcumin.
Curcumin treatment in BPA exposed group signiﬁcantly improved
learning and memory, ultrastructural architecture and myelin sheath
thickness. Results highlight the signiﬁcance of curcumin as potential
therapeutics against xenobiotics induced neurotoxicity.
MTU14-16
The unfolded protein response (UPR) is upregulated in
several important regions of the sids brain
S. Thomson1, K. Waters1,2,3, R. Machaalani1,3,2
1University of Sydney, Faculty of Medicine and Health, Sydney,
Australia
2Westmead Children’s Hospital, Child and Adolescent Health,
Sydney, Australia
3Bosch Institute, Central Clinical School, Sydney, Australia
The unfolded protein response (UPR) is linked to multiple
neurodegenerative diseases such as Alzheimers’ and Parkinsons’,
and has also been implicated in a subset of SIDS infants. Recent
work in our laboratory identiﬁed an increase in phosphorylated
protein kinase R (PKR)-like ER kinase (p-PERK) - a key component
of one arm of the UPR - in the hypothalamus of SIDS infants
(p<0.000) (Hunt et al., 2015). We aimed to determine whether p-
PERK is similarly increased in other brain regions of SIDS babies
including the brainstem and cerebellum, as well as any potential
links to SIDS risk factors of ‘prone sleeping’, ‘upper respiratory
tract infection (URTI)’, ‘bed-sharing’ and ‘parental smoking’. The
immunohistochemical expression of p-PERK was studied in the
brainstem pons, medulla and cerebellum of SIDS (n=28) compared
to non-SIDS (n=12) infants. The p-PERK positive neuron percent-
age was signiﬁcantly increased in the cuneate nucleus (p=0.035) in
SIDS compared to non-SIDS cases, and the inferior olivary nucleus
(ION) and locus coerulus (LC) showed a trend towards the increase
(p=0.057, p=0.084 respectively). Analysis for the risk factors
showed changes attributed to bed-sharing only, with a signiﬁcant
increase in the purkinje cell layer of the cerebellum (p=0.025) and
the dorsal raphe nuclei of the pons (p=0.048), as well as a trend
towards the increase in the LC (p=0.073) and the ION (p=0.066) of
bed-sharing infants. These results indicate that a certain subset of
SIDS infants are experiencing an upregulation of the UPR via the p-
PERK pathway, and that bed-sharing plays a contributing role.
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Dopaminergic neuroregeneration in the diencephalon of
6-OHDA-lesioned adult zebraﬁsh-based parkinson’s
disease model
Y. Vijayanathan1, S. M. Lim2, M. P. Tan1, F. T. Lim2,
A. B. A. Majeed2, K. Ramasamy2
1Universiti Malaya, Faculty of Medicine, Kuala Lumpur, Malaysia
2Universiti Teknologi MARA, Faculty of Pharmacy, Puncak Alam,
Malaysia
Studies on endogenous neuroregeneration using mammalian-
based Parkinson’s disease (PD) models are often hampered with
futile axogenesis. The emergence of zebraﬁsh with remarkable
neuroregeneration capacity may address these limitations. This
study established a 6-OHDA-lesioned adult zebraﬁsh-based PD
model and investigated the neuroregenerative processes of dien-
cephalic dopaminergic neurons (DpN). 25 mg/kg of 6-OHDA were
intracerebroventricularly administered into the diencephalon of adult
zebraﬁsh (Danio rerio). Immnunoﬂurorescence was conducted to
quantify tyrosine hydroxylase immunoreactive (TH-ir; indicating
DpN) and Bromodeoxyuridine-immunoreactive (BrdU-ir; indicating
proliferative cells) at brain regions of interest [olfactory bulb (OB),
telencephalon, diencephalon]. To elucidate neurodifferentiation
activity, Foxa2 and Nurr1 differential gene expressions at different
regions were enumerated using qPCR. At day 3 post-lesion,
diencephalic TH-ir cell count revealed >85% DpN signiﬁcantly
(p<0.05) ablated when compared to intact ﬁsh. Whereas, at day-30
post-lesion TH-ir cell count increased signiﬁcantly (p<0.05) than
day-3 post-lesion; but exhibited no signiﬁcant difference with intact.
Cellular proliferation demonstrated a transient yet signiﬁcant
(p<0.05) decrease and then increase in OB (-55%; +114%) and
telencephalon (-73%; +194%) at day 5 and 7 post-lesion, but BrdU-
ir cell count in diencephalon remained unchanged at all time points.
Conversely, signiﬁcant (p<0.05) decline and gradual increase of
Foxa2 (-44% at day 3 and 9 post-lesion) and Nurr1 (-46% at day 3, 9
and -65% at day 14 post-lesion) were observed in the diencephalon;
whilst no signiﬁcant changes (p>0.05) of both differential markers
were discerned in OB and telencephalon. These ﬁndings warrant
further investigations to harness these potentials and apply towards
future human DpN regenerative studies.
MTU14-18
New modulators of the capsaicine receptor TRPV1 in
fermented foods
Y. Yamada, T. Sato, M. Hamano, S. Idemoto
Kindai University, Faculty of Engineering, Higashi-Hiroshima,
Japan
TRPV1 (transient receptor potential vanilloid subfamily, member
1), similar to other TRP channels, is a putative six-transmembrane-
spanning protein with a pore region localized between transmem-
brane segments 5 and 6. TRPV1 is a non-selective cation channel
with a preference for calcium that is directly activated by noxious
temperature (43 °C) or capsaicin. Generally speaking, capsaicin-
sensitive neurons are bipolar neurons with unmyelinated axons (C-
ﬁbres) and somata in sensory (dorsal root and trigeminal) ganglia.
Of note, a subset of sensory neurons with thin myelinated axons (Ad
ﬁbres) is also capsaicin sensitive. TRPV1 is thought to mediate the
phenomenon of peripheral sensitization that involves a reduction in
the threshold of activation and an increase in the responsiveness of
the peripheral termini of nociceptors. TRPV1 has been reported to
have anti-obesity effect by sweating, neuropathic pain curing effect
by desensitization, the protective effect against neural cells, and
headache inhibition. It was reported that polyamines, by virtue of
their cationic charge, can regulate the activity of TRPV1. To
investigate new substances acting on TRPV1, we examined the
effect of ingredients in fermented food on it. The fermented food
contained various amines. We focused the amines contained in
Japanese sake. Agmatine and 2-phenylethylamine showed TRPV1
agonist activity and these EC50 were 250 lM and 14.2 lM,
respectively. At that time, the EC 50 of capsaicin was 3.7 lM.
Tyramine, isoamylamine, and putrescine did not show any activity
against TRPV1. Lactic acid, phthalic acid, and crotonic acid
potentiated TRPV1. It was indicated that the substances existing in
sake modulate TRPV1 activity. To investigate the mechanism of
action of these substances, we will examine about electrophysio-
logical activities in detail and perform behavioral experiments by
animals.
MTU14-19
Effect of repeated transcranial magnetic stimulation on
opioid status in ﬁbromyalgia patients by sucrose induced
analgesia
A. H. Ansari1, R. Mathur2, K. Mukherjee2
1Texila American University, Physiology and Neurosciences, East
Bank Demerara, Guyana
2All India Institute of Medical Sciences, Physiology, New Delhi,
India
Fibromyalgia (FM), is a chronic pain syndrome involving altered
pain modulation system and no effective treatment yet. The
endogenous opioids are one of the important regulators of
Gonadotropin Releasing hormone(GnRH) in the hypothalamus.
There was an indirect estimation of opioid levels by estimating
plasma LH level. Opioids are known to exert an inhibitory control
on gonadotropic releasing hormone (GnRH) neurons. The GnRH
neurons in turn control the release of LH and FSH. Endogenous
opioid system was assessed in FM patients before and after
treatment with Repeated Transcranial Magnetic Stimulation (rTMS)
and compared along with subjective symptoms. Series of blood
samples were collected from the FM patients (n = 86) and healthy
Controls (n = 90) before (2 ml each 10 min earlier) and after (at 0, 5,
10, 15 and 20-min intervals) the participant was provided 25%
freshly prepared sucrose solution to drink. The patients were given
rTMS as treatment for 4 weeks (5 days per week/20 days). Again,
blood samples were collected after the treatment and pre and post
treatment data were compared. LH was estimated in blood by
Electrochemiluminescence immunoassay methods. The basal LH
concentration (lg/dl) in controls was 6.1 2.85 which decreased to 5
min post-sucrose ingestion. It gradually decreased signiﬁcantly at
5,10,15 and 20 min (5.6 2.58, 5.3 2.52, 5.1 2.39, 4.8 2.34
respectively). LH concentration in FM before rTMS remained
unaltered from the basal level (4.5 2.12) through 20 min post
sucrose ingestion (4.3 2.13, 4.1 2.52, 4.2 2.06. 4.1 2.11) while after
rTMS there was signiﬁcant decrease in LH level after sucrose
ingestion, indicating effects of rTMS in FM patients. rTMS elicited
a sustained beneﬁcial effect in FM patients.
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